<<

2ESOURCESFOR %MERGENCY #ONTRACEPTIVE 0ILL0ROGRAMMING

!4//,+)4

Acknowledgement

PATH gratefully acknowledges the fi nancial support of the Compton Foundation, Inc.; the Andrew W. Mellon Foundation; the Mildred and Mary Wohlford Fund of the Tides Foundation; and the William and Flora Hewlett Foundation for the development of Resources for Emergency Contraceptive Pill Programming: A Toolkit. We would like to thank all of the organizations that contributed materials and experiences to the development of the toolkit: AltaCare; Association of Reproductive Health Professionals; Deliver Project at John Snow, Inc.; Family Guidance Association of Ethiopia; Family Health International (FHI); International Federation of Gynecologists and Obstetricians; Family Planning Association of Sri Lanka; International Consortium for ; International Planned Parenthood Federation; Pacifi c Institute for Women’s Health; Population Action International; Population Council; Population Services International; Profamilia Colombia; Reproductive Health Research Unit of the University of the Witwatersrand; United Nations Population Fund; United States Agency for International Development; and the World Health Organization. Special thanks to Daya Abeywickrema, Charlotte Ellertson, John Skibiak, Jenni Smit, Elizabeth Warnick, Elisa Wells, and all of the organizations and individuals who participated in the needs assessment and who have played an active role in paving the way for the mainstreaming of emergency contraception. PATH takes full responsibility for this document’s content, which does not necessarily refl ect the opinions of the document’s reviewers or contributors.

Copyright © 2004, Program for Appropriate Technology in Health (PATH). All rights reserved. The material in this document may be reproduced and freely used for educational or noncommercial purposes, provided that PATH is acknowledged and the materials are made available free of charge or at cost.

PATH 1455 NW Leary Way Seattle, WA 98107 Tel: (206) 285-3500 Fax: (206) 285-6619 Web: www.path.org

4ABLEOF#ONTENTS

)NTRODUCTIONVII

-ODULE!)NFORMATIONFOR0OLICY-AKERS !  4OOLS „ !#/'.EWS2ELEASE!  „)#%#%VIDENCE "ASED0OLICY3TATEMENTS !  „&)'/%THICS#OMMITTEE2EPORT !  „)00&3TATEMENT!  „53!)$AND5.&0!3TATEMENTS!  „7(/3TATEMENTON%MERGENCY#ONTRACEPTION !  „ !NNOTATED"IBLIOGRAPHYOF#ORE%VIDENCE "ASED2ESEARCH ON%MERGENCY#ONTRACEPTION !  „+EY&ACTS!BOUT%MERGENCY#ONTRACEPTION! 

-ODULE"#OST#ONSIDERATIONS " 

-ODULE#2AISING0UBLIC!WARENESS#  4OOLS „ !GENDAFORA-EDIA7ORKSHOPON%MERGENCY#ONTRACEPTION  #  „ %MERGENCY#ONTRACEPTION2ADIO3CRIPT  #  „ %MERGENCY#ONTRACEPTION4ELEPHONE(OTLINE3CRIPT #  „ 0OSTERS  #  „ 0OSTCARDS  # 

-ODULE$)NFORMING#LIENTS $  4OOLS „ 3AMPLE4EXTFOR"ROCHURES$  „ "ROCHUREIN4HREE&ORMATS $  „ 3OUTH!FRICA"ROCHURE  $ 

-ODULE%!SSESSMENT  %  4OOLS „ #LIENT+NOWLEDGE !TTITUDES 0RACTICES1UESTIONNAIRE %  „ 0ROVIDER+NOWLEDGE !TTITUDES 0RACTICES3URVEYON %MERGENCY#ONTRACEPTIVE0ILLS%  „ )N $EPTH)NTERVIEW'UIDEFOR+EY2EPRODUCTIVE(EALTH!UTHORITIES %  „ -YSTERY3HOPPER3URVEY %  4ABLEOF#ONTENTS -ODULE)%VALUATION -ODULE(0ROVIDER4RAINING #ONTRACEPTIVE0ILLS%#0S #ONTRACEPTIVES#/#S AS.ON $EDICATED%MERGENCY -ODULE'4HE/PTIONOF0ROVIDING#OMBINED/RAL AND$ISTRIBUTIONOFA0ROGESTIN /NLY%#0 -ODULE&2EGULATION 0ROCUREMENT 4OOLS 4OOLS 4OOLS 4OOLS „ „ „ „ „ „ „ „ „ „ „ „ „ „ „ „ „ „ „ „                     %XAMPLE/UTLINEOFAN%#00ROGRAM%VALUATION2EPORT %XAMPLE2ESULTS&RAMEWORKFORAN%MERGENCY#ONTRACEPTION0ROJEC 3ITUATION2OLE 0LAYS 4RAINING!ID%MERGENCY#ONTRACEPTIVE0ILL#LIENT 4RAINING!ID$EMONSTRATION2OLE 0LAY #ONTRACEPTIVE0ILL#LIENTS 4RAINING!ID'RAB"AGˆ+EY-ESSAGESFOR%MERGENCY (ANDOUT#OUNSELING3KILLS/BSERVER#HECKLIST (ANDOUT#OUNSELINGFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTS 3CREENING#HECKLIST (ANDOUT3AMPLE%MERGENCY#ONTRACEPTIVE0ILL (ANDOUT+EY-ESSAGESFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENT 0RE AND0OST 3ESSION1UESTIONNAIRE %MERGENCY#ONTRACEPTION#URRICULUM %MERGENCY#ONTRACEPTION 0ROVISIONOFA/NE -ONTH3UPPLYOF#/#SFOR %MERGENCY#ONTRACEPTION )NFORMATIONTO)NCLUDE7HEN0ROVIDING#/#SFOR !SSOCIATIONOF%THIOPIA 2EPACKAGING&ORMAT5SEDBYTHE&AMILY'UIDANCE #/#SFOR%MERGENCY#ONTRACEPTION%XAMPLEOFTHE 0ROTOTYPE0ACKAGE&ORMAT 0ROCUREMENT4HROUGH)NTERNATIONAL0ROCUREMENT3ERVICES 0REFERENTIAL0RICINGFOR0UBLIC 3ECTOR!GENCIES 3AMPLE0ROCUREMENT3PECIlCATION,EVONORGESTREL /NLY%#03 )NFORMATIONTO)NCLUDEINA,EVONORGESTREL /NLY%#00ACKAGE)NS 0OTENTIAL-ARKETFOR%#0S!"ASIC$EMAND-ODEL               &  &  (   )  &  (   (   )   '    '   (   &  '   '   '   (  &  ERT  (   S &   (   T  (   )  (  (    4ABLEOF#ONTENTS 7EBSITE2ESOURCES %MERGENCY#ONTRACEPTIVE0ILLS-EDICALAND3ERVICE $ELIVERY'UIDELINES   „ „ !PPENDIX! !PPENDIX"

)NTRODUCTION

2ESOURCESFOR%MERGENCY #ONTRACEPTIVE0ILL0ROGRAMMING !4OOLKIT

%MERGENCY#ONTRACEPTIVE0ILLS%#0S  !CONTRACEPTIVEMETHODTHATCANPREVENTPREGNANCYAFTERUNPROTECTEDSEX 2ESOURCESFOR%MERGENCY#ONTRACEPTIVE0ILL0ROGRAMMING !4OOLKIT 4OOLSTOHELPPROGRAMMANAGERS POLICYMAKERS ANDDONORSMAKE%#0SWIDELY AVAILABLETOWOMENINDEVELOPINGCOUNTRIESTHROUGHLARGE SCALEFAMILYPLANNING PROGRAMS

%#0SARESPECIALDOSESOFBIRTHCONTROLPILLSTHATCANBEUSEDAFTERUNPROTECTEDINTERCOURSE TOPREVENTPREGNANCY!LTHOUGH%#0SOFFERASAFEANDEFFECTIVECONTRACEPTIVEOPTION WITH SOMENOTABLEEXCEPTIONSTHEMETHODHASYETTOBEWIDELYINTEGRATEDINTODEVELOPING COUNTRYFAMILYPLANNINGPROGRAMS4HEPURPOSEOFTHISTOOLKITISTOFACILITATETHE INTEGRATIONOF%#0SINTODEVELOPING COUNTRYFAMILYPLANNINGANDREPRODUCTIVEHEALTH PROGRAMS)TINCLUDESRESOURCESFOR%#0ADVOCACY ASSESSMENT SERVICEPROVISION ANDEVALUATION4HEPLANNINGANDIMPLEMENTATIONTOOLSREPRESENTBESTPRACTICESAND EXPERIENCETHATWILLHELPPROGRAMSMOVETHROUGHTHESTEPSREQUIREDTOMAKE%#0SERVICES ROUTINELYAVAILABLETHROUGHHEALTHSERVICEDELIVERYSYSTEMS4HEINTENTOFTHETOOLKITIS TOSHAREWIDELYANARRAYOFMATERIALSDEVELOPEDBY0!4(ANDBYOTHERORGANIZATIONS AS THEYWORKEDINAVARIETYOFSETTINGSTOINCORPORATE%#0SINTOFAMILYPLANNINGSERVICES)T ISHOPEDTHATBYBRINGINGTOGETHERTHESERESOURCESINAFORMATTHATFACILITATESTHEIRUSE THE TOOLKITCANREDUCEDUPLICATIONOFEFFORTS REDUNDANCY ANDUNNECESSARYEXPENSE !LTHOUGHTHEFOCUSOFTHISTOOLKITISTOFACILITATEACCESSTO%#0SˆAMETHODTHATCAN BEINTEGRATEDINTOAWIDEARRAYOFSERVICESTHROUGHAVARIETYOFPROVIDERSˆTHEOTHER EMERGENCYCONTRACEPTIVEMETHOD INSERTIONOFANINTRAUTERINEDEVICE)5$ WITHIN SEVENDAYSAFTERUNPROTECTEDINTERCOURSE SHOULDNOTBEIGNORED"ECAUSEMANYFAMILY PLANNINGPROGRAMSPROVIDE)5$SASAREGULARCONTRACEPTIVEMETHODFORONGOINGFAMILY PLANNING THEYAREWIDELYAVAILABLE)FEMERGENCYCONTRACEPTIONISTOBECOMPREHENSIVELY

-ATERIALSFORTHISTOOLKITWEREGRACIOUSLYPROVIDEDBY!LTA#ARE!SSOCIATIONOF2EPRODUCTIVE(EALTH0ROFESSIONALS$ELIVER 0ROJECTAT*OHN3NOW )NC&AMILY(EALTH)NTERNATIONAL&() &AMILY'UIDANCE!SSOCIATIONOF%THIOPIA)NTERNATIONAL &EDERATIONOF'YNECOLOGISTSAND/BSTETRICIANS&AMILY0LANNING!SSOCIATIONOF3RI,ANKA)NTERNATIONAL#ONSORTIUMFOR %MERGENCY#ONTRACEPTION)NTERNATIONAL0LANNED0ARENTHOOD&EDERATION0ACIlC)NSTITUTEFOR7OMENS(EALTH 0OPULATION!CTION )NTERNATIONAL0OPULATION#OUNCIL0OPULATION3ERVICES)NTERNATIONAL0ROFAMILIA#OLUMBIA2EPRODUCTIVE(EALTH2ESEARCH5NITOF THE5NIVERSITYOF7ITWATERSRAND5NITED.ATIONS0OPULATION&UND5NITED3TATES!GENCYFOR)NTERNATIONAL$EVELOPMENTANDTHE 7ORLD(EALTH/RGANIZATION VII VIII )NTRODUCTION  WWWCECINFOORGHTMLRES DOWNLOADABLE MTRLSHTM #OLLABORATIVE!PPROACHTO-EETING7OMENS.EEDS )NTERNATIONAL#ONSORTIUMFOR%MERGENCY#ONTRACEPTION %#0STHROUGHTHEIRFAMILYPLANNINGPROGRAMS NEEDTOPROVIDEASTHEYMOVEFORWARDTOSUCCESSFUL SUSTAINABLE THATWILLHELPTHEMIDENTIFYTHEGROUPSTHEYNEEDTOWORKWITH EMERGENCYCONTRACEPTIONADVOCATES DECISIONMAKERS ANDPROGRAM 2ESOURCESFOR%MERGENCY#ONTRACEPTIVE0ILL0ROGRAMMING!4OOLK FORTHEIRPARTICULARSITUATION TOTHEIRNEEDS ADAPTINGINFORMATIONANDMATERIALSINORDERTO VARIABILITY THETOOLKITISDESIGNEDASAFOUNDATIONUPONWHICH WORK ANDWHYITISIMPORTANTFORWOMENTOHAVETIMELYACCESST GROUPSTHATMUSTBEREACHEDWITHINFORMATIONABOUT%#0SˆWHATTH ANDTHESTATUSOFADEDICATED%#0PRODUCT#OUNTRIESALSODIFFE #OUNTRIESVARYASTOCURRENTAWARENESSANDAVAILABILITYOFEMER PROGRAMPLANNERSMOVEFORWARDTOACHIEVEBROADPROGRAMMINGOF% INTRODUCTIONPROCESSANDPROVIDESINFORMATIONANDMATERIALSTHA INANARRAYOFCOUNTRIES%ACHMODULEOFTHETOOLKITFOCUSESON ISINVOLVEDINCARRYINGOUTSPECIlCSTEPSANDPROVIDESSAMPLES %MERGENCY#ONTRACEPTIVE0ILL0ROGRAMMING!4OOLKIT !PPROACHTO-EETING7OMENS.EEDS v )#%#SREPORTh%XPANDING'LOBAL!CCESSTO%MERGENCY#ONTRACEPTI #ARE0ROVIDERSAND0ROGRAM-ANAGERS INFORMATIONPACKET CONTRACEPTIONˆINSEVERALDEVELOPINGCOUNTRIES4HEFRAMEWORKWA INTRODUCEADEDICATED%#0ˆAPRODUCTSPECIlCALLYPACKAGEDANDLA IMPLEMENTATION)#%#DEVELOPEDTHISINTRODUCTIONFRAMEWORKTOG #ONTRACEPTION)#%# ANDMOVEFROMTHECONCEPTOF%#0INTRODUCT FOR)NTRODUCTIONTHATWASDEVELOPEDBYTHE)NTERNATIONAL#ONSOR 4HETOOLKITISDESIGNEDTOHELPFAMILYPLANNINGPROGRAMSBUILD INTEGRATINGEMERGENCYCONTRACEPTIONINTOTHEIRFAMILYPLANNING ANDRESOURCESTHATDEVELOPING COUNTRYPROGRAMMANAGERSWOULDlN MAINSTREAMINGEMERGENCYCONTRACEPTION4HEASSESSMENTRESULTSI 5.&0! ANDDIFFERENTORGANIZATIONSANDINDIVIDUALSWHOHAVEP !GENCYFOR)NTERNATIONAL$EVELOPMENT53!)$ AND5NITED.ATIONS ASSESSMENTOFCOUNTRYPROGRAMPLANNERS COUNTRYREPRESENTATIVES 0!4(BEGANDEVELOPMENTOFTHIS%#0PROGRAMMINGTOOLKITBYCONDU RAISING ANDCLINICALSERVICESˆFORPROVISIONOF)5$SFOREMERGE OFEMERGENCYCONTRACEPTIONSHOULDADVOCATEATALLLEVELSˆPOLICY CONTRACEPTIONOPTIONSPROVIDEDTOWOMEN ALONGWITH%#0S7HERE INCORPORATEDINTOLARGE SCALEPROGRAMS INSERTIONOF)5$SSHOUL DISSEMINATINGEVALUATIONRESULTS"UILDINGONTHISSTEP WISEAP PROVIDERS  INTRODUCING%#0SERVICES  MONITORINGANDEVA ISSUES  PLANNINGFORDISTRIBUTION  MEETINGCLIENTSINF NEEDS  RAISINGSUPPORTATTHENATIONALANDCOMMUNITYLEVELS REQUIREDTOSUCCESSFULLYINTEGRATE%#0SINTOLARGEDELIVERYCHA %MERGENCY#ONTRACEPTIVE0ILLS!2ESOURCE0ACKETFOR(EALTH /CTOBER!CCESSIBLETHROUGHTHE#ONSORTIUMSWEBSITEAT PUBLISHEDIN ANDALSOWASFEATUREDIN %XPANDING'LOBAL!CCESSTO%MERGENCY#ONTRACEPTION!  4HEFRAMEWORKSPELLSOUTNINESTEPS DESCRIBESINMOREDETAILWHAT ORMATIONNEEDS  TRAINING DEVELOPTHEBESTAPPROACH USERSCANBUILDACCORDING NNELS ASSESSING ONEASPECTOFTHE PROACH ANDTHEINFORMATIONTHEY RINPOLITICALCLIMATEAND  ADDRESSINGPRODUCT OFTOOLSUSEDSUCCESSFULLY GENCYCONTRACEPTION ONTHE&RAMEWORK PROGRAMS DBEONEOFTHEEMERGENCY ROUTINEPROVISIONOF TIUMFOR%MERGENCY LUATINGSERVICES AND TCANHELPADVOCATESAND NCYCONTRACEPTION OTHEM"ECAUSEOFTHIS OFTHE5NITED3TATES PUBLICAWARENESS LAYEDANACTIVEROLEIN DENTIlEDTHECONTENT UIDEITSEFFORTSTO MANAGERSˆARESOURCE SINCLUDEDIN)#%#S BELEDFOREMERGENCY POSSIBLE ADVOCATES DMOSTUSEFULIN IONTO EYARE HOWTHEY ON!#OLLABORATIVE #0S 0OPULATION&UND CTINGANEXTENSIVE IT 2ESOURCESFOR ISARESOURCEFOR HTTP -ODULE!

)NFORMATIONFOR0OLICY-AKERS

/BJECTIVE

4ODEVELOPAPOLICYENVIRONMENTˆBOTHPOLITICALANDSOCIALˆSUPPORTINGTHEINTRODUCTIONAND BROADPROGRAMMINGOFEMERGENCYCONTRACEPTIVEPILLS%#0S 

4HISMODULEPROVIDESINFORMATIONTHATWILLHELPADVOCATESWORKWITHKEYPOLITICALLEADERS GOVERNMENTOFlCIALS ANDOTHERSTAKEHOLDERSINTHEHEALTHANDFAMILYPLANNINGCOMMUNITY TOFACILITATEPROVISIONOFAN%#0PRODUCTANDRELATEDSERVICES4HEFOLLOWINGTOPICSARE DISCUSSED s 0OLITICAL#ONTEXT s 2ESOURCES s +EY!UDIENCES s +EY-ESSAGES s -EXICO#ITY0OLICYAND%MERGENCY#ONTRACEPTION s $OMESTIC6IOLENCE 2APE AND%MERGENCY#ONTRACEPTION s #HOOSING%FFECTIVE#HANNELSTO#OMMUNICATE-ESSAGES s ,OCAL$ATA)LLUSTRATING.EEDFOR%MERGENCY#ONTRACEPTION -ODULE!)NFORMATIONFOR0OLICY-AKERS -ODULE#2AISING0UBLIC!WARENESS AND-ODULE $)NFORMING#LIENTS ARECLOSELYRELATED)DEALLY %#0ACCESSWILLINVOLVEALLTHEAREAS DISCUSSEDINTHESETHREEMODULESˆPOLICY PUBLICAWARENESS ANDINFORMINGCLIENTS%ACH MODULEPROVIDESRESOURCES TOOLS ANDTECHNIQUESTHATCANBEADAPTEDACCORDINGTOTHETARGET AUDIENCEANDTHEENVIRONMENT

4OOLS0ROVIDEDATTHE%NDOF4HIS-ODULE

3TATEMENTSON%#0SBY)NTERNATIONAL/RGANIZATIONS !GENCIES AND-AJOR$ONORSOF #ONTRACEPTIVE#OMMODITIES „ !MERICAN#OLLEGEOF/BSTETRICIANSAND'YNECOLOGISTS!#/' .EWS2ELEASE&EBRUARY  „ )NTERNATIONAL#ONSORTIUMFOR%MERGENCY#ONTRACEPTION)#%# %VIDENCE "ASED0OLICY 3TATEMENTS*ULY  „ )NTERNATIONAL&EDERATIONOF'YNECOLOGYAND/BSTETRICS&)'/ %THICS#OMMITTEE2EPORT 'UIDELINESIN%MERGENCY#ONTRACEPTION)NTERNATIONAL*OURNALOF'YNECOLOGY/BSTETRICS    „ )NTERNATIONAL0LANNED0ARENTHOOD&EDERATION)00& )NTERNATIONAL-EDICAL!DVISORY0ANEL )-!0 3TATEMENTON%MERGENCY#ONTRACEPTION/CTOBER 

!  !  -ODULE! 2ESOURCES 0OLITICAL#ONTEXT 4OOLSCONTINUED !RETHEREORGANIZATIONALRESOURCESTOUNDERTAKEALARGE SCALE s 7HATARETHEPOTENTIALSOURCESOFlNANCIALSUPPORTFORPROVID s &ROMWHATTYPESOFLEADERSISITMOSTCRITICALTOGAINSUPPOR s 7HATARETHEREPRODUCTIVEHEALTHISSUESTHATRAISECONCERNAM s 7HATARETHESOCIAL CULTURAL ORRELIGIOUSATTITUDESTOWARD s )STHECURRENTPOLITICALENVIRONMENTFAVORABLETOWARDFAMILY s SHOULDTAKE FOLLOWINGQUESTIONSCANBEUSEFULINHELPINGTODETERMINETHED CONSIDERINGTHElNANCIAL ASWELLASTHEHUMAN RESOURCESTHAT ASHOLDINGWORKSHOPSANDMEETINGWITHREPRESENTATIVES CANBEF CONSIDERATION3OMESTRATEGIESFORINmUENCINGPOLICYCANBEVER 4HEAVAILABILITYOFRESOURCESTOBUILDSUPPORTINAGIVENENVIR THEYRELATETOFAMILYPLANNING BEFOREINITIATING%#0INTEGRATI ENVIRONMENTSCANBEDIFlCULT ITISESSENTIALTOUNDERSTANDTHE PROVISIONOF%#0STHROUGHGOVERNMENT FUNDEDPROGRAMS"ECAUSEN AMAJORPOLITICALISSUE POLITICALLEADERSHAVEBEENRELUCTANT CONTINGENTONTHEAPPROVALOFRELIGIOUSLEADERS)NOTHERCOUNT DEDICATED%#0PRODUCTWASDELAYEDOVERlVEYEARSBECAUSEGOVERN LACKOFSUPPORTPRESENTSSERIOUSBARRIERS&OREXAMPLE INONE SUPPORTISESSENTIAL ITCANBEDIFlCULTTOOBTAIN DUETOSTRO AVAILABILITYOFAN%#0PRODUCTANDAPPROPRIATESERVICEPROVISIO SUCHASTHEMINISTRYOFHEALTHANDTHEDRUGREGULATORYAGENCYI INTEGRATING%#0SINTOALARGE SCALEPROGRAM4HECOLLABORATION 'OVERNMENTSUPPORTWHETHEREXPLICITORIMPLICIT ISAPREREQUI 2ESOURCESFOR$EVELOPING-ESSAGESFOR0OLICY-AKERS „ „ „ „ „ +EY&ACTS!BOUT%MERGENCY#ONTRACEPTION !NNOTATED"IBLIOGRAPHYOF#ORE%VIDENCE "ASED2ESEARCHON%MER 7ORLD(EALTH/RGANIZATION7(/ 3TATEMENTON%MERGENCY#ONTRA 5NITED3TATES!GENCYFOR)NTERNATIONAL$EVELOPMENT53!)$ 3T 5NITED.ATIONS0OPULATION&UND5.0&! 3TATEMENTON%MERGENCY SUPPORT ORSHOULDASMALLER MOREFOCUSEDCAMPAIGNBECONSIDER MAKERSANDSTAKEHOLDERS ANDHOWMUCHEFFORTWILLBENEEDEDTO HEALTHSERVICES .O*UNE  #ONTRACEPTION  NGPOLITICALPRESSURESˆAND TOBECOMEINVOLVEDWITH ONMENTISANOTHERIMPORTANT ON POLITICALCURRENTSANDHOW COUNTRY REGISTRATIONOFA RIESWHEREIS FAMILYPLANNING SCRITICALTOENSURETHE WILLBEINVOLVED THE IRECTIONTHESTRATEGY N!LTHOUGHGOVERNMENT SITEFORSUCCESSFULLY T OFGOVERNMENTAGENCIES YCOSTLYOTHERS SUCH PLANNINGANDREPRODUCTIVE EFFORTTOGENERATE%#0 AIRLYLOW COST)N INGINFORMATIONTOPOLICY ONGPOLITICALLEADERS MENTAPPROVALWAS AVIGATINGSUCH SECURETHATSUPPORT ED ATEMENTON%MERGENCY GENCY#ONTRACEPTION #ONTRACEPTION  CEPTION&ACT3HEET -ODULE!

(ARNESSINGRESOURCESAVAILABLEFORINCORPORATING%#0SINTOFAMILYPLANNINGPROGRAMS CANBEACHALLENGE)NSOMECOUNTRIES LIKE-EXICO FOUNDATIONDONORSWEREINTEGRALTO PROVIDINGSUBSTANTIALFUNDINGFORTHELARGE SCALEADVOCACYCAMPAIGNUNDERTAKENTHERE)N MANYPLACES HOWEVER THISTYPEOFFUNDINGMAYBEDIFlCULTTOACCESS ANDITISIMPORTANT TOBEAWAREOFOTHERSUPPORTAVAILABLEANDTHEMECHANISMSTHROUGHWHICHITCANBE OBTAINED 4HEREAREDIFFERENTTYPESOFRESOURCESORORGANIZATIONSTHATMAYBEINTERESTEDIN CONTRIBUTINGTOEFFORTSTOINTEGRATE%#0SINTOPUBLIC SECTORPROGRAMS)NSOMESETTINGS GOVERNMENTMAYBEABLETOMAKE%#0SPARTOFTHECOUNTRYSMETHODMIXANDINTEGRATE %#0INFORMATIONINTOONGOINGCLIENTOUTREACHANDPROVIDERTRAINING"ILATERALDONORSOR MULTILATERALDONORS PARTICULARLYTHOSEWHOPROVIDECONTRACEPTIVESORSUPPORTREPRODUCTIVE HEALTHACTIVITIES CANBEARESOURCE4HISSUPPORTISMOSTEFFECTIVELYSOUGHTATTHECOUNTRY LEVELMISSIONORCOUNTRYOFlCEENGAGEDINHEALTHANDORREPRODUCTIVEHEALTHWORK 0RIVATEFOUNDATIONSORLOCALDONORSSUPPORTIVEOFREPRODUCTIVEHEALTHMAYHAVEINTEREST INSUPPORTINGACTIVITIESRELATEDTO%#0INTEGRATION)NCLUDETHESEPOTENTIALDONORSEARLYIN THEPLANNINGSTAGESTOASSESSTHEIRINTERESTANDlNDOUTWHATTHEYCANORCANNOTSUPPORT

+EY!UDIENCES 7HENRESOURCESREQUIREMENTSANDAVAILABILITYAREKNOWN THENEXTSTEPISTOIDENTIFYTHE STAKEHOLDERSANDPOLICYMAKERSWHOSESUPPORTISNEEDED)NSEVERALCOUNTRIESTHATHAVE SUCCESSFULLYINTEGRATED%#0SINTOLARGEPROGRAMS THESEWEREINDIVIDUALSFROMTHEHEALTH CARESECTORINCLUDINGGOVERNMENT INTERNATIONALAIDAGENCIES ANDPROFESSIONALMEDICAL GROUPS1UESTIONSTHATWILLHELPIDENTIFYTHETARGETAUDIENCESINCLUDE s 7HOARETHEKEYPOLICYMAKERSANDSTAKEHOLDERSINTHEHEALTHANDFAMILYPLANNING COMMUNITY s 7HOCONTRIBUTESTODECISIONSABOUTCONTRACEPTIVEMETHODMIX s !MONGTHESEPOLICYMAKERSANDSTAKEHOLDERS WHICHONESARELIKELYORUNLIKELYTOSUPPORT %#0MAINSTREAMINGEFFORTS s 7HOARETHECULTURALORRELIGIOUSLEADERSTHATMIGHTOPPOSEORSUPPORTINCREASINGACCESS TO%#0S s 7HATOTHERGROUPSORINDIVIDUALSINmUENCEPOLICYRELATEDTOHEALTHANDFAMILYPLANNING ANDWHICHOFTHEMCOULDPROVIDESUPPORT

!  !  -ODULE! WHENADVOCATINGFORWIDEACCESSTO%#0S SUCCESSFULINTRODUCTIONOF%#0S ANDTHISAPPROACHSHOULDBEAP FROMIMPORTANTSTAKEHOLDERS)NSEVERALCOUNTRIESTHISHASBEEN OFPEOPLERECEIVINGACCURATEMESSAGESABOUT%#0S ANDGAINTHE THROUGHWHICHTOADDRESSISSUESAROUNDEMERGENCYCONTRACEPTION INTRODUCTIONFROMAVARIETYOFPERSPECTIVES4HESEFORUMSCANS MOMENTUMOFADVOCACYEFFORTSISIMPORTANT&ORUMSCANSORTOUT FROMTHESEGROUPSCANFACILITATEEFFECTIVECOLLABORATION AVOID FORCOMMUNICATIONANDCOLLABORATIONAMONGTHEM#REATINGAFORU )NCASESWHEREMULTIPLESTAKEHOLDERSAREINVOLVED ITISIMPORT %#0FORUMFORSTAKEHOLDERS %XAMPLESOFSTAKEHOLDERSINTHEPROVISIONOF%#0SINCLUDE 0ROVIDERS 0RE SERVICEACADEMICINSTITUTIONS 0ROFESSIONALGROUPS ,OCALLEADERS %XAMPLESOF/RGANIZATIONS LEVELS PLANNERSATNATIONALANDLOCAL $ECISIONMAKERSANDPROGRAM +EY!UDIENCES -IDWIVESTRADITIONALBIRTHATTENDANTS s 3AFEABORTIONSERVICEPROVIDERS s #LINICHEALTHWORKERS s $IRECTORSOFHOSPITALSANDCLINICS s 0HARMACYSCHOOLS s .URSINGSCHOOLS s -EDICALSCHOOLS s 2ESEARCHCOUNCILSANDINSTITUTES s 0HARMACISTSASSOCIATIONS s -EDICALEDUCATIONINSTITUTIONS s -EDICALASSOCIATIONSANDSOCIETIES s 0OLICEANDLOCALLAWOFlCERS s $OMESTICVIOLENCESUPPORTGROUPS s 2ELIGIOUSLEADERS s 7OMENSGROUPS s ,OCALHEALTHGROUPS s #OMMUNITY s 2EPRESENTATIVESFROMMULTILATERALANDBILATERALDONOR s (EALTHINSURANCEPROGRAMS s -INISTRYOFJUSTICE s n.ATIONALMATERNALANDCHILDHEALTHDIVISION n.ATIONALFAMILYPLANNINGPROGRAM -INISTRYOFHEALTH s AGENCIES DUPLICATION ANDMAINTAIN ANTTOCREATEMECHANISMS AKEYFACTORINTHE ERVEASAMECHANISM PLIEDWHEREVERPOSSIBLE ATTENTIONOFANDSUPPORT ISSUESANDLOOKAT%#0 INCREASETHENUMBER MWHEREINDIVIDUALS -ODULE!

,ESSONS,EARNED

(OLDINGA.ATIONAL#ONSENSUS&ORUMIN)NDIA )NCOOPERATIONWITHSEVERALORGANIZATIONS THE#ONSORTIUMON.ATIONAL#ONSENSUS FOREMERGENCYCONTRACEPTIONIN)NDIAHELDATWO DAYFORUMONEMERGENCY CONTRACEPTION4HEMAINOBJECTIVESOFTHEFORUMWERETOPRESENTUPDATESONTHE LATESTADVANCESINEMERGENCYCONTRACEPTION TODISCUSSANDDEBATETHESTRATEGIES FOR%#0INTRODUCTION ANDTOSETFORTHGUIDELINESFORINTRODUCINGEMERGENCY CONTRACEPTIONIN)NDIA0ARTICIPANTSINCLUDEDAHOSTOFINTERNATIONALANDNATIONAL TECHNICALEXPERTS POLICYMAKERS RESEARCHERS PHARMACEUTICALCOMPANIES WOMENS ADVOCATES LEGALEXPERTS NONGOVERNMENTALORGANIZATIONS PROFESSIONALBODIES AND SERVICEPROVIDERS4HElRSTDAYOFTHEFORUMCONSISTEDOFlVESESSIONSDURINGWHICH LEADINGEXPERTSADDRESSEDTHEMAINISSUES CURRENTDATA ANDlNDINGSFROMOTHER COUNTRIESWHERE%#0SAREALREADYINTEGRATED$URINGTHESECONDDAY ANEXPERT FORUMWASHELDONSIXKEYISSUESRELATEDTO%#0INTRODUCTIONIN)NDIA!CONSENSUS ONHOWTOMOVEFORWARDWITHRESPECTTOEACHOFTHEAREASWASREACHEDAND ADOPTED4HEMAINISSUESONWHICHACONSENSUSWASREACHEDWERESELECTIONOFA DEDICATEDMETHODFOR%#IN)NDIA PREINTRODUCTIONOFMEDIACAMPAIGNSFORPUBLIC AWARENESS TRAININGCURRICULUMFORHEALTHCAREPROVIDERS IDEALAPPROACHTOBROAD SCALEINTRODUCTIONANDDISTRIBUTIONOF%#0S ANDCLIENTINFORMATIONANDCOUNSELINGFOR SAFEUSE4HE.ATIONAL#ONSENSUS&ORUM WHICHOCCURREDIN HELPEDPAVETHE WAYFORINTRODUCTIONOFEMERGENCYCONTRACEPTIONIN)NDIA)NFORMATIONONTHISFORUM HASBEENCOMPILEDINTHE4HE2EPORT2ECOMMENDATIONSOF.ATIONAL#ONSENSUSOF #ONSORTIUM WHICHCANBEACCESSEDONLINEATKWWSZZZHFLQGLDRUJUHSRUWKWP

)NCLUDINGA2ANGEOF)NTERESTS(ELPS'ARNER3UPPORTFOR%MERGENCY #ONTRACEPTIONIN:AMBIA )N:AMBIA %#0ADVOCATESINVITEDAGROUPOFINDIVIDUALSREPRESENTINGAWIDERANGE OFORGANIZATIONSTOPARTICIPATEINDISCUSSIONSANDMEETINGSONISSUESRELATEDTO EMERGENCYCONTRACEPTION,EADERSFROMWOMENSGROUPS THE#ATHOLIC#HURCH THE-INISTRYOF(EALTH ANDOTHERGROUPSWEREINVITEDTOPARTICIPATEINADISCUSSION ABOUTTHERESULTSOFAN%#0STUDYCONDUCTEDBYTHE0OPULATION#OUNCIL4HE FOCUSEDDISCUSSIONSAROUNDTHISSTUDYHELPEDHIGHLIGHTEVIDENCEABOUT%#0S ANDSIMULTANEOUSLYINFORMEDGROUPSONALLSIDESOFTHEISSUEABOUTEMERGENCY CONTRACEPTION)TPROVEDTOBEAVERYEFFECTIVEWAYTOBUILDCONSENSUSONTHEISSUES SURROUNDINGTHELOCALINTRODUCTIONOF%#0SIN:AMBIA4HISSTUDYISINCLUDEDINTHE ANNOTATEDBIBLIOGRAPHYINTHETOOLSSECTIONOFTHISMODULE3KIBIAKETAL 

!  !  -ODULE! +EY-ESSAGES "ECAUSE%#0SHAVEBEENSHOWNTOBESAFEANDEFFECTIVE MANYC s 7(/HASSTATEDTHATTHEREARENOCONTRAINDICATIONSTO%#0SDU s )NTHE YEARPERIODFOLLOWINGTHEAVAILABILITYOFTHEDEDIC s 2ESEARCHERSOFTENEXTRAPOLATEDATAFROMSAFETYSTUDIESCONDUC s /RGANIZATION7(/ HAVESTATEDTHAT%#0SARESAFEFORUSE "OTHTHE5NITED3TATES&OODAND$RUG!DMINISTRATION&$! ANDT %#0SAREBOTHSAFEANDEFFECTIVEFORWOMENTOUSE %#0SARESAFE THATMAYBEUSEFULINDEVELOPINGMESSAGES WHICHISLOCATEDINTHETOOLSSECTION4HEBIBLIOGRAPHYALSOCO OFTHEARTICLESANDRESOURCESLISTEDBELOWAREINCLUDEDINTHE PROGRAM SPECIlCMESSAGESANDINFORMATIONDISSEMINATIONSTRATEGI ARISEAMONGPOLICYMAKERS,INKSTOARTICLESANDRESOURCESTHAT DESIGNEDTOPROVIDESUCCINCTINFORMATIONONIMPORTANTTOPICSAN ISSUESTHATAREFREQUENTLYBROUGHTUPFORDISCUSSION4HEFOLLO WITHINFORMATIONONISSUESSUCHAS%#0SMECHANISMOFACTION SA 2ECENTRESEARCHON%#0SHASRESULTEDINANEXCELLENTBODYOFWI ADDRESSCOMMONMISPERCEPTIONSABOUT%#0STHATAREOFTENTHECAU INTEGRATINGITINTOAFAMILYPLANNINGPROGRAM0ROVISIONOFCOR EMERGENCYCONTRACEPTION INCLUDINGWHYITISAPUBLICHEALTHIS ANDSTRATEGIES ITISCRITICALTODRAWFROMEVIDENCE BASEDAND MOSTEFFECTIVELYINFORMTHEIR /NCEAUDIENCESHAVEBEENIDENTIlED THENEXTSTEPISTODETERMI 4HEONLYCONDITIONRESTRICTINGUSEOF%#0SISANESTABLISHED s -ADAGASCAR -ALI -AURITIUS .AMIBIA 0ORTUGAL 3ENEGAL 3OUTH #ONGO $ENMARK &INLAND &RANCE 'ABON 'UINEA "ISSAU )SRAEL %#0SAREAVAILABLEDIRECTFROMAPHARMACISTIN!LBANIA "ELGIUM ACCESSBYMAKINGTHEMAVAILABLEWITHOUTPRESCRIPTIONORDIRECTL HORMONEDOSEANDSHORTDURATIONOFUSE EVENTSWITHUSEOFTHE9UZPEREGIMEN OVERMILLIONTIMES-EDICALREPORTSSHOWEDNOCLEAREVIDENCE PROGESTIN ORCOMBINED REGIMENPRODUCTIN'REAT"RITA DEMONSTRATETHAT%#0SARESAFE PILLS/#0S TAKENDAILYOVERALONGPERIODOFTIMEFORREGULAR ORALCONTRACEPTIVESPOSENORISKOFBIRTHDEFECTS BASEDONSTUDIESOFORALCONTRACEPTIVEPILLS INCLUDINGHIGH DO INADVERTENTLYDURINGPREGNANCYWILLNOTHARMADEVELOPINGFETUS WORKIFAWOMANISALREADYPREGNANT2ESEARCHERSHAVECONCLUDED BEGINNINGWITHIMPLANTATION NOTBECAUSE%#0SAREHARMFUL BUT CONTRAINDICATIONSFORUSEOFDAILYORALCONTRACEPTIONARENOTA RESEARCHERSHAVECONCLUDEDINREVIEWSOFPUBLISHEDDATAON/#0S DECISIONSANDGARNERTHEIRSUPPOR  "ECAUSE%#0SARETAKENFORAVERYSHORTPERIODOFTIME            ANNOTATEDBIBLIOGRAPHY PUBLISHEDINFORMATIONABOUT WINGSECTIONHASBEEN NTAINSADDITIONALRESOURCES RECTINFORMATIONHELPS T)NPLANNINGKEYMESSAGES SUEANDTHEBENElTSOF CANBEUSEDINDEVELOPING ATED9UZPEALSOKNOWNASTHE NEWHATINFORMATIONCAN DQUESTIONSTHATOFTEN PREGNANCY DElNEDAS DELYPUBLISHEDSTUDIES PPLICABLETO%#0S SEFORMULATIONS THATSHOW FETY ANDEFlCACYˆ TEDONORALCONTRACEPTIVE CONTRACEPTIONTO ESAREPROVIDED-ANY SEOFCONTROVERSY ETOTHESMALLOVERALL HE7ORLD(EALTH YFROMAPHARMACIST DIRECTLYLINKINGADVERSE 4HESECONCLUSIONSARE OUNTRIESHAVESIMPLIlED IN THEREGIMENWASUSED BECAUSETHEYWILLNOT "ENIN #AMEROON !FRICA 3RI,ANKA AND%#0S THATTHE THAT%#0STAKEN )VORY#OAST ,ITHUANIA  -ODULE!

3WITZERLAND 4HAILAND 4OGO 4UNISIA 5NITED+INGDOM ANDPARTSOF5NITED3TATESAND #ANADA4HEYAREAVAILABLEOVER THE COUNTERIN.ORWAYAND3WEDEN)NAN&$! REVIEWPANELRECOMMENDEDTHATPROGESTIN ONLY%#0SBEAVAILABLEOVER THE COUNTERINTHE 5NITED3TATES

%#0SAREEFFECTIVE 4HEEFFECTIVENESSOF%#0SVARIES DEPENDINGONTHEREGIMENANDHOWSOONAFTERSEXTHEY ARETAKEN s 4HEREARETWOMAJORTYPESOF%#0SONTHEMARKETTODAYTHE ONLYALSO KNOWNASPROGESTIN ONLY REGIMENANDTHE9UZPEORCOMBINEDESTROGENANDPROGESTIN REGIMEN4HELEVONORGESTREL ONLYREGIMENHASFEWERSIDEEFFECTSANDISMOREEFFECTIVE s /NAVERAGE IFWOMENHAVEUNPROTECTEDINTERCOURSEDURINGTHETIMEOFTHEMONTH WHENTHEYAREMOSTFERTILE WILLBECOMEPREGNANT)FTHEYALLTOOKTHELEVONORGESTREL ONLY%#0REGIMEN WOULDBEEXPECTEDTOBECOMEPREGNANTANPERCENTREDUCTIONIN PREGNANCYRISK  )FALLOFTHOSEWOMENUSEDTHE9UZPEREGIMEN WOULDBEEXPECTEDTO BECOMEPREGNANTAPERCENTREDUCTIONINPREGNANCYRISK  s 4HESOONERAFTERUNPROTECTEDINTERCOURSEAWOMANTAKES%#0S THELOWERHERRISKOF PREGNANCY%#0SWILLBEMOSTEFFECTIVEIFTAKENWITHINHOURSTHEEFFECTIVENESS DIMINISHESWITHEACHDAY UPTOHOURSDAYS    

-ECHANISMOFACTIONOF%#0S s %#0SAREEFFECTIVEONLYBEFOREAPREGNANCYISESTABLISHEDCLINICALLYDElNEDAS IMPLANTATIONOFAFERTILIZEDEGGINTHELININGOFTHEUTERUS  4HEYCANNOTWORKAFTERA FERTILIZEDEGGHASBEENIMPLANTED s %#0SPRIMARYMECHANISMOFACTIONISTHEINHIBITIONORDELAYOFOVULATION         s "ESIDESINHIBITINGORDELAYINGOVULATION THEREISNOUNEQUIVOCALCLINICALEVIDENCEFOR OTHERMECHANISMSOFACTIONALTHOUGH%#0SMAYWORKBY n )NHIBITINGFERTILIZATIONTHROUGHTHICKENINGOFTHECERVICALMUCOUSRESULTINGINTRAPPING OFSPERMORALTERATIONSINTHETUBALTRANSPORTOFSPERMOREGGˆBUTNODATAEXISTTO CONlRMTHISPOSSIBLEMECHANISMOFACTION   n )MPAIRINGENDOMETRIALRECEPTIVITYTOIMPLANTATIONOFAFERTILIZEDEGG      (OWEVER THEEVIDENCESHOWINGENDOMETRIALEFFECTSOF%#0TREATMENTISMIXED ANDIT ISNOTCLEARTHATTHEENDOMETRIALCHANGESWOULDINHIBITIMPLANTATION    s 4IMINGPLAYSAKEYROLEINHOW%#0SWORK3TUDIESHAVESHOWNTHATTHESPECIlC MECHANISMOFACTIONANDEFFECTIVENESSOF%#0SMAYDEPENDON n #YCLEDAYONWHICHINTERCOURSEOCCURRED n #YCLEDAYONWHICHTREATMENTISUSED     

4HESEESTIMATESOFREDUCTIONINTHERISKOFPREGNANCYFOLLOWING%#0USEAREBASEDONSTUDIESTHATEVALUATED%#0USEWITHINA  HOURTIMEFRAME )NDIVIDUALSHAVETHEIROWNINTERPRETATIONSOFWHENAPREGNANCYBEGINS4HEDElNITIONABOVEISPROVIDEDWITHINAMEDICAL CLINICALCONTEXT

!  !  -ODULE! $EPARTMENTOF(EALTH)NDISCUSSINGBARRIERMETHODS THESEGUID 34)()6INFECTION ISPROVIDEDBYTHE.ATIONAL#ONTRACEPTION0O

CONTRACEPTIONCONTRACEPTIONPDFHTTPWWWDOHGOVZADOCSF &RAMEWORK2EPUBLICOF3OUTH!FRICA $EPARTMENTOF(EALTH CONTRACEPTIONSHOULDBEPROMOTEDMOREEXTENSIVELYv.ATIONAL#O !MODELFORADUALPROTECTIONAPPROACHANAPPROACHTHATPROMOT 7OMENWHORECEIVED%#0SINADVANCEOFNEEDWEREMORELIKELYT s %FFECTIVENESSOF%#0SISINCREASEDBYADVANCEPROVISION !STUDYCONDUCTEDIN:AMBIA HOWEVER PROVIDEDSOMEEVIDENCE s !NOTHERSTUDYSHOWEDTHATWOMENDIDNOTABANDONREGULARUSEO s !3COTTISHSTUDYSHOWEDTHATWOMENDIDNOTSTOPUSINGOTHERM s -OSTRESEARCHSUGGESTSTHATADVANCEPROVISIONOF%#0SDOESNO s NEGATIVELYAFFECTREGULAR ONGOINGCONTRACEPTIVEUSE -OSTEVIDENCESUGGESTSTHATADVANCEPROVISIONOF%#0SDOESNOT )NA#HINESESTUDY RESEARCHERSESTIMATEDTHATNEARLYHALF s )TISESTIMATEDTHATINTHE5NITED3TATESIN  PRE s EACHYEAR 2ESEARCHSUGGESTSTHATACCESSTO%#0SCANREDUCETHENUMBEROF %#0SCANHELPREDUCETHENUMBEROF TOOLSSECTIONOFTHISMODULE #ONSORTIUMFOR%MERGENCY#ONTRACEPTIONSSTATEMENTONMECHANISM &ORMOREINFORMATIONONTHEMECHANISMOFACTIONOF%#0S REFER WITHEMERGENCYCONTRACEPTIONASABACKUP -EDICALPROVIDERSSHOULDEMPHASIZECONTINUEDUSEFORCLI NEEDEDTHANTHOSEWHODIDNOTHAVEASUPPLYATHOME TRAININGANDUSEREDUCATION TOTHEUSEOF%#0SANDOTHERFAMILYPLANNINGMETHODSCANBEOVE ADVANCEPROVISIONOF%#0STOWOMENISANIMPORTANTOPTIONANDT PREFERENCEFORTHECONVENIENCEOF%#0S$ESPITETHIS RESEARCHE %#0EFFECTIVENESSGIVENITSHIGHERDOSAGECOMPAREDTOREGULARO USERSFORREASONSSUCHASCOERCIONBYSPOUSE CURIOSITYABOUTT OF%#0SMAYHAVEENCOURAGEDNONUSEOFREGULARFAMILYPLANNINGM RELYINGONIFEMERGENCYCONTRACEPTIONISAVAILABLEASA INFECTION34) AND()64HESTUDYCONCLUDEDTHATCOUPLESMAYF ANDDISEASEPROTECTION WHICHWOULDHAVEINCREASEDTHEIRRISKO CONTRACEPTIVEMETHODSWHENABACK UPMETHODSUCHAS%#0SWASAV CONTRACEPTIVEUSE BEENAVAILABLETOWOMEN 3HANGHAICOULDHAVEBEENPREVENTEDIFCOMBINED REGIMEN9UZPEM RESULTEDINABORTIONSWEREPREVENTEDBYTHEUSEOF%#0S       ELINESSTATE h)NTHEEVENTOFCONDOMFAILURE ACCESSTOEMERGE ACTSHEETSGUIDELINESCONTRACEPTIONCONTRACEPTIONPDF LICY'UIDELINESISSUEDBYTHE2EPUBLICOF3OUTH!FRICAS NTRACEPTION0OLICY'UIDELINES7ITHINA2EPRODUCTIVE(EALTH ESSTRATEGIESTHATPREVENTBOTHUNWANTEDPREGNANCYAND HTTPWWWDOHGOVZADOCSFACTSHEETSGUIDELINES   GNANCIESTHATWOULDHAVE  OFTHEABORTIONSIN ABORTIONSTHATOCCUR TOTHE)NTERNATIONAL HEMETHOD CONlDENCEIN ENTSATRISKOF34)S FSEXUALLYTRANSMITTED RSSTILLCONCLUDEDTHAT TNEGATIVELYAFFECTREGULAR OREEFFECTIVE BACKUPMETHOD RALCONTRACEPTIVES AND EELMORECONlDENTABOUT FCONDOMSFORPREGNANCY THATADVANCEPROVISION RCOMEWITHPROVIDER OFACTIONINTHE HATISSUESPERTAINING OUSETHEMWHEN ETHODSAMONG ETHOD %#0SHAD AILABLEINADVANCE  NCY  -ODULE!

s 7OMENWHOHAVE%#0SINADVANCEOFNEEDWILLMOSTLIKELYUSETHEMSOONERAFTER UNPROTECTEDINTERCOURSE WHICHINCREASESTHEEFFECTIVENESSOFTHISMETHOD  s 4HEEFFECTIVENESSOF%#0SDECREASESSIGNIlCANTLYTHELONGERAWOMANWAITSAFTER INTERCOURSETOTAKETHEM!DVANCEPROVISIONISANIMPORTANTOPTIONBECAUSEITREDUCES BARRIERSTOTIMELYACCESS &ORMOREINFORMATIONONTHETIMINGOF%#0SANDEFFECTIVENESS SEETHE)NTERNATIONAL #ONSORTIUMFOR%MERGENCY#ONTRACEPTIONSSTATEMENTONREGIMENINTHETOOLSSECTIONOF THISMODULE

!CCESSTO%#0SDOESNOTCAUSEPROMISCUITYAMONGADOLESCENTS 4HECONCERNISFREQUENTLYVOICEDTHATACCESSTO%#0SWILLCAUSEPROMISCUITYAMONG YOUTH4WORECENTSTUDIESPROVIDEDEVIDENCETHATINFORMATIONABOUTANDACCESSTO CONTRACEPTIVEMETHODS INCLUDING%#0S DOESNOTLEADTOPROMISCUITYOREARLIERINITIATION OFSEXAMONGADOLESCENTS 

2EPEATUSEOF%#0SDOESNOTPOSEHEALTHRISKS s 2EPEATUSEOF%#0SPOSESNOHEALTHRISKS ACCORDINGTO7(/ WHICHHASPLACEDREPEATED %#0USEIN#ATEGORYOFITSMEDICALELIGIBILITYGUIDELINES INDICATINGTHATTHEREISNO RESTRICTIONFORTHEREPEATEDUSEOFTHISCONTRACEPTIVEMETHOD s %XPERIENCEWITH%#0SSUGGESTSTHATREPEATUSEWITHINTHESAMECYCLEISUNCOMMON5SE OFLEVONORGESTREL ONLY%#0SASFREQUENTLYASFOURTIMESAMONTHDIDNOTREVEALNEGATIVE HEALTHRISKS7HILEREPEATUSEISNOTAREASONTODENYAWOMANACCESSTO%#0S ITIS ANINDICATIONTHATAWOMANNEEDSFURTHERCOUNSELINGONROUTINECONTRACEPTIVEMETHODS ASMOSTOTHERMETHODSAREMOREEFFECTIVEFORREGULARUSE7OMENWHOHAVEREGULAR INTERCOURSEMORETHANFOURTIMESPERMONTH ARENOTADVISEDTOUSE%#0SASAREGULAR CONTRACEPTIVEMETHODBECAUSETHEYARENOTASEFFECTIVEASREGULARCONTRACEPTION &ORMOREINFORMATIONONREPEATUSE SEETHE)NTERNATIONAL#ONSORTIUMFOR%MERGENCY #ONTRACEPTIONSSTATEMENTONREPEATUSEOFEMERGENCYCONTRACEPTIONINTHETOOLSSECTION OFTHISMODULE

-EXICO#ITY0OLICYAND%MERGENCY#ONTRACEPTION %MERGENCYCONTRACEPTION LIKEOTHERMETHODSOFCONTRACEPTION ISNOTSUBJECTTO53 GOVERNMENTRESTRICTIONSONDEVELOPMENTFUNDSTHATAPPLYTOABORTIONSERVICES COUNSELING ANDREFERRAL ORLOBBYING4HISHASBEENAPOINTOFCONFUSION&OREIGNGOVERNMENTSAND NONGOVERNMENTALORGANIZATIONSTHATRECEIVE53DEVELOPMENTASSISTANCEMAYPROVIDE EMERGENCYCONTRACEPTIONSERVICES INFORMATION ANDREFERRAL&ORMOREINFORMATION SEETHE0OPULATION!CTION)NTERNATIONAL0!) PUBLICATION h%MERGENCY#ONTRACEPTION ANDTHE'LOBAL'AG2ULEˆ!N5NOFlCIAL'UIDE vWHICHPROVIDESINFORMATIONAND CLARITYABOUTTHE-EXICO#ITY0OLICY)TCANBEACCESSEDATTHE0!)WEBSITEHTTP WWWPOPULATIONACTIONORGRESOURCESPUBLICATIONSGLOBALGAGRULE'AG2ULE?DOWNLOADHTM

!  !  -ODULE! #HOOSING%FFECTIVE#HANNELSTO#OMMUNICATE-ESSAGES $OMESTIC6IOLENCE 2APE AND%MERGENCY#ONTRACEPTION (OWCANTHESEPOINTSBEMADESOTHEYHAVEMAXIMUMIMPACTONT s 7HATARETHEMOSTIMPORTANTPOINTSTHATNEEDTOBEMADE s 7HATTYPEOFINFORMATIONDISSEMINATIONACTIVITIESWOULDBEMO s COMMUNICATIONCHANNELSTOUSE REACHINGTHEINTENDEDAUDIENCES4HEFOLLOWINGQUESTIONSCANHE /NCETHEKEYMESSAGESHAVEBEENIDENTIlED SELECTTHEMOSTEFFE INTHEIRLIVES BEINGHITOROTHERWISEPHYSICALLYHARMEDBYANINTIMATEMALEPA POPULATION BASEDSURVEYSFOUNDTHATBETWEENANDPERCENTO SEXUAL PSYCHOLOGICAL ANDECONOMICABUSEOFWOMEN!REVIEWOF 'ENDER BASEDVIOLENCEISASIGNIlCANTPROBLEMWORLDWIDE)TCAN ENVIRONMENT LATINAMERICAHTML -ODULE#2AISING0UBLIC!WARENESSANDON0)7(SWEBSITEHTTP -OREINFORMATIONON0)7(SWORKWITHEMERGENCYCONTRACEPTIONCA CONTRACEPTIONINTHEFAMILYPLANNINGNORMSOFTHE-EXICAN-INIS ABOUTEMERGENCYCONTRACEPTIONANDADVOCATEFORTHEINCLUSIONOF IN"AJA#ALIFORNIAAND0LANNED0ARENTHOODIN3AN$IEGOTORAISE PERSONNELON%#0SERVICEPROVISION0)7(HASALSOWORKEDWITHO DE-UJERES)NDEPENDIENTESIN-EXICOWORKEDTOTRAIN4IJUANA3EC ISSUEINMANYCOMMUNITIES&OLLOWINGSUCHAWORKSHOP THE/RGAN ASSAULTEDORWERELIVINGWITHDOMESTICVIOLENCE HIGHLIGHTINGT SEVERAL,ATIN!MERICANCOUNTRIESALLHADASSISTEDWOMENWHOHAD BASEDHEALTHCAREPROVIDERSPARTICIPATINGINASERIESOFWORKSH PARTNERSHIPSWITHLOCALORGANIZATIONSIN,ATIN!MERICA0)7(FO ANDDOMESTICVIOLENCESURVIVORSKNOWLEDGEABOUTANDACCESSTO 4HE0ACIlC)NSTITUTEFOR7OMENS(EALTH0)7( HASBEENWORKIN TRAININGSISANIMPORTANTASPECTOFENSURING%#0SREACHWOMENW ANDRAPESURVIVORS SUCHASPOLICEANDLOCALLAWOFlCERS INAD ADVOCACYAVENUES)NCLUDINGTHOSEGROUPSANDINDIVIDUALSWHOAS ABOUT%#0SCANBEPROVIDED ITISIMPORTANTTHATTHEYBEREACHE BECAUSEMANYWOMENINTHISSITUATIONNEVERSEEKMEDICALCAREWH TOPREVENTDISEASE STOPTHEMFROMUSINGFAMILYPLANNINGANDTOHAVEHADAPARTNER USEFAMILYPLANNINGCLANDESTINELYTHEYALSOAREMORELIKELYTO WHOHAVEBEENSEXUALLYABUSEDAREMUCHMORELIKELYTHANNONABUS AFFECTEDBYVIOLENCE EMERGENCYCONTRACEPTIONISPARTICULARLYI ESPECIALLYINTERMSOFTHEIRREPRODUCTIVEANDSEXUALHEALTH&O  4HISVIOLENCECANHAVESERIOUSHEALTHCONSEQUENCESFORWOMEN  2APESURVIVORSAREALSOATRISKOFUNINTENDEDPREGNANCY BUT HAVEHADTHEIRPARTNER RWOMENWHOARE HESEVERITYOFTHE VOCACYCAMPAIGNSAND OPSCONDUCTEDIN MPORTANT7OMEN CTIVECHANNELSFOR LPINCONSIDERINGWHICH UNDTHATCOMMUNITY DTHROUGHOTHER AWARENESS RTNERATSOMEPOINT REFUSECONDOMUSE INCLUDEPHYSICAL TRYOF(EALTH STEFFECTIVEINTHECURRENT HONEEDTHEM BEENSEXUALLY %#0STHROUGH SISTSEXUALABUSE EMERGENCY RETARYOF(EALTH GTOIMPROVERAPE RGANIZATIONS ALMOST WWWPIWHORG EREINFORMATION FWOMENREPORT IZACIÍN,ILITH EDWOMENTO HEINTENDEDAUDIENCE NBEFOUNDIN -ODULE!

,OCAL$ATA)LLUSTRATING.EEDFOR%MERGENCY#ONTRACEPTION 3PECIlCLOCALDATACANSIGNIlCANTLYSTRENGTHENTHEARGUMENTFORMAKING%#0SWIDELY AVAILABLEINACOUNTRY$ATAONSERIOUSHEALTH POVERTYREDUCTION ANDSOCIALPROBLEMS THATCANBEPOSITIVELYAFFECTEDBYDECREASINGTHENUMBEROFUNINTENDEDPREGNANCIESAND ABORTIONSCANBEPOWERFULTOOLSINADVOCATINGPOLICYCHANGETOSUPPORTACCESSTO%#0S 5SEFULDATAINCLUDE s !DOLESCENTPREGNANCYRATES s 5NINTENDEDPREGNANCYRATES s !BORTIONRATESANDSEQUELAE s 'OVERNMENTEXPENDITURESONUNINTENDEDPREGNANCYANDABORTIONORPOSTABORTIONCARE s "IRTHSPACINGSTATISTICS #OUNTRY SPECIlCDATAFOROVERCOUNTRIESCANBEFOUNDONTHE)NTERNETATTHE 0OPULATION2EFERENCE"UREAUWEBSITE HTTPWWWPRBORG WHICHHASLINKSTOADDITIONAL DATARESOURCES -EASUREAND0OP.ET!NOTHERRESOURCEISTHE'LOBAL(EALTH#OUNCIL WEBSITE HTTPGLOBALHEALTHORG5SEFULDATAFOR%#0INFORMATIONDISSEMINATIONCANBE ACCESSEDATHTTPWWWGLOBALHEALTHORGNEWSARTICLE

2EFERENCES (O 0#AND+WAN -3!PROSPECTIVERANDOMIZEDCOMPARISONOFLEVONORGESTRELWITHTHE9UZPEREGIMENIN POST COITALCONTRACEPTION(UMAN2EPRODUCTION   

7(/4ASK&ORCEON0OSTOVULATORY-ETHODSOF&ERTILITY2EGULATION2ANDOMISEDCONTROLLEDTRIALOF LEVONORGESTRELVERSUSTHE9UZPEREGIMENOFCOMBINEDORALCONTRACEPTIVESFOREMERGENCYCONTRACEPTION,ANCET    

'LASIER !3AFETYOFEMERGENCYCONTRACEPTION*OURNALOF!MERICAN-EDICAL7OMENS!SSOCIATION3UPPL    

.ORRIS4URNER !AND%LLERTSON #(OWSAFEISEMERGENCYCONTRACEPTION $RUG3AFETY   

'LASIER !%MERGENCYPOSTCOITALCONTRACEPTION.EW%NGLAND*OURNALOF-EDICINE   

7ORLD(EALTH/RGANIZATION)MPROVING!CCESSTO1UALITY#AREIN&AMILY0LANNING-EDICAL%LIGIBILITY#RITERIA FOR#ONTRACEPTIVE5SENDED'ENEVA2EPRODUCTIVE(EALTHAND2ESEARCH 7ORLD(EALTH/RGANIZATION  7(/2(2&00

(UGGINS '2AND#ULLINS 6%&ERTILITYAFTERCONTRACEPTIONORABORTION&ERTILITYAND3TERILITY    

3IMPSON *,AND0HILLIPS /03PERMICIDES HORMONALCONTRACEPTIONANDCONGENITALMALFORMATIONS!DVANCED #ONTRACEPTION   

(ARLAP 3 3HIONO 0( AND2AMCHARAN 3#ONGENITALABNORMALITIESINTHEOFFSPRINGOFWOMENWHOUSEDORAL ANDOTHERCONTRACEPTIVESAROUNDTHETIMEOFCONCEPTION)NTERNATIONAL*OURNALOF&ERTILITY   

3AVOLAINEN % 3AKSELA % AND3AXEN ,4ERATOGENICHAZARDSOFORALCONTRACEPTIVESANALYZEDINANATIONAL MALFORMATIONREGISTER!MERICAN*OURNALOF/BSTETRICSAND'YNECOLOGY   

2AMAN 7ILMS ,ETAL&ETALGENITALEFFECTSOFlRST TRIMESTERSEXHORMONEEXPOSUREAMETA ANALYSIS /BSTETRICSAND'YNECOLOGY   

!  !  -ODULE! 3TERILITY 3PRING3UMMER  EMERGENCYCONTRACEPTION      /BSTETRICIAET'YNECOLOGICA3CANDINAVICA &ERTILITYAND3TERILITY    WITHEARLYEMBRYONICDEVELOPMENTINTHEHUMANSPECIES PROSPECTIVESTUDIES  UTERINELUMINALmUID    ))%FFECTOFPOSTOVULATORYADMINISTRATIONONOVARIANFUNCTION      EMERGENCYCONTRACEPTIONAREVIEWOFTHELITERATURE  POSTFERTILIZATIONEVENTSINTHERAT  #ONTRACEPTION    THEMENSTRUALCYCLE  CONTRACEPTION  /BSTETRICSAND'YNECOLOGY   AFTERUNPROTECTEDSEXUALINTERCOURSE  CONTRACEPTIONTOHOURS  7(/MULTICENTRERANDOMIZEDTRIAL    ,ING 79ETAL-ODEOFACTIONOFDL ANDETHINYLE 4RUSSELL *AND2AYMOND %'3TATISTICALEVIDENCECONCERNING +ESSERU %ETAL)NVITROACTIONOFONSPERMMIG +ESSERU %ETAL4HEHORMONALANDPERIPHERALEFFECTSOFDL NO #ROXATTO (" /RITZ -% -ULLER !,-ECHANISMSOFACTION #ROXATTO (" $EVOTO , $URAND - ETAL-ECHANISMOFACT -ULLER !, ,LADOS #- AND#ROXATTO ("0OSTCOITALTREAT #ROXATTO ("ETAL%FFECTSOFTHE9UZPEREGIMEN GIVENDURIN 3WAHN -,ETAL%FFECTOFPOST COITALCONTRACEPTIVEMETHODS ,ING 79ETAL-ODEOFACTIONOFDL NORGESTRELANDETHINYLES (APANGAMA $ 'LASIER !& AND"AIRD $44HEEFFECTSOFPE $URAND -ETAL/NTHEMECHANISMSOFACTIONOFSHORT TERMLEV -ARIONS ,ETAL%MERGENCYCONTRACEPTIONWITHAN "ACIC - 7ESSELIUSDE#ASPARIS ! AND$ICZFALUSY %&AILUR 2ODRIGUES ) 'ROU & AND*OLY *%FFECTIVENESSOFEMERGENC %LLERTSON # %VANS - &ERDEN 3 ETAL%XTENDINGTHETIME VON(ERTZEN (ETAL,OWDOSEMIFEPRISTONEANDTWOREGIMENSO "RACKEN -"/RALCONTRACEPTIONANDCONGENITALMALFORMATIONSI 9UZPE !!ETAL0OSTCOITALCONTRACEPTION APILOTSTUDY 9OUNG $#ETAL%MERGENCYCONTRACEPTIONALTERS )NTERNATIONAL#ONSORTIUMFOR%MERGENCY#ONTRACEPTION4HE%MERG         #ONTRACEPTION /BSTETRICSAND'YNECOLOGY #ONTRACEPTION     /BSTETRICSAND'YNECOLOGY /BSTETRICSAND'YNECOLOGY     /BSTETRICSAND'YNECOLOGY     #ONTRACEPTION     ,ANCET !MERICAN*OURNALOF/BSTETRICSAND'YNECOLOGY         0T            #ONTRACEPTION 0T        !MERICAN*OURNALOF/BSTETRICSAND'YNECOLOGY *OURNALOF2EPRODUCTIVE-EDICINE ANDENDOMETRIUM LIMITFORSTARTINGTHE9UZPEREGIMENOFEMERGENCY YCONTRACEPTIVEPILLSBETWEENANDHOURS STRADIOLCOMBINATIONINPOSTCOITALCONTRACEPTION TRADIOLCOMBINATIONINPOST COITALCONTRACEPTION GTHEFOLLICULARPHASE ONOVARIANFUNCTION RGESTRELINPOSTCOITALCONTRACEPTION RATIONINHUMANCERVICALMUCUS MENTWITHLEVONORGESTRELDOESNOTDISRUPT EOFLARGEDOSESOFETHINYLTOINTERFERE ONTHEENDOMETRIUMANDTHEMENSTRUALCYCLE RI OVULATORYADMINISTRATIONOFLEVONORGESTRELON THEMECHANISMOFACTIONOFTHE9UZPEREGIMENOF IONOFHORMONALPREPARATIONSUSEDFOR ASSOCIATEDENDOMETRIALPROTEININSERUMAND ONORGESTRELADMINISTRATIONINEMERGENCY OFEMERGENCYCONTRACEPTION DLEVONORGESTRELMECHANISMOFACTION     FLEVONORGESTRELFOREMERGENCYCONTRACEPTIONA NOFFSPRINGAREVIEWANDMETA ANALYSISOFTHE ENCY#ONTRACEPTION.EWSLETTER  &ERTILITYAND3TERILITY         3TEROIDS &ERTILITYAND #ONTRACEPTION   )NPRESS   !CTA -ODULE!

+UBBA !!ETAL4HEBIOCHEMISTRYOFHUMANENDOMETRIUMAFTERTWOREGIMENSOFPOSTCOITALCONTRACEPTIONA DL NORGESTRELCOMBINATIONORDANAZOL&ERTILITYAND3TERILITY   

-OGGIA !ETAL4HEUSEOFPROGESTOGENSASPOSTCOITALCONTRACEPTIVES*OURNALOF2EPRODUCTIVE-EDICINE    

2AYMOND %'ETAL%FFECTOFTHE9UZPEREGIMENOFEMERGENCYCONTRACEPTIONONMARKERSOFENDOMETRIAL RECEPTIVITY(UMAN2EPRODUCTION   

4ASKIN /ETAL(IGHDOSESOFORALCONTRACEPTIVESDONOTALTERENDOMETRIALDANDDX”INTEGRINSINTHELATE IMPLANTATIONWINDOW&ERTILITYAND3TERILITY   

,ING 79ETAL-ODEOFACTIONOFDL NORGESTRELANDTHINYLESTRADIOLCOMBINATIONINPOSTCOITALCONTRACEPTION )))%FFECTOFPREOVULATORYADMINISTRATIONFOLLOWINGTHELUTEINIZINGHORMONESURGEONOVARIANSTEROIDOGENESIS &ERTILITYAND3TERILITY   

4RUSSELL * %LLERTSON # AND$ORmINGER ,%FFECTIVENESSOFTHE9UZPEREGIMENOFEMERGENCYCONTRACEPTION BYCYCLEDAYOFINTERCOURSEIMPLICATIONSOFMECHANISMOFACTION#ONTRACEPTION   

*ONES 2+ $ARROCH *% (ENSHAW 3+#ONTRACEPTIVEUSEAMONG53WOMENHAVINGABORTIONSIN 0ERSPECTIVESON3EXUALAND2EPRODUCTIVE(EALTH   

#HAOHUA ,ETAL)NVESTIGATIONONKNOWLEDGEOFANDATTITUDETOEMERGENCYCONTRACEPTIONAMONGINDUCED ABORTIONWOMEN2EPRODUCTIONAND#ONTRACEPTION%NGLISHEDITION    2ESULTSSUMMARIZED IN5SEOF%MERGENCY#ONTRACEPTIVE0ILLS#OULD(ALVETHE)NDUCED!BORTION2ATEIN3HANGHAI #HINA3OCIAL 3CIENCE2ESEARCH0OLICY"RIEFS 3ERIES.O;!UGUST=5.$05.&0!7(/7ORLD"ANK3PECIAL 0ROGRAMMEOF2ESEARCH $EVELOPMENT AND2ESEARCH4RAININGIN(UMAN2EPRODUCTIVE(EALTHAND2ESEARCH 7ORLD(EALTH/RGANIZATION

'LASIER !AND"AIRD $4HEEFFECTSOFSELF ADMINISTERINGEMERGENCYCONTRACEPTION.EW%NGLAND*OURNALOF -EDICINE   

,OVVORN !ETAL0ROVISIONOFEMERGENCYCONTRACEPTIVEPILLSTOUSERSIN'HANA#ONTRACEPTION    

%LLERTSON #ETAL%MERGENCYCONTRACEPTIONRANDOMIZEDCOMPARISONOFADVANCEPROVISIONANDINFORMATION ONLY/BSTETRICSAND'YNECOLOGY   

"LANCHARD +ETAL%VALUATIONOFANEMERGENCYCONTRACEPTIONADVANCEPROVISIONSERVICE#ONTRACEPTION    

3KIBIAK *0ETAL4ESTING3TRATEGIESTO)MPROVE!CCESSTO%MERGENCY#ONTRACEPTION0ILLS0RESCRIPTIONVS 0ROPHYLACTIC$ISTRIBUTION0OPULATION#OUNCIL 

0IAGGIO 'ETAL4IMINGOFEMERGENCYCONTRACEPTIONWITHLEVONORGESTRELOFTHE9UZPEREGIMEN,ANCET   

!IKEN !- 3ACKEY . AND'OLD -!4HATWASTHEN THISISNOWCHANGESINYOUNGWOMENSKNOWLEDGE ATTITUDES ANDPERCEIVEDBARRIERSTOUSINGEMERGENCYCONTRACEPTION*OURNALOF0EDIATRICAND!DOLESCENT 'YNECOLOGY   !BSTRACTOFPAPERPRESENTEDATTHE.ORTH!MERICAN3OCIETYOF0EDIATRICAND !DOLESCENT'YNECOLOGY-EETING*UNE 

'RAHAM ! -OORE , 3HARP $ ETAL)MPROVINGTEENAGERSKNOWLEDGEOFEMERGENCYCONTRACEPTIONCLUSTER RANDOMIZEDCONTROLLEDTRIALOFATEACHERLEDINTERVENTION"RITISH-EDICAL*OURNAL 

7(/4ASK&ORCEON0OSTOVULATORY-ETHODSOF&ERTILITY2EGULATION%FlCACYANDSIDEEFFECTSOFIMMEDIATE POSTCOITALLEVONORGESTRELUSEDREPEATEDLYFORCONTRACEPTION#ONTRACEPTION   

(EISE ,ETAL%NDING6IOLENCE!GAINST7OMEN0OPULATION2EPORTS 3ERIES, .O"ALTIMORE*OHNS (OPKINS5NIVERSITY3CHOOLOF0UBLIC(EALTH 0OPULATION)NFORMATION0ROGRAM$ECEMBER 

!  !  -ODULE! -ODULE!4OOLS,IST

3PECIAL.OTE4HEINFORMATIONCONTAINEDINSOMEOFTHESEDOCUMENTSMAYNOTBEUPDATED TOREmECTPUBLISHEDRESEARCHREGARDINGTIMINGANDDOSAGESEETHE)#%#STATEMENTON TIMINGANDDOSAGEFORUPDATED ACCURATEINFORMATIONONTHESETOPICS  x %#0SSHOULDBEUSEDASSOONASPOSSIBLEAFTERUNPROTECTEDINTERCOURSE BUTCANBEUSEDWITHIN HOURS x ,EVONORGESTREL ONLY%#0SCANBEADMINISTEREDINONE MGDOSE

3TATEMENTSON%#0SBY)NTERNATIONAL/RGANIZATIONS !GENCIES AND-AJOR$ONORSOF#ONTRACEPTIVE#OMMODITIES „ !#/'.EWS2ELEASE 4HISSTATEMENTINSUPPORTOFEMERGENCYCONTRACEPTIONISSUEDBY!#/'CANBEFOUNDONLINE ATKWWSZZZDFRJRUJIURPBKRPHSXEOLFDWLRQVSUHVVBUHOHDVHVQUFIP

„ )#%#%VIDENCE "ASED0OLICY3TATEMENTS )#%#HASISSUEDASETOFlVESTATEMENTSWITHACCURATE UP TO DATEINFORMATIONONIMPROVING ACCESS EMERGENCYCONTRACEPTIONANDMEDICALABORTION REPEATUSE MECHANISMOFACTION AND TIMINGANDDOSAGE4HEYCANALSOBEACCESSEDONLINEATKWWSZZZFHFLQIRRUJKWPOUHV GRZQORDGDEOHPWUOVKWP

„ &)'/%THICS#OMMITTEE2EPORT 4HISSTATEMENTPROVIDESTHEGUIDELINESISSUEDBYTHE&)'/%THICS#OMMITTEEONUSE ACCESS ANDPROVISIONOFEMERGENCYCONTRACEPTION4HESTATEMENTWASORIGINALLYPRINTEDIN 'UIDELINESIN%MERGENCY#ONTRACEPTION )NTERNATIONAL*OURNALOF'YNECOLOGY/BSTETRICS   

„ )00&3TATEMENT 4HISDOCUMENTPRESENTSINFORMATIONISSUEDBYTHE)00&)NTERNATIONAL-EDICAL!DVISORY0ANEL ABOUTPROVISIONOFEMERGENCYCONTRACEPTIONINFAMILYPLANNINGPROGRAMSWORLDWIDE4HE STATEMENTDEVELOPED-AYANDREVISEDIN/CTOBER

YRQ+HUW]HQ+HWDO/RZGRVHPLIHSULVWRQHDQGWZRUHJLPHQVRIOHYRQRUJHVWUHOIRUHPHUJHQF\FRQWUDFHSWLRQD:+2PXOWLFHQWUH UDQGRPL]HGWULDO/DQFHW    

!  „ 53!)$AND5.&0!3TATEMENTS 4WOOFTHEMAJORDONORSOFCONTRACEPTIVESFORDEVELOPING COUNTRYFAMILYPLANNINGPROGRAMS 5.&0!AND53!)$ HAVEPROVIDEDSTATEMENTSSUPPORTINGTHEPROVISIONOF%#0S3TATEMENTS OFBOTHAGENCIESCLARIFYINGTHETYPESANDLEVELSOFSUPPORTTHEYOFFERAREPROVIDED -ODULE!

„ 7(/3TATEMENTON%MERGENCY#ONTRACEPTION

4OOLS 4HISSTATEMENTBY7(/ARTICULATESTHESAFETY EFlCACY ANDEASEOFEMERGENCYCONTRACEPTION USE)TWASORIGINALLYPRINTEDAS7(/&ACT3HEET.O*UNE 

2ESOURCESFOR$EVELOPING-ESSAGESFOR0OLICY-AKERS

„ !NNOTATED"IBLIOGRAPHYOF#ORE%VIDENCE "ASED2ESEARCHON%MERGENCY #ONTRACEPTION 4HISANNOTATEDBIBLIOGRAPHYCONTAINSANNOTATIONSOFTHEARTICLESREFERENCEDIN-ODULE! )NFORMATIONFOR0OLICY-AKERS%XCEPTIONSINCLUDETHOSEARTICLESSUMMARIZEDINEITHER h3TATISTICAL%VIDENCE#ONCERNINGTHE-ECHANISMOF!CTIONOFTHE9UZPEREGIMENOF EMERGENCYCONTRACEPTIONvORh-ECHANISMOF!CTIONOF(ORMONAL0REPARATIONS5SEDFOR EMERGENCYCONTRACEPTION!2EVIEWOFTHE,ITERATURE vBOTHOFWHICHAREINCLUDEDINTHIS BIBLIOGRAPHY!DDITIONALLY ARTICLESPERTAININGTOSTUDIESCONDUCTEDONORALCONTRACEPTIVESAND DOMESTICVIOLENCEARENOTINCLUDEDINTHISBIBLIOGRAPHY4HEANNOTATIONSPROVIDEKEYDATAAND SUMMARIESOFSTUDIESTHATWILLBEUSEFULINADVOCACYANDEDUCATIONCAMPAIGNS

„ +EY&ACTS!BOUT%MERGENCY#ONTRACEPTION !FACTSHEETSUMMARIZINGKEYPOINTSABOUTEMERGENCYCONTRACEPTION4HISDOCUMENTCAN BEMODIlEDANDADAPTEDTOEMPHASIZEORHIGHLIGHTPARTICULARISSUES TAILORINGITTOTHE ENVIRONMENTINWHICHADVOCACYACTIVITIESTAKEPLACE

!  4OOLS

$&2*1(:65(/($6( -ODULE! (PEDUJRHGXQWLO)HEUXDU\ 30(67

(PHUJHQF\&RQWUDFHSWLRQ

:$6+,1*721'&7KH$PHULFDQ&ROOHJHRI2EVWHWULFLDQVDQG*\QHFRORJLVWV $&2* KDVLVVXHGQHZ DQGUHYLVHGGRFXPHQWVRQWKHVDIHW\DQGDYDLODELOLW\RIHPHUJHQF\RUDOFRQWUDFHSWLRQ (& $&2*VD\VWKH IDOOEDFNFRQWUDFHSWLYHPHWKRGDUHJLPHQRIRUDOFRQWUDFHSWLYHVWKDWPXVWEHWDNHQZLWKLQKRXUVDIWHU XQSURWHFWHGLQWHUFRXUVHKDVWKHSRWHQWLDOWRUHGXFHE\KDOIWKHPLOOLRQXQLQWHQGHGSUHJQDQFLHVRFFXUULQJ HDFK\HDULQWKH86

$&2*VXSSRUWVPDNLQJ(&DYDLODEOHWRZRPHQRYHUWKHFRXQWHULQDGHVLJQDWHG SUHSDFNDJHG SURGXFW DFFRUGLQJWRLWVUHFHQW6WDWHPHQW6XSSRUWLQJWKH$YDLODELOLW\RI2YHUWKH&RXQWHU(PHUJHQF\ &RQWUDFHSWLRQ³7KHWLPHKDVFRPHIRUZRPHQWRKDYHDFFHVVWRDSURGXFWWKDWWKH\QHHG´UHSRUWV$&2* UHIHUULQJWRWKHRQJRLQJEDUULHUVWRZRPHQ¶VDFFHVVWRWKHGUXJ&LWLQJWKH)'$¶VGHFODUDWLRQWKDW(&LVVDIH DQGHIIHFWLYHLQSUHYHQWLQJSUHJQDQF\$&2*EHOLHYHV³HPHUJHQF\RUDOFRQWUDFHSWLRQFDQPHHWWKH)'$ FULWHULDIRURYHUWKHFRXQWHUDYDLODELOLW\´

,Q(PHUJHQF\2UDO&RQWUDFHSWLRQDUHYLVHG3UDFWLFH%XOOHWLQLVVXHGWRGD\$&2*KDVXSGDWHGLWV UHFRPPHQGDWLRQVWRSK\VLFLDQVUHJDUGLQJWKHVDIHW\DQGHI¿FDF\RISUHVFULSWLRQ(&$&2*SURYLGHVFKDUWV RQKRZWRFRPELQHFRPPRQSUHVFULSWLRQRUDOFRQWUDFHSWLYHVLQGRVDJHVWKDWSURYLGH(&DQGKDVQRZDGGHG LQIRUPDWLRQRQWZR(&GHVLJQDWHGSURGXFWV3UHYHQDQG3ODQ%

,QDQRWKHUHIIRUWWRLQFUHDVHZRPHQ¶VDFFHVVWR(&$&2*QRWHVWKDWGXULQJURXWLQHJ\QHFRORJLFYLVLWV SK\VLFLDQVPD\ZLVKWRRIIHUSDWLHQWVDQDGYDQFHSUHVFULSWLRQIRU(&IRUXVHLQDQ\IXWXUHHPHUJHQF\(& VKRXOGEHWDNHQZLWKLQKRXUVRIXQSURWHFWHGLQWHUFRXUVHEXWPD\SURYLGHWKHJUHDWHVWHI¿FDF\LIWDNHQ ZLWKLQKRXUVVD\V$&2*



7KH$PHULFDQ&ROOHJHRI2EVWHWULFLDQVDQG*\QHFRORJLVWVLVWKHQDWLRQDOPHGLFDORUJDQL]DWLRQUHSUHVHQWLQJ QHDUO\SK\VLFLDQVZKRSURYLGHKHDOWKFDUHIRUZRPHQ

4HISMATERIALWASREPRINTEDWITHPERMISSIONFROMTHE!MERICAN#OLLEGEOF/BSTETRICIANSAND'YNECOLOGISTS

!  -ODULE! 4OOLS

!  Tools Module A Module A Tools Tools

A-18 A-19 -ODULE! 4OOLS

4HISMATERIALWASREPRINTEDWITHPERMISSIONFROMTHE)NTERNATIONAL#ONSORTIUMFOR%MERGENCY#ONTRACEPTION

!  4OOLS 4OOLS -ODULE! -ODULE!

!  -ODULE! 4OOLS

4HISMATERIALWASREPRINTEDWITHPERMISSIONFROMTHE)NTERNATIONAL#ONSORTIUMFOR%MERGENCY#ONTRACEPTION

!  4OOLS 4OOLS -ODULE! -ODULE!

!  -ODULE! 4OOLS

4HISMATERIALWASREPRINTEDWITHPERMISSIONFROMTHE)NTERNATIONAL#ONSORTIUMFOR%MERGENCY#ONTRACEPTION

!  Tools Module A Module A Tools Tools

A-24 A-25 Tools Module A Module A Tools Tools

This material was reprinted with permission from the International Consortium for Emergency Contraception.

A-26 A-27 4OOLS 4OOLS -ODULE! -ODULE!

!  -ODULE! 4OOLS

4HISMATERIALWASREPRINTEDWITHPERMISSIONFROMTHE)NTERNATIONAL#ONSORTIUMFOR%MERGENCY#ONTRACEPTION

!  4OOLS

'UIDELINES)SSUEDBYTHE&)'/%THICS#OMMITTEE -ODULE! "ACKGROUND  4HE#OMMITTEERECOGNIZESTHATBASICHUMANRIGHTSTOHEALTHINCLUDETHEFREEDOMTOCONTROL SEXUALANDREPRODUCTIVEHEALTH)NDIVIDUALSALSOHAVETHERIGHTTOENJOYTHEBENElTSOFNEW SCIENTIlCKNOWLEDGEINSEXUALANDREPRODUCTIVEHEALTH  4HE#OMMITTEENOTEDITSPRIORSTATEMENTTHATh&AILURETOADVOCATEPOLICIESTHATWILLIMPROVE WOMENSHEALTHCAREANDADVANCEWOMENSRIGHTSBROADLYWILLDELETERIOUSLYINmUENCETHE HEALTHCAREOFINDIVIDUALPATIENTSCAREDFORBYTHE/B'YNv  )NUNPROTECTEDINTERCOURSE EMERGENCYCONTRACEPTIONISHIGHLYEFFECTIVEINDIMINISHING THENUMBEROFUNWANTEDPREGNANCIESWITHOUTTHENEEDOFANABORTION %ARLYEVIDENCE SUGGESTSTHATABORTIONRATESAMONGTEENAGERSDROPFOLLOWINGACCESSTOINFORMATIONANDUSEOF EMERGENCYCONTRACEPTION

2ECOMMENDATIONS  %ARLYACCESSTOHORMONALEMERGENCYCONTRACEPTIONIMPROVESTHESUCCESSRATEANDTHEREFORE DECREASESHEALTHRISKS4HEREFORE ATAPUBLICPOLICYLEVEL THEMEDICALPROFESSIONSHOULD ADVOCATETHATEMERGENCYCONTRACEPTIONBEEASILYAVAILABLEANDACCESSIBLEATALLTIMESTOALL WOMEN  %MERGENCYCONTRACEPTIONISNOTMEDICALLYAPPROPRIATEASANONGOINGCONTRACEPTIVEMETHOD 0HYSICIANSHAVETHEOBLIGATIONTOASSUREACCURATEINFORMATIONISAVAILABLEREGARDING EMERGENCYCONTRACEPTION ASWELLASDISCUSSFUTURESTRATEGIESFORINDIVIDUALSTOAVOIDTHENEED FOREMERGENCYCONTRACEPTION  !CCESSTOEMERGENCYCONTRACEPTIONSHOULDBEANESSENTIALCOMPONENTOFIMMEDIATECAREFOR WOMENWHOSUFFERRAPEANDAREEXPOSEDTOPREGNANCY!DOLESCENTSBECAUSEOFTHEIRSPECIAL VULNERABILITYINSOCIETYFORMANOTHERGROUPFORWHOMEMERGENCYCONTRACEPTIONSHOULDBE MADEEASILYAVAILABLE

4HE2OLEOFTHE/B'YNAS!DVOCATESFOR7OMENS(EALTHPAGE2ECOMMENDATIONSON%THICAL)SSUESIN/BSTETRICSAND'YNECOLOGY BY4HE&)'/#OMMITTEEFORTHE%THICAL!SPECTSOF(UMAN2EPRODUCTIONAND7OMENS(EALTH !UGUST $ElNITIONOFPREGNANCYh.ATURALHUMANREPRODUCTIONISAPROCESSWHICHINVOLVESTHEPRODUCTIONOFMALEANDFEMALEGAMETESAND THEIRUNIONATFERTILIZATION0REGNANCYISTHATPARTOFTHEPROCESSTHATCOMMENCESWITHTHEIMPLANTATIONOFTHECONCEPTUSINAWOMAN ANDENDSWITHEITHERTHEBIRTHOFANINFANTORANABORTIONv4HE&)'/#OMMITTEEFORTHE%THICAL!SPECTSOF(UMAN2EPRODUCTIONAND 7OMENS(EALTH !UGUST 0UBLISHEDINTHE)NTERNATIONAL*OURNALOF'YNECOLOGYAND/BSTETRICS -ARCHVOLUME h)NDUCEDABORTIONMAYBEDElNEDASTHETERMINATIONOFPREGNANCYUSINGDRUGSORSURGICALINTERVENTIONAFTERIMPLANTATIONAND BEFORETHECONCEPTUSHASBECOMEINDEPENDENTLYVIABLEv7(/DElNITIONOFABIRTHWEEKSMENSTRUALAGEORMORE 4HE&)'/ #OMMITTEEFORTHE%THICAL!SPECTSOF(UMAN2EPRODUCTIONAND7OMENS(EALTH !UGUST 0UBLISHEDINTHE)NTERNATIONAL*OURNAL OF'YNECOLOGYAND/BSTETRICS -ARCHVOLUME

4HISMATERIALORIGINALLYPRINTEDINTHE)NTERNATIONAL*OURNALOF'YNECOLOGYAND/BSTETRICS   2EPRINTEDWITHPERMISSIONFROMTHE)NTERNATIONAL&EDERATIONOF'YNECOLOGYAND/BSTETRICS&)'/ %THICS #OMMITTEE.OTE#OMMITTEEDOCUMENTSDONOTREPRESENT&)'/SOFlCIALPOSITIONRATHERTHEYREPRESENTTHE VIEWSOFAGROUPOFINDEPENDENTEXPERTS

!  -ODULE! 4OOLS

!  4OOLS

)NTERNATIONAL0LANNED0ARENTHOOD&EDERATION -ODULE! 3TATEMENTON%MERGENCY#ONTRACEPTION

)NTRODUCTION $ESPITETHEAVAILABILITYOFHIGHLYEFFECTIVEMETHODSOFCONTRACEPTION MANYPREGNANCIES AREUNPLANNEDANDUNWANTED3UCHPREGNANCIESCANRESULTINABORTIONANDCARRYANEXCESS RISKOFMORBIDITYANDMORTALITY4HERISKOFPREGNANCYWITHONEUNPROTECTEDACTOFSEXUAL INTERCOURSECANBEASHIGHASONEINTHREE DEPENDINGONTHECYCLEDAYOFEXPOSUREIN RELATIONTOOVULATION&ORTHEWOMANEXPOSEDTOUNPROTECTEDSEXUALINTERCOURSE EG LACKOF CONTRACEPTIVEUSE CONDOMBREAKAGE MISSEDPILLS ORSEXUALASSAULT EMERGENCYCONTRACEPTION CANBEUSEDTOPREVENTANUNWANTEDPREGNANCY 3INCETHEMID S THEPOST COITALUSEOFCERTAINORALLYADMINISTEREDSTEROIDHORMONESHAS BEENSHOWNTOBEEFFECTIVEINPREVENTINGPREGNANCY)NADDITION INTRAUTERINEDEVICES)5$ ANDTHEANTI MIFEPRISTONEAREALSOHIGHLYEFFECTIVEFOREMERGENCYCONTRACEPTION

(ORMONAL-ETHODS 4WOCOMMONLYAVAILABLEORALREGIMENSHAVEPROVEDTOBESAFEANDEFFECTIVEFOREMERGENCY CONTRACEPTION

,EVONOGESTREL ONLYREGIMEN 4HEMOSTCONVENIENTREGIMENISASINGLEDOSECONSISTINGOFMGLEVONORGESTRELTAKEN ASSOONASPOSSIBLEAFTERUNPROTECTEDINTERCOURSEALTERNATIVELY ONEDOSEOFMG LEVONORGESTRELCANBETAKENASSOONASPOSSIBLEAFTERUNPROTECTEDINTERCOURSEFOLLOWEDBYTHE SAMEDOSETAKENHOURSLATER ,EVONORGESTRELPILLSAREMOREEFFECTIVETHESOONERTHEYARETAKENAFTERUNPROTECTED INTERCOURSE4HEYAREMOSTEFFECTIVEIFTAKENWITHINDAYSHOURS (OWEVER THEREISSTILL SOMEEFFECTUPTODAYSAFTERUNPROTECTEDINTERCOURSE 7HEREPILLSCONTAININGMGLEVONORGESTRELARENOTAVAILABLE MGLEVONORGESTREL PILLSWHICHAREUSEDFORREGULARCONTRACEPTIONOFFERAPOSSIBLEALTERNATIVE4WENTY lVEOF THESEMINIPILLSSHOULDBETAKENINITIALLY ANDAFURTHERTWENTY lVEHOURSLATER4HEREIS ANECDOTALEVIDENCETOSUPPORTTHISREGIMEN BUTNOCLINICALSTUDIESHAVEEVALUATEDITSEFlCACY

#OMBINEDESTROGEN PROGESTINREGIMEN 4HISREGIMENCONSISTSOFTWO—GETHINYLESTRADIOLMGLEVONORGESTRELPILLS ORFOUR —GETHINYLESTRADIOLMGLEVONORGESTRELPILLS TAKENASSOONASPOSSIBLEWITHINHOURS AFTERUNPROTECTEDINTERCOURSE FOLLOWEDBYASECONDSIMILARDOSEHOURSLATER4HISMETHOD SHOWSLITTLEEFlCACYAFTERHOURSFROMUNPROTECTEDINTERCOURSE

!  #HOICEOFMETHOD 4HELEVONOGESTREL ONLYREGIMENSHOULDBETHElRSTCHOICEWHEREAVAILABLEBECAUSEITIS MOREEFFECTIVEANDISLESSLIKELYTOCAUSENAUSEATHANTHECOMBINEDREGIMEN(OWEVER THE COMBINEDREGIMENSHOULDREMAINANOPTIONWHERETHELEVONORGESTREL ONLYREGIMEISLESS -ODULE! ACCESSIBLEANDMORECOSTLY ASINMANYCOUNTRIES

-ECHANISMOFACTION

4OOLS (ORMONALEMERGENCYCONTRACEPTIONACHIEVESITSCONTRACEPTIVEEFFECTBYSEVERALMECHANISMS DEPENDINGONTHETIMEINAWOMANSCYCLEITISTAKEN)TCANINHIBITORDELAYOVULATIONAND MAYALSOINTERFEREWITHOVUMANDSPERMTRANSPORTANDFERTILIZATION3TUDIESDIFFERONWHETHER HORMONALEMERGENCYCONTRACEPTIONCANCAUSECHANGESINTHEENDOMETRIUMTHATWOULDBE SUFlCIENTTOINTERFEREWITHIMPLANTATION4HEREISNOEVIDENCETHATHORMONALEMERGENCY CONTRACEPTIONDISLODGESTHEEMBRYOAFTERIMPLANTATIONHASOCCURRED(ORMONALEMERGENCY CONTRACEPTIONDOESNOTCAUSEANABORTIONv

%FlCACY 6ARIOUSSTUDIESHAVESHOWNTHATTHELEVONORGESTREL ONLYREGIMENREDUCESTHERISKOF PREGNANCYBY ORMOREAFTERASINGLEACTOFINTERCOURSE ANDTHECOMBINEDREGIMEN REDUCESITBY )NDIRECTCOMPARISONS THELEVONORGESTRELREGIMENHASBEENSHOWN TOBESUBSTANTIALLYMOREEFFECTIVETHANTHECOMBINEDREGIMEN%#0SARENOTASEFFECTIVEAS CONSISTENTANDCORRECTUSEOFMOSTMODERNCONTRACEPTIVEMETHODS

%LIGIBILITYCRITERIA .OKNOWNCONTRAINDICATIONSEXISTTOTHEUSEOFHORMONALEMERGENCYCONTRACEPTION!LTHOUGH THISMETHODISNOTINDICATEDFORAWOMANWITHAKNOWNORSUSPECTEDPREGNANCY ITWILL NOTAFFECTTHECOURSEOFHERPREGNANCY ORHARMTHEFOETUS4HEREISNONEEDFORAPHYSICAL EXAMINATIONORPREGNANCYTESTBEFOREITISPROVIDED

3IDE EFFECTS .AUSEAANDVOMITINGARECOMMONAMONGWOMENUSINGTHECOMBINEDREGIMENAND CONSIDERABLYLESSCOMMONAMONGWOMENUSINGTHELEVONORGESTREL ONLYREGIMEN7HEN THECOMBINEDREGIMENISUSED ANTI EMETICPRETREATMENTMAYBECONSIDEREDWITHTHE LEVONORGESTREL ONLYREGIMENTHISISUNNECESSARY )FVOMITINGOCCURSWITHINONEHOURAFTERTAKINGADOSE ITISCOMMONPRACTICETOREPEATTHE DOSE(OWEVER THEREISNOEVIDENCETHATTHISIMPROVESEFlCACYINDEED VOMITINGCANBE ANINDICATIONTHATTHEHORMONEHASBEENABSORBED)NCASEOFVOMITING FURTHERPILLSMAYBE ADMINISTEREDVAGINALLY!LTHOUGHTHEREARENOCLINICALDATASUPPORTINGTHEEFlCACYOFTHIS PRACTICE CONTRACEPTIVESTEROIDHORMONESAREKNOWNTOBEREADILYABSORBEDFROMTHEVAGINA /THERSIDE EFFECTSWITHHORMONAL%#INCLUDEABDOMINALPAIN FATIGUE HEADACHE DIZZINESS ANDBREASTTENDERNESS!FTERTHEUSEOFHORMONALEMERGENCYCONTRACEPTION MENSESUSUALLY OCCURATTHEREGULARTIME BUTMAYBEEITHEREARLIERORLATER3OMEWOMENMAYEXPERIENCE IRREGULARBLEEDINGORSPOTTINGAFTERTAKING%#0S

!  4OOLS

$RUGINTERACTIONS -ODULE! 7OMENSHOULDBEADVISEDTHATTHEEFFECTIVENESSOF%#0MAYBEREDUCEDIFTHEYARETAKING DRUGSWHICHREDUCETHEEFlCACYOFREGULARORALCONTRACEPTIVESINCLUDINGBUTNOTLIMITEDTO RIFAMPICIN GRISEOFULVIN BARBITURATES !TTHECURRENTTIMETHEREISINSUFlCIENTINFORMATIONON DRUGINTERACTIONSTOMAKEANYSPECIlCRECOMMENDATIONSONINCREASED%#0DOSINGSCHEDULES

&REQUENCYOFUSE (ORMONALEMERGENCYCONTRACEPTIONSHOULDNOTBEUSEDFORROUTINEPREGNANCYPREVENTION SINCETHECUMULATIVEPREGNANCYRATEFORFREQUENTUSEOF%#0ISHIGHERTHANTHATWITHREGULAR CONTRACEPTION(OWEVER IFUNPROTECTEDINTERCOURSEOCCURSINACYCLEWHERETHEEMERGENCY CONTRACEPTIONHASALREADYBEENUSEDITCANBEREPEATED7OMENSHOULDUNDERSTANDTHAT EMERGENCYCONTRACEPTIONPILLSMAYNOTPROTECTTHEMFROMTHEPOSSIBILITYOFPREGNANCYFROM EPISODESOFUNPROTECTEDINTERCOURSEMORETHANDAYSBEFORETHE%#0SARETAKENORFROM INTERCOURSEAFTERTHEPILLSARETAKEN )NCYCLESWHEREUNPROTECTEDINTERCOURSEHASOCCURREDMORETHANONCE HORMONALEMERGENCY CONTRACEPTIONCANBEUSED(OWEVER EFlCACYWILLBEINmUENCEDBYTHETIMEINTERVALSINCE THElRSTACTOFUNPROTECTEDINTERCOURSE)FTHEWOMANISALREADYPREGNANTBECAUSEOFEARLIER INTERCOURSE EMERGENCYCONTRACEPTIONWILLNOTBEEFFECTIVE

-IFEPRISTONE !SINGLEDOSEOFMIFEPRISTONEMGTAKENWITHINDAYSOFUNPROTECTEDINTERCOURSEISHIGHLY EFFECTIVEFOREMERGENCYCONTRACEPTION)THASALOWINCIDENCEOFSIDE EFFECTS(OWEVER  OFWOMENEXPERIENCEADELAYOFMENSESOFMORETHANDAYS7OMENSHOULDBE COUNSELLEDAPPROPRIATELY!MAJORCONSTRAINTFROMTHEUSEOFMIFEPRISTONEISITSLIMITED AVAILABILITY

#OPPER RELEASING)5$S 4HECOPPER RELEASING)5$ISALSOHIGHLYEFFECTIVEFOREMERGENCYCONTRACEPTION)TCANREDUCE THECHANCEOFPREGNANCYBYMORETHANWHENINSERTEDWITHINDAYSOFUNPROTECTED INTERCOURSE4HISMETHODMAYBEPARTICULARLYUSEFULWHENTHECLIENTISCONSIDERINGITSUSEFOR LONG TERMCONTRACEPTIONANDORWHENTHEHORMONALREGIMENSARELESSEFFECTIVEBECAUSEMORE THANHOURSHAVEELAPSED7HENUSINGAN)5$FOREMERGENCYCONTRACEPTION THEELIGIBILITY CRITERIAARETHESAMEASTHOSEFORREGULARUSEOFTHESEDEVICES

%SSENTIALINFORMATIONFORUSERS )NFORMATIONONEMERGENCYCONTRACEPTIONSHOULDBEAVAILABLETOALLWOMENWHOMAYNEEDTHE METHOD7HETHERCONTAINEDINPRODUCTPAMPHLETSOROFFEREDBYASERVICEPROVIDER ITSHOULD INCLUDEGUIDANCEONTHEFOLLOWING s #ORRECTUSE s 0OSSIBLESIDE EFFECTSANDTHEIRMANAGEMENT

!  s 2ISKOFPREGNANCYDETECTIONANDMANAGEMENTOFPOSSIBLEFAILUREOFTHE%#0STOPREVENT PREGNANCY s #HANGESINTHEMENSTRUALPATTERN

-ODULE! s 0REFERENCESFORREGULARCONTRACEPTION s 34)RISK

2ISKOFPREGNANCY

4OOLS )FMENSTRUATIONISDELAYEDBYMORETHANONEWEEKFROMTHEEXPECTEDTIMEORIFITISMUCH LIGHTERTHANNORMAL EMERGENCYCONTRACEPTIONMAYHAVEFAILEDANDTHEWOMANSHOULD CONSIDERTHEPOSSIBILITYTHATSHEMAYBEPREGNANT)NTHEEVENTOFAPREGNANCY SHESHOULDBE COUNSELLEDONTHEAVAILABLEOPTIONSANDHERDECISIONSHOULDBERESPECTEDANDSUPPORTED)F SHECHOOSESTOCONTINUEWITHTHEPREGNANCY SHESHOULDBEREASSUREDTHATTHEREISNOEVIDENCE THATHORMONALEMERGENCYCONTRACEPTIONAFFECTSTHEFOETUS4HEUSEOFHORMONALEMERGENCY CONTRACEPTIONHASNOIMPACTONFUTUREFERTILITY

2EGULARCONTRACEPTION !FTERUSEOFEMERGENCYCONTRACEPTION WOMENSHOULDEMPLOYANOTHERMETHODOF CONTRACEPTIONEGCONDOMS IFSHECONTINUESTOHAVESEXUALINTERCOURSE)FORALCONTRACEPTION ISCHOSEN ITCANBESTARTEDTHEDAYAFTERTHE%#0REGIMENISCOMPLETED 7OMENWHOBEGAN REGULARUSEOFHORMONALCONTRACEPTIONIMMEDIATELYAFTEREMERGENCYCONTRACEPTIONSHOULDBE ADVISEDTOEXPECTWITHDRAWALBLEEDINGTHREEWEEKSAFTERSTARTINGTHEPILLS7OMENCHOOSING ALONG ACTINGHORMONALCONTRACEPTIVESHOULDSTARTTHEMETHODAFTERTHEONSETOFTHElRST MENSTRUALPERIODORAFTERPREGNANCYHASBEENEXCLUDED7OMENOPTINGFORTHE)5$FOR EMERGENCYCONTRACEPTIONSHOULDBEADVISEDTHATTHE)5$WILLPROVIDEONGOINGPROTECTION FROMPREGNANCYFROMTHETIMEOFINSERTIONFOLLOW UPSHOULDBEARRANGEDAFTERTHEEXPECTED DATEOFMENSTRUATIONTOENSURETHATPREGNANCYHASBEENPREVENTEDANDFORCOUNSELLING ONREGULARCONTRACEPTION7OMENWHOCHOOSETOCONTINUEUSINGTHE)5$FORLONG TERM CONTRACEPTIONSHOULDSUBSEQUENTLYRECEIVETHESAMESERVICESASANYOTHER)5$USER)F AWOMANCHOOSESTOHAVETHE)5$REMOVED SHESHOULDBEADVISEDTOCOMEBACKDURING MENSTRUATIONFORREMOVALANDINITIATIONOFANOTHERCONTRACEPTIVEMETHOD

3EXUALLYTRANSMITTEDINFECTIONS34)S %MERGENCYCONTRACEPTIONDOESNOTPROTECTAGAINSTSEXUALLYTRANSMITTEDINFECTIONS7OMEN WHOHAVEHADUNPROTECTEDINTERCOURSESHOULDBEADVISEDABOUTTHEPOSSIBILITYOF34)S4HOSE WHOMAYHAVEBEENEXPOSEDTO34)SSHOULDBEOFFEREDTESTINGORPRESUMPTIVETREATMENTTHAT CURESTHECOMMONLYOCCURRING34)SANDBECOUNSELLEDAPPROPRIATELY&ORWOMENWHOMAY HAVEBEENEXPOSEDTO()6 POSTEXPOSUREPROPHYLAXISWITH!26SSHOULDBEOFFEREDWHERE AVAILABLEANDWITHAPPROPRIATECOUNSELLINGANDFOLLOW UP

!DVOCACYAND!CCESS )00&MEMBERASSOCIATIONSHAVEANIMPORTANTROLETOPLAYININCREASINGAWARENESSOF EMERGENCYCONTRACEPTIONANDADVOCATINGFORITSEASYACCESSINLOCALCOMMUNITIES-EMBER ASSOCIATIONSSHOULDUNDERTAKEACTIVITIESINTHEFOLLOWINGAREAS

!  4OOLS

)NCREASINGTHEAVAILABILITYOFEMERGENCYCONTRACEPTION -ODULE! -EMBERASSOCIATIONSPROVIDINGSERVICESSHOULDINCLUDEEMERGENCYCONTRACEPTIONIN THEIRMETHODMIXANDINTEGRATEEMERGENCYCONTRACEPTIONINTOTHEIRNATIONALPROGRAMMES !SSOCIATIONSCANPLAYALEADROLEINENSURINGTHEEXISTENCEOFADEDICATED%#PRODUCTINTHEIR COUNTRIESANDCAMPAIGNINGFORITSOVER THE COUNTERSTATUS

!DVOCACYANDDISSEMINATION -EMBERASSOCIATIONSSHOULDDISSEMINATEINFORMATIONONEMERGENCYCONTRACEPTIONANDHOW TOOBTAINIT BYMEANS INCLUDINGMASSMEDIA TRAININGOFSERVICEPROVIDERS ANDSEXUALAND REPRODUCTIVEHEALTHEDUCATIONPROGRAMMES)NFORMATIONGEAREDSPECIlCALLYTOTHENEEDSOF YOUNGPEOPLEISPARTICULARLYIMPORTANT

)NCREASINGACCESSTOSUPPLIESANDSERVICES %MERGENCYCONTRACEPTIONSHOULDBEWIDELYAVAILABLEINCLINICALANDNONCLINICALSETTINGS SUCHASCOMMUNITY BASEDSERVICES SOCIALMARKETINGPROGRAMMES ANDTHECOMMERCIAL SECTOR-EMBERASSOCIATIONSCANWORKTOINCREASEACCESSTHROUGHTHEADVANCEPROVISIONOF EMERGENCYCONTRACEPTIONTOINDIVIDUALWOMEN

/VERCOMINGOBSTACLES -EMBERASSOCIATIONSSHOULDINITIATELOCALLYRELEVANTEFFORTSAIMEDATREMOVINGTHEMULTIPLE SOCIAL CULTURALANDRELIGIOUSBARRIERSTOEMERGENCYCONTRACEPTION

 6WDWHPHQWGHYHORSHGE\WKH,QWHUQDWLRQDO0HGLFDO$GYLVRU\3DQHO ,0$3 0D\DQGUHYLVHGLQ2FWREHU,0$3 UHVHUYHVWKHULJKWWRDPHQGWKLV6WDWHPHQWLQWKHOLJKWRIIXUWKHUGHYHORSPHQWVLQWKLV¿HOG

,17(51$7,21$/3/$11('3$5(17+22')('(5$7,21 5(*(17¶6&2//(*(,11(5&,5&/(5(*(17¶63$5./21'211:168. 7(/(3+21(     )$;   (0$,/$''5(66PHGWHFK#LSSIRUJ  ,33):(%6,7(ZZZLSSIRUJ

4HISMATERIALWASREPRINTEDWITHPERMISSIONFROMTHE)NTERNATIONAL0LANNED0ARENTHOOD&EDERATION

!  -ODULE! 4OOLS

!  4OOLS

5NITED.ATIONS0OPULATION&UND5.&0! -ODULE! 3TATEMENTON%MERGENCY#ONTRACEPTION 4HE5NITED.ATIONS0OPULATION&UND5.&0! ENDORSESTHEVIEWTHATTHEAIMOFFAMILY PLANNINGPROGRAMSMUSTBETOENABLECOUPLESANDINDIVIDUALSTODECIDEFREELYANDRESPONSIBLY THENUMBERANDSPACINGOFTHEIRCHILDRENANDTOHAVETHEINFORMATIONANDMEANSTODOSOAND TOENSUREINFORMEDCHOICESANDMAKEAVAILABLEAFULLRANGEOFSAFEANDEFFECTIVEMETHODS )#0$PARA )NRESPONSETOGOVERNMENTREQUESTS 5.&0!CANPROVIDESUPPLIESFOR THOSEMETHODSINCLUDINGPROGESTIN ONLYDEDICATEDEMERGENCYCONTRACEPTIVEPILLS5.&0! ISCOMMITTEDTOREDUCINGTHEINCIDENCEOFABORTIONANDITDOESNOTPROMOTEORSUPPORT ABORTIONINANYCOUNTRY5.&0!SUPPORTSEMERGENCYCONTRACEPTIONASAMEANSFOREXPANDING CONTRACEPTIVECHOICEANDREDUCINGABORTION)NLINEWITHACCEPTEDDElNITIONSOFMEDICAL SCIENCE THE7ORLD(EALTH/RGANIZATIONSTATES h%MERGENCYCONTRACEPTIVEPILLSDONOT INTERRUPTPREGNANCYANDTHUSARENOFORMOFABORTIONv"YMAKINGEMERGENCYCONTRACEPTION MOREWIDELYAVAILABLE REPRODUCTIVEHEALTHCAREPROVIDERSOFFAMILYPLANNINGCANHELPREDUCE UNPLANNEDPREGNANCIES MANYOFWHICHRESULTINUNSAFEABORTIONANDTAKEALARGETOLLON WOMENSHEALTH%MERGENCYCONTRACEPTIONALSOISANESSENTIALPARTOFTREATMENTFORWOMEN WHOAREVICTIMSOFSEXUALASSAULT5.&0!SHARESTHEVIEWTHAT%#SHOULDBEPROMPTLY AVAILABLEASABACK UPFORUNPROTECTEDINTERCOURSE7ITHITSMAJORROLEINTHEPREVENTION OFBOTHUNINTENDEDPREGNANCIESANDRECOURSETOABORTION %#ISAVALUABLEADDITIONTO REPRODUCTIVEHEALTHPROGRAMS5.&0!COLLABORATESWITHNATIONALAUTHORITIESTOIMPROVE ACCESSTO%#ASPARTOFHIGH QUALITYCAREFORREPRODUCTIVEHEALTH

4HISSTATEMENTISPROVIDEDHEREWITHPERMISSIONFROMTHE5NITED.ATIONS0OPULATION&UND 

!  -ODULE! 4OOLS

!  4OOLS

5NITED3TATES!GENCYFOR)NTERNATIONAL -ODULE! $EVELOPMENT53!)$ 3TATEMENTON%MERGENCY#ONTRACEPTION 53!)$ISCOMMITTEDTOPROVIDINGAFULLRANGEOFCONTRACEPTIVEOPTIONS0ROVIDING INFORMATIONABOUT%#0SHASBECOMEAMEDICALNORM)NFACT THE!MERICAN#OLLEGEOF /BSTETRICIANSAND'YNECOLOGISTS!#/' NOWRECOMMENDSTHATWOMENBEINFORMEDOF %#0SASSTANDARDGOODMEDICALPRACTICE4HE53&$!ACTIONFURTHERREINFORCESTHISNORM !CCORDINGLY 53!)$SUPPLIESINFORMATIONABOUTTHEUSEOF%#0SINAVARIETYOFITSTECHNICAL ANDTRAININGMATERIALS ANDSUPPORTSSHARINGINFORMATIONWITHFAMILYPLANNINGCLIENTSABOUT THISCONTRACEPTIVEOPTION!NOTHERROLEFOR53!)$ SUPPORTEDPROGRAMSISTOCOLLECTDATAON THENEED USE ANDPOTENTIALIMPACTOF%#0SINPARTICIPATINGCOUNTRIESTOCONDUCTOPERATIONS RESEARCHONHOWTHEPROVISIONOF%#0SCANBEINTEGRATEDWITHINFAMILYPLANNINGANDOTHER REPRODUCTIVEHEALTHPROGRAMSANDWHICHGROUPSWOULDBENElTMOSTFROMHAVING%#0S AVAILABLEANDBIOMEDICALRESEARCHONTHEMECHANISMOFACTION USE ANDEFFECTIVENESSOF %#0S!LTHOUGH53!)$ SUPPLIEDORALCONTRACEPTIVEPILLSAREAMONGTHE&$! APPROVED FORMULATIONSTHATCANBEUSEDFOREMERGENCYCONTRACEPTION 53!)$DOESNOTCURRENTLY FUNDSEPARATEPACKAGINGOFPILLSFORTHISPURPOSENORHAS53!)$PURCHASEDANYOFTHETWO 53&$! APPROVEDDEDICATED%#0PRODUCTS53!)$ISABLETOHELPINTERESTED-ISSIONSSEEK OUTOTHERSOURCESOFDONORSUPPORTFORTHEPROVISIONOFADEDICATED%#PRODUCT

4HE53&$!PUBLISHEDAFORMALNOTICEON&EBRUARY  INTHE&EDERAL2EGISTERSTATINGTHATANYONEOFSIXDIFFERENT;ANDNOW MANYMORE=COMMONBRANDSOFCOMBINEDORALCONTRACEPTIVEPILLS ALLCONTAININGNORGESTRELORLEVONORGESTRELANDETHINYLESTRADIOL ARE SAFEANDEFFECTIVEFORUSEASEMERGENCYCONTRACEPTIONUPTODAYSAFTERUNPROTECTEDSEX

4HISSTATEMENTISPROVIDEDHEREWITHPERMISSIONFROMTHE5NITED3TATES!GENCYFOR)NTERNATIONAL$EVELOPMENT   !  -ODULE! 4OOLS

!  4OOLS

7ORLD(EALTH/RGANIZATION%MERGENCY -ODULE! #ONTRACEPTION3TATEMENT

%MERGENCY#ONTRACEPTION %MERGENCYCONTRACEPTIONREFERSTOCONTRACEPTIVEMETHODSTHATCANBEUSEDBYWOMENIN THElRSTFEWDAYSFOLLOWINGUNPROTECTEDINTERCOURSETOPREVENTANUNWANTEDPREGNANCY %MERGENCYCONTRACEPTIVEMETHODSAREEFFECTIVEANDSAFEFORTHEMAJORITYOFWOMENWHOMAY NEEDTHEM ASWELLASBEINGSIMPLETOUSE

7HOMAYNEEDEMERGENCYCONTRACEPTION !NYWOMANOFREPRODUCTIVEAGEMAYNEEDEMERGENCYCONTRACEPTIONATSOMEPOINTTOAVOID ANUNWANTEDPREGNANCY)TISMEANTTOBEUSEDINSITUATIONSSUCHAS s AFTERVOLUNTARYSEXUALINTERCOURSETHATTOOKPLACEWITHNOCONTRACEPTIVEPROTECTION s AFTERINCORRECTORINCONSISTENTUSEOFREGULARCONTRACEPTIVEMETHODSORWHENTHEREHASBEENAN ACCIDENTALFAILUREOFOTHERCONTRACEPTIVEMETHODSSUCHAS s CONDOMBREAKAGEORSLIPPAGE s MISCALCULATIONOFTHEINFERTILEPERIODWHENUSINGPERIODICABSTINENCEORFAILURETOABSTAIN FROMSEXUALINTERCOURSEDURINGTHEFERTILEDAYS s EXPULSIONOFANINTRAUTERINEDEVICE)5$  s FAILEDCOITUSINTERRUPTUS WHENEJACULATIONHASOCCURREDINTHEVAGINAORONTHEEXTERNAL GENITALIA s FAILURETOTAKEORALCONTRACEPTIVESFORMORETHANDAYS s BEINGLATEFORACONTRACEPTIVEINJECTION s WHENAWOMANHASBEENAVICTIMOFSEXUALASSAULTANDHASHADNOCONTRACEPTIVEPROTECTION

-ETHODSOFEMERGENCYCONTRACEPTION 4HEMOSTCOMMONMETHODSOFEMERGENCYCONTRACEPTIONARE s HIGHDOSESOFCOMBINEDORALCONTRACEPTIVES#/#S CONTAININGETHYNYLESTRADIOLAND LEVONORGESTREL9UZPEREGIMEN  s HIGHDOSESOFPROGESTOGEN ONLYPILLCONTAININGLEVONORGESTREL

-ODEOFACTION %MERGENCYCONTRACEPTIONPILLS%#0S ARETHOUGHTTOPREVENTOVULATION FERTILIZATION ANDOR IMPLANTATION%#0SARENOTEFFECTIVEONCETHEPROCESSOFIMPLANTATIONHASBEGUN ANDWILLNOT CAUSEABORTION

!  %FlCACY !FTERASINGLEACTOFUNPROTECTEDSEXUALINTERCOURSE THE9UZPEREGIMENFAILSINABOUT PERCENTOFWOMENWHOUSEITCORRECTLYTHECHANCESOFPREGNANCYAREAPPROXIMATELYFOUR TIMESGREATERWHENNOEMERGENCYCONTRACEPTIVEISUSED 4HEPROGESTOGEN ONLYREGIMENIS -ODULE! EQUALLYEFFECTIVE

%LIGIBILITYCRITERIA

4OOLS 4HE7ORLD(EALTH/RGANIZATION7(/ HASDRAWNUPMEDICALELIGIBILITYCRITERIAFORTHEUSE OFEMERGENCYCONTRACEPTIONPILLSBASEDONTHERELATIVEHEALTHRISKSANDBENElTSOFTHEMETHOD FORWOMENWITHGIVENCONDITIONS 4HESOLECONTRAINDICATIONFORTHEUSEOFEMERGENCYCONTRACEPTIONPILLSISPREGNANCY %MERGENCYCONTRACEPTIONPILLSSHOULDNOTBEGIVENTOAWOMANWHOHASACONlRMED PREGNANCYPRIMARILYBECAUSETHEYWILLNOTBEEFFECT%XPERTSBELIEVETHEREISNOHARMTOA PREGNANTWOMANORFETUSIFEMERGENCYCONTRACEPTIVEPILLSAREINADVERTENTLYUSEDDURINGEARLY PREGNANCY%MERGENCYCONTRACEPTIVEPILLSAREFOREMERGENCYUSEONLYANDNOTRECOMMENDED FORROUTINEUSEBECAUSEOFTHEHIGHERPOSSIBILITYOFFAILURECOMPAREDTOREGULARCONTRACEPTIVES ANDTHEINCREASEINSIDEEFFECTSSUCHASNAUSEAANDVOMITTING(OWEVER THEIRREPEATEDUSE POSESNOKNOWNHEALTHRISKS

&URTHERREADING #ONSORTIUMFOR%MERGENCY#ONTRACEPTION%MERGENCY#ONTRACEPTIVE0ILLS!RESOURCEPACKET FORHEALTHCAREPROVIDERSAND0ROGRAMME-ANAGERS 7ELLS% #ROOK" -ULLER.%MERGENCY#ONTRACEPTION!RESOURCE-ANUALFOR0ROVIDERS 0!4(  7ORLD(EALTH/RGANIZATION%MERGENCY#ONTRACEPTION!GUIDEFORSERVICEDELIVERY7(/ &2(&00 7ORLD(EALTH/RGANIZATION)MPROVING!CCESSTO1UALITY#AREIN&AMILY0LANNING-EDICAL %LIGIBILITY#RITERIAFOR#ONTRACEPTIVE5SE7(/&2(&00

4HISINFORMATIONORIGINALLYPRINTEDAS7(/FACTSHEET.O*UNE WASREPRINTEDWITHPERMISSIONFROM THE7ORLD(EALTH/RGANIZATION

!  4OOLS

!NNOTATED"IBLIOGRAPHYOF#ORE%VIDENCE "ASED -ODULE! 2ESEARCHON%MERGENCY#ONTRACEPTION

3PECIAL.OTE 7KLVDQQRWDWHGELEOLRJUDSK\FRQWDLQVDQQRWDWLRQVRIPRVWRIWKHDUWLFOHVUHIHUHQFHGLQ 0RGXOH$,QIRUPDWLRQIRU3ROLF\0DNHUV([FHSWLRQVLQFOXGHWKRVHDUWLFOHVVXPPDUL]HG LQHLWKHU6WDWLVWLFDO(YLGHQFH&RQFHUQLQJWKH0HFKDQLVPRI$FWLRQRIWKH

!IKEN !- 3ACKEY . AND'OLD -!4HATWASTHEN THISISNOWxCHANGESINYOUNGWOMENS KNOWLEDGE ATTITUDES ANDPERCEIVEDBARRIERSTOUSINGEMERGENCYCONTRACEPTION*OURNALOF0EDIATRIC AND!DOLESCENT'YNECOLOGY    7KLVDEVWUDFWGHVFULEHVDVWXG\SUHVHQWHGDWWKH1RUWK$PHULFDQ6RFLHW\RI3HGLDWULFDQG $GROHVFHQW*\QHFRORJ\¶VDQQXDOFRQIHUHQFHRQ0D\LQ3KLODGHOSKLD3HQQV\OYDQLD 7KHSXUSRVHRIWKHVWXG\ZDVWRFRPSDUHWKHNQRZOHGJHDWWLWXGHVDQGSHUFHLYHGEDUULHUV WR(&3XVHEHWZHHQWZRVDPSOHVRI\RXQJZRPHQRQHIURPDQGWKHRWKHUIURP 2QHKXQGUHG\RXQJZRPHQZHUHUHFUXLWHGLQIURPWKHVDPHDGROHVFHQWFOLQLF DVWKHVDPSOH6HYHQW\VHYHQSHUFHQWZHUH$IULFDQ$PHULFDQDQGSHUFHQWRIWKH SDUWLFLSDQWVKDGEHHQVH[XDOO\DFWLYH3DUWLFLSDQWVZDWFKHGDò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¿OORXWDTXHVWLRQQDLUHDQGWKRVHZKRSURYLGHGWHOHSKRQHFRQWDFWLQIRUPDWLRQZHUHFDOOHG IRUPRUHGHWDLOHGLQIRUPDWLRQ2YHUDWKUHHPRQWKSHULRGZRPHQZKRUHTXHVWHG(&3V

!  ZHUHJLYHQTXHVWLRQQDLUHV7ZRKXQGUHGDQG¿IW\QLQHZRPHQUHWXUQHGWKHTXHVWLRQQDLUH  SHUFHQWUHVSRQVHUDWH 2IWKRVHZRPHQZKRUHWXUQHGWKHTXHVWLRQQDLUHZHUHIROORZHGXS IRUIXUWKHULQWHUYLHZVDQGZHUHLQWHUYLHZHG:RPHQZHUHVXSSRUWLYHRIDGYDQFHSURYLVLRQ DQGLQGLFDWHGWKDWLWZRXOGQRWFKDQJHWKHLUUHJXODUFRQWUDFHSWLYHXVH7KH\VXSSRUWHGZLGHU

-ODULE! GLVVHPLQDWLRQRILQIRUPDWLRQDQGVHUYLFHVHVSHFLDOO\IRU\RXQJHUZRPHQ6HYHUDOZRPHQ WKRXJKWWKDWSRWHQWLDO³DEXVH´RUKHDOWKULVNVRI(&3VZDUUDQWHGVWULFWFRQWUROZKLOHRWKHUV ZHUHVXSSRUWLYHRI(&3V7KHDXWKRUVFRQFOXGHGWKDWZRPHQDQGSURYLGHUVQHHGDFFXUDWH LQIRUPDWLRQDERXW(&3VDGYDQFHSURYLVLRQLVLPSRUWDQWHVSHFLDOO\LQFRXQWULHVZKHUH(&3V DUHQRW\HWDYDLODEOHIURPSKDUPDFLVWVDQGXSWDNHRIDGYDQFHSURYLVLRQPLJKWEHLPSURYHG 4OOLS E\VXEVLGL]LQJWKHFRVWRIWKHPHWKRG "RACKEN -"/RAL#ONTRACEPTIONANDCONGENITALMALFORMATIONSINOFFSPRINGAREVIEWANDMETA ANALYSISOFTHEPROSPECTIVESTUDIES/BSTETRICSAND'YNECOLOGY0T     7KLVPHWDDQDO\VLVZDVFRQGXFWHGRQSURVSHFWLYHHSLGHPLRORJLFVWXGLHVRQRUDOFRQWUDFHSWLYH SLOOV 2&3V DQGFRQJHQLWDOPDOIRUPDWLRQVWRGHWHUPLQHWKHRYHUDOOUHODWLYHULVNRIDQ DVVRFLDWLRQEHWZHHQFRQJHQLWDOPDOIRUPDWLRQVDQGUHJXODURUDOFRQWUDFHSWLYHV7KHDQDO\VLV IRXQGYHU\VWURQJHYLGHQFHDJDLQVWWKHK\SRWKHVLVWKDWH[SRVXUHWR2&3VLQSUHJQDQF\LV UHODWHGWRDULVNRIPDOIRUPDWLRQVLQVWLOOERUQEDELHVRUOLYHQHZERUQV*LYHQWKDWPXFKRIWKH VDIHW\GDWDRQ(&3VLVH[WUDSRODWHGIURPVWXGLHVFRQGXFWHGRQUHJXODU2&3VWKLVVWXG\KDV EHHQFLWHGLQVHYHUDOSDSHUVRQ(&3VDIHW\KLJKOLJKWLQJWKHLPSODXVLELOLW\WKDWLQDGYHUWHQW XVHGXULQJSUHJQDQF\PLJKWKDYHDQHIIHFWRQDGHYHORSLQJIHWXV #HAOHUA ,ETAL)NVESTIGATIONONKNOWLEDGEOFANDATTITUDETOEMERGENCYCONTRACEPTIONAMONG INDUCED ABORTIONWOMEN2EPRODUCTIONAND#ONTRACEPTION%NGLISHEDITION     7KLVSDSHUGHVFULEHVDVWXG\FRQGXFWHGLQ6KDQJKDL&KLQDWRDVVHVVZRPHQ¶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

!  4OOLS

WRWRRUWRPP 5HVXOWVVKRZHGWKDWRYXODWLRQGLGQRWRFFXUGXULQJWKH

HQVXLQJ¿YHGD\VLQSHUFHQWRIWKHSDUWLFLSDQWVQRULQSHUFHQWRIWKHSDUWLFLSDQWVZKR -ODULE! UHFHLYHGWKHIXOODQGKDOIGRVHUHVSHFWLYHO\DWIROOLFOHVL]HPP,QSHUFHQWRIWKRVH SDUWLFLSDQWVZKRUHFHLYHGDSODFHERQRRYXODWLRQRFFXUUHGGXULQJWKHFULWLFDOSHULRG$W IROOLFOHVL]HWRPPRYXODWLRQZDVQRWSUHYHQWHGE\WUHDWPHQW,QPRVWRIWKHWUHDWHG F\FOHVVH[VWHURLGDQGSODVPDJRQDGRWURSLQOHYHOVZHUHVLJQL¿FDQWO\GHSUHVVHGGXULQJ WKHFULWLFDOSHULRGHYHQZKHQIROOLFXODUUXSWXUHRFFXUUHG7KHDXWKRUVFRQFOXGHGWKDWWKH

!  WKHSLWXLWDU\RYDULDQD[LVFRUSXVOXWHXPIXQFWLRQDQGHQGRPHWULXPDWGLIIHUHQWVWDJHVRI WKHRYDULDQF\FOHZDVXQGHUWDNHQLQKHDOWK\VXUJLFDOO\VWHULOL]HGZRPHQZLWKUHJXODU PHQVWUXDOF\FOHVRYHUWZRF\FOHV'XULQJWKHVHFRQGPHQVWUXDOF\FOH WUHDWPHQWF\FOH WZR GRVHVRIPJOHYRQRUJHVWUHOZHUHJLYHQKRXUVDSDUW:RPHQUHFHLYHGWKHWUHDWPHQWLQ

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¿QGLQGLFDWLRQV RIKRUPRQHDFWLRQDIWHU/+VXUJH5HVXOWVRIWKHVWXG\VXJJHVWWKDWLQWHUIHUHQFHRI OHYRQRUJHVWUHORQWKH/+SUHRYXODWRU\VXUJHLVVWURQJO\GHSHQGHQWRQWKHVWDJHRIIROOLFXODU GHYHORSPHQW$QRYXODWLRQREVHUYHGLQ*URXS$LVDUHVXOWRIGLVUXSWLQJWKHGHYHORSPHQW DQGRUKRUPRQHDFWLYLW\RIWKHIROOLFOHRQO\LQWKHSUHRYXODWRU\VWDJH/HYRQRUJHVWUHOGLG QRWDIIHFWWKHFRUSXVOXWHXPIXQFWLRQRUHQGRPHWULXPZKHQJLYHQGXULQJWKHSHULDQG SRVWRYXODWRU\VWDJHV %LLERTSON #ETAL%MERGENCYCONTRACEPTIONRANDOMIZEDCOMPARISONOFADVANCEPROVISIONAND INFORMATIONONLY/BSTETRICSAND'YNECOLOGY    7KLVDUWLFOHUHSRUWVWKHUHVXOWVRIDVWXG\XQGHUWDNHQLQ,QGLDWRGHWHUPLQHZKHWKHUVHYHUDO FRXUVHVRI(&3VSURYLGHGLQDGYDQFHWRZRPHQZRXOGWHPSWZRPHQXVLQJEDUULHUPHWKRGV WRWDNHPRUHULVNVZLWKWKHLUHIIHFWLYHRQJRLQJFRQWUDFHSWLYHV0RVWRIWKHZRPHQHQUROOHG LQWKHVWXG\ZHUHFRQGRPXVHUV)RXUKXQGUHGDQGHOHYHQZRPHQZKRXVHGEDUULHU FRQWUDFHSWLYHVZHUHUDQGRPO\DVVLJQHGWRRQHRIWZRJURXSVWKRVHWRUHFHLYHLQIRUPDWLRQ DQGWKUHHFRXUVHVRI(&3VLQFDVHRIQHHGDQGWKRVHWRUHFHLYHRQO\LQIRUPDWLRQ ZKLFK LQFOXGHGZKHUHWKH\FRXOGJRWRREWDLQ(&3VLIQHHGHG 5HVXOWVLQGLFDWHGWKDWZRPHQLQ ERWKJURXSVUHSRUWHGQHDUO\LGHQWLFDOUDWHVRIXQSURWHFWHGLQWHUFRXUVH$PRQJZRPHQZKR UHSRUWHGXQSURWHFWHGLQWHUFRXUVHWKRVHZLWKDGYDQFHSURYLVLRQZHUHDOPRVWWZLFHDVOLNHO\ WRXVH(&3VDVWKRVHZKRUHFHLYHGLQIRUPDWLRQRQO\1RZRPDQXVHG(&3VPRUHWKDQRQFH 1LQHW\HLJKWSHUFHQWRIZRPHQZLWKDGYDQFHVXSSOLHVVDLGKDYLQJ(&3VGLGQRWPDNHWKHP WDNHPRUHFKDQFHVZLWKFRQGRPV %LLERTSON # %VANS - &ERDEN 3 ETAL%XTENDINGTHETIMELIMITFORSTARTINGTHE9UZPEREGIMENOF EMERGENCYCONTRACEPTIONTOHOURS/BSTETRICSAND'YNECOLOGY    &XUUHQWSURWRFROVFDOOIRULQLWLDWLRQRIHPHUJHQF\FRQWUDFHSWLRQZLWKLQKRXUVRI XQSURWHFWHGLQWHUFRXUVH7KLVVWXG\TXHVWLRQHGZKHWKHULQLWLDWLRQRI(&3VDIWHUKRXUV FRXOGKDYHDQ\EHQH¿WV,QYHVWLJDWRUVFRQGXFWHGDSURVSHFWLYHREVHUYDWLRQDOVWXG\WR GHWHUPLQHWKHHIIHFWLYHQHVVRIWKH

!  4OOLS

WKDWWKHUHJLPHQFDQVXEVWDQWLDOO\UHGXFHWKHULVNRISUHJQDQF\HYHQDIWHUWRGD\VRI

XQSURWHFWHGLQWHUFRXUVH -ODULE! 'LASIER !%MERGENCYPOSTCOITALCONTRACEPTION.EW%NGLAND*OURNALOF-EDICINE    ,QWKLVUHYLHZDUWLFOH*ODVLHUGH¿QHV(&3V¶PHFKDQLVPRIDFWLRQWKHLQGLFDWLRQVIRU(&3V DQGWKHYDULRXVIRUPVRI(&3V*ODVLHUDOVRGHVFULEHVWKHFRQWURYHUV\DQGPLVFRQFHSWLRQWKDW (&3VDUHDQDERUWLIDFLHQW7KHDXWKRUH[SODLQVWKDW³WKHEDODQFHRIHYLGHQFHVXJJHVWVWKDWWKH PRVWZLGHO\XVHGKRUPRQDOHPHUJHQF\FRQWUDFHSWLYH>DWWKHWLPH@HVWURJHQSOXVSURJHVWLQ ZRUNVPDLQO\E\LQKLELWLQJRUGHOD\LQJRYXODWLRQ´*ODVLHUHPSKDVL]HVWKDW(&3VLQWHUIHUH ZLWKRYXODWLRQDQGQRWIHUWLOL]DWLRQDQGLWVWDWHVWKDWLPSODQWDWLRQLVQRWDFKLHYHGXQWLODWOHDVW VHYHQGD\VDIWHURYXODWLRQ(&3VWDNHQZLWKLQKRXUV>RUXSWR¿YHGD\V@WKHUHIRUHFDQQRW EHFRQVLGHUHGDQLQWHUUXSWLRQRISUHJQDQF\*ODVLHUDOVRQRWHVWKDWDYDLODELOLW\DQGDFFHVVWR (&3VDUHFULWLFDOWRDFKLHYLQJPD[LPXPHIIHFWLYHQHVV%HFDXVHWKH(&3UHJLPHQPXVWVWDUW ZLWKLQKRXUVRIXQSURWHFWHGLQWHUFRXUVHDZRPDQKDVWRNQRZDERXWWKHPHWKRGVEHIRUH WKHQHHGIRULWDULVHV5HFRPPHQGDWLRQVDUHPDGHIRULQFUHDVHGNQRZOHGJHDERXWKRZ(&3V ZRUNSDUWLFXODUO\LWVWLPLQJDIWHUXQSURWHFWHGLQWHUFRXUVHDQGLPSURYHGDFFHVVLELOLW\ 'LASIER !3AFETYOFEMERGENCYCONTRACEPTION*OURNALOF!MERICAN-EDICAL7OMENS!SSOCIATION 3UPPL    7KLVSDSHUGHVFULEHVWKHVDIHW\UHFRUGVRIFRPELQHGRUDOFRQWUDFHSWLYHV HWKLQ\OHVWUDGLRO DQGOHYRQRUJHVWUHO OHYRQRUJHVWUHORQO\PLIHSULVWRQHDQGWKH,8'ZKHQXVHGDVHPHUJHQF\ FRQWUDFHSWLRQ7KHDXWKRUGHWHUPLQHVWKDWEDVHGRQDYDLODEOHLQIRUPDWLRQDOOIRXU PHWKRGVKDYHFRQVLGHUDEOHGDWDFRQ¿UPLQJWKHLUVDIHW\7KHFDVHLVPDGHWKDWHPHUJHQF\ FRQWUDFHSWLRQLVRIWHQRYHUPHGLFDOL]HG LHUHTXLULQJDJ\QHFRORJLFH[DPRUSUHVFULSWLRQ IURPSK\VLFLDQ DQGWKDWFRQVLGHUDWLRQVKRXOGEHJLYHQWRPDNLQJ(&3VDYDLODEOHZLWKRXWD SUHVFULSWLRQZKHUHYHUSRVVLEOH 'LASIER !AND"AIRD $4HEEFFECTSOFSELF ADMINISTERINGEMERGENCYCONTRACEPTION.EW%NGLAND *OURNALOF-EDICINE    7KHDXWKRUVFRPSDUHGWKHXVHRI(&3VLQZRPHQZKRZHUHSURYLGHGZLWKDUHSODFHDEOH VXSSO\RIKRUPRQDO(&3VWREHWDNHQDWKRPH WKHWUHDWPHQWJURXS DQGZRPHQZKR FRXOGREWDLQ(&3VWKURXJKDGRFWRU WKHFRQWUROJURXS 7KHVWXG\IRXQGWKDWZRPHQLQWKH WUHDWPHQWJURXSZHUHQRPRUHOLNHO\WRXVHHPHUJHQF\FRQWUDFHSWLRQUHSHDWHGO\WKDQZRPHQ LQWKHFRQWUROJURXSDQGWKDWQHDUO\DOOZRPHQXVHGHPHUJHQF\FRQWUDFHSWLRQFRUUHFWO\7KH DXWKRUVFRQFOXGHGWKDWPDNLQJHPHUJHQF\FRQWUDFHSWLRQPRUHHDVLO\DWWDLQDEOHPD\UHGXFH WKHUDWHRIXQZDQWHGSUHJQDQFLHVDQGGRHVQRWSRVHDQ\ULVNVRULQFUHDVHWKHOLNHOLKRRGRI UHSHDWXVH 'RAHAM ! -OORE , 3HARP $ ETAL)MPROVINGTEENAGERSKNOWLEDGEOFEMERGENCY CONTRACEPTIONCLUSTERRANDOMIZEDCONTROLLEDTRIALOFATEACHER LEDINTERVENTION"RITISH-EDICAL *OURNAL  7KLVSDSHUSUHVHQWVWKHUHVXOWVRIDFOXVWHUUDQGRPL]HGFRQWUROOHGWULDOXQGHUWDNHQWRDVVHVV WKHHIIHFWLYHQHVVRIDWHDFKHUOHGLQWHUYHQWLRQWRLPSURYHWHHQDJHUV¶NQRZOHGJHDERXW HPHUJHQF\FRQWUDFHSWLRQ3DUWLFLSDQWVLQWKHWULDOLQFOXGHGER\VDQGJLUOVDJHG WR\HDUVRIDJHIURPPL[HGVH[VHFRQGDU\VFKRROVLQ(QJODQG7HDFKHUVZHUH LQVWUXFWHGRQKRZWRWHDFKVWXGHQWVDERXWHPHUJHQF\FRQWUDFHSWLRQDQGWKHQJDYHVWXGHQWV

!  DVLQJOHOHVVRQRQHPHUJHQF\FRQWUDFHSWLRQ4XHVWLRQQDLUHVZHUHJLYHQWRVWXGHQWVDVD EDVHOLQHDQGDWVL[PRQWKV,QIRUPDWLRQJDWKHUHGYLDWKHTXHVWLRQQDLUHLQFOXGHGNQRZOHGJH RIWKHFRUUHFWXVHRI(&3VDVZHOODVWLPHOLPLWVIRU(&3VDQG,8'VDVHPHUJHQF\ FRQWUDFHSWLRQ,WDOVRLQFOXGHGVH[XDODFWLYLW\XVHRIHPHUJHQF\FRQWUDFHSWLRQDQGLQWHQWLRQ

-ODULE! WRXVHHPHUJHQF\FRQWUDFHSWLRQLQWKHIXWXUH5HVXOWVVKRZHGWKDWWKRVHLQWKHLQWHUYHQWLRQ JURXSVKRZHGKLJKHUOHYHOVRINQRZOHGJHRIHPHUJHQF\FRQWUDFHSWLRQWKDQWKRVHLQWKH FRQWUROJURXSDQGWKHUHZHUHQRGLIIHUHQFHVEHWZHHQWKHWZRJURXSVLQWHUPVRIWKRVHZKR KDGQHYHUKDGVH[KDGXVHGHPHUJHQF\FRQWUDFHSWLRQRULQWHQGHGWRXVHLWLQWKHIXWXUH 7KHDXWKRUVFRQFOXGHGWKDWWKHLQWHUYHQWLRQGLGQRWFKDQJHSDUWLFLSDQWV¶VH[XDODFWLYLW\RU 4OOLS LQFUHDVHXVHRIHPHUJHQF\FRQWUDFHSWLRQEXWWKDWLWGLGVLJQL¿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¿UVWDQGWKLUGF\FOHV VL[ZRPHQWRRN/1*LQWKH¿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¿FDQWSDUWRIWKHUHFHQWUHGXFWLRQLQDERUWLRQVQDWLRQDOO\,QWHUHVWLQJO\ SHUFHQWRIZRPHQGLGQRWXVHDFRQWUDFHSWLYHPHWKRGLQWKHPRQWKWKH\EHFDPHSUHJQDQW PDLQO\EHFDXVHRISHUFHLYHGORZULVNRISUHJQDQF\DQGFRQFHUQVDERXWFRQWUDFHSWLRQ7KH DXWKRUVVXJJHVWWKDWZRPHQDQGPHQQHHGPRUHRSSRUWXQLWLHVWRGLVFXVVLVVXHVVXFKDVZKHQ DQGZKHWKHUWRKDYHVH[XDOLQWHUFRXUVHLQDUHODWLRQVKLSPHWKRGVRISUHJQDQF\SUHYHQWLRQ DQGDSSURSULDWHWLPLQJRIFKLOGEHDULQJ

!  4OOLS

,OVVORN !ETAL0ROVISIONOFEMERGENCYCONTRACEPTIVEPILLSTOSPERMICIDEUSERSIN'HANA

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¿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¶VHIIHFWLYHQHVV -ULLER !, ,LADOS #- AND#ROXATTO ("0OSTCOITALTREATMENTWITHLEVONORGESTRELDOESNOT DISRUPTPOSTFERTILIZATIONEVENTSINTHERAT#ONTRACEPTION    7KLVSDSHUSUHVHQWVWKHUHVXOWVRIDVWXG\FRQGXFWHGWRGHWHUPLQHWKHHIIHFWRIDFXWHWUHDWPHQW ZLWKOHYRQRUJHVWUHO /1* RQRYXODWLRQIHUWLOL]DWLRQDQGLPSODQWDWLRQLQWKHUDW7KHPDLQ LQWHUYHQWLRQVZHUHDGPLQLVWUDWLRQRI/1*UHODWLYHWRRYXODWLRQPDWLQJDQGIHUWLOL]DWLRQ 5HVXOWVVKRZHGWKDW/1*GHSHQGLQJRQWLPHRIWUHDWPHQWDQGRUGRVDJHHLWKHUWRWDOO\RU SDUWLDOO\LQKLELWHGRYXODWLRQ/1*KDGQRHIIHFWRQIHUWLOL]DWLRQRULPSODQWDWLRQZKHQJLYHQ HLWKHUVKRUWO\EHIRUHRUDIWHUPDWLQJRUEHIRUHLPSODQWDWLRQ7KHDXWKRUVFRQFOXGHWKDW/1* ZKHQDGPLQLVWHUHGLQGRVHVPXFKKLJKHUWKDQWKRVHXVHGLQZRPHQKDGQRSRVWIHUWLOL]DLWRQ HIIHFWVLQWKHUDW

!  .ORRIS4URNER !AND%LLERTSON #(OWSAFEISEMERGENCYCONTRACEPTION $RUG3AFETY    7KLVDUWLFOHUHYLHZVWKHVDIHW\LQIRUPDWLRQDYDLODEOHDERXWHPHUJHQF\FRQWUDFHSWLRQXVLQJ GLUHFWDQGLQGLUHFWELRPHGLFDODQGVRFLDOVFLHQFHOLWHUDWXUHWKHH[WHQVLYHO\GRFXPHQWHG -ODULE! VDIHW\SUR¿OHRIUHJXODURUDOFRQWUDFHSWLYHVDQGRYHU\HDUVFOLQLFDOH[SHULHQFHZLWK KRUPRQDOHPHUJHQF\FRQWUDFHSWLRQ7KHHIIHFWLYHQHVVGRVDJHDQGWLPLQJRIWKH

!  4OOLS

2ODRIGUES ) 'ROU & AND*OLY *%FFECTIVENESSOFEMERGENCYCONTRACEPTIVEPILLSBETWEENAND

HOURSAFTERUNPROTECTEDSEXUALINTERCOURSE!MERICAN*OURNALOF/BSTETRICSAND'YNECOLOGY -ODULE!     7KLVDUWLFOHGLVFXVVHVWKHUHVXOWVRIWKH¿UVWVWXG\XQGHUWDNHQWRGHWHUPLQHWKHHIIHFWLYHQHVV RIWKH

!  4RUSSELL *AND2AYMOND %'3TATISTICALEVIDENCECONCERNINGTHEMECHANISMOFACTIONOFTHE9UZPE REGIMENOFEMERGENCYCONTRACEPTION/BSTETRICSAND'YNECOLOGY0T    $QDQDO\VLVRISXEOLVKHGVWXGLHVRQWKHVWDWLVWLFDOHYLGHQFHRQWKHHIIHFWLYHQHVVRIWKH

!  4OOLS

HWKLQ\OHVWUDGLROSOXVPJOHYRQRUJHVWUHOUHSHDWHGKRXUVODWHU 7KHFUXGHSUHJQDQF\

UDWHZDVSHUFHQWZLWKWKHOHYRQRUJHVWUHORQO\UHJLPHQDQGSHUFHQWZLWKWKH

4HISMATERIALWASDEVELOPEDBY0!4(

!  -ODULE! 4OOLS

!  4OOLS

+EY&ACTS!BOUT%MERGENCY#ONTRACEPTION -ODULE! 7HATISEMERGENCYCONTRACEPTION 4HETERMEMERGENCYCONTRACEPTIONREFERSTOMETHODSUSEDBYWOMENWITHINAFEWHOURSOR AFEWDAYSAFTERUNPROTECTEDINTERCOURSETOPREVENTPREGNANCYBEFOREITHAPPENS4HEMOST COMMONMETHODOFEMERGENCYCONTRACEPTIONINVOLVESTAKINGEMERGENCYCONTRACEPTIVEPILLS %#0S WHICHAREANELEVATEDDOSEOFHORMONALCONTRACEPTIVEPILLS ASSOONASPOSSIBLEAFTER UNPROTECTEDINTERCOURSEANDWITHINNOTHANTHANlVEDAYSHOURS !NOTHEREMERGENCY CONTRACEPTIVEMETHODISINSERTIONOFTHEINTRAUTERINEDEVICE)5$ INTOAWOMANSUTERUS WITHINSEVENDAYSOFUNPROTECTEDINTERCOURSETOPREVENTPREGNANCY

7HATTYPESOF%#0SAREUSEDFOREMERGENCYCONTRACEPTIONANDHOW EFFECTIVEARETHEY %#0SCONTAININGONLYAPROGESTINLEVONORGESTREL ORCONTAININGBOTHESTROGENETHINYL ESTRADIOL ANDPROGESTINLEVONORGESTRELORNORGESTREL CANBEUSEDASCONTRACEPTIONAFTER INTERCOURSETOREDUCETHERISKOFUNINTENDEDPREGNANCY2ESEARCHDEMONSTRATESTHATTHE LEVONORGESTREL ONLYREGIMENHASFEWERSIDEEFFECTSANDISMOREEFFECTIVETHANTHECOMBINED REGIMEN%ITHERREGIMENOF%#0SCANBETAKENUPTOHOURSAFTERUNPROTECTEDINTERCOURSE BUTTHESOONERAFTERUNPROTECTEDINTERCOURSETHATAWOMANTAKES%#0S THELOWERHERRISK OFPREGNANCY)FUSEDDURINGTHEMOSTFERTILEPERIOD THEREISAPERCENTANDPERCENT REDUCTIONINPREGNANCYRISKRESPECTIVELYFORWOMENUSINGTHE9UZPEANDLEVONORGESTREL ONLY REGIMENSWITHINHOURS

7HYDOWOMENNEEDEMERGENCYCONTRACEPTION 4HE'LOBAL(EALTH#OUNCILESTIMATESTHATNEARLYMILLIONUNINTENDEDPREGNANCIESOCCUR WORLDWIDEEACHYEAR%MERGENCYCONTRACEPTIONHASTHEPOTENTIALTOPREVENTMILLIONSOF THESEPREGNANCIES%MERGENCYCONTRACEPTIONCANBEUSEDANYTIMEAWOMANHASUNPROTECTED INTERCOURSEBUTDOESNOTWANTTOBECOMEPREGNANT%#0S WHICHARESAFEANDCANBEMADE EASILYACCESSIBLE PROVIDEANIMPORTANTOPPORTUNITYFORWOMENWHODONOTWISHTOBECOME PREGNANTTOPREVENTPREGNANCYIFCONTRACEPTIONFAILS SEXISFORCED ORCONTRACEPTIONISNOT USED

7HOCANUSEEMERGENCYCONTRACEPTION !LLWOMEN EVENTHOSEWOMENWHOFORMEDICALREASONSCANNOTUSEBIRTHCONTROLPILLSASA REGULARMETHODOFCONTRACEPTION CANUSE%#0S

(OWDOESEMERGENCYCONTRACEPTIONWORK %#0SWORKBYINTERRUPTINGAWOMANSREPRODUCTIVECYCLE%#0SAREEFFECTIVEONLYBEFOREA PREGNANCYISESTABLISHEDCLINICALLYDElNEDASIMPLANTATIONOFAFERTILIZEDEGGINTHEUTERUS  4HEYCANNOTWORKAFTERAFERTILIZEDEGGHASBEENIMPLANTED%#0SPRIMARYMECHANISM OFACTIONISTHEINHIBITIONORDELAYOFOVULATIONORTHERELEASEOFANEGGFROMAWOMANS OVARIES 

4HEDElNITIONPROVIDEDABOVEISPROVIDEDWITHINAMEDICALCLINICALCONTEXT)NDIVIDUALSMAYHAVETHEIROWNBELIEFS ABOUTWHENAPREGNANCYBEGINS

!  $OESEMERGENCYCONTRACEPTIONCAUSEANABORTION -EDICALSCIENCECONSIDERSTHATAPREGNANCYHASBEGUNONCEIMPLANTATIONOFAFERTILIZEDEGGIN THELININGOFAWOMANSUTERUSISCOMPLETE4HEPROCESSOFIMPLANTATIONBEGINSSIXDAYSAFTER FERTILIZATIONANDISCOMPLETEDABOUTONEWEEKLATER%#0SUSEDDURINGTHISPERIODPREVENT -ODULE! PREGNANCYFROMOCCURRINGBEFOREIMPLANTATION WHICHISCONTRACEPTIONANDNOTABORTION "ASEDONMEDICALDElNITIONS EMERGENCYCONTRACEPTIONISPREVENTIONOFPREGNANCYBECAUSEIT WORKSBEFOREIMPLANTATION%MERGENCYCONTRACEPTIVESAREINEFFECTIVEONCEIMPLANTATIONHAS BEGUN4HEYCANNOTCAUSEANABORTIONIFTHEWOMANISALREADYPREGNANT 4OOLS

!RE%#0SSAFE 4HE7ORLD(EALTH/RGANIZATIONHASSTATEDTHATTHEREARENOABSOLUTECONTRAINDICATIONSTO THEUSEOFEMERGENCYCONTRACEPTIVEPILLSDUETOTHESMALLOVERALLHORMONEDOSEANDSHORT DURATIONOFUSE%#0SDONOTHAVETHESAMECONTRAINDICATIONSASDAILYORALCONTRACEPTIVES 2ESEARCHERSHAVECONCLUDEDTHATNOEVIDENCEEXISTSTOSUGGESTTHAT%#0SWILLHARMA DEVELOPINGFETUS

)SREPEATUSEOF%#0SHARMFUL 2EPEATUSEOF%#0SPOSESNOHEALTHRISKS%XPERIENCEWITH%#0SSUGGESTSTHATREPEATUSE WITHINTHESAMECYCLEISUNCOMMON5SEOFLEVONORGESTREL ONLY%#0SASFREQUENTLYAS FOURTIMESAMONTHDIDNOTREVEALNEGATIVEHEALTHRISKS7HILEREPEATUSEISNOTAREASONTO DENYAWOMANACCESSTO%#0S ITISANINDICATIONTHATAWOMANNEEDSFURTHERCOUNSELINGON ROUTINECONTRACEPTIVEMETHODS ASALLOTHERMETHODSAREMOREEFFECTIVE7OMENWHOHAVE REGULARINTERCOURSEMORETHANFOURTIMESPERMONTH ARENOTADVISEDTOUSE%#0SASAREGULAR CONTRACEPTIVEMETHODBECAUSEITISNOTASEFFECTIVEASREGULARCONTRACEPTION

$O%#0SPREVENTSEXUALLYTRANSMITTEDINFECTIONS %#0SDONOTPROTECTAGAINST()6!)$3OROTHERSEXUALLYTRANSMITTEDINFECTIONSLIKESYPHILIS GONORRHEA CHLAMYDIA ANDHERPES

4HISMATERIALWASDEVELOPEDBY0!4(

!  -ODULE"

#OST#ONSIDERATIONS

/BJECTIVE 4ODEMONSTRATEHOW%#0SCANREDUCETHEPUBLIC SECTORCOSTSASSOCIATEDWITHUNINTENDED PREGNANCYINADEVELOPING COUNTRYCONTEXT

#ONSIDERATIONSFOR$ECISION-AKERS

„ ,OW COSTPROVISIONOF%#0S THROUGHNONCLINICALSTAFFFOREXAMPLE CANLEADTOCOSTSAVINGS INUNINTENDEDPREGNANCYCOSTSPERWOMANHAVINGUNPROTECTEDSEX „ )NCREASEDCOSTOF%#0PROVISIONSUCHASCLINICALCONSULTATIONOREXAMINATION REDUCESTHESE COSTSAVINGS „ 4HELARGERTHEPRICEDIFFERENTIALBETWEENTHECOSTOFPROVIDING%#0SANDTHECOSTOF PREGNANCYOUTCOMES THEMORECOST EFFECTIVETHEUSEOF%#0SWILLBE „ #OUNTRIESWITHHIGHMATERNALHEALTHCARECOSTSARELIKELYTOACCRUELARGEBENElTSFROM MAKING%#0SAVAILABLE

)NADVOCATINGFORLARGE SCALEPROVISIONOF%#0S ITISIMPORTANTTODEMONSTRATEHOW%#0S CANREDUCETHEPUBLIC SECTORCOSTSASSOCIATEDWITHUNINTENDEDPREGNANCIESINDEVELOPING COUNTRIES0ROVIDEDHEREISASIMPLEMODELTHATASSESSESTHECOST EFFECTIVENESSOFPROVIDING %#0STHROUGHDEVELOPING COUNTRYPUBLIC SECTORSERVICES4HERESULTSHIGHLIGHTCONSIDERATIONS FORMAKINGDECISIONSABOUTINCORPORATINGEMERGENCYCONTRACEPTIVEPILLSINTOTHEBROADER PACKAGEOFFAMILYPLANNINGOPTIONSAVAILABLETOWOMENINLOW RESOURCESETTINGS4HESE CONSIDERATIONSARESUMMARIZEDABOVE

)NTRODUCTION %VERYYEAR NEARLYMILLIONUNINTENDEDPREGNANCIESOCCURWORLDWIDE&ROMTO NEARLY WOMENDIEDASARESULTOFUNINTENDEDORUNWANTEDPREGNANCY-ATERNAL MORBIDITYANDMORTALITYASSOCIATEDWITHUNINTENDEDPREGNANCYINCURINCALCULABLESOCIALCOSTS ANDPERSONALCOSTSTOFAMILIES5NINTENDEDPREGNANCYALSOIMPOSESANECONOMICBURDENON ACOUNTRYSHEALTHCARESYSTEMBECAUSEOFTHEINCREASEDMATERNALHEALTHCARECOSTSASSOCIATED WITHANTENATALCARE BIRTHS ABORTIONS ANDPOSTABORTIONCARE%MERGENCYCONTRACEPTION ASTHE ONLYEASILYACCESSIBLE SAFE ANDEFFECTIVEPOSTCOITALCONTRACEPTIVEMETHOD HASANIMPORTANT ROLETOPLAYINPREVENTINGUNINTENDEDPREGNANCY#ONSIDERTHATIF WOMENWHODO NOTWANTTOBECOMEPREGNANTHAVEUNPROTECTEDINTERCOURSE ANESTIMATEDWILLBECOME PREGNANT)FALL WOMENUSELEVONORGSTREL ONLY%#0S THENUMBEROFPREGNANCIESCANBE REDUCEDTOˆANPERCENTREDUCTIONINUNINTENDEDPREGNANCY

"  "  -ODULE" #OUNTRY3ETTINGS !SSESSINGTHE#OST %FFECTIVENESSOF%#0SIN$EVELOPING "ACKGROUND ANALYSISDESCRIBEDBELOWEXAMINESTHECOSTSTOAPUBLICHEALTH ANALYSISTHATMODELSTHECOSTSANDOUTCOMESASSOCIATEDWITHPRO MAKING4HISSECTIONDESCRIBESTHERESULTSOFARELATIVELYSIMP EVENASIMPLEAPPROACHCANPROVIDEUSEFULILLUSTRATIVEINFORMAT EFFECTIVENESSANALYSISAROUNDTHEPROVISIONOF%#0SINADEVELO 4HEREAREANUMBEROFCHALLENGESINDEVELOPINGARIGOROUSANDC THE5NITED3TATESAND#ANADA 4HEPUBLISHEDLITERATURETODATEPROVIDESEVIDENCEOFTHECOST REDUCEDMATERNALMORBIDITYANDMORTALITY DIFlCULTTOCAPTURETHECOSTSAVINGSTOTHEHEALTHSECTORANDS RESULTINGINLOWERDIRECTMEDICALCOSTS WHICHCANBECAPTURED ANDMORTALITY)NCREASEDACCESSTO%#0SWILLRESULTINFEWERPR ANDRELATEDCOMPLICATIONSABORTIONANDABORTIONCOMPLICATIONS CRITICALCOSTSINCLUDETHOSEASSOCIATEDWITHPROVISIONOFTHE% WITHTHESTATUSQUO7HENLOOKINGATTHEIMPLICATIONSOFWIDESP ORMOREALTERNATIVES MAKINGITPOSSIBLETOSEEHOWANEWINTER HEALTHSYSTEMS#OST EFFECTIVENESSANALYSISCOMPARESTHECOSTS INCORPORATINGNEWHEALTHINTERVENTIONS HEALTHTECHNOLOGIES OR EFFECTIVENESSANALYSISCANPROVIDEHELPFULINFORMATIONFORMAKI HAVEANIMPORTANTHEALTHIMPACT BUTALSOMAKETHEMOSTOFSCAR 3EVERELYLIMITEDHEALTHBUDGETSREQUIREFUNDSBEALLOCATEDTOI INDEVELOPINGCOUNTRIESANDNOTAVAILABLETHROUGHTHEPUBLICSE CAPITAHEALTHEXPENDITURESANDTHECOSTOFSERVICES4HIRD ABO ANDMIDDLE INCOMECOUNTRIES WHERETHEPRODUCTCOSTOF%#0SMAY HIGH INCOMECOUNTRIES SUCHAS#ANADAANDTHE5NITED3TATES4H DEVELOPEDCOUNTRIES3ECOND THEPRODUCTCOSTOFTHE%#0SISRE INTENSIVETHANINDEVELOPEDCOUNTRIES RESULTINGINLOWERHEALT COSTSTRUCTURESINDEVELOPINGCOUNTRIESAREMORELABOR INTENSIV DEVELOPINGCOUNTRIESFORSEVERALREASONS&IRST THEHEALTHSER ONTHECOSTSANDOUTCOMESFROMDEVELOPED COUNTRYSETTINGSISNO CONTRACEPTIONASPARTOFFAMILYPLANNINGPROGRAMSINDEVELOPING 4HEREISVERYLITTLEINFORMATIONONTHECOSTSORCOST EFFECTIVE UNINTENDEDPREGNANCIES CONTRACEPTIONREDUCEDTHEEXPENDITURESONMEDICALCARETHROUGH OUTCOMESISHIGH ESPECIALLYWHENCOMPAREDTOTHELOWPRICEOF )N#ANADAANDTHE5NITED3TATES WHERETHEAVERAGECOSTOFBIRT ASSOCIATEDWITHINDUCEDABORTION BIRTH SPONTANEOUSABORTION ADVANCETOBEUSEDASNEEDED4HESESTUDIESFOCUSEDPRIMARILYO PARTYINSURER WHENUSEDAFTERANACTOFUNPROTECTEDINTERCOURS EITHERCOST EFFECTIVEORRESULTEDINCOSTSAVINGSTOTHEPUBLIC  4HESESTUDIESFOUNDTHATEMERGENCYCONTRACEPTIONWAS PAYER MANAGEDCARE ORTHIRD NESSOFTHEUSEOFEMERGENCY OCIETYASSOCIATEDWITH VICEDELIVERYSYSTEMSAND #0SPREGNANCY DELIVERY HCARECOSTSCOMPAREDTO LECOST EFFECTIVENESS RTIONSERVICESMAYBEILLEGAL EFFECTIVENESSOF%#0SIN NTERVENTIONSTHATNOTONLY E ORWHENOBTAINEDIN EGNANCIESANDABORTIONS EANDLESSTECHNOLOGY ASCOSTSAVINGS)TISMORE VENTIONWOULDCOMPARE TREATMENTSINTOEXISTING CTOR ANDECTOPICPREGNANCIES SYSTEMOFASETOFEXPECTED IONTOHELPGUIDEDECISION HSANDPREGNANCY RELATED ANDOUTCOMESOFTWO NGDECISIONSABOUT LATIVELYINEXPENSIVEIN PING COUNTRYSETTING BUT CERESOURCES#OST READACCESSTO%#0S ANDMATERNALMORBIDITY VISIONOF%#0S4HE %#0S USEOFEMERGENCY NTHEDIRECTMEDICALCOSTS OMPREHENSIVECOST COUNTRIES4HEEVIDENCE THEPREVENTIONOF TDIRECTLYTRANSFERABLETO ISISNOTTHECASEINLOW BEHIGHRELATIVETOPER -ODULE"

OUTCOMESRELATEDTOWOMENSUSINGORNOTUSING%#0SAFTERUNPROTECTEDINTERCOURSE 4HECOSTSINCLUDEDINTHISANALYSISAREREPRESENTATIVEOFHEALTHSERVICESPROVIDEDBYTHE PUBLIC SECTORCLINICS4HEMODELUSESANEXISTINGFRAMEWORKTHATDESCRIBESASPECIlC SETOFPOSSIBLEOUTCOMESOCCURRINGASTHERESULTOFUNPROTECTEDINTERCOURSE4HESE INCLUDEPREGNANCY INDUCEDABORTION SPONTANEOUSABORTION ORMISCARRIAGE ECTOPIC PREGNANCY ANDBIRTHSEE&IGURE 5SINGTHISMODEL ITISPOSSIBLETOAPPLYPROBABILITIES OFPREGNANCYANDOUTCOMES DRAWNFROMPUBLISHEDLITERATURE ASWELLASCOUNTRY SPECIlC DATAONUNINTENDEDPREGNANCY ABORTION ANDHEALTHSYSTEMCOSTS

&IGURE$ECISIONMODELFORUSEORNONUSEOFEMERGENCYCONTRACEPTIVEPILLS

-ODELAND!SSUMPTIONS

4HEPROBABILITYTHATAWOMANBECOMESPREGNANTFOLLOWINGANUNPROTECTEDACTOF INTERCOURSEISESTIMATEDATPERCENT4HEUSEOFALEVONORGESTREL ONLY%#0REDUCES THATRISKOFPREGNANCYBYPERCENT4HERISKOFPREGNANCYINWOMENWHOAREUSING %#0SBASEDONTHESEPROBABILITIESISPERCENT4HEMODELASSUMESTHATIFAWOMAN BECOMESPREGNANT THEREISAPERCENTCHANCESHEWILLEXPERIENCEASPONTANEOUS ABORTION ANDAPERCENTRISKOFANECTOPICPREGNANCY4HEPROBABILITYOFINDUCED ABORTIONVARIESBYCOUNTRYANDISESTIMATEDATPERCENTIN#AMBODIA PERCENTIN 0ERU PERCENTIN5GANDA ANDPERCENTIN'HANA 4HEANALYSISALSORELIESONDATAFROMFOURDEVELOPINGCOUNTRIES#AMBODIA 'HANA 0ERU AND5GANDA4HESEFOURCOUNTRIESWERESELECTEDBECAUSETHEYDEMONSTRATEBOTH GEOGRAPHICANDECONOMICDIFFERENCES!PPENDIXPROVIDESMATERNALHEALTHCARECOST ESTIMATESINTHEFOURCOUNTRIES3OCIO DEMOGRAPHICANDREPRODUCTIVEHEALTHINDICATORS FOREACHCOUNTRYAREINCLUDEDIN!PPENDIX$ATAONTHECOSTSOFMATERNALHEALTHCARE SERVICESARESCARCE ANDEVENMOREDIFlCULTTODETERMINEARETHECOSTSASSOCIATEDWITH ABORTIONANDPOSTABORTIONCARE ESPECIALLYINCOUNTRIESWHEREABORTIONISILLEGAL4HEFOUR COUNTRIESALSOWERESELECTEDBECAUSEOFTHEAVAILABILITYOFCOSTDATATHROUGHPUBLISHED LITERATURE5GANDAAND'HANA PERSONALCOMMUNICATION#AMBODIA ANDTHROUGHARAPID -/(SURVEY0ERU 4HESURVEYISINCLUDEDIN!PPENDICES AND

%STIMATEDFROMANUNPUBLISHEDINTERNETSOURCEKWWSZZZXPDQLWREDFDZRPHQVBKHDOWKJOREDOUKWP "  "  -ODULE" SERVICES 4HEPERUNITCOSTISEXCLUSIVEOFSHIPPINGCOSTS WH &ON2EGULATION 0ROCUREMENTAND$ISTRIBUTIONOFA0ROGESTIN /N o OFTHEWOMANIN5GANDA THECOSTOFABORTIONISTHEESTIMATED ABORTIONSERVICES)N0ERU 'HANA AND5GANDA WHEREABORTIONS ,EVINETAL  COSTS4HESECOMPLICATIONCOSTSHAVEBEENESTIMATEDATP DEPENDINGUPONTHESIZEOFTHEORDER 4HISISTHECURRENTPRICEFORLEVONORGESTREL ONLYPILLSPROCUR )N#AMBODIA WHEREABORTIONISLEGALANDSERVICESAREPROVIDED s s s 3CENARIO s s 3CENARIO s s s 3CENARIO s s 3CENARIO AREASSUMEDTOBEPERCENTOFBIRTHCOSTS CAREVISITS!BORTIONCOSTSAREDIFlCULTTOOBTAIN ANDWHEREN SERVICESINPUBLIC SECTORCLINICSORHOSPITALS#OSTESTIMATES 4HEMODELASSUMESTHATALLWOMENWHOBECOMEPREGNANTRECEIVEMA 4HEMODELUSEDFOURSCENARIOS INCLUDECLINICALCONSULTATIVESERVICESANDHIGHERABORTIONCOST 4OPROVIDEARANGEOFCOSTESTIMATES THEMODELESTIMATESCOSTS PROBABILITIESOFEACHOUTCOMEFORUNINTENDEDPREGNANCIES ABORTION SPONTANEOUSABORTION ECTOPICPREGNANCYANDBIRTH WI THEWOMANBECOMEPREGNANT)TISCALCULATEDASTHEWEIGHTEDAVE OFTHETREATMENTIE %#0S MINUSTHETOTALCOSTSTHATWOULD 4HECOSTOFANUNINTENDEDPREGNANCYREPRESENTSTHEhNETCOSTvE PROGRAMATACOSTOFPERUNIT           !BORTIONCOSTSAREPERCENTHIGHERTHANBIRTHCOSTS 4HECOSTOFACONSULTATIVEOFlCEVISITISINCLUDED %#0SAREOBTAINEDFROMAPUBLICHEALTHCLINICWITHAREQUIREDC 4HECOSTOFACONSULTATIVEOFlCEVISITISINCLUDED %#0SAREOBTAINEDFROMAPUBLICHEALTHCLINICWITHAREQUIREDC !BORTIONCOSTSAREPERCENTHIGHERTHANBIRTHCOSTS .OCOSTSASSOCIATEDWITHANOFlCEVISIT %#0SCANBEOBTAINEDFROMAPUBLICHEALTHCLINICORDISPENSARY .OCOSTSASSOCIATEDWITHANOFlCEVISIT %#0SCANBEOBTAINEDFROMAPUBLICHEALTHCLINICORDISPENSARY o ANDAREPROVIDEDTOCLIENTSFREEOFCHARGE EDTHROUGH5.&0!3EEINFORMATIONINTHETOOLSSECTIONOF-ODU ICHWILLRAISETHEPERUNITCOSTBYPERCENTTOOVERPERC

AVERAGECOSTTOTHEPUBLICSECTORFORPOSTABORTIONCOMPLICATION ERCOMPLICATIONFOR0ERUAND'HANAANDFOR5GANDA AREPERMITTEDONLYUNDERCERTAINCONDITIONSEGTOSAVETHEL %#0SAREASSUMEDTOBEPROCUREDBYTHE LY%#0ONPROCUREMENTTHROUGHINTERNATIONALPROCUREMENT BYTHEPUBLICSECTOR THECOSTESTIMATEISFORTHEPROVISIONO FORBIRTHINCLUDEANTENATAL HAVEBEENINCURREDHAD OTAVAILABLETHESECOSTS S FORFOURSCENARIOSTHAT QUALTOTHETOTALCOST THTHEWEIGHTSEQUALTOTHE RAGEOFTHECOSTSOF LINICALCONSULTATION LINICALCONSULTATION WITHOUTANOFlCEVISIT WITHOUTANOFlCEVISIT TERNALHEALTHCARE ENT F IFE LE -ODULE"

&INDINGS 5NDERTHEASSUMPTIONSOF3CENARIO THEPROVISIONOF%#0SISCOST SAVINGINALL COUNTRIES3EE&IGUREBELOWFORANILLUSTRATIONOFTHECOSTSAVINGSIN53 VERSUS THECOSTINCREASESUNDERTHEFOURSCENARIOS &OREXAMPLE IN0ERU THEAVERAGECOSTOF ANUNINTENDEDPREGNANCYWASPERWOMAN4HEUSEOF%#0SREDUCESTHATCOSTBY ˆANPERCENTREDUCTION)N5GANDA COSTSWEREREDUCEDBYPERCENT REDUCEDBY IN#AMBODIA BYPERCENTREDUCEDBY ANDIN 'HANA BYPERCENTREDUCEDBY 5NDER3CENARIO IF WOMEN EXPERIENCEDUNINTENDEDPREGNANCYINASINGLEYEARIN0ERUANDHALFOFTHESEWOMEN RECEIVED%#0SFROMAPUBLICHEALTHDISPENSARY MILLIONWOULDBESAVEDINUNINTENDED PREGNANCYCOSTSWITHINTHEPUBLICSECTOR4HISLEVELOFCOSTSAVINGSISPARTICULARLY NOTEWORTHYBECAUSEOFTHENEEDTOTREATALLWOMENATRISKOFUNINTENDEDPREGNANCYWITH %#0S EVENTHOUGHONLYAPORTIONOFTHEMWOULDLIKELYBECOMEPREGNANTFROMASINGLE ACTOFINTERCOURSE

&IGURE3AVINGSORCOSTSIN53 PERWOMANTOPUBLICPAYERTOAVOIDANUNINTENDEDPREGNANCY RESULTINGFROMUNPROTECTEDSEXIN#AMBODIA 0ERU 5GANDA AND'HANAUNDERFOUR%#0PROVISION SCENARIOSÁ

!SMIGHTBEANTICIPATED EVENGREATERCOSTSAVINGSAREREALIZEDACROSSALLCOUNTRIES WHENTHECOSTOFABORTIONISPERCENTHIGHERTHANTHECOSTOFABIRTHANDWHEN%#0S AREACCESSIBLEWITHOUTACLINICALCONSULTATION3CENARIO 7HENAREQUIREDCLINICAL CONSULTATIONISINCLUDED3CENARIO THECOSTOFPROVIDING%#0INCREASESˆWITHTHE RESULTTHATINTHREEOFTHEFOURCOUNTRIES#AMBODIAISTHEEXCEPTION THECOSTSINCURRED INPROVIDING%#0SAPPEARTOOUTWEIGHTHECOSTSAVINGSGAINEDFROMPREVENTIONOF UNINTENDEDPREGNANCY)N3CENARIO WHEREABORTIONCOSTSAREINCREASEDAND%#0SARE OBTAINABLEONLYWITHACLINICALCONSULTATION %#0PROVISIONSTILLAPPEARSCOST EFFECTIVEIN #AMBODIA ALMOSTNEUTRALIN5GANDA ANDHIGHERIN0ERUAND5GANDA

Á#OSTSBELOWTHELINEREPRESENTSAVINGSANDCOSTSABOVETHELINEREPRESENTEXPENDITURES "  "  -ODULE" † UNPROTECTEDINTERCOURSEBY WOMENIN#AMBODIA 0ERU 5GA 4ABLE5NINTENDEDPREGNANCIES ABORTIONS ANDMATERNALDEATH $ISCUSSION +INGDOM ANDPARTSOF5NITED3TATESAND#ANADA4HEYAREAVAILA -ADAGASCAR -ALI -AURITIUS .AMIBIA 0ORTUGAL 3ENEGAL 3OUTH IN!LBANIA "ELGIUM "ENIN #AMEROON #ONGO $ENMARK &INLAND 4HE%MERGENCY#ONTRACEPTION.EWSLETTERREPORTSTHATASOF3PRI AVAILABLEOVER THE COUNTERORTHROUGHPHARMACIES PROlLEOF%#0SHASLEDANUMBEROFCOUNTRIESTOINCREASE%#0AC ABOUT%#0S ANDIFTHEYAREEASILYAVAILABLEWITHOUTACLINICAL LOWIF%#0SAREAVAILABLEATASUBSIDIZEDPRICETOTHEGOVERNME TOTHEPUBLICSECTORWHENTHECOSTOFPROVIDINGTHE%#0SISKEP 4HERESULTSOFTHISANALYSISSUGGESTTHATEMERGENCYCONTRACEPTI USED%#0S PREVENTEDIF WOMENATRISKOFUNINTENDEDPREGNANCYINE TABLEPROVIDESANESTIMATEDNUMBEROFABORTIONSANDMATERNALDE ALSOLEADTOMATERNALDEATHS"ASEDONDATAFROMTHE'LOBAL(EA PERCENTIN#AMBODIATOPERCENTIN'HANA ENDINABORTION5N SCARCERESOURCES!SIGNIlCANTPROPORTIONOFUNINTENDEDPREGNAN NOTTHEONLYFACTORPOLICYMAKERSMUSTCONSIDERWHENMAKINGDEC &INALLY ALTHOUGHTHEFOCUSOFTHISANALYSISWASCOST EFFECTIVE ORTHEPRIVATESECTOR  HEALTHSERVICES ORABORTIONSERVICESTHROUGHOTHERSECTORSFO PUBLICHEALTHCARESYSTEM4HISMAYNOTBETHECASEIFAWOMAN PRODUCTIVITYANDMATERNALDEATHS&INALLYTHEMODELASSUMESALL COMPLETESOCIETALCOSTS SUCHASTHEINDIRECTCOSTSASSOCIATED PREGNANCYBECAUSEITDIDNOTINCLUDECOSTSRELATEDTOPREGNANCY !DDITIONALLY THEMODELMOSTLIKELYUNDERESTIMATEDCOSTSASSOCI ASSOCIATEDWITHPREGNANCYOUTCOMESANDONLYINCLUDEDSOMEVARIA 4HEFOURSCENARIOSINTHEMODELDIDNOTINCLUDEVARIATIONINAN ASSUMPTIONS COMPLETENESSOFTHECOSTDATA ANDDATAACCURACY THEPUBLICPAYER4HECOSTSANDPOTENTIALSAVINGSWILLALSOVAR ABORTIONANDBIRTHRELATIVETOTHECOSTOFPROVIDING%#0S THE PARTICULAR HOW%#0SAREDELIVEREDTOWOMEN4HEHIGHERTHECOS PREGNANCYANDRESULTINGABORTIONS COSTSOFPREGNANCYOUTCOMES COSTSINCURREDWILLDEPENDUPONMANYFACTORS INCLUDINGTHEEXT 4HERESULTSOFTHEANALYSISALSODEMONSTRATETHATTHEEXTENTOF THISEASY ACCESSAPPROACH 5NINTENDEDPREGNANCIES  -ATERNALDEATHS !BORTIONS ABDA0R GNA'HANA 5GANDA 0ERU #AMBODIA               !FRICA 3RI,ANKA 3WITZERLAND 4HAILAND 4OGO 4UNISIA 5NITED BLEOVER THE COUNTERIN.ORWAYAND3WEDEN NG3UMMER %#0SAREAVAILABLEDIRECTFROMAPHARMACIST &RANCE 'ABON 'UINEA "ISSAU )SRAEL )VORY#OAST ,ITHUANIA † 0UBLICHEALTHSYSTEMSCOULDEMULATE SAVERTEDTHROUGHUSEOF%#0SAFTER NDA AND'HANA WITHLOSSESINLABOR NESS DIRECTMEDICALCOSTSARE GREATERTHECOSTSAVINGSTO REXAMPLETHROUGHAN.'/ COSTSAVINGSOROFADDITIONAL YDEPENDINGONTHEMODEL CONSULTATION4HESAFETY YOFTHEPROBABILITIES VEPILLSCANBECOST SAVING TLOW4HECOSTCANBEKEPT NT IFWOMENAREINFORMED COMPLICATIONSOR ENTOFUNINTENDED ATEDWITHUNINTENDED COSTSAREBORNEWITHINTHE ACCESSES%#0S MATERNAL LTH#OUNCIL THEFOLLOWING CIESRANGINGFROM COSTOF%#0S ANDIN ATHSTHATCOULDBE TSASSOCIATEDWITHBOTH CESSBYMAKINGTHEM INTENDEDPREGNANCIES ACHOFTHEFOURCOUNTRIES ISIONSABOUTALLOCATING TIONINCOSTS  -ODULE"

4HESIGNIlCANTNUMBEROFNEGATIVEOUTCOMESAVERTEDTHROUGHTHEUSEOFEMERGENCY CONTRACEPTIONILLUSTRATEDINTHETABLEABOVEDEMONSTRATESANADDITIONALCRITICALBENElTOF THEUSEOFEMERGENCYCONTRACEPTIONINDEVELOPING COUNTRYSETTINGS4HECOSTSASSOCIATED WITHMATERNALDEATHSARENOTREmECTEDINTHISANALYSIS BUTTHEISSUESHOULDCERTAINLYBE CONSIDEREDWHENASSESSINGTHECOSTSASSOCIATEDWITHINTEGRATINGEMERGENCYCONTRACEPTION INTOTHEPUBLICSECTOR

"  "  -ODULE" !PPENDIX#OSTESTIMATES53 3PONTANEOUSABORTION %CTOPICPREGNANCY )NDUCEDABORTION %#OFlCEVISIT "IRTH %#0 ABDA0R GNA'HANA 5GANDA 0ERU #AMBODIA                                #OUNTRY -ODULE"

!PPENDIX3ELECTEDSOCIO DEMOGRAPHICANDREPRODUCTIVE HEALTHINDICATORSFORTHEPERIOD 

#OUNTRY #AMBODIA 0ERU 5GANDA 'HANA 4OTAL0OPULATION             '$0PERCAPITA      .UMBEROFWOMENAGED              --RATE      -ATERNALDEATHS         0REGNANCIES             "IRTHS             5NINTENDEDPREGNANCIES             !BORTIONS           5NINTENDEDBIRTHS          3OURCE'LOBAL(EALTH#OUNCIL0ROMISESTO+EEP4HE4OLLOF5NINTENDED 0REGNANCIESON7OMENS,IVESINTHE$EVELOPING7ORLD

"  "  -ODULE" ABORTION ANDABORTION RELATEDCOSTS !PPENDIX'UIDELINESFORCOLLECTINGINFORMATIONONBIRTH MAYBEABLETOCOLLECTACROSSDIFFERENTTYPESOFFACILITIES !PPENDIXISASUMMARYTABLETHATCANBEUSEDTOENTERAVERAGE !PPENDIXISAMOREDETAILEDTABLETHATCANBEUSEDFORASING 4WOTABLESAREPROVIDEDTOHELPCOLLECTANDORGANIZECOSTDATA OFSERVICE)FNOT ASKWHATPERCENTAGEOFTHEFULLCOSTDOTHE )FYOURECEIVEAUSER FEEMANUALORFEESCHEDULE ASKIFTHESE INFORMATIONMAYBEINSURANCE HOSPITAL ORCLINICUSER FEESMAN LABOR MATERIALS ANDINDIRECTCOSTSUSEDINPROVIDINGANYSERV )TWOULDBEEASIESTTOGET #OSTSASSOCIATEDWITHABORTIONCOMPLICATIONS  !BORTIONSUSING-6!ANDSURGICALPROCEDURES  %CTOPICPREGNANCYORCOMPLICATEDDELIVERYASAPROXY   5NCOMPLICATEDVAGINALDELIVERY  !NTENATALCAREAVERAGECOSTPERWOMAN   !NOFlCEVISITTOOBTAIN%#0S  %XPLAINTOWHOEVERYOUMEETTHATYOUAREINTERESTEDINGETTING WOULDBEUSEFULTOGETURBANANDRURALESTIMATES SINCETHESEPRESUMABLYCOVERCOSTSANDMAYBEMOREREALISTICOF CENTERSAND.'/HEALTHCENTERS9OUMAYALSOBEINTERESTEDINP 4RYTOMEETWITHINDIVIDUALSWHOCANPROVIDEINFORMATIONONPUB AVERAGEPERPATIENTCOSTS BUTTHESECOSTSSHOULDINCLUDE ICETOWOMEN!SOURCEOF LEFACILITY ESTIMATESOFCOSTSFOR USERFEESREPRESENT UALSORFEESCHEDULES FEESCOVERTHEFULLCOST TRUERESOURCEUSE)T RIVATEHOSPITALORCLINICS COSTESTIMATESTHATYOU LICHOSPITALSANDHEALTH -ODULE"

!PPENDIX#OSTDATABYFACILITY

4RYTOlLLINTHEFOLLOWINGINFORMATION&ILLINONEOFTHESETABLESFOREACHFACILITYASNEEDED  .AMEOFFACILITY??????????????????????  ,OCATION????????????????  4YPEOFFACILITY0UBLIC0RIVATE.'/CIRCLEONE

#HARGESPERPATIENT FROMUSERFEES #OSTPERPATIENTOTHER !VERAGENUMBER SOURCEˆFULLCOSTOF OFHOURSORDAYSIN ,OCAL  PROVIDINGSERVICEIN CLINICORHOSPITAL CURRENCY OFFULLCOST LOCALCURRENCY HOURSORDAYS

/FlCEVISIT MINUTE

!NTENATALCARE

"IRTH

6AGINALDELIVERY

#OMPLICATEDDELIVERY

)NDUCEDABORTION

-6!

3URGICAL

%CTOPICPREGNANCY

3PONTANEOUSABORTION

0OSTABORTION COMPLICATIONS

/PTIONAL

$AILYBEDCHARGES

/BGYNCONSULTATION

.OTE7EAREINTERESTEDINTHEFULLCOSTTOTHEPROVIDERFOREACHOFTHESESERVICES)FNOT AVAILABLE WECANUSEPATIENTCHARGESORUSERFEESTHATIS WHATTHEPATIENTPAYS ASAPROXY ANDTRYTOESTIMATEHOWMUCHTHOSECOSTSARESUBSIDIZEDINPUBLICHEALTHSETTINGS

"  "  -ODULE" !PPENDIX3UMMARYOFCOSTS UP%#0S MINUTE %CTOPICPREGNANCY /FlCEVISITTOPICK )NDUCEDABORTION 6AGINALDELIVERY !NTENATALCARE COMPLICATIONS 3PONTANEOUS 0OSTABORTION ABORTION 3URGICAL -6! "IRTH VISIT ,OCALCURRENCY0ROVIDEEXCHANGERATE53??????????? (OSPITAL 0UBLIC (OSPITALS (OSPITAL 0RIVATE #ENTER (EALTH 0UBLIC (EALTH#ENTERS .'/OR -ISSION #ENTER (EALTH 0RIVATE #LINIC -ODULE"

2EFERENCES 'LOBAL(EALTH#OUNCIL0ROMISESTO+EEP4HE4OLLOF5NINTENDED0REGNANCIESON7OMENS,IVESINTHE $EVELOPING7ORLD.EW9ORK'LOBAL(EALTH#OUNCIL 

4RUSSELL * +OENIG * %LLERTSON # AND3TEWART &0REVENTINGUNINTENDEDPREGNANCYTHECOST EFFECTIVENESSOFTHREEMETHODSOFEMERGENCYCONTRACEPTION!MERICAN*OURNALOF0UBLIC(EALTH   

4RUSSELL * 7IEBE % 3HOCHET 4 AND'UILBERT %#OSTSAVINGSFROMEMERGENCYCONTRACEPTIVEPILLSIN #ANADA/BSTETRICSAND'YNECOLOGY  

-ARCIANTE + 'ARDNER * 6EENSTRA $ AND3ULLIVAN 3-ODELINGTHECOSTANDOUTCOMESOFPHARMACIST PRESCRIBEDEMERGENCYCONTRACEPTION!MERICAN*OURNALOF0UBLIC(EALTH   

7(/4ASK&ORCEON0OSTOVULATORY-ETHODSOF&ERTILITY2EGULATION2ANDOMISEDCONTROLLEDTRIALOF LEVONORGESTRELVERSUSTHE9UZPEREGIMENOFCOMBINEDORALCONTRACEPTIVESFOREMERGENCYCONTRACEPTION ,ANCET  

!WOJOB /!AND/GUNSINA 3%CTOPICPREGNANCYINARURALPRACTICE.IGER*OURNALOF-EDICINE  

" 

-ODULE#

2AISING0UBLIC!WARENESS

/BJECTIVE 4OGENERATEPUBLICSUPPORTFORLARGE SCALEPROVISIONOFEMERGENCYCONTRACEPTIVEPILLS%#0S 

"UILDINGCOMMUNITYSUPPORTANDCREATINGDEMANDFOR%#0SAREIMPORTANTSTEPSINPREPARING FORTHEIRINTRODUCTIONINTOALARGE SCALEFAMILYPLANNINGPROGRAM)NORDERFORAN%#0PROGRAM TOBEEFFECTIVE POTENTIALCLIENTSNEEDTOBEAWARETHATTHEOPTIONEXISTS UNDERSTANDWHEN%#0S AREAPPROPRIATE ANDKNOWWHERETOOBTAIN%#0SWHENTHEYNEEDTHEM"YEDUCATINGTHE COMMUNITYABOUTEMERGENCYCONTRACEPTIONANDINVOLVINGALLSTAKEHOLDERSINPLANNINGFOR%#0 INTRODUCTION %#0ADVOCATESCANHELPTOCREATEBROADAWARENESSANDSUPPORTFORTHEMETHOD THATWILLLEADTOCLIENTDEMAND 4HEFOLLOWINGTOPICSAREDISCUSSEDINTHISMODULE s 3OCIAL#ONTEXTAND&INANCIAL2ESOURCES s +EY!UDIENCES s &RAMING+EY-ESSAGES  7OMENSRIGHTSANDHUMANRIGHTSAPPROACH  %#0SANDPUBLICHEALTHMESSAGES  7EB BASEDRESOURCESFORRIGHTSANDPUBLICHEALTHMESSAGES s #HOOSING%FFECTIVE#HANNELSTO#OMMUNICATE-ESSAGES  #OMMUNITYRESOURCES  -EDIA s !WARENESS 2AISING!PPROACHES  )NFORMATIONALWORKSHOPSFORTHEMEDIA  .ETWORKINGWITHADVOCATES 4HISMODULEISCLOSELYRELATEDTO-ODULE!)NFORMATIONFOR0OLICY-AKERS AND-ODULE$ )NFORMING#LIENTS4HETOOLSPROVIDEDINTHESEMODULESCANBEUSEDACROSSALLTHREEAREASOF ACTIVITIES4HETOOLSAREPRESENTEDASEXAMPLESANDSHOULDBEADAPTEDACCORDINGTOLOCALNEEDS

4OOLS0ROVIDEDATTHE%NDOF4HIS-ODULE

„ !GENDAFORA-EDIA7ORKSHOPON%MERGENCY#ONTRACEPTION „ %MERGENCY#ONTRACEPTION2ADIO3CRIPT „ %MERGENCY#ONTRACEPTION4ELEPHONE(OTLINE3CRIPT „ 0OSTERS „ 0OSTCARDS #  #  -ODULE# +EY!UDIENCES 3OCIAL#ONTEXTAND&INANCIAL2ESOURCES s s s s IDENTIFYTHECRITICALTARGETAUDIENCES OFTHEORGANIZATIONCARRYINGOUTTHEADVOCACYWORK4HEFOLLOWI ONTHEAVAILABILITYOF%#0SINTHECOUNTRY lNANCIALRESOURCES CARRIEDOUTATTHEGRASSROOTSLEV AUDIENCES WHOARETHEMOSTIMPORTANTTOREACH!WARENESS RAIS 'IVENTHERESOURCESANDCONSTRAINTSIDENTIlEDABOVE THENEXTS s s s s HELPFULINWORKINGTHROUGHTHISPROCESSINCLUDE EFFORTSWILLHELPDETERMINETHEDIRECTIONOFTHESTRATEGY3OME lNANCIALRESOURCESAVAILABLEASWELLASTHEORGANIZATIONALCAPA BETARGETEDINASSESSINGTHEMOSTCOST EFFECTIVESTRATEGIESTO AGAINSTPOTENTIALOUTCOMES)TISIMPORTANTTOBECLEARABOUTT IMPLEMENTINGALLOFTHESTRATEGIESTHEYWOULDLIKE)NSTEAD RE WITHWOMENSGROUPS CANBEFAIRLYINEXPENSIVE2ARELYDOPEOPL ADVERTISEMENTS CANBEVERYCOSTLYOTHERS SUCHASHOLDINGWOR AVAILABILITYOFRESOURCES3OMESTRATEGIESFORRAISINGPUBLICA SOCIALANDCULTURALENVIRONMENTOFTHECOUNTRY!NOTHERIMPORTA 7HENDEVELOPINGSTRATEGIESFORRAISINGPUBLICAWARENESS ITIS SECTIONONRESOURCESIN-ODULE!)NFORMATIONFOR0OLICY-AKERS &ORINFORMATIONONPOTENTIALSOURCESOFlNANCIALRESOURCESTHAT         %#0S 7HICHGROUPSWILLHAVETHEGREATESTIMPACTINTERMSOFHELPING !RETHEREORGANIZEDGROUPSTHROUGHWHICHTHESEPEOPLECANBERE 7HOHASTHEGREATESTNEEDFORTHISMETHOD 7HOWILLHAVETHEMOSTINTERESTINMESSAGESABOUT%#0S TARGETEDAPPROACH RESOURCESAVAILABLE SHOULDADVOCACYEFFORTSFOCUSONALARGE S 'IVENTHESOCIALCONTEXTANDTHEACCOMPANYINGPOLITICALCURREN WHATOTHERRESOURCESWILLBENEEDED 'IVENTHEORGANIZATIONSSTAFFEXPERTISEANDCAPACITYTOCONDUC 7HATlNANCIALRESOURCESAREAVAILABLETOCONDUCTANAWARENESS R MECHANISMSOFAWARENESS RAISING REPRODUCTIVEHEALTHISSUESINTHECOUNTRY ANDHOWWILLTHEYAF 7HATARETHESOCIAL CULTURAL ANDRELIGIOUSATTITUDESTOWARDF EL ASWELLASATTHENATIONAL LEVEL4HESTRATEGYWILLDEPEND IMPLEMENT+NOWINGTHE WARENESS SUCHASTELEVISION HEAUDIENCESTHATWILL SOURCESMUSTBEWEIGHED QUESTIONSTHATMAYBE ANDTHEGEOGRAPHICALREACH VITALTOUNDERSTANDTHE CITYTOCARRYOUTADVOCACY TEPISTODETERMINETHEKEY MAYBEAVAILABLE SEETHE KSHOPSANDMEETINGS NTCONSIDERATIONISTHE NGQUESTIONSWILLHELP AMILYPLANNINGAND INGCANBEEFFECTIVELY EHAVETHELUXURYOF  FECTTHEMESSAGESAND CALECAMPAIGNORAMORE TANAWARENESSCAMPAIGN SPREADTHEMESSAGEABOUT TS ASWELLASTHE AISINGCAMPAIGN ACHEDEFFECTIVELY -ODULE#

3UCCESSFUL%#0ADVOCACYCAMPAIGNSAROUNDTHEWORLDHAVEBEENAIMEDATTHEFOLLOWING AUDIENCES s 7OMENSGROUPS s /RGANIZATIONSOFHEALTHPROFESSIONALS s #LIENTSOFPUBLICHEALTHCLINICS s 9OUTH SERVINGORGANIZATIONS  'ENERALPUBLIC  .'/SBOTHLOCALANDINTERNATIONAL.'/SANDTHEIRAFlLIATES  #OMMUNITY BASEDHEALTHORGANIZATIONSANDCOMMUNITY BASEDDISTRIBUTORS  -EDIA INCLUDINGJOURNALISTS

&RAMING+EY-ESSAGES 7HENDEVELOPINGAPUBLICAWARENESSCAMPAIGN KEYMESSAGESAREOFTENCOMMUNICATED WITHINANOVERALLFRAMEWORK ORAPPROACH DESIGNEDTOAPPEALTOASPECIlCAUDIENCE %XAMPLESOFFRAMEWORKSTHATHAVEBEENUSEDWHENADVOCATINGFOR%#0SINDIFFERENT POLITICALANDCULTURALENVIRONMENTSINCLUDEWOMENSRIGHTSANDHUMANRIGHTS ASWELLAS PUBLICHEALTH4HEFRAMEWORKMUSTBEAPPROPRIATEFORTHESOCIALANDPOLITICALCONTEXTAND RESONATEWITHTHEPUBLICIFTHECAMPAIGNISTOBESUCCESSFUL2EGARDLESSOFTHEMESSAGES SELECTED ITISIMPORTANTTOPRETESTTHEMWITHMEMBERSOFTHETARGETAUDIENCE3OME FRAMINGAPPROACHESTHATHAVEBEENUSEDSUCCESSFULLYAREDESCRIBEDBELOW

7OMENSRIGHTSANDHUMANRIGHTSAPPROACH 4HERIGHTS BASEDAPPROACHFORREPRODUCTIVEANDSEXUALHEALTHHASBEENHIGHLIGHTEDAT SEVERALINTERNATIONALCONFERENCESDURINGTHEPASTTWODECADES INCLUDINGTHE)NTERNATIONAL #ONFERENCEON0OPULATIONAND$EVELOPMENT)#0$ INANDTHE&OURTH7ORLD #ONFERENCEON7OMENIN4HE)#0$0ROGRAMMEOF!CTIONCLEARLYPUTSACCESS TOCONTRACEPTIONWITHINTHEFRAMEWORKOFHUMANRIGHTS STATING h2EPRODUCTIVERIGHTS EMBRACECERTAINHUMANRIGHTSTHATAREALREADYRECOGNIZEDINNATIONALLAWS INTERNATIONAL HUMANRIGHTSDOCUMENTSANDOTHERCONSENSUSDOCUMENTS4HESERIGHTSRESTONTHE RECOGNITIONOFTHEBASICRIGHTOFALLCOUPLESANDINDIVIDUALSTODECIDEFREELYAND RESPONSIBLYTHENUMBER SPACINGANDTIMINGOFTHEIRCHILDRENANDTOHAVETHEINFORMATION ANDMEANSTODOSO ANDTHERIGHTTOATTAINTHEHIGHESTSTANDARDOFSEXUALANDREPRODUCTIVE HEALTHv%#0SAREAUNIQUECONTRACEPTIVEMETHODANDASSUCHNEEDTOBEPUTINTHE CONTEXTOFTHERIGHTTOCONTRACEPTIVECHOICE !USEFULRESOURCEFORCONSIDERINGARIGHTS BASEDAPPROACHINTHECONTEXTOFREPRODUCTIVE HEALTHISTHERECENTISSUEOF0!4(SPUBLICATION /UTLOOK!2IGHTS "ASED!PPROACHTO 2EPRODUCTIVE(EATHHTTPWWWPATHORGRESOURCESPUB?OUTLOOKHTM

#  #  -ODULE# „ „ „ ELEMENTOFTHEIRSUCCESS BEENACORNERSTONEOFTHEWORKDONEBY,!#%#GROUPSANDHASBEE EMPOWERSWOMENTODECIDEWHETHERANDWHENTHEYWILLBECOMEPREG EMPHASIZINGTHEFACTTHAT%#0SAREAFEMALE CONTROLLEDMETHODA PLANNINGPROGRAMSANDNORMSWITHINASEXUALANDREPRODUCTIVERI EFFORTSOF,!#%#MEMBERORGANIZATIONSFOCUSONINTEGRATING%#0S THE,ATIN!MERICAN#ONSORTIUMFOR%MERGENCY#ONTRACEPTION,!#% 4HERIGHTS BASEDAPPROACHHASALSOBEENSUCCESSFULINTHEINITI CANBEFOUNDONTHEIRWEBSITEHTTPWWWPIWHORGLATINAMERICA WHENANDIFSHEWILLHAVECHILDREN-OREINFORMATIONON0)7(S WOMANWANTINGTOAVOIDORDELAYPREGNANCYANDTHATITISAWOMA TRAININGANDADVOCACYABOUT%#0S STRESSINGTHATITISANIMPOR 0)7(HASCOLLABORATEDCLOSELYWITHOTHERGROUPSINTHESECOUNTR AND.ICARAGUAINAPROJECTTITLEDh%MERGENCY#ONTRACEPTIONASA 7OMENS(EALTH0)7( HASUSEDTHISAPPROACHTOADVOCATEFOR%# SUCCESSFULINTHE,ATIN!MERICANREGION3INCE THE0ACIlC ,INKING%#0ACCESSTOHUMANANDWOMENSRIGHTSISSUESHASBEEN EMAILINFO PROFAMILIAORGCO &AMILIA#OLOMBIANA #ALLE.O  3ANTA&EDE"OGOT´ "OGO &ORADDITIONALINFORMATION CONTACT0ROFAMILIAAT!SOCIACION0 ON0ROFAMILIASEXPERIENCECANBEFOUNDINBOTH%NGLISHAND3PA REGISTRATIONANDWOMENSACCESSTOADEDICATED%#0PRODUCT-OR %#0SSHOULDBEANINTEGRALOPTIONINFAMILYPLANNINGPROGRAMST GROUPSANDTHEUNDERSTANDINGONTHEPARTOFTHEGOVERNMENTAND REGISTRATIONOFADEDICATED%#0PRODUCT)NTHEEND ITWASTHE 0ROFAMILIAWHENTHELOCALRELIGIOUSLEADERSMOUNTEDACAMPAIGN ANDYOUTHNETWORKS4HEGROUPSWITHINTHESEALLIANCESPROVEDTO ANDHELPEDBUILDALLIANCESWITHTHEMEDIA WOMENSGROUPS MEDI THEFAMILYPLANNINGPROGRAM0ROFAMILIASTAFFCHAMPIONEDTHECA STANDARDSALREADYINCLUDED%#0S WHICHMEANTTHEYWERESANCTION REITERATED!DDITIONALLY 0ROFAMILIAPUBLICIZEDTHEFACTTHATT GOVERNMENTTOENSUREACCESSTOTHEWIDESTRANGEOFCONTRACEPTIV OFTHE)#0$ WHICH#OLOMBIASIGNEDIN THERESPONSIBILITY TO%#0SASASEXUALANDREPRODUCTIVERIGHTASSTATEDBYTHE0RO %#0SlRSTANDFOREMOSTASANIMPORTANTRIGHTSANDLEGALISSUE REGISTERINGADEDICATEDLEVONORGESTREL ONLY%#0PRODUCTIN #ATHOLICRELIGIOUSLEADERS3EVERALELEMENTSWERECRUCIALTO0R PLANNINGSYSTEMDUETOSTRONGOPPOSITIONBYCONSERVATIVEFORCES )N#OLOMBIA 0ROFAMILIAFACEDANUPHILLBATTLETOINTEGRATE%#0 ZZZLSSIZKURUJSXEOLFDWLRQVGRZQORDGVHULDOBLVVXHVVSRW(&BVS %#0S (UMAN2IGHTS AND7OMENS2IGHTS  IN,ATIN!MERICA HE-INISTRYOF(EALTH OFAMILIASSUCCESSIN SUPPORTOFTHESE SINTOTHEFAMILY ATIVESUNDERTAKENBY "YHIGHLIGHTINGACCESS RO "IENSTARDELA TANTOPTIONFORANY GRAMMEOF!CTION )NSTITUTEFOR HATHELPEDSECURE 0ROFAMILIAFRAMED OFTHE#OLOMBIAN GI USEOF%#0ACCESS INCLUDINGLOCAL NISHAT BEKEYALLIESWITH 7OMANS2IGHTv OPPOSINGTHE EMETHODSWAS NDTHATTHISMETHOD IESTOPROVIDE APPROACHANDWORK GHTSFRAMEWORK HTMLECRIGHT CALASSOCIATIONS INTOFAMILY  THEPUBLICTHAT EDASPARTOF EINFORMATION PARTICULARLY NSRIGHTTODECIDE T´ #OLOMBIAOR 0SIN-EXICO # !DVOCACY NCITEDASAKEY NANT)THAS KWWS -ODULE#

%#0SANDPUBLICHEALTHMESSAGES

5NINTENDEDPREGNANCY

"YPREVENTINGPREGNANCYBEFOREITHAPPENS %#0SHELPREDUCETHENUMBEROFUNINTENDED PREGNANCIESANDPREGNANCY RELATEDMATERNALDEATHS WHICHCANHAVEADEVASTATINGEFFECT ONTHELIVESOFWOMENANDFAMILIESINTHEWORLDSPOORESTCOUNTRIES x 4HE5NITED.ATIONSESTIMATESTHATMILLIONWOMENBECOMEPREGNANTEACHYEAR AND ONE THIRDOFTHOSEPREGNANCIESAREUNINTENDED x %VERYYEAR TOMILLIONWOMENEXPERIENCECONTRACEPTIVEFAILURE  x 4HESTRESSANDRISKSRELATEDTOCARRYINGAPREGNANCYTOTERMANDDELIVERINGACHILDARE EXTREMELYHIGHINCOUNTRIESWHEREFAMILYPLANNINGSERVICESARELIMITED)NFACT AWOMAN DELIVERINGACHILDISTWICEASLIKELYTODIEASAWOMANUNDERGOINGANABORTION x 4HE'LOBAL(EALTH#OUNCILCALCULATESTHATFROMTONEARLY WOMENDIED ASARESULTOFANUNINTENDEDORUNWANTEDPREGNANCY

!BORTION

'REATERACCESSTO%#0SCOULDREDUCENOTONLYTHENUMBEROFUNINTENDEDPREGNANCIES BUT ALSOTHENUMBEROFABORTIONSANDASSOCIATEDMATERNALMORTALITY x 7ORLDWIDE ABORTION RELATEDCOMPLICATIONSARETHECAUSEOFPERCENTOFALLMATERNAL DEATHS x -ANYUNINTENDEDPREGNANCIESINTHEDEVELOPINGWORLDRESULTFROMALACKOFACCESSTO ADEQUATEFAMILYPLANNINGSERVICES7OMENWHODECIDETOTERMINATETHEIRPREGNANCIES AREOFTENFACEDWITHUNDERGOINGUNSAFEABORTIONS WHICHSEVERELYTHREATENSTHEIRLIVES )NTHEREPORT0ROMISESTO+EEP4HE4OLLOF5NINTENDED0REGNANCIESON7OMENS,IVES INTHE$EVELOPING7ORLD THE'LOBAL(EALTH#OUNCILNOTESTHATEVERYYEARNEARLY MILLIONUNINTENDEDPREGNANCIESOCCUR RESULTINGINAPPROXIMATELYMILLIONABORTIONS /FTHESEMILLIONABORTIONS APPROXIMATELY RESULTINTHEDEATHOFTHEMOTHER 4HESEDEATHSOCCURNOTBECAUSEABORTIONISANINHERENTLYUNSAFEPROCEDURE BUTBECAUSE OFTHEPOORANDUNSAFECONDITIONSINWHICHABORTIONSOFTENTAKEPLACEINCOUNTRIESWHERE ADEQUATEFAMILYPLANNINGSERVICESARENOTAVAILABLEANDACCESSTOSAFEABORTION ISRESTRICTED

/PTIMALBIRTHSPACING

!CCESSTO%#0SWOULDENABLEWOMENTOACHIEVETHEOPTIMALSPACINGOFTHREEYEARS BETWEENBIRTHSˆWHICHHASSHOWNTOIMPROVETHEHEALTHOFBOTHMOTHERSANDCHILDREN x /VERPERCENTOFNONlRSTBIRTHSINDEVELOPINGCOUNTRIESOCCURWITHLESSTHANTHREE YEARSSPACING WHICHCANHAVESERIOUSADVERSEEFFECTSONTHEHEALTHOFBOTHMOTHERSAND CHILDREN x )NFANTSANDCHILDRENBORNLESSTHANTHREEYEARSAPARTARESIGNIlCANTLYMORELIKELYTODIE THANTHEIRCOUNTERPARTSBORNMORETHANTHREEYEARSAPART#HILDRENBORNWITHBIRTHSPACING INTERVALSOFTOMONTHSSHOWAPERCENT PERCENT ANDPERCENTREDUCTIONIN NEONATAL INFANT ANDUNDER lVEDEATHS RESPECTIVELY COMPAREDTOTHOSECHILDRENBORNJUST TOMONTHSAPART

#  #  -ODULE# #HOOSING%FFECTIVE#HANNELSTO#OMMUNICATE-ESSAGES x x x WHICHCHANNELSANDMESSAGESWOULDBEMOSTEFFECTIVE MESSAGESFORTHETARGETAUDIENCES!NSWERINGTHEFOLLOWINGQUES NECESSARYTODECIDEWHICHCHANNELSWILLBEMOSTEFFECTIVE ASW 4OEDUCATETHEPUBLICANDRAISEAWARENESSABOUTEMERGENCYCONTR ADOLESCENCE EMPOWERMENT AND()6!)$334)PREVENTION AREAS INCLUDINGOPTIMALBIRTHSPACING POSTABORTIONCARE SOUT 4HISSITECONTAINSINFORMATIONABOUT#ATALYST#ONSORTIUMPROJEC #ATALYST#ONSORTIUM PUBLICATIONSCANBEFOUNDONTHISSITE )NFORMATIONFORMEDIAANDADVOCACYEFFORTSANDDESCRIPTIONSOF 0)7( CONTRACEPTION ABORTION ADOLESCENTS EQUALITY ANDSAFEPREGNA SITES PUBLICATIONS NEWS ANDINFORMATIONONADVOCACY HUMANR ISSUESANDEVENTSRELATEDTOREPRODUCTIVEHEALTHANDRIGHTS)T 4HE#ENTERFOR2EPRODUCTIVE2IGHTSWEBSITECONTAINSUPDATEDINF 0ROMISES4O+EEPPDF 7OMENS,IVESINTHE$EVELOPING7ORLD 'LOBAL(EALTH#OUNCILREPORT ISSUESANDNEWSFROMAROUNDTHEWORLDASWELLASPUBLICATIONSU 4HE'LOBAL(EALTH#OUNCILWEBSITECONTAINSINFORMATIONONINTER 'LOBAL(EALTH#OUNCIL RESOURCESFORCREATINGADVOCACYMESSAGES AREALSOINCLUDEDINTHEWEBSITERESOURCESAPPENDIX WHICHLIST ADVOCATINGFOR%#0ACCESSBASEDONTHEISSUESOFRIGHTSANDPUB ,ISTEDBELOWAREWEBSITESOFFERINGINFORMATIONANDRESOURCESTH 7EB BASEDRESOURCESFORRIGHTSANDPUBLICHEALTHISSUES x x 4HE#ENTERFOR2EPRODUCTIVE2IGHTS ABORTIONANDRELATEDMATERNALMORTALITY ASWELLASLINKSTOOT $OESTHEAUDIENCEHAVEACCESSTOMASSMEDIASUCHASNEWSPAPERS 7HATISTHELITERACYLEVELOFTHEAUDIENCE )STHEAUDIENCEINARURALORURBANAREA MORTALITYINASTUDYCONDUCTEDUSINGDATAFROMNINETEEN,ATIN! ,ONGERBIRTHINTERVALSALSOSHOWEDSIGNIlCANTLYREDUCEDRISKSI STUNTINGANDAPERCENTREDUCTIONINUNDERWEIGHTCHILDREN $ATASHOWTHATBIRTHINTERVALSOFTOMONTHSSHOWAPER ,ONGERBIRTHINTERVALSAREALSOASSOCIATEDWITHIMPROVEDNUTRIT  HTTPWWWPIWHORG HTTPWWWPIWHORGLATINAMERICAHTML CONTAINSGLOBALANDREGIONALSTATISTICSONUNINTENDEDPREGNAN  HTTPWWWRHCATALYSTORG  HTTPWWWGLOBALHEALTHORG 0ROMISESTO+EEP4HE4OLLOF5NINTENDED0REGNANCIESON  HTTPWWWCRLPORG  HTTPWWWGLOBALHEALTHORGASSETSPUBLICATIONS INCLUDESLINKSTOOTHER HERDATASOURCES H TO SOUTHCOLLABORATION NCY SWEBSITESANDOTHER ELLASHOWTOTAILORKEY ATCANBEUSEDFOR 0)7(PROGRAMSAND IGHTS LEGALISSUES LICHEALTH4HESEWEBSITES   SEFULFORADVOCATES4HE TSANDFOCUSPROGRAM TIONSCANHELPDETERMINE ORMATIONONGLOBAL NATIONALPUBLICHEALTH ACEPTION ITWILLBE IONALSTATUSOFCHILDREN NTERMSOFMATERNAL CENTREDUCEDRATEOF MERICANCOUNTRIES MAGAZINES ANDRADIO CYAND  -ODULE#

s #ANTHEAUDIENCEBETARGETEDASAGROUP ORWOULDPERSON TOPERSONCONTACTBEMORE FEASIBLEANDEFFECTIVE 4HEFOLLOWINGAPPROACHESHAVEBEENUSEDSUCCESSFULLYFOR%#0ADVOCACY

#OMMUNITYRESOURCES s %NLISTINGLOCALCHAMPIONSSUCHASEDUCATORS STUDENTS WOMENSADVOCATES COMMUNITY WORKERS .'/STAFF ANDFACTORYUNIONREPRESENTATIVESTOCONDUCTADVOCACYABOUT EMERGENCYCONTRACEPTION7ITHTRAINING THESEINDIVIDUALSCANSPREADTHEMESSAGE THROUGHMECHANISMSOFTHEIROWNCHOOSINGSUCHASHOLDINGMEETINGSANDDISCUSSIONS ATWORKPLACES COMMUNITYGATHERINGHALLS ANDSCHOOLSPUTTINGUPPOSTERSPASSINGOUT INFORMATIONANDSHARINGINFORMATIONWITHFRIENDSANDFAMILY s (OLDINGINFORMATIONSESSIONSATWOMENSGROUPMEETINGS SCHOOLS OFlCES FACTORIES AND OTHERWORKPLACES

-EDIA -ASSMEDIACANBEANEXCELLENTMETHODOFRAISINGPUBLICAWARENESS0AIDADVERTISING TENDSTOBEANEXPENSIVEAPPROACHHOWEVER MESSAGESCANALSOBEINTEGRATEDINTO TELEVISIONORRADIOPROGRAMMING INCORPORATEDINTOTHETHEMESOFSTORYLINES ORDELIVERED THROUGHPUBLICSERVICEANNOUNCEMENTS0RESSBRIElNGSCANPROVIDEJOURNALISTSWITH INFORMATIONTHATTHEYUSETOWRITETHEIROWNSTORIESABOUT%#0S-EDIAOUTLETSTOCONSIDER INCLUDE s 2ADIO s 46 s .EWSPAPERS PRESSRELEASES s -AGAZINES s 4RADITIONALFOLKMEDIA THEATER s 3OAPOPERAS

!WARENESS 2AISING!PPROACHES )NFORMATIONALWORKSHOPSFORTHEMEDIA 7ORKSHOPSTHATPREPAREJOURNALISTSTOREPORTACCURATELYANDEFFECTIVELYONISSUESRELATED TOEMERGENCYCONTRACEPTIONHELPENSURETHATCORRECTINFORMATIONISCOMMUNICATEDTOA LARGEAUDIENCEˆINCLUDINGPOTENTIALUSERS PROVIDERS ADVOCATES ANDEVENOPPONENTS 4HE0OPULATION#OUNCILIN-EXICOCONDUCTEDSUCCESSFULWORKSHOPSFORJOURNALISTSIN BOTH-EXICOAND(ONDURASTHATPROVIDEDBACKGROUNDONREPRODUCTIVEHEALTHISSUESAND KEYINFORMATIONABOUTEMERGENCYCONTRACEPTION%MERGENCYCONTRACEPTIONADVOCATES FOUNDTHATTHISAPPROACHNOTONLYRAISEDAWARENESS BUTALSOHELPEDTONEUTRALIZEA MISINFORMATIONCAMPAIGNMOUNTEDBYSEVERALOPPOSITIONGROUPSIN-EXICO4HEAGENDA OFTHE0OPULATION#OUNCILSJOURNALISTWORKSHOPISPROVIDEDASATOOLATTHEENDOF THISSECTION4HEEMERGENCYCONTRACEPTIONFACTSHEETPROVIDEDASATOOLIN-ODULE! )NFORMATIONFOR0OLICY-AKERSCANBEDISTRIBUTEDTOWORKSHOPPARTICIPANTSTOTAKEWITH THEMASAREFERENCEFORINFORMINGTHEPUBLICABOUTEMERGENCYCONTRACEPTIONINTHEMEDIA #  #  -ODULE# 2EFERENCES     s s s s s DISSEMINATEDMOREBROADLY'ROUPSTHATWOULDBEEFFECTIVENETWO SHARINGEMERGENCYCONTRACEPTIONINFORMATIONANDADVOCACYMATERI ORFORMINGLOCALEMERGENCYCONTRACEPTIONALLIANCESCANBEEFFEC STRENGTHENTHEBASEOFSUPPORTFOREMERGENCYCONTRACEPTIONADVO .ETWORKINGWITHGROUPSTHATPROVIDEREPRODUCTIVEHEALTHINFORMA .ETWORKINGWITHADVOCATES 5NITED.ATIONS0OPULATION&UND 0ACIlC)NSTITUTEFOR7OMENS(EALTHWEBSITEWWWPIWHORG 0!4(!2IGHTS "ASED!PPROACHTO2EPRODUCTIVE(EALTH )#0$0ROGRAMOF!CTION0ARAGRAPH       GOVERNMENTOFlCIALS THEBARRIERSCREATEDBYPOLITICALPRESSURESANDTHEMULTIPLECO WASPOSSIBLETOMAKEPROGRESSWITHINTHEGOVERNMENTSYSTEMSAND TWOPHYSICIANSWHOACTIVELYCHAMPIONEDTHECAUSEOFGREATERACC ONRADIOANDTELEVISION"YIDENTIFYINGANDWORKINGWITHINDIVI INFORMATIONABOUT%#0STOTHEPUBLICTHROUGHTHEMEDIA PARTICI THEHEALTHSYSTEM4HETWOPHYSICIANSALSOBECAMEVERYINVOLVED CLINICIANSANDBECAUSEOFTHISWEREABLETOBECOMEACATALYSTF 4HEPHYSICIANSCONDUCTEDNUMEROUS%#0TRAININGSESSIONSFOR-IN RESPECTEDPHYSICIANSWHOWERESTRONGLYSUPPORTIVEOFINCREASED OUTmYERSATFAIRSANDCONCERTS4HE0OPULATION#OUNCILALSOWO AWARENESSOFEMERGENCYCONTRACEPTIONˆESPECIALLYAMONGADOLESCEN OFGRASSROOTSORGANIZATIONSSUCHASYOUTHGROUPS WHOSEMEMBERS CONTRACEPTIONIN-EXICO4HE0OPULATION#OUNCILIN-EXICOENLIS LOCALCHAMPIONS WERESUCCESSFULSTRATEGIESFORINCREASINGACCE 7ORKINGWITHLOCALNETWORKSANDCOMMUNITYGROUPS ASWELLASEN %#0MANUFACTURERORDISTRIBUTOR 'OVERNMENTSECTOR !CADEMICANDHEALTHINSTITUTIONS 9OUTHADVOCACYGROUPS 7OMENSGROUPS $EVELOPING,OCAL#HAMPIONS 4HE3TATEOF7ORLD0OPULATION /UTLOOK ACCESSED3EPTEMBER  .EW9ORK5.&0!      NCERNSFACEDBY DUALSLIKETHESE TIVEMECHANISMSFOR ORCHANGEWITHIN SSTOEMERGENCY CACY(OLDINGWORKSHOPS RKEDWITHTWOHIGHLY TIONANDSERVICESCAN PATINGININTERVIEWS RKINGADVOCATESINCLUDE ACCESSTO%#0S INPROVIDING ALS WHICHCANBE TEDTHEHELP ESSTO%#0S IT ISTRYOF(EALTH HELPEDRAISE CIRCUMVENT COURAGINGACTIVE TSˆBYHANDING -ODULE#

3EGAL 3*AND,A'UARDIA +$4ERMINATIONOFPREGNANCYˆAGLOBALVIEW"AILLIERES#LINICAL/BSTETRICSAND 'YNAECOLOGY   

'LOBAL(EALTH#OUNCIL0ROMISESTO+EEP4HE4OLLOF5NINTENDED0REGNANCIESON7OMENS,IVESINTHE $EVELOPING7ORLD.EW9ORK'LOBAL(EALTH#OUNCIL 

3ETTY 6ENUGOPAL 6AND5PADHYAY 5$"IRTH3PACING4HREETO&IVE3AVES,IVES0OPULATION2EPORTS3ERIES , .O"ALTIMORE*OHNS(OPKINS5NIVERSITY"LOOMBERG3CHOOLOF0UBLIC(EALTH 0OPULATION)NFORMATION 0ROGRAM 

2UTSTEIN 3h%FFECTSOF"IRTH)NTERVALON-ORTALITYAND(EALTH-ULTIVARIATE#ROSS #OUNTRY!NALYSISv 0RESENTATIONATTHE/"3)#HAMPIONS-EETING 7ASHINGTON $#-AY 

#ONDE !GUDELO !AND"ELIZAN *--ATERNALMORBIDITYANDMORTALITYASSOCIATEDWITHINTERPREGNANCY INTERVALCROSS SECTIONALSTUDY"RITISH-EDICAL*OURNAL   

#  #  -ODULE#4OOLS,IST

„!GENDAFORA-EDIA7ORKSHOPON %MERGENCY#ONTRACEPTION 4HE0OPULATION#OUNCILCONDUCTEDSUCCESSFULWORKSHOPSFORJOURNALISTSINBOTH-EXICOAND (ONDURAS WHICHPROVIDEDBACKGROUNDONREPRODUCTIVEHEALTHISSUESANDKEYINFORMATION ABOUTEMERGENCYCONTRACEPTIONTOENCOURAGEACCURATEREPORTINGONTHEISSUES!SAMPLE AGENDAFROMTHESEMEETINGSISPROVIDEDHERETOASSISTINIMPLEMENTINGSUCHAWORKSHOPIN OTHERSETTINGS

„%MERGENCY#ONTRACEPTION2ADIO3CRIPT /UTREACHTHROUGHMASSMEDIACANBEVERYEFFECTIVE0ROFAMILIA#OLOMBIAUSEDRADIO STATIONSTOAIRMESSAGESTAILOREDTODIFFERENTDEMOGRAPHICGROUPSINTHECOUNTRY0ROFAMILIA STRATEGICALLYAIREDMESSAGESATDIFFERENTTIMESTHROUGHOUTTHEDAYTOCOVERTHEVARIOUSTARGET AUDIENCES&OR46ORRADIOADVERTISING ASERIESOFMESSAGESTHATCHANGEFREQUENTLYCAN MOREEFFECTIVELYRETAINPEOPLESATTENTIONTHANASINGLEMESSAGE5SINGMULTIPLEMESSAGES ALSOMAKESITPOSSIBLETOCOVERMULTIPLEISSUES!TRANSCRIPTIONOFARADIOSPOTDEVELOPEDBY 0ROFAMILIAIN#OLOMBIAISPROVIDEDHERE

„ %MERGENCY#ONTRACEPTION4ELEPHONE(OTLINE3CRIPT (OTLINESARETELEPHONESERVICESINDIVIDUALSCANCALLTORECEIVEINFORMATIONORTOREQUESTHELP WITHANEMERGENCYORAPROBLEMREQUIRINGIMMEDIATEATTENTION(OTLINES USUALLYTOLL FREE HAVEPROVENTOBEUSEFULTOOLSFORINCREASINGACCESSTOEMERGENCYCONTRACEPTIONINFORMATION 4HEYCANPROVIDEINFORMATIONABOUTWHATEMERGENCYCONTRACEPTIONIS HOWITWORKS ITS ADVANTAGESANDDISADVANTAGES WHERETOGETIT ANDHOWTOTAKEIT3OMEHOTLINESPROVIDE RECORDEDINFORMATIONOTHERSARESTAFFEDBYTRAINEDOPERATORSWHOSPEAKDIRECTLYWITHCALLERS ABOUTTHEIRCONCERNSANDPROVIDEINFORMATIONABOUTHOWANDWHERETOOBTAIN%#0S !NEMERGENCYCONTRACEPTIONHOTLINE SETUPBYTHE0OPULATION#OUNCIL WASSUCCESSFULIN -EXICO RECEIVINGOVER CALLSAMONTHATITSPEAK4HE0OPULATION#OUNCILIN-EXICO HASDOCUMENTEDTHISSUCCESSINTWOARTICLES4HEHOTLINERECEIVEDAGREATDEALOFATTENTION FROMJOURNALISTSANDRECEIVEDGOODCOVERAGEINTHEMEDIA RAISINGAWARENESSOF%#0SAND HELPINGTHEEFFORTSOFADVOCATES 7HENDEVELOPINGANEMERGENCYCONTRACEPTIONHOTLINE ITISCRITICALTOENSURETHATWOMEN RECEIVEACCURATEANDOBJECTIVEINFORMATION4HISTOOLISADAPTEDFROMATRANSCRIPTOF INFORMATIONPROVIDEDTOWOMENCALLINGTHE  .OT  ,ATEAUTOMATEDEMERGENCY CONTRACEPTIONHOTLINEINTHE5NITED3TATES DEVELOPEDANDOPERATEDBYTHE/FlCEOF 0OPULATION2ESEARCHAT0RINCETON5NIVERSITYANDTHE!SSOCIATIONOF2EPRODUCTIVE(EALTH 0ROFESSIONALS)TPROVIDESINFORMATIONABOUT%#0SANDALSODIRECTSCALLERSTOPROVIDERSWHO HAVESAIDTHEYAREWILLINGANDLICENSEDTOPRESCRIBE%#0S)TISANEXAMPLEOFTHEKINDOF%#0 INFORMATIONTHATCANBEPROVIDEDTHROUGHANEMERGENCYCONTRACEPTIONHOTLINE

#  „ 0OSTERS 0OSTERSPLACEDSTRATEGICALLYINPLACESFREQUENTEDBYWOMENAREANOTHEREFFECTIVEWAYTORAISE AWARENESSABOUTEMERGENCYCONTRACEPTION7OMENSCENTERS HEALTHCENTERS NIGHTSPOTSSUCH

-ODULE# ASBARSORDISCOS UNIVERSITIES ANDPUBLICTRANSPORTATIONSUCHASBUSES SUBWAYS ANDTRAINS AREJUSTSOMEOFTHEPLACESWHEREPOSTERSADVOCATINGEMERGENCYCONTRACEPTIONCANBEPLACED %XAMPLESOFPOSTERSUSEDIN:AMBIAAND3OUTH!FRICAAREPROVIDEDHERETOSTIMULATEIDEAS !LLMESSAGESANDVISUALPRESENTATIONSSHOULDBETESTEDWITHAUDIENCESTOENSURETHEYWILL WORKWELL 4OOLS

„ 0OSTCARDS 4HE0OPULATION#OUNCILIN-EXICOUSEDADVERTISINGPOSTCARDSINEFFORTSTOEDUCATEWOMEN ABOUTEMERGENCYCONTRACEPTION3TAFFPLACEDPOSTCARDSINCAFES BARS RESTAURANTS ONPUBLIC TRANSPORTATION ATBRIDALSHOWS ANDOTHERAREASWHEREYOUNGWOMENMIGHTHAVETHECHANCETO SEETHEM3AMPLEPOSTCARDSFROMTHE-EXICOCAMPAIGNAREPROVIDEDHERE

%LLERTSON #ETAL)NFORMATIONCAMPAIGNANDADVOCACYEFFORTSTOPROMOTEACCESSTOEMERGENCYCONTRACEPTIONIN-EXICO #ONTRACEPTION   (EIMBURGER !ETAL0RACTICESAMONGPROVIDERSANDPOTENTIALCLIENTSAFTERA YEARINTRODUCTIONEFFORT#ONTRACEPTION   

#  4OOLS

!GENDAFORA-EDIA7ORKSHOPON -ODULE# %MERGENCY#ONTRACEPTION%# 'ENERAL/BJECTIVE )NFORMMEMBERSOFTHEMEDIAABOUTTHEIMPORTANCEOFEMERGENCYCONTRACEPTION

3PECIlC/BJECTIVES A ,EARNTHELEGALSTANDARDORFRAMEWORK FORTHEINTRODUCTIONOF%#IN(ONDURAS B ,EARNTHEMOSTIMPORTANTMEDICALASPECTSOF%# C $ETERMINETHEROLEOFMASSMEDIAINREPORTINGONANDPROMOTING%#

4ARGET!UDIENCEMEMBERSOFTHEMEDIA

$ATE.OVEMBER

,OCATION4EGUCIGALPA !GENDA

nAM 7ELCOME $R3ANDRA'ARCÓA 0OPULATION#OUNCIL $R#ARLOS-ORLACCHI %XECUTIVE$IRECTOR !SHONPLAFA nAM 7HATIS%# (ISTORYANDMEDICALASPECTSOF%# $R'UILLERMINA-EJÓA #ONSULTANT 0OPULATION#OUNCIL -EXICO

nAM %XPERIENCESFROM%#INTRODUCTIONINOTHER ,IC0ATRICIA-ERLO )-)&!0 -EXICO COUNTRIES nAM 0RESENTATIONOFTHE%#PROJECTIN(ONDURAS AND -TRA3UYAPA0AVØN !SHONPLAFA PRESENTATIONOFRESEARCHRESULTSIN!SHONPLAFA (ONDURAS CLINICS $R$IANA,ARA 0OPULATION#OUNCIL -EXICO nAM ,EGALFRAMEWORKFOR%#INTRODUCTIONIN $R-ARIELOS"ARAHONA !SHONPLAFA (ONDURAS ANDSTRATEGYOFINTRODUCTIONIN (ONDURAS !SHONPLAFA nAM 4HEROLEOFMASSMEDIAINREPORTINGONAND -TRO6LADIMIR,ØPEZ2ECINOS PROMOTING%#2ESULTSOFAREVIEWOFVARIOUS TYPESOFMEDIA

nAM 1UESTIONSANDANSWERS

nPM #LOSING $R#ARLOS-ORLACCHI !SHONPLAFA nPM ,UNCH

4HISMATERIALWASREPRINTEDWITHPERMISSIONFROMTHE0OPULATION#OUNCILOF-EXICO

#  -ODULE# 4OOLS

#  4OOLS

%MERGENCY#ONTRACEPTION2ADIO3CRIPT -ODULE#

%MERGENCY#ONTRACEPTION 9OUHADSEX "UTTHEREWASNOPROTECTION 9OUWEREFORCEDORTHEMETHODFAILED ,OOK )WILLGIVEYOUTHESOLUTION !LTHOUGHITISBETTERTOUSEFAMILYPLANNING THEREAREEMERGENCYMETHODS

#ALL???????????????ORLOGONTO?????????FORMOREINFORMATION

4HISMATERIAL ORIGINALLYDEVELOPEDIN3PANISH WASREPRODUCEDWITHPERMISSIONFROM0ROFAMILIA

#  -ODULE# 4OOLS

#  4OOLS

%MERGENCY#ONTRACEPTION4ELEPHONE -ODULE# (OTLINE3CRIPT

!PPLICATION6OICE3CRIPT %NGLISH'REETING 7ELCOMETOTHE%MERGENCY#ONTRACEPTION(OTLINE NOWMANAGEDBYTHE!SSOCIATIONOF 2EPRODUCTIVE(EALTH0ROFESSIONALS)FYOUARECALLINGFROMAROTARYPHONE PLEASEGETREADYTO WRITEDOWNTHENAMESANDPHONENUMBERSOFTHEPROVIDERSNEARYOU)FYOUHAVEATOUCHTONE PHONE PLEASEPRESSTOHEARMOREIN%NGLISH

)NTRODUCTION %MERGENCYCONTRACEPTIVESAREBIRTHCONTROLMETHODSTHATCANPREVENTPREGNANCYAFTERSEX %MERGENCYCONTRACEPTIONDOESNOTPROTECTAGAINSTSEXUALLYTRANSMITTEDINFECTIONS 4HISHOTLINETELLSYOUABOUTEMERGENCYCONTRACEPTIONANDGIVESTHENAMESANDPHONENUMBERS OFPLACESNEARBYWHEREYOUCANGETEMERGENCYCONTRACEPTIVES$ONOTUSEEMERGENCY CONTRACEPTIONEXCEPTUNDERTHECAREOFAHEALTHCAREPROVIDERWHOISLICENSEDTOPRESCRIBE4HIS HOTLINEISNOTTIEDTOANYCOMPANIESTHATMAKEORSELLEMERGENCYCONTRACEPTIVES 9OUWILLNOWHEARAMENUOFSIXCHOICES4ORETURNTOTHISMENUATANYTIME PRESSTHESTARKEY

-ENU &ORINFORMATIONONWHEREYOUCANGETEMERGENCYCONTRACEPTIONPRESS &ORMOREINFORMATIONONEMERGENCYCONTRACEPTIVEPILLS PRESS &ORMOREINFORMATIONONEMERGENCYINSERTIONOFA#OPPER 4)5$ PRESS &ORGUIDELINESONMAKINGCALLSTOPROVIDERS PRESS )FYOUAREAPROVIDERWHOWOULDLIKETOBEINCLUDEDINTHEDIRECTORYORYOURDIRECTORY INFORMATIONHASCHANGED ORIFYOUAREACONSUMERWHOWOULDLIKETOCOMMENTON THEHOTLINE PRESS &ORMOREINFORMATIONABOUTEMERGENCYCONTRACEPTIONANDWHERETOOBTAINITANYWHEREIN THECOUNTRY PLEASEVISITOURWEBSITE/URADDRESSISINSERTWEBADDRESS )FYOUWOULDLIKE ADDITIONALWRITTENINFORMATIONABOUTEMERGENCYCONTRACEPTION ASKYOURHEALTHCARE PROVIDERORPRESS

0ROVIDERS 4HISDIRECTORYLISTSHOSPITALS PRIVATEDOCTORS FAMILYPLANNINGCLINICS PHARMACIES ANDOTHERS WHOCANTELLYOUABOUTEMERGENCYCONTRACEPTIVESANDWHOHAVESAIDTHEYAREWILLINGAND LICENSEDTOPRESCRIBEEMERGENCYCONTRACEPTION!SWITHALLHEALTHCARECHOICES TAKECARE WHENCHOOSINGAPROVIDEROFEMERGENCYCONTRACEPTION4HEOPERATORSOFTHISHOTLINEMAKE NOCLAIMSABOUTTHEQUALITYORCOSTOFTHESERVICESOFFERED)FYOUHAVEAREGULARHEALTHCARE PROVIDER YOUMAYWISHTOCALLTHEPROVIDERlRST

)FYOUHAVEHADSEXTHATWASNOTPROTECTEDBYBIRTHCONTROL ORIFYOURMETHODFAILEDINTHE #  PASTFEWDAYSANDYOUDONOTWISHTOBECOMEPREGNANT CALLAPROVIDERASSOONASYOUCAN ANDTELLTHEPERSONWHOANSWERSTHEPHONETHATYOUNEEDEMERGENCYCONTRACEPTION 9OUWILLNOWHEARTHENAME LOCATION ANDPHONENUMBEROFlVECLINICSNEARYOU(AVEAPEN ANDPAPERREADY)FYOUlNDANERRORINTHENAMESANDPHONENUMBERSLISTED PLEASECALLTHE -ODULE# HOTLINEAGAINANDPRESSTOLETUSKNOW 4HElVEPROVIDERSNEARESTYOUARE

4OOLS 2EPEAT/PTION 4ORETURNTOTHEMAINMENU PRESSTHESTARKEY4OREPEATTHISMESSAGE PRESSTHEPOUNDKEY %MERGENCY#ONTRACEPTIVE0ILLS 4HEREARETWOTYPESOFEMERGENCYCONTRACEPTIVEPILLS/NETYPEISNOTHINGMORETHANORDINARY BIRTHCONTROLPILLSTHATCONTAINHORMONESCALLEDESTROGENANDPROGESTIN4HEBRANDNAME OFTHECOMBINEDBIRTHCONTROLSPECIALLYPACKAGEDANDLABELEDFOREMERGENCYUSEININSERT NAMEOFCOUNTRY ISINSERTBRANDNAME !BOUTPERCENTOFWOMENWHOUSETHISTYPE GETNAUSEATEDANDPERCENTVOMIT5SEOFTHISTYPEOFPILLCUTSTHECHANCEOFPREGNANCY BYPERCENT4HEOTHERTYPEOFEMERGENCYCONTRACEPTIVEPILLCONTAINSONLYTHEHORMONE CALLEDPROGESTIN4HISTYPEISSPECIALLYPACKAGEDANDLABELEDFOREMERGENCYUSEASTHEBRAND NAMEINSERTBRANDNAME )TISMOREEFFECTIVETHANTHElRSTTYPE ANDTHERISKOFNAUSEAAND VOMITINGISALSOLOWER 3OMEPEOPLECALLEMERGENCYCONTRACEPTIVEPILLShMORNINGAFTERvPILLS"UTYOUDONOTHAVE TOWAITUNTILTHEMORNINGAFTER9OUCANSTARTTHEPILLSRIGHTAWAYORUPTOlVEDAYSAFTER YOUHAVEHADUNPROTECTEDSEXˆTHATISSEXDURINGWHICHYOUDIDNOTUSEBIRTHCONTROLOR YOURBIRTHCONTROLMAYHAVEFAILED9OURHEALTHCAREPROVIDERWILLTELLYOUTOTAKETHElRST DOSEWITHINHOURSAFTERUNPROTECTEDSEX4HEPROVIDERWILLTELLYOUTOTAKETHESECOND DOSEHOURSAFTERTHElRSTDOSE%ACHDOSEIS   ORPILLS DEPENDINGONTHEBRAND .OTALLBRANDSOFBIRTHCONTROLPILLSCANBEUSEDFOREMERGENCYCONTRACEPTION%MERGENCY CONTRACEPTIVEPILLSREQUIREAPRESCRIPTION$ONOTUSETHEMEXCEPTUNDERTHECAREOFSOMEONE LICENSEDTOPRESCRIBE -OSTWOMENCANSAFELYUSEEMERGENCYCONTRACEPTIVEPILLS EVENIFTHEYCANNOTUSEBIRTH CONTROLPILLSASTHEIRREGULARMETHODOFBIRTHCONTROL 4ORETURNTOTHEMAINMENU PRESSTHESTARKEY4OREPEATTHISMESSAGE PRESSTHEPOUNDKEY

%MERGENCY)NSERTIONOFA#OPPER 4)5$ !N)5$ ORINTRAUTERINEDEVICE ISASMALLDEVICETHATISPLACEDINTOTHEUTERUS ALSOCALLEDTHE WOMB9OUCANGETTHEEMERGENCY#OPPER 4)5$INSERTEDUPTOSEVENDAYSAFTERUNPROTECTED SEXˆTHATISSEXDURINGWHICHYOUDIDNOTUSEBIRTHCONTROLORYOURBIRTHCONTROLMAYHAVE FAILED)5$SREQUIREAPRESCRIPTION!PROVIDERWILLTELLYOUTHEADVANTAGESANDDISADVANTAGES OFUSINGAN)5$ &ORMEDICALREASONS THE)5$ISNOTTHEBESTOPTIONFORMANYWOMENWHONEEDEMERGENCY

#  4OOLS

CONTRACEPTION4HE)5$ISTHEMOSTEXPENSIVEEMERGENCYCONTRACEPTIVE BUTITMAYBELEFTIN

PLACETOPROVIDEHIGHLYEFFECTIVECONTRACEPTIONFORUPTOYEARSAFTERINSERTION4HECOPPER -ODULE# 4)5$ISTHEMOSTEFFECTIVEEMERGENCYCONTRACEPTIVE!NEMERGENCYINSERTIONOFTHE#OPPER 4)5$CUTSTHECHANCEOFPREGNANCYBYMORETHANPERCENT 4ORETURNTOTHEMAINMENU PRESSTHESTARKEY4OREPEATTHISMESSAGE PRESSTHEPOUNDKEY

3ENDA-ESSAGE )FYOUAREACONSUMERWITHCOMMENTSABOUTTHISHOTLINEORAPROVIDERWHOSEINFORMATIONHAS CHANGED YOUMAYEITHERWRITEINYOURCOMMENTSORLEAVEAVOICE MAILMESSAGE#ONSUMERS SHOULDWRITETOPROVIDEADDRESSFORWRITTENCORRESPONDENCE 0ROVIDERSSHOULDWRITETO PROVIDEADDRESSFORWRITTENCORRESPONDENCE 0LEASESTAYONTHELINETOLEAVEAVOICE MAIL MESSAGE1UESTIONSABOUTINDIVIDUALMEDICALPROBLEMSWILLNOTBEANSWERED0LEASECONSULTA CLINICIANFORTHOSEQUESTIONS

4IPSFOR#ALLING0ROVIDERS )FYOUNEEDEMERGENCYCONTRACEPTION CHANCESAREYOUAREFEELINGWORRIED MAYBEEVEN PANICKED7HENYOUCALLTOMAKEANAPPOINTMENT ASKANYQUESTIONSYOUMAYHAVEABOUT EMERGENCYCONTRACEPTIONORABOUTWHATWILLHAPPENWHENYOUCOMEINFORANAPPOINTMENT -ANYPROVIDERSAREHAPPYTOTAKETHETIMETOGIVEMOREINFORMATIONWHENASKED"YSEEKING OUTINFORMATIONANDSERVICESTOAVOIDANUNINTENDEDPREGNANCY YOUAREACTINGRESPONSIBLY 4HEFOLLOWINGTIPSMAYHELPYOUGETTHEMOSTOUTOFYOURCALLSTOHOTLINEPROVIDERS "EAWARETHATTHEDIRECTORYOFPROVIDERSISNOTPERCENTFAILPROOF)FAHOTLINEPROVIDER CANNOTHELPYOU WESTRONGLYENCOURAGEYOUTOLETUSKNOWBYLEAVINGAMESSAGEONTHE HOTLINEOPTIONONTHEMAINMENU  +EEPINMINDTHATTHECOSTOFSERVICESWILLVARY"ESURETOASKHOWMUCHAVISITWILLCOSTAND CHECKTOSEEIFTHEREISASLIDINGSCALEFEEDEPENDINGONYOURINCOME )FTHERECEPTIONISTDOESNOTHAVEINFORMATIONEMERGENCYCONTRACEPTIONORTHINKSITISNOT PROVIDEDTHERE ASKTOSPEAKTOANURSEORPHYSICIANIFPOSSIBLE )FYOUCALLASITEWITHASPECIlCCLINICIANLISTEDANDTHATCLINICIANISUNAVAILABLE ASKIFTHERE ISSOMEONEELSETHEREWHOWILLPRESCRIBEEMERGENCYCONTRACEPTION ORASKFORAREFERRALTO ANOTHERPROVIDER !SKWHETHERTHECLINICIANCANPHONEINANEMERGENCYCONTRACEPTIONPRESCRIPTIONTOYOURLOCAL PHARMACIST "EPREPAREDTOANSWERQUESTIONSREGARDINGTHESTARTDATEOFYOURLASTPERIOD WHEN UNPROTECTEDINTERCOURSETOOKPLACE YOURMEDICALHISTORY ANDYOURLASTPELVICEXAM )FYOUARECONCERNEDYOUWILLRUNOUTOFTIMEBEFOREAPROVIDERCANSEEYOU TRYYOURLOCAL EMERGENCYROOM 4ORETURNTOTHEMAINMENU PRESSTHESTARKEY4OREPEATTHISMESSAGE PRESSTHEPOUNDKEY

2EQUEST0HONE.UMBER

#  )NORDERTOCONNECTYOUTOTHEEMERGENCYCONTRACEPTIONHOTLINE PLEASEENTERYOURTENDIGIT TELEPHONENUMBER BEGINNINGWITHTHEAREACODElRST0LEASEENTERNOW

'OODBYE -ODULE# 4HANKYOUANDGOOD BYE 4OOLS

#ONTENTANDFORMATADAPTEDWITHPERMISSIONFROM!SSOCIATIONOF2EPRODUCTIVE(EALTH0ROFESSIONALS!2(0 %MERGENCY#ONTRACEPTIVE(OTLINE!PPLICATION6OICE3CRIPT

#  4OOLS

0OSTERS -ODULE#

4HISMATERIALWASREPRINTEDWITHPERMISSIONFROMTHE2EPRODUCTIVE(EALTH2ESEARCH5NITOFTHE5NIVERSITYOF 7ITWATERSRAND 3OUTH!FRICA

#  -ODULE# 4OOLS

4HESEMATERIALSWEREREPRINTEDWITHPERMISSIONFROMTHE0OPULATION#OUNCIL

#  4OOLS

0OSTCARDS -ODULE#

)FYOUFORGOTTOSAVE FORARAINYDAY

)FSPRINGISNTOVERYET ANDYOUDIDNTTAKE PRECAUTIONSx

xYOUHAVEHOURS TOAVOIDPREGNANCY

4HESEMATERIALSWEREREPRINTEDFROMTHE0OPULATION#OUNCIL xYOUHAVEHOURS TOAVOIDPREGNANCY #  -ODULE# 4OOLS

)FYOUATETHE WHOLEPIEx

xYOUHAVEHOURS TOAVOIDPREGNANCY

    INTHREEDAYS 9OURCALLISCONlDENTIAL WWWINTHREEDAYSORGMX

4HESEMATERIALSWEREDEVELOPEDAND TRANSLATEDBYTHE0OPULATION#OUNCILOF -EXICOANDREPRINTEDHEREWITHTHEIR PERMISSION

)FLOVEWASSUGARSWEETAND YOUDIDNTTAKEPRECAUTIONSx

#ONSULTYOURPHYSICIAN

#  -ODULE$

)NFORMING#LIENTS

/BJECTIVE 4OEDUCATECLIENTSABOUTTHEAVAILABILITYOFEMERGENCYCONTRACEPTIVEPILLS%#0S AND ENSURECORRECTUSE

7HEN%#0SHAVEBEENSUCCESSFULLYINCORPORATEDINTOAFAMILYPLANNINGPROGRAM ITISIMPORTANT TOPROVIDEADEQUATEINFORMATIONABOUTTHISCONTRACEPTIVEOPTIONSOTHATCLIENTSCANMAKEAN INFORMEDDECISIONABOUTWHETHERORNOTTOUSE%#0SˆANDIFTHEYCHOOSETOUSETHEM TOENSURE THEYDOITCORRECTLY-ANYWOMENDONOTKNOWABOUT%#0S ANDMANYWHOHAVEHEARDABOUT THEMTHROUGHADVOCACYCAMPAIGNSMAYHAVEQUESTIONSANDCONCERNSABOUTTHEMETHOD4HIS MODULEDISCUSSESDEVELOPMENTOFCLIENTMATERIALSTHATPROVIDEESSENTIALINFORMATIONANDANSWER SPECIlCQUESTIONSWOMENMAYHAVEABOUT%#0S)NDEVELOPINGCLIENTMATERIALS ITISIMPORTANT TOAVOIDOVERBURDENINGTHECLIENTWITHINFORMATION YETSTILLPROVIDEENOUGHSOTHATSHEFEELS CONlDENTANDSAFETAKING%#0S4HEFOLLOWINGTOPICSAREDISCUSSEDINTHISMODULE s )DENTIFYING+EY!UDIENCES s $EVELOPING)NFORMATIONAL-ATERIALSFOR#LIENTS s #HANNELSFOR#OMMUNICATING%#0-ESSAGESTO#LIENTS 4HISMODULEISCLOSELYRELATEDTO-ODULE!)NFORMATIONFOR0OLICY-AKERSAND-ODULE# 2AISING0UBLIC!WARENESS4HETOOLSPROVIDEDINTHESEMODULESCANBEUSEDACROSSALLTHREEAREAS OFACTIVITIES4HETOOLSAREPRESENTEDASEXAMPLESANDSHOULDBEADAPTEDACCORDINGTOLOCALNEEDS

4OOLS0ROVIDEDATTHE%NDOF4HIS-ODULE

„3AMPLE4EXTFOR"ROCHURES „ "ROCHUREIN4HREE&ORMATS „ 3OUTH!FRICA"ROCHURE !DDITIONALTOOLSTHATMAYBEUSEFULFORPROVIDINGINFORMATIONFORCLIENTSCANBEFOUNDINTHE TOOLSSECTIONOF-ODULE&2EGULATION 0ROCUREMENT AND$ISTRIBUTIONOFA0ROGESTIN /NLY %#0AND-ODULE'4HE/PTIONOF0ROVIDING#OMBINED/RAL#ONTRACEPTIVES#/#S AS .ONDEDICATED%MERGENCY#ONTRACEPTIVE0ILLS%#0S 

4HEAPPROACHESUSEDFORINFORMING%#0CLIENTSANDPOTENTIAL%#0USERSWILLDEPENDONANUMBER OFFACTORSINCLUDINGRESOURCESAVAILABLEANDTHESOCIALANDCULTURALENVIRONMENTSOFTHECLIENTS 4HEMAINOBJECTIVEISTOREACHASLARGEANUMBEROFPOTENTIALCLIENTSASPOSSIBLEWITHCORRECT CONCISEINFORMATIONABOUT%#0S

$  $  -ODULE$ APREGNANCYBEGINS 4HEDElNITIONPROVIDEDABOVEISPROVIDEDWITHINAMEDICALCLIN $EVELOPING)NFORMATIONAL-ATERIALSFOR#LIENTS )DENTIFYING+EY!UDIENCES %#0SARESAFE4HEREISNOEVIDENCETHATTAKING%#0SHARMSA s %#0SARENOTRECOMMENDEDFORUSEASAREGULARCONTRACEPTIVE s %#0SARECONVENIENTLYAVAILABLE s %#0SAREEASYTOUSE s %#0SCANNOTPROTECTAGAINSTSEXUALLYTRANSMITTEDINFECTIONS s %#0SCANNOTINTERRUPTANESTABLISHEDPREGNANCY s %#0SWORKBYPREVENTINGAPREGNANCYBEFOREITHAPPENS%#0S s +EYFACTSANDMESSAGES FORCLIENTSTOUNDERSTANDANDTOPRE TESTMESSAGESTOBESURET FACTSTHATWOMENMAYNEEDORWANTTOKNOW)TISIMPORTANTTOU INORDERTOMAKEINFORMEDCHOICESABOUTUSINGEMERGENCYCONTRAC PLANNINGPROGRAMS CLIENTMATERIALSTYPICALLYPROVIDEFACTUALI )NCOUNTRIESWHERE%#0SHAVEBEENSUCCESSFULLYINTEGRATEDINTO QUESTIONNAIRE AREPROVIDEDIN-ODULE%!SSESSMENT WITHSEVERALASSESSMENTTOOLSˆINCLUDINGACLIENTKNOWLEDGE ATT ASSESSMENTOFCLIENTINFORMATIONNEEDS!DISCUSSIONOFTHEASS AMONGOTHERS!STARTINGPOINTINDEVELOPING%#0MATERIALSFOR NOTUSINGREGULARONGOINGCONTRACEPTIONMETHODS ANDTHOSEWHO PILLUSERSMAYMISSPILLS WOMENWHOHAVEINTERCOURSEINFREQUE CONSISTENTLYCONDOMUSERSMAYEXPERIENCEBREAKAGEORSLIPPAGE CONTRACEPTIVEUSERSWHOEXPERIENCEAMETHODFAILUREORDONOTU 7OMENWHOMAYNEEDEMERGENCYCONTRACEPTIONINCLUDESEXUALLYACT !LTHOUGHNOSTUDIESHAVEBEENCONDUCTEDON%#0SANDFUTUREFE s ,EVONORGESTREL ONLY%#0SANDCOMBINEDPROGESTIN ESTROGEN%#0 s EFFECTS EFFECTIVEFORREGULARUSE MATERIALSPROVIDEINFORMATIONONWHEREWOMENCANGOTOGET%#0S REPLACECONDOMSFORPROTECTIONAGAINST34)SOR()6!)$3 %#0SCANPROTECTAGAINSTPREGNANCYAFTERUNPROTECTEDINTERCOURS TOTHEUTERUS ISALREADYPREGNANT0REGNANCYISDElNEDASIMPLANTATION WHEN CONTRACEPTIONHASNOEFFECTONFUTUREFERTILITY EFFECTONLONG TERMFERTILITY2ESEARCHERSHAVETHUSCONCLUDED ONORALCONTRACEPTIVESTODETERMINETHEIREFFECTONFERTILITYH MIFEPRISTONE WHICHISCOMMONLYKNOWNASTHEABORTIONPILL25 )FAWOMANISALREADYPREGNANTANDTAKES%#0S THEYWILLNOT n    

0ROVIDERSSHOULDMAKESURETHATCLIENTOUTREACH ICALCONTEXT)NDIVIDUALSMAYHAVETHEIROWNBELIEFSABOUTWHEN   HEYAREUNDERSTOOD NFORMATIONTHATCLIENTSNEED ESSMENTPROCESS ALONG AVESHOWNTHATTHEYHAVENO CLIENTSISTOCONDUCTAN SELANGUAGETHATISEASY LARGE SCALEFAMILY SETHEIRMETHOD ITUDES ANDPRACTICES NTLY THOSEWHOARE 34)S OR()6!)$37HILE WANTTOSPACEBIRTHS ORALCONTRACEPTIVE THATHORMONALEMERGENCY HARMTHEDEVELOPINGFETUS EPTION"ELOWAREKEY WOMANORCAUSESILLHEALTH OTHERMETHODSAREMORE WILLNOTWORKIFAWOMAN E THISMETHODCANNOT THEFERTILIZEDEGGATTACHES RTILITY STUDIESCONDUCTED IVEADOLESCENTS SARENOTTHESAMEAS  

   -ODULE$

+EYTECHNICALINFORMATIONFORDEVELOPINGCLIENTINFORMATION s 4HEREARETWOOPTIONSFOREMERGENCYCONTRACEPTIONDOSESOFTHEHORMONESUSEDINORAL CONTRACEPTIVESANDINSERTIONOFAN)5$(ORMONALCONTRACEPTIONUSEDASEMERGENCY CONTRACEPTIONISEFFECTIVEFORUPTODAYSHOURS AFTERUNPROTECTEDSEX)NSERTION OFTHE)5$ISEFFECTIVEASEMERGENCYCONTRACEPTIONFORUPTODAYSAFTERUNPROTECTED INTERCOURSE s %#0SSHOULDBETAKENASSOONASPOSSIBLE BUTNOTLATERTHANHOURSORlVEDAYSAFTER UNPROTECTEDINTERCOURSE)TISIMPORTANTTOTAKETHEPILLSASSOONASPOSSIBLE BECAUSETHEIR EFFECTIVENESSDECREASESOVERTIME4HEREARETWOTYPESOFORALCONTRACEPTIVEHORMONES USEDFOREMERGENCYCONTRACEPTION n 0ROGESTIN ONLY%#0S/NEMGDOSETABLETS TAKENASSOONASPOSSIBLEAFTER UNPROTECTEDINTERCOURSE IDEALLYWITHINHOURSORlVEDAYS 7HENUSEDCORRECTLY PROGESTIN ONLY%#0SREDUCETHERISKOFPREGNANCYBYPERCENTFORASINGLEACT OFUNPROTECTEDINTERCOURSE 0ROGESTIN ONLY%#0SHAVEFEWERSIDEEFFECTSTHAN COMBINEDORALCONTRACEPTIVESUSEDFOR%# n #OMBINED%STROGEN0ROGESTIN%#0S4HElRSTDOSESHOULDBETAKENASSOONAS POSSIBLEAFTERUNPROTECTEDINTERCOURSEANDTHESECONDDOSEHOURSLATER4HEPILLS SHOULDBETAKENASSOONASPOSSIBLEAFTERUNPROTECTEDINTERCOURSE ASEFFECTIVENESS DECREASESOVERTIME BUTTHEYCANBEUSEDUPTOHOURSORlVEDAYSLATER7HEN USEDCORRECTLY COMBINEDORALCONTRACEPTIVESTAKENFOREMERGENCYCONTRACEPTION REDUCETHERISKOFPREGNANCYBYPERCENTFORASINGLEACTOFUNPROTECTED INTERCOURSE

/THERSOURCESOFINFORMATIONFORCLIENTS %MERGENCYCONTRACEPTIONMATERIALSSHOULDDIRECTCLIENTSTOOTHERRESOURCESWHERETHEY CANGETMOREINFORMATIONABOUT%#0S%XAMPLESINCLUDEHOTLINENUMBERS WEBSITES AND ORGANIZATIONSTHATPROVIDE%#0SERVICES

!DVICEFORDEVELOPINGMESSAGESFORCLIENTS s +EEPMESSAGESSHORT CLEAR ANDEASYTOUNDERSTAND s 5SEINNOVATIVELANGUAGEANDAPRESENTATIONSTYLETHATISEYECATCHINGANDAPPEALING s "ESENSITIVETOETHNIC CULTURAL ANDREGIONALPERSPECTIVESONTOPICSRELATEDTOSEXAND REPRODUCTIVEHEALTH s #ONSIDERTRANSLATIONOFEMERGENCYCONTRACEPTIONINFORMATIONINTOLOCALDIALECTSAND MULTIPLELANGUAGES IFNEEDED TOCOVERTHEWIDESPECTRUMOFCLIENTSTOBESERVED

4HESINGLE DOSEREGIMENMAYDIFFERFROMPRODUCTLABELING DUETOTHEPUBLICATIONINOFTHERESULTSOFASTUDYINDICATINGTHAT ASINGLEDOSEOFMGOFLEVONORGESTRELCANSUBSTITUTEFORTWOMGOFLEVONORGESTREL 4HESEESTIMATESOFREDUCTIONINTHERISKOFPREGNANCYFOLLOWING%#0USEAREBASEDONSTUDIESTHATEVALUATED%#0USEWITHINA  HOURTIMEFRAME

$  $  -ODULE$ -ESSAGESTO#LIENTS #HANNELSFOR#OMMUNICATING%MERGENCY#ONTRACEPTION 2EFERENCES ABOUTEMERGENCYCONTRACEPTION CONDOMS HORMONALINJECTIONS ANDOTHERSTOINCLUDEACCURATEAN IMPORTANTTOUPDATEBROCHURESONOTHERCONTRACEPTIVEMETHODSSU ANDWALLETCARDS WHICHCLIENTSCANTAKEHOMEWITHTHEMFORFUT OTHERMETHODSTHATCANFAILORBEUSEDINCORRECTLY#LINICSALS BIRTHCONTROLMETHODSSUCHASORALCONTRACEPTIVES CONDOMS HOR CLIENTSATRISKOFUNINTENDEDPREGNANCY4HISISPARTICULARLYI EMERGENCYCONTRACEPTIONˆAND WHEREPOSSIBLE TODISTRIBUTE%#0S REGULARVISITSFORCONTRACEPTIVEANDOTHERHEALTHSERVICESASO COMMUNICATINGEMERGENCYCONTRACEPTIONINFORMATION0ROVIDERSCA (EALTHCAREANDFAMILYPLANNINGCLINICSHAVEPROVENTOBEVERY     /BSTETRICS 'YNECOLOGIC4ERMINOLOGY  INTERFEREWITHEARLYEMBRYONICDEVELOPMENTINTHEHUMANSPECIES  ,ANCET LEVONORGESTRELVERSUSTHE9UZPEREGIMENOFCOMBINEDORALCONTRA  INPOST COITALCONTRACEPTION      'YNECOLOGY 7(/4ASK&ORCEON0OSTOVULATORY-ETHODSOF&ERTILITY2EGULATION (O 0#AND+WAN -3!PROSPECTIVERANDOMIZEDCOMPARISONOF 'LASIER !%MERGENCYCONTRACEPTION .ORRIS4URNER !AND%LLERTSON #(OWSAFEISEMERGENCYCONTR (UGHES %#AND#OMMITTEEOF4ERMINOLOGYOFTHE!MERICAN#OLLE "ACIC - 7ESSELIUSDE#ASPARIS ! AND$ICZFALUSY %&AILUR         (UMAN2EPRODUCTION 0HILADELPHIA&!$AVIS  "EST0RACTICE2ESEARCH#LINICAL/BSTETRICSAND'YNECOLOGY     EOFLARGEDOSESOFETHINYLESTRADIOLTO CEPTIVESFOREMERGENCYCONTRACEPTION ACEPTION  !MERICAN*OURNALOF/BSTETRICSAND MPORTANTFORCLIENTSRECEIVING PPORTUNITIESTODISCUSS OCANDISTRIBUTEBROCHURES 2ANDOMISEDCONTROLLEDTRIALOF LEVONORGESTRELWITHTHE9UZPEREGIMEN GEOF/BSTETRICIANSAND'YNECOLOGISTS EFFECTIVECHANNELSFOR UREREFERENCE)TISALSO MONALINJECTIONS OR DUPDATEDINFORMATION CHASORALCONTRACEPTIVES $RUG3AFETY INADVANCEOFNEEDTO NUSETHEIRCLIENTS    -ODULE$4OOLS,IST

„3AMPLE4EXTFOR"ROCHURES 4HISISKEYTEXTTHAT0!4(HASUSEDINITSBROCHURES4HISISANEXAMPLEOFTHEINFORMATION THATCANBEINCLUDEDINCLIENTMATERIALS4HISTEXTCANBEMODIlEDANDADAPTEDFORLOCAL SETTINGSDEPENDINGONTHENEEDSANDKNOWLEDGELEVELOFCLIENTS

„"ROCHUREIN4HREE&ORMATS 4HISPOCKET SIZEDBROCHUREISDESIGNEDTOBECARRIEDINAWALLETORPURSEANDCANBEACCESSED FOREASYREFERENCE)TPROVIDESABBREVIATEDINFORMATIONABOUT%#0SANDREFERSCLIENTSTOOTHER RESOURCESFORINFORMATIONSUCHASANEMERGENCYCONTRACEPTIONHOTLINE4HECOVERSOFTHREE DIFFERENTVERSIONSDEVELOPEDBY0!4(TOREACHWOMENFROMDIVERSELANGUAGEANDETHNIC COMMUNITIESINTHE5NITED3TATESARESHOWNHERE

„3OUTH!FRICA"ROCHURE 4HISFULL PAGE TRI FOLDBROCHUREWASDEVELOPEDBYTHE2EPRODUCTIVE(EALTH2ESEARCH5NIT OFTHE5NIVERSITYOF7ITWATERSRANDIN3OUTH!FRICAANDHASBEENUSEFULFORPROVIDINGCLIENTS WITHINFORMATIONABOUT%#0S

$  -ODULE$ 4OOLS

$  4OOLS

3AMPLE4EXTFOR"ROCHURES -ODULE$ %MERGENCY#ONTRACEPTIVE0ILLS

7HATAREEMERGENCYCONTRACEPTIVEPILLS%#0S

s %#0SAREASAFEANDEFFECTIVEMETHODOFBIRTHCONTROLTHATCANPREVENTPREGNANCYAFTERSEX s 9OUSHOULDSTART%#0SWITHINHOURSDAYS AFTERUNPROTECTEDSEXIFYOUDONTWANTTO BECOMEPREGNANT s %#0SAREMOREEFFECTIVETHESOONERAFTERSEXTHEYARETAKEN s %#0SARENOTABORTIONPILLS4HEYWILLNOTWORKIFYOUAREALREADYPREGNANT

7HENDO)USEEMERGENCYCONTRACEPTIVEPILLS

%#0SCANBEUSEDIFYOUHADUNPROTECTEDSEXINTHELASTDAYS5SE%#0SIF s 9OUDIDNTUSEANYBIRTHCONTROL s 4HECONDOMBROKE s 9OUMISSEDORMOREBIRTHCONTROLPILLSORSTARTEDYOURPACKLATE s 9OURDIAPHRAGMSLIPPED s 9OUMISSEDYOURBIRTHCONTROLSHOT s 9OUWEREFORCEDTOHAVESEX

(OWDOEMERGENCYCONTRACEPTIVEPILLSWORK

%#0SPREVENTPREGNANCYBY s 4EMPORARILYSTOPPINGANEGGFROMBEINGRELEASED s 3TOPPINGFERTILIZATIONOFTHEEGG s 3TOPPINGAFERTILIZEDEGGFROMATTACHINGTOTHEWALLOFTHEUTERUS %#0SDONOTPROTECTAGAINSTSEXUALLYTRANSMITTEDINFECTIONS INCLUDING()6!)$3

!RETHERESIDEEFFECTS

%#0SMAKESOMEWOMENFEELSICKTOTHEIRSTOMACHORVOMIT3OMEWOMENMAYHAVESORE BREASTSORHEADACHES4HESESIDEEFFECTSLASTABOUTONEDAY%#0SCANALSOCAUSESOME WOMENgSPERIODSTOCOMEALITTLEEARLYORLATE4HEYDONOTAFFECTAWOMANSABILITYTOBECOME PREGNANTINTHEFUTURE

(OWDO)TAKEEMERGENCYCONTRACEPTIVEPILLS

s &ORTHEPROGESTIN ONLYREGIMEN TAKEASINGLEDOSEOFMGLEVONORGESTRELASSOONAS POSSIBLEWITHINHOURSAFTERUNPROTECTEDSEX s &ORTHEESTROGENANDPROGESTINREGIMEN TAKETHElRSTDOSEASSOONASPOSSIBLEWITHIN HOURSAFTERUNPROTECTEDSEXANDTAKETHESECONDDOSEHOURSLATER s +EEPAPACKETOF%#0SATHOMETOUSEWHENYOUNEEDTHEM

$  !RETHEREDIFFERENTTYPESOF%#0S

s 9ES DIFFERENTTYPESOF%#0SHAVEDIFFERENTLEVELSOFEFFECTIVENESS s 4AKENINSPECIALDOSES SOMEREGULARBIRTHCONTROLPILLSCANBEUSEDASEMERGENCY

-ODULE$ CONTRACEPTION

3OMETIMESYOUNEEDASECONDCHANCE

9OUHAVEHOURSTOACT 4OOLS &OREMERGENCYCONTRACEPTIVEPILLS

s #ALLYOURDOCTORORCLINIC s 6ISITTHEEMERGENCYCONTRACEPTIONWEBSITEWWWNOT  LATECOM

4HISMATERIALWASDEVELOPEDBY0!4(

$  4OOLS

"ROCHUREIN4HREE&ORMATS -ODULE$

4HESETRI FOLDBROCHURES INCLUDEINFORMATIONABOUT %#0SONTHEINSIDE

4HISMATERIALWASDEVELOPEDBY0!4(

$  -ODULE$ 4OOLS

$  4OOLS

3OUTH!FRICA"ROCHURE -ODULE$

$  -ODULE$ 4OOLS

4HISMATERIALWASREPRINTEDWITHPERMISSIONFROMTHE2EPRODUCTIVE(EALTH2ESEARCH5NITOFTHE 5NIVERSITYOF7ITWATERSRAND 3OUTH!FRICA

$  -ODULE%

!SSESSMENT

/BJECTIVE 4OGATHERINFORMATIONFORGUIDINGTHEINTEGRATIONOFEMERGENCYCONTRACEPTIVEPILLS%#0S INTOLARGE SCALEFAMILYPLANNINGORHEALTHPROGRAMS

!NIMPORTANTSTEPINDEVELOPINGASUCCESSFULEMERGENCYCONTRACEPTIONPROGRAMISTOGAINAN UNDERSTANDINGOFTHEEXISTINGCONTEXT INCLUDINGTHEPERCEPTIONSOFCLIENTS PROVIDERS PROGRAM PLANNERS ANDDECISIONMAKERS4HISUNDERSTANDINGWILLPROVIDETHEBASISFORDEVELOPING APPROPRIATE%#0INTRODUCTIONSTRATEGIESANDWILLENSURETHAT%#0INFORMATIONANDSERVICES ARETAILOREDTOLOCALNEEDS4HEFOLLOWINGTOPICSAREDISCUSSEDINTHISMODULE s !SSESSMENTOF%XISTING0ROGRAM s %#0)NTRODUCTION!SSESSMENT s +EY1UESTIONSAND#ONSIDERATIONSFOR!N!SSESSMENT s %FFECTIVE7AYSTO'ATHER)NFORMATION s -OVINGFROM!SSESSMENTTO!CTION s 5SINGAND!DAPTING!SSESSMENT4OOLS

4OOLS0ROVIDEDATTHE%NDOFTHIS-ODULE

„ #LIENT+NOWLEDGE !TTITUDES AND0RACTICES1UESTIONNAIRE „ 0ROVIDER+NOWLEDGE !TTITUDES AND0RACTICES3URVEYON%MERGENCY#ONTRACEPTIVE0ILLS „ )N $EPTH)NTERVIEW'UIDEFOR+EY2EPRODUCTIVE(EALTH!UTHORITIES „ -YSTERY3HOPPER3URVEY'UIDELINES

!SSESSMENTOF%XISTING0ROGRAM 4HE7ORLD(EALTH/RGANIZATION7(/ PUBLICATION -AKING$ECISIONSABOUT#ONTRACEPTIVE )NTRODUCTION!'UIDEFOR#ONDUCTING!SSESSMENTSTO"ROADEN#ONTRACEPTIVE#HOICE AND)MPROVE1UALITYOF#ARE ISAUSEFULTOOLTHATCANHELPPROGRAMPLANNERSPREPAREFOR INTRODUCTIONOFANEWCONTRACEPTIVEMETHODBYASSESSINGUSERPERSPECTIVESASWELLASTHE QUALITYOFFAMILYPLANNINGSERVICESCURRENTLYBEINGDELIVERED)TADDRESSESTHREEQUESTIONS  )STHEREANEEDTOIMPROVETHEPROVISIONOFCURRENTLYAVAILABLECONTRACEPTIVEMETHODS  )STHEREANEEDTOREMOVEANYMETHODSFROMAGIVENSETTING  )STHEREANEEDTOINTRODUCENEWCONTRACEPTIVEMETHODS %  %  -ODULE% +EY1UESTIONSAND#ONSIDERATIONSFORAN!SSESSMENT %#0)NTRODUCTION!SSESSMENT 7HATAREPROVIDERSCAPABILITIESWITHREGARDTO%#0INFORMATI s 7HATSTANDARDSOFCAREWOULDBEREQUIREDFOR%#0SERVICES s $OPROVIDERSPERCEIVEANEEDFOR%#0S s 7HATISTHECURRENTOVERALLKNOWLEDGEAMONGPROVIDERSOFFAMI s 3ERVICEDELIVERYCAPABILITIES !REPHARMACISTSANDOTHERNONMEDICALHEALTHPROFESSIONALSAUT s #ANMEDICALPROVIDERSPRESCRIBECOMBINEDORALCONTRACEPTIVES s 7HATARETHEPROCEDURESFORCHANGINGTHELABELINGFOREXISTIN s )SAPOST COITALCONTRACEPTIVEORSPECIALLYPACKAGED%#0PROD s 2EGULATORYSYSTEMREQUIREMENTS EMERGENCYCONTRACEPTIONINTRODUCTION #ONTRACEPTION CANHELPSTIMULATETHINKINGONISSUESTHATNEED 4HEFOLLOWINGQUESTIONS OUTLINEDBYTHE)NTERNATIONAL#ONSORTI 4HEINFORMATIONTHATISAVAILABLEANDINFORMATIONGAPSTHEG s 4HEPRIORITYGROUPSINFORMANTSFROMWHOMINFORMATIONSHOULDB s 0RIORTODEVELOPINGANASSESSMENTPLANITWILLBEIMPORTANTTO RELATETOTHESEINFORMATIONNEEDS INORDERTOOBTAINAPPROPRIA WHATINFORMATIONISNEEDEDANDHOWITWILLBEUSED4HEASSESSM DESIGNANINTRODUCTIONPLAN4HElRSTSTEPINUNDERTAKINGTHIS ASSESSMENTSPECIlCTO%#0INTRODUCTIONWILLPROVIDEINFORMATION /NCETHEDECISIONHASBEENMADETOINTRODUCE%#0SINTOALARGE STRATEGIESFORIMPROVINGACCESSTOANDTHEQUALITYOFEMERGENCY DELIVERYSUPPORTSYSTEMSWEREDEVELOPEDANDTESTEDTOGETHERWIT :AMBIANNATIONALFAMILYPLANNINGPROGRAM&OLLOWINGTHISRECOMM ONERECOMMENDATIONTHATEMERGEDWASTOINTRODUCEEMERGENCYCONT 7HENTHIS7(/ASSESSMENTPROCESSWASUNDERTAKENIN:AMBIA BEGI THROUGHTHEASSESSMENTPROCESS DETERMININGWHATINFORMATIONISALREADYKNOWNANDWHATGAPSWIL GENERALAND%#0SINPARTICULAR CONTRACEPTIVES )FSO DOESTHATAUTHORIZATIONALSOAPPLYTO%# NOT WHATREQUIREMENTSMUSTBEMETFORREGISTRATIONAPPROVAL KEYQUESTIONS  %#0INTRODUCTIONSTRATEGIESEG MINISTRYOFHEALTHOFlCIALS  4HISLISTOFKEYQUESTIONSCANPROVIDEASTARTFOR TEANDTARGETEDINFORMATION ASSESSMENTISTOIDENTIFY IDENTIFY TOBEADDRESSEDIN UMFOR%MERGENCY CONTRACEPTIONSERVICES HSEVERALALTERNATIVE APSWILLDETERMINETHE GPRODUCTS SOCIALMARKETINGGROUPS  SCALEPROGRAM AN ENTTOOLSSHOULDDIRECTLY UCTREGISTEREDFORUSE )F THATCANBEUSEDTO ONANDSERVICES 0S LNEEDTOBEADDRESSED HORIZEDTODISTRIBUTE FOROFF LABELUSES LYPLANNINGMETHODSIN ENDATION %#0SERVICE RACEPTIONINTOTHE EGATHEREDTOHELPSHAPE NNINGIN  -ODULE% s 7HATMECHANISMSEXISTFORTHEDISTRIBUTIONOFREGULARORALCONTRACEPTIVESCLINICS HOSPITALS PHARMACIES SOCIALMARKETING ANDCOMMUNITY BASEDANDCOMMERCIAL DISTRIBUTIONSYSTEMS s 7HATISTHECAPACITYOFTHESEDISTRIBUTIONCHANNELSTOTAKEONANADDITIONAL CLOSELY RELATEDPRODUCT s 7HATISTHECAPACITYOFNON FAMILYPLANNINGREPRODUCTIVEHEALTHCAREPROVIDERSEG HOSPITALEMERGENCYROOMS MATERNALANDCHILDHEALTHCLINICS ANDSEXUALASSAULTCRISIS CENTERS TOSUPPLY%#0S s 7HATLEVELOFPROVIDERTRAININGWOULDBEREQUIREDTOENSUREHIGH QUALITYSERVICES s 7HATTRAININGANDINFORMATIONMECHANISMSAREPREFERREDBYPROVIDERS s 7HATDOPROVIDERSCONSIDERTOBEBARRIERSTOPROVIDINGQUALITY%#0SERVICES

#LIENTNEEDSANDPERSPECTIVES s !REPOTENTIALCLIENTSAWAREOFFAMILYPLANNINGINGENERALANDTHEMETHODINPARTICULAR s 7HENTOLDABOUTTHEMETHOD DOPOTENTIALCLIENTSPERCEIVEANEEDFORIT s 7HATQUESTIONSDOTHEYHAVEABOUTIT s !RERUMORSORMISINFORMATIONABOUTTHEMETHODWIDESPREAD s 7HICHPOPULATIONGROUPSREPORTTHEGREATESTNEEDFOR%#0SERVICES s 7HATDISTRIBUTIONMECHANISMSWOULDBEMOSTCONVENIENTANDACCEPTABLETO POTENTIALCLIENTS s 7HATAREUSERPERCEPTIONSOFEXISTINGSERVICESTHROUGHWHICH%#0SMIGHTBEPROVIDED s 7HATINFORMATIONCHANNELSBOTHFORMALANDINFORMAL AREPREFERREDBYPOTENTIALCLIENTS

%  %  -ODULE% $#0!4(  7ITTET 3 3OURCE)NFORMATIONON+!0SURVEYS IN DEPTHINTERVIEWSAND&'$ %FFECTIVE7AYSTO'ATHER)NFORMATION PRACTICE+!0 $ATA'ATHERING ATTITUDE AND $ESKRESEARCH &OCUSGROUP +NOWLEDGE CONSIDERINDETERMININGWHICHMETHODSWILLBEUSEDASPARTOFT 4HEFOLLOWINGTABLESUMMARIZESCHARACTERISTICSOFDATAGATHERIN GATHERINGINFORMATIONWILLMEETTHEPROGRAMNEEDSFORASSESSMEN PROCESSNEEDSTOBEANDWHETHERRELATIVELYSIMPLE INEXPENSIVE METHODSAREBESTINAPARTICULARSETTING#ONSIDERHOWSCIENTIl )TISIMPORTANTTOTHINKABOUTHOWTHEINFORMATIONWILLBEUSED 4HEREAREANUMBEROFUSEFULINFORMATIONGATHERINGMETHODSTOH DISCUSSIONS INTERVIEWS SHOPPERSOR )N DEPTH SURVEYS &'$S -YSTERY EHD)SSUESTO#ONSIDER -ETHOD CLIENTS $EVELOPING(EALTHAND&AMILY0LANNING-ATERIALSFOR,OW ,ITERAT 2EQUIREPARTICIPANTSRANDOMLYSELECTEDFROMVARIOUSPARTSOF s #ANUSECLOSE ENDEDOROPEN ENDEDQUESTIONSORBOTH(OWEVER s !REUSEFULFORASSESSINGCLIENTANDPROVIDERPERSPECTIVESABO s !REUSEDWHENITISIMPORTANTTODETERMINEWHATPERCENTAGEOF s 2EQUIREMORETIMETOANALYZEBECAUSETHEYCONTAINMANYOPEN E s !REAGOODMETHODFORGATHERINGINFORMATIONFROMHARD TO REAC s 0ROVIDEDETAILEDINSIGHTINTOPEOPLESTHOUGHTS FEELINGS AN s .EEDTOENSURETHATMYSTERYCLIENTSURVEYSAREHANDLEDETHICA s #ANBEUSEDTOPROVIDEAMEASUREOFWHETHERANDHOW%#0INFOR s !RERESEARCHERSORMEMBERSOFTHERESEARCHTEAM WHOPOSEAS s -AYBEPOSSIBLETOFRAMETHEISSUEOF%#0PROVISIONINABROA s #ANIDENTIFYEXISTINGINFORMATIONONRELEVANTTOPICSSUCHAS s )SCOLLECTINGDATAFROMSECONDARYSOURCES WHICHCANBEAUSE s !REOFTENTHEMETHODOFCHOICEFORAUDIENCERESEARCHGEAREDT s 0RODUCEQUALITATIVERESULTSTHEYAREANEXPLORATIONOFKNOWL s !REIN DEPTHDISCUSSIONS USUALLYONETOTWOHOURSINLENGTH s QUESTIONSAREMOREDIFlCULTTOCOLLECTANDANALYZE COMMUNITYORPARTICULARGROUPKNOWORBELIEVECERTAINTHINGSOR RESEARCHTECHNIQUESMAYBEMOREAPPROPRIATE OFTHINGSPEOPLEBELIEVE)NTHELATTERCASE QUICKERANDLESS PROPORTIONOFPEOPLEBELIEVESOMETHING ORWHETHERITISENOUGH BEEXPENSIVEANDTIMECONSUMING#ONSIDERWHETHERITISNECESSA AUDIENCEMEMBERSSUCHASPOLICYMAKERS USEDCONSTRUCTIVELY SERVICESAREPROVIDED PROVIDERSRESPONSE  THEPROVIDERTHATSHEHADSEXANDDOESNOTWANTTOGETPREGNANT HOWSERVICESAREBEINGPROVIDEDEG AMYSTERYSHOPPERWALKS ECONOMIC ANDPOLITICALENVIRONMENTBASEDONEXISTINGINFORMATI REGULATORYINFORMATION ASSESSMENTPROCESS PRINTMATERIALS ANDATTITUDES TOPICSOFPARTICULARIMPORTANCETOTHEFORTHCOMINGPROGRAM REPRESENTATIVESOFTHETARGETAUDIENCE UNDERTHEGUIDANCEOFA SADAPTEDFROM:IMMERMAN - .EWTON . &RUMIN , E!UDIENCES!'UIDEREVISEDED  CTHEINFORMATIONGATHERING INDETERMININGWHICH ANDQUICKMETHODSOF GMETHODSANDISSUESTO HE%#0ASSESSMENT ELP%#0INTRODUCTION T DBEHAVIORS EXPENSIVEQUALITATIVE DEMOGRAPHICOR EDGE BELIEFS CONCERNS INWHICHSIXTOTEN UT%#0S THECOMMUNITYANDCAN DERSOCIOCULTURAL LLYANDTHATRESULTSARE FULlRSTSTEPINAN%#0 OWARDDEVELOPING FACILITATOR DISCUSS HORINmUENTIALTARGET PEOPLEINA INTOCLINICANDTELLS CLIENTSTOASSESS ON TOKNOWWHATKINDS ACTINSPECIlCWAYS ANDDOCUMENTSTHE OPEN ENDED NDEDQUESTIONS MATIONAND RYTOKNOWWHAT 7ASHINGTON -ODULE%

-OVINGFROM!SSESSMENTTO!CTION 4HEMOSTIMPORTANTASPECTOFANASSESSMENTISENSURINGTHATTHEINFORMATIONGATHERED ISUSEDTOGUIDEANDINFORMTHEPROGRAMDEVELOPMENTDECISIONMAKINGPROCESS"EFORE UNDERTAKINGTHEASSESSMENT ITISGENERALLYHELPFULTODEVELOPAPLANFORANALYZINGAND INTERPRETINGTHEDATATHATWILLBEGATHERED)TMAYBEUSEFULTOORGANIZETHEASSESSMENT lNDINGSINAMATRIXACCORDINGTOTHEORIGINALRESEARCHQUESTIONS THECENTRALlNDINGSFROM THEASSESSMENT ANDPROGRAMMATICRECOMMENDATIONSTHATCOMEOUTOFTHElNDINGS 4HEMATRIXBELOW BASEDONANINITIALASSESSMENTIN3RI,ANKADEMONSTRATESHOW ASSESSMENTlNDINGSCANINFORMPROGRAMMATICDECISIONS0ROGRAMPLANNERSIN3RI,ANKA COMPLETEDABASELINESURVEY APOSTALQUESTIONNAIREOFMEDICALSERVICEDELIVERYPERSONNEL IN DEPTHINTERVIEWSWITHCOMMUNITYLEADERS ANDGROUPDISCUSSIONSWITHFAMILYHEALTH WORKERSMIDWIVES SELECTEDFROMDIFFERENTPARTSOFTHECOUNTRY4HEINTRODUCTIONPLAN INFORMEDBYTHISASSESSMENTWASSUCCESSFUL4HENEWMETHODWASWELLRECEIVEDBYBOTH PROVIDERSANDCLIENTSAND%#0USEHASCONTINUEDTOEXPANDOVERTIME

!SSESSMENT 1UESTIONS +EY&INDINGS 0ROGRAMMATIC2ECOMMENDATIONS 7HATARE s $OCTORSANDMIDWIVESWILLINGTO s 4RAINCLINICSTAFFANDTELEPHONEOPERATORSON PROVIDER DISTRIBUTE%#0S HOW%#0INFORMATIONSHOULDBEPROVIDEDTO ATTITUDESABOUT s #ONCERNSEXPRESSEDTHATSOME POSSIBLEUSERS %#0S PEOPLEWOULDRESORTTO%#0USE s 4RAINCLINICIANSWILLINGTOINTRODUCE%#0SIN INPLACEOFREGULARCONTRACEPTIVE CLINICS METHODS s )NPROVIDERTRAINING ADDRESSCONCERNS s #ONCERNSEXPRESSEDABOUTPOSSIBLE REGARDINGUSEOF%#0SASAREGULAR SPREADOF34)SAND()6!)$3 CONTRACEPTIVEMETHODANDPOSSIBLE DUETOINCREASEDSEXUALACTIVITY DECREASEINCONDOMUSE3TUDIESHAVE WITHOUTCONDOMSSINCEPREGNANCY PROVIDEDEVIDENCETHATTHESECONCERNS PROTECTIONAVAILABLETHROUGH%#0S  ARENOTBORNEOUTˆSEEADISCUSSIONOFTHIS ISSUEIN-ODULE!)NFORMATIONFOR0OLICY -AKERS s 4RAINPROVIDERSTOUSE%#0PROVISIONAS ANOPPORTUNITYTODISCUSSITSCORRECTUSE ANDENCOURAGECLIENTSTOADOPTREGULAR CONTRACEPTIVEMETHODS (OWWILLTHE s 3UBJECTISNEWTOTHEGENERALPUBLIC s !NAGGRESSIVEEDUCATIONALANDPUBLICITY PUBLICRESPOND s )DEAOF%#0WELLACCEPTEDBYBOTH CAMPAIGNSHOULDBEIMPLEMENTED TOAN%#0 MARRIEDANDUNMARRIEDMENAND s %DUCATIONALACTIVITIESANDMATERIALSSHOULD PRODUCT WOMEN BEAIMEDATPREVENTINGTHEMISCONCEPTION s 0ERCEPTIONTHAT%#0CANBEUSEDTO THAT%#0WOULDBE3EE CAUSEANABORTION -ODULE!)NFORMATIONFOR0OLICY-AKERS 7HATARE s "RANDNAMESHOULDBEGIVEN s 'IVENTHATPUBLICITYOFTHEBRANDNAME THEISSUES WIDEPUBLICITYTOMAXIMIZEPUBLIC ISNOTPOSSIBLE DUETOGOVERNMENT REGARDING AWARENESS RESTRICTIONS PROMOTIONALCAMPAIGNSHOULD MARKETINGOFA s 3ERVICEPROVIDERSWOULDBEHAPPY FOCUSONTHECONCEPTOFEMERGENCY BRANDED%#0 TOPOPULARIZESUCHAPRODUCT CONTRACEPTION s 'OVERNMENTRESTRICTIONSPREVENT MEDIAADVERTISINGOFDRUGSTHAT REQUIREADOCTORSPRESCRIPTION 3OURCE-ATRIXADAPTEDFROMASSESSMENTlNDINGSDESCRIBEDIN!BEYWICKREMA $ "ASNAYAKE 3 3UBASINGHE # AND "AMUNUSINGHE *!NEVALUATIONREPORTONTHEMARKETINGOF0OSTINORIN3RI,ANKA&AMILY0LANNING!SSOCIATIONOF3RI,ANKA -ARCH  %  %  -ODULE% 5SINGAND!DAPTING!SSESSMENT4OOLS 2EFERENCES IMPORTANTTOSEEKHELPFROMLOCALEXPERTSTOMEETTHATNEED DEVELOPMENTTOMEETLOCALNEEDS)FMOREACADEMICRESEARCHIST INTENDEDTOBEUSEDFOROPERATIONSRESEARCH BUTRATHERAREGEA EXAMPLESOFTHEMULTIPLEWAYSTHATASSESSMENTSCANBEPERFORMED BEENUSEDINAVARIETYOFlELDSETTINGSAROUNDTHEWORLD4HEY 4HEASSESSMENTTOOLSINCLUDEDINTHISMODULEAREADAPTATIONSOF SUCCESSFULPROGRAM WHENDETERMININGHOWTOBESTTRANSLATETHEDATACOLLECTEDINTO CONSIDERAVAILABLERESOURCES THEFEASIBILITYOFPROPOSEDSOLUT ISAWAYOFENSURINGTHATAPPROPRIATESOLUTIONSTOISSUESAREI )NCLUDINGPARTNERSANDCOMMUNITYMEMBERSINTHEDEVELOPMENTOF $EVELOPINGRECOMMENDATIONSFROMASSESSMENTlNDINGSCANBEADIF GUIDEANDTOSTANDARDIZETHEWAYINWHICHTHEQUESTIONSAREASK TOHOLDATRAININGSESSIONFORINTERVIEWERSORMYSTERYSHOPPER POSSIBLERESPONSEORRECORDONLYTHERESPONSESOFFEREDBYTHEI INTERVIEWERSSUCHASWHETHERTHEYARESUPPOSEDTOPROMPTTHEI TODEVELOPAGUIDETHATEXPLAINSEACHQUESTIONANDDETAILSANY )FMULTIPLEINTERVIEWERSWILLPARTICIPATEINTHEDATACOLLECTIO $ATACOLLECTION ANDANALYZINGTHETYPEOFDATATHATWILLBECOLLECTED -AKESURETHATTHEASSESSMENTTEAMINCLUDESSTAFFWITHEXPERIEN ENSURETHATTHEINSTRUMENTSAREDESIGNEDTOFACILITATETHESEPR )TISUSEFULTODEVELOPAPLANFORDATAENTRYANDANALYSISBEFO $ATAENTRYANDANALYSIS EFFECTIVELYYIELDTHEINFORMATIONSOUGHT ANDCULTURALLYAPPROPRIATEFORTHESETTINGINWHICHTHEYWILLB DEVELOPEDPRIORTOPRODUCINGTHElNALVERSION TOMAKESURETHA NEEDEDFORUSEINPARTICULARSETTINGS)TWILLBEIMPORTANTTO 4HESEINSTRUMENTSORPORTIONSOFTHEM MAYBETRANSLATEDANDF 4OOLADAPTATIONANDPRETESTING #ONTRACEPTION!#OLLABORATIVE!PPROACHTO-EETING7OMENS.EED .OVEMBER 3ERVICES!VAILABLEATHTTPWWWWHOINTREPRODUCTIVE HEALTH !CCESSED.OVEMBER HTTPWWWWHOINTREPRODUCTIVE HEALTHPUBLICATIONSRHR???C #ONDUCTING!SSESSMENTSTO"ROADEN#ONTRACEPTIVE#HOICEAND)MPR    )NTERNATIONAL#ONSORTIUMFOR%MERGENCY#ONTRACEPTION 7ORLD(EALTH/RGANIZATION4HE3TRATEGIC!PPROACHTO)MPROVING 7ORLD(EALTH/RGANIZATION-AKING$ECISIONSABOUT#ONTRACEPTIV %XPANDING'LOBAL!CCESSTO%MERGENCY STRATEGIC?APPROACHZAMBIAENHTML!CCESSED NPROCESS ITMAYBEHELPFUL ONTRACEPTIVE?INTRODUCTIONCI GUIDEPDF PRETESTTHETOOLSTHATARE 1UALITYOF#AREIN2EPRODUCTIVE(EALTH E)NTRODUCTION!'UIDEFOR RETOOLSARElNALIZEDTO DENTIlED)TISIMPORTANTTO OCESSESASMUCHASPOSSIBLE SPECIALINSTRUCTIONSFORTHE S TOREVIEWTHEINTERVIEW NTERVIEWEE )TISALSOUSEFUL OVE1UALITYOF#ARE!VAILABLEAT EUSEDANDTHATTHEYWILL IONS ANDPROGRAMPRIORITIES S REDTOWARDSHAPINGPROGRAM /CTOBER  EDANDDATAISRECORDED NTERVIEWEEBYREADINGEACH AREINTENDEDTOSERVEAS THEACTIONSREQUIREDFORA TTHEQUESTIONSARECLEAR INSTRUMENTSTHATHAVE REELYADAPTEDAS CEDESIGNINGDATABASES HEOBJECTIVE ITWILLBE 4HESETOOLSARENOT RECOMMENDATIONS lCULTPROCESS -ODULE%4OOLS,IST

„#LIENT+NOWLEDGE !TTITUDES AND0RACTICES1UESTIONNAIRE 4HISSTRUCTUREDINTERVIEWGUIDEWASDEVELOPEDBYTHE0OPULATION#OUNCILIN-EXICOAS AFOLLOW UPTOABASELINESURVEYEVALUATINGTHEINTRODUCTIONOF%#0SIN-EXICO)TWAS IMPLEMENTEDBYINTERVIEWINGCLIENTSATAFAMILYPLANNINGCLINIC4HEQUESTIONS HOWEVER ARERELEVANTFORUSEASPARTOFAPRELIMINARYASSESSMENTOFCLIENT+!0 THOUGHTHEYSHOULD BEADAPTEDFORANDPRETESTEDINTHESETTINGINWHICHTHEYWILLAPPLIED4HEFORMATOFTHE TOOLCOULDALSOBEADAPTEDFORUSEASAPAPERSURVEYIFAPAPERSURVEYISAPPROPRIATEFORTHE LITERACYLEVELOFTHECLIENTPOPULATION 

„0ROVIDER+NOWLEDGE !TTITUDES AND0RACTICES3URVEYON %MERGENCY#ONTRACEPTIVE0ILLS 4HISPROVIDER+!0SURVEYWASADAPTEDFROMDIFFERENTPROVIDERSURVEYSDEVELOPEDBY0!4( THE0OPULATION#OUNCILIN-EXICO ANDTHE&AMILY0LANNING!SSOCIATIONOF3RI,ANKA)TIS FORMATTEDASAPAPERSURVEYTHATCOULDBEMAILEDORDISTRIBUTEDTOPROVIDERSPERHAPSATA MEETINGORCONFERENCE HOWEVER THEQUESTIONSCOULDBEADAPTEDFORUSEINADIFFERENTFORMAT SUCHASANINTERVIEW IFAPAPERSURVEYISNOTPRACTICAL

„)N $EPTH)NTERVIEW'UIDEFOR+EY2EPRODUCTIVE (EALTH!UTHORITIES 4HISIN DEPTHINTERVIEWGUIDEWASDEVELOPEDBY0!4(FORUSEWITHHIGH LEVELREPRODUCTIVE HEALTHMEDICALAUTHORITIES)TISGEAREDTOWARDLEARNINGABOUTREPRODUCTIVEHEALTHAUTHORITIES ATTITUDESTOWARD%#0S THEIRPERCEPTIONSOFTHENEEDFOR%#0SANDBARRIERSTOPROVIDING HIGH QUALITY%#0SERVICES ANDTHEIROPINIONSABOUTTRAININGNEEDSOFTHEIRSTAFFANDTHEBEST MECHANISMTOEXPAND%#0INFORMATION

„-YSTERY3HOPPER3URVEY 4HISMYSTERYSHOPPERSURVEYWASADAPTEDFROMMYSTERYSHOPPERSURVEYSDEVELOPEDBY0!4( ANDTHE2EPRODUCTIVE(EALTH2ESEARCH5NITOFTHE5NIVERSITYOF7ITWATERSRAND 3OUTH!FRICA )TISINTENDEDASAMEASUREOFWHETHERANDHOW%#0INFORMATIONANDSERVICESAREPROVIDED INAPHARMACYSETTING)NTHISTOOLTHEPRIMARYSCENARIOINCLUDESAWOMANPOSINGASASECRET SHOPPERANDWALKINGINTOAPHARMACYANDTELLINGTHEPHARMACIST h9ESTERDAY)HADSEXAND DIDNTUSEANYMETHODOFCONTRACEPTION)AMWORRIEDABOUTGETTINGPREGNANTAND)WOULD LIKETOKNOWIFTHEREISSOMETHING)CANDOTOPREVENTPREGNANCYv)MMEDIATELYFOLLOWINGTHE PHARMACYVISIT ANOTHERMEMBEROFTHERESEARCHTEAMINTERVIEWSTHEWOMANWHOVISITEDTHE PHARMACYANDDOCUMENTSHEREXPERIENCEINTHEPHARMACYONTHERECORDINGSHEET7HILETHIS TOOLWASDEVELOPEDFORUSEINAPHARMACYSETTING THEQUESTIONSCOULDBEADAPTEDFORUSEIN CLINICALSETTINGS

%  -ODULE% 4OOLS

%  4OOLS

#LIENT+NOWLEDGE !TTITUDES AND -ODULE% 0RACTICES1UESTIONNAIRE

&OLLOW UPON%MERGENCY#ONTRACEPTIVE0ILLS

1UESTIONNAIREFOR&AMILY0LANNING5SERS

))DENTIlCATION$ATA

 $ATEOFINTERVIEW $AY-ONTH9EAR

 5SERSSEX &EMALE † -ALE †

 4IMEINTERVIEWBEGAN (OURS-INUTES

 4IMEINTERVIEWlNISHED (OURS-INUTES  0LACE

 )NTERVIEWERINITIALS

)NTRODUCTION 4HISINTERVIEWISPARTOFASTUDYTOEVALUATETHEINTRODUCTIONONALARGERSCALEOFA CONTRACEPTIVEMETHOD!SAFOLLOW UPTOASURVEY WEARENOWINTERVIEWINGCLIENTSOFSOME FAMILYPLANNINGCLINICS7EEXPECTTHEINTERVIEWTOTAKEABOUTMINUTES9OUDONOTNEEDTO PROVIDEYOURNAME NONEOFTHEINFORMATIONCOLLECTEDTHROUGHTHISINTERVIEWWILLBEINCLUDED INYOURCLINICALRECORD)FYOUPREFERNOTTORESPOND YOURDECISIONWILLNOTAFFECTINANYWAY THESERVICESYOUARERECEIVINGATTHECLINIC0LEASEBEASSUREDTHATALLTHEINFORMATIONGATHERED WILLBEKEPTSTRICTLYCONlDENTIAL!REYOUWILLINGTOPARTICIPATEINOURSTUDY

9ES † 3KIPTO .O † 4HANKYOUANYWAY (AVEANICEDAY %  ))"ACKGROUND)NFORMATION 4HElRSTQUESTIONSARETOOBTAINGENERALINFORMATION  (OWOLDAREYOU -ODULE% $OESNOTRESPOND†  7HATISTHEHIGHESTLEVELOFEDUCATIONYOUATTAINED 0RIMARY† 4OOLS 3ECONDARY† 4ECHNICALNOTLEADINGTOSECONDARYDEGREE† 0REPARATORY † 4ECHNICALLEADINGTOSECONDARYDEGREE† 5NIVERSITY † 0OSTGRADUATESTUDIES † $EGREEOBTAINED ???????????????? 9EARS????????? $OESNOTKNOWNOTRESPOND† .OSTUDIESATALL†  (AVEYOUEVERHADSEXUALRELATIONSHIPS 9ES† .O† 3KIPTO  (AVEYOUORYOURPARTNER EVERBEENPREGNANT 9ES† 9ES )AMPREGNANTRIGHTNOW† .O†  )NTHECASEOFAMALEUSER (AVEYOUEVERGOTTENAPARTNERPREGNANT 9ES† .O† .!†  $OYOUORYOURPARTNER USEACONTRACEPTIVEMETHOD )NCASETHECLIENTIS PREGNANTˆ7EREYOUORYOURPARTNERUSINGAMETHODBEFOREYOUGOTPREGNANT 9ES† .O† 3KIPTO  7HICHCONTRACEPTIVEMETHODORMETHODSAREYOUUSING 2EADANDCHECKTHOSEMETHODSMENTIONEDANDTHENPROMPT!NYOTHER 0ILLS† )NJECTABLES† #ONDOMS †

%  4OOLS

)5$†

4UBALLIGATION † -ODULE% 6ASECTOMY † 7ITHDRAWALYOURHUSBANDTAKESCAREOFYOU † #ALENDARRHYTHM † /THER† 3PECIFY???????????????

)))+NOWLEDGE!BOUT%MERGENCY#ONTRACEPTION  (AVEYOUEVERHEARDABOUTEMERGENCYCONTRACEPTIONORTHEMORNING AFTERPILL 9ES† .O† 3KIPTO  7HENWASTHElRSTTIMEYOUHEARDSOMETHINGABOUTEMERGENCYCONTRACEPTION ,ESSTHANMONTHSAGO †  MONTHSAGO†  YEARSAGO † YEARSAGO † $OESNOTREMEMBER †  7HEREDIDYOUHEARABOUTIT 2EADANDCHECKTHOSEMETHODSMENTIONEDANDTHEN PROMPT3OMEWHEREELSE !TTHISCLINIC † !TADIFFERENTCLINICHEALTHCENTER† 4HROUGHFRIENDSORRELATIVESCOMMENTS† 4HROUGHTHENEWS INMAGAZINES † 4HROUGHTHERADIO† 4ELEVISION † #OURSEORFORMALLECTURE† 4ELEPHONELINE † )NTERNETPAGE† /THER† 3PECIFY??????????????? $OESNOTREMEMBER †

%   $OYOUKNOWWHEREAWOMANCANOBTAINEMERGENCYCONTRACEPTIVEPILLS 2EADANDCHECKTHOSEMETHODSMENTIONEDANDTHENPROMPT3OMEWHEREELSE (OSPITALHEALTHCENTERCLINIC†

-ODULE% 3OCIALWORKERCOMMUNITYWORKER† 0RIVATECLINIC† 0HARMACY† 3UPERMARKET † 4OOLS /THER† 3PECIFY??????????????? )TISNOTPOSSIBLETOOBTAINTHEM † $OESNOTKNOW†  7OULDEMERGENCYCONTRACEPTIVEPILLSWORKIFTHEREISAMENSTRUALDELAY 9ES† .O† $OESNOTKNOW†  (OWLONGAFTERUNPROTECTEDSEXSHOULDEMERGENCYCONTRACEPTIVEPILLSBETAKEN )MMEDIATELYAFTERSEX† 7ITHINHOURS† 7ITHINHOURSDAYS † 7ITHINONEWEEK† !TANYTIMEBEFORETHElRSTDAYOFTHENEXTMENSES † /THER† $OESNOTKNOW† 3PECIFY???????????????  7HICHDRUGDOYOUBELIEVEISCONTAINEDINEMERGENCYCONTRACEPTIVEPILLS 2EADANDCHECKRESPONSESMENTIONED 4HESAMEASINNORMALCONTRACEPTIVEPILLS † 4HESAMEONE BUTSTRONGER † !COMPLETELYDIFFERENTDRUG † $OESNOTKNOW†

%  4OOLS

 $IDTHEPERSONORMEDIAFOREXAMPLE TELEVISION RADIO ETC FROMWHICHYOUOBTAINED

INFORMATIONABOUT%#EXPLAINTOYOU2EADANDCIRCLETHOSEMETHODSMENTIONED -ODULE%

9%3 ./ .2 7HICHMETHODSCANBEUSED    (OWOFTENYOUCANUSETHEM    7HERETHEYCANBEOBTAINED    4HATITWOULDBEADVISABLETOTALKABOUTTHEMETHODWITH    YOURPARTNER 4HATYOUWOULDNOTHAVEANYPROBLEMTOBECOME    PREGNANTINTHEFUTURE 4HATAFTERUSINGEMERGENCYCONTRACEPTIONITWOULDBE    ADVISABLETOSTARTUSINGADIFFERENTCONTRACEPTIVEMETHOD

 (OWEFFECTIVEAREEMERGENCYCONTRACEPTIVEPILLSINPREVENTINGAPREGNANCY 2EADANDCHECKTHOSEMETHODSMENTIONED !LMOSTALWAYS † 4HREEOUTOFFOUR † (ALFOFTHETIMES † ,ESSTHANTHETHIRDPART † .OTSURE †

)61UALITYOF#ARE  (AVEYOURECEIVEDDURINGTHELASTYEARLATELY INFORMATIONABOUTEMERGENCY CONTRACEPTIONATTHISCENTER 9ES† .O† 3KIPTO $OESNOTREMEMBER †  7HOPROVIDEDTHISINFORMATION $OCTOR† 0SYCHOLOGIST † 3OCIALWORKER† 'ROUPTALK† 0OSTER† "ROCHURES † 6IDEO † /THER† 3PECIFY??????????????? $OESNOTREMEMBER † %  65SEOF%MERGENCY#ONTRACEPTIVE-ETHOD  (AVEYOUORYOURPARTNER EVERUSEDEMERGENCYCONTRACEPTIVEPILLS 9ES† -ODULE% .O† 3KIPTO  (OWMANYTIMESHAVEYOUUSEDTHISMETHODDURINGTHELASTYEAR ??????????????? $OESNOTREMEMBER † 4OOLS  7HORECOMMENDEDIT 2EADIFTHEPERSONDOESNOTRESPOND !FRIEND † 0ARTNERMALE † 4ELEPHONELINE † 7EBPAGE† 2ADIOPROGRAM† 4ELEVISIONPROGRAM† /THER† 3PECIFY??????????????? $OESNOTREMEMBERKNOW †  7HYDIDYOUUSEIT 2EADANDCHECKTHOSEMETHODSMENTIONED 9OUDONOTUSEACONTRACEPTIVEMETHOD† 4HETIMINGWASMISCALCULATEDRHYTHM † 4HECONDOMBROKEORSLIPPED† 9OUMISSEDPILLS † 9OUWEREFORCEDTOHAVESEX† 4HEWITHDRAWALFAILED† /THER† 3PECIFY??????????????? $OESNOTREMEMBER †  !FTERYOUORYOUPARTNER USEDEMERGENCYCONTRACEPTION DIDYOUSTARTUSINGAREGULAR METHODOFBIRTHCONTROLORONEDIFFERENTFROMTHEMETHODYOUWEREUSING 9ES† .O† 3KIPTO $OESNOTREMEMBER † 3KIPTO $OESNOTKNOW† 3KIPTO

%  4OOLS

 7HICHMETHODDIDYOUSTARTUSING

0ILLS† -ODULE% )NJECTABLES† #ONDOMS † )5$† 4UBALLIGATION † 6ASECTOMY † 7ITHDRAWAL † #ALENDARRHYTHM † /THER† 3PECIFY??????????????? $OESNOTREMEMBER †

6)!TTITUDES4OWARD%MERGENCY#ONTRACEPTION ,ETMEDElNEBRIEmYWHATEMERGENCYCONTRACEPTIVEPILLSARE4HEYARETRADITIONAL CONTRACEPTIVEPILLS THOSETHATARETAKENDAILY BUTADMINISTEREDINHIGHERDOSESANDFORA SHORTTIME7OMENCANUSETHEMAFTERHAVINGHADUNPROTECTEDSEXANDASAWAYTOHELP THEMPREVENTAPREGNANCY4HISMETHODISSOMETIMESCALLEDTHEhMORNING AFTERPILL vBUTTHE WOMANACTUALLYHASUPTOlVEDAYSAFTERINTERCOURSETOGETPROTECTED %MERGENCYCONTRACEPTIVEPILLSMUSTBETAKENASSOONASPOSSIBLEWITHINTHElRSTHOURS AFTERUNPROTECTEDSEX)FTAKENWITHINHOURS ANDWITHTHECORRECTDOSES THEYPREVENT ABOUTOUTOFPREGNANCIESTHATWOULDHAVEOTHERWISEOCCURRED3OMEWOMENWHOHAVE TAKENTHEMHAVEEXPERIENCEDNAUSEAORVOMITING4HEINGREDIENTINTHESEPILLSISTHESAME ASTHEONEINNORMALCONTRACEPTIVEPILLS BUTINHIGHERDOSES4HISMETHODISUSEDINCASEOF EMERGENCYITISNOTRECOMMENDEDFORROUTINEUSE  7HATDOYOUTHINKABOUTTHISMETHOD !DEQUATEFORWOMEN † )NADEQUATEFORWOMEN† !DEQUATEFORSOMEWOMEN† 9OUWOULDLIKETOHAVEMOREINFORMATION† /THER† $OESNOTKNOW† 3PECIFY???????????????  $OYOUHAVEANYQUESTIONSORCONCERNSABOUTTHISMETHOD 9ES† .O† 3KIPTO

%   7HICHAREYOURCONCERNS )TMAYCAUSEHEALTHPROBLEMS† )TMAYHURTTHEBABYINCASEITDOESNOTWORK†

-ODULE% )TMAYRESULTINCOMPLICATIONSTOGETPREGNANTINTHEFUTURE† )TISABORTIFACIENT† )TSUSEMAYBEILLEGAL†

4OOLS )TWILLRESULTINMOREWOMENSUFFERINGFROM34) ANDEVEN!)$3† )FMENKNOWTHATTHISMETHODEXISTSTHEYWOULDEXERT PRESSUREONWOMENTOUSEIT † 3OMEWOMENMAYUSEITFREQUENTLYINSTEADOFUSING REGULARCONTRACEPTIVES† /THER† 3PECIFY??????????????? )DONOTHAVEENOUGHINFORMATION †  7HEREDOYOUTHINKTHISCONTRACEPTIVEMETHODSHOULDBEPROVIDED 2EADANDCHECKTHOSEMETHODSMENTIONED 0UBLICHOSPITALS † 0RIVATEHOSPITALS † )NSTITUTIONALHEALTHCENTERS † #OMMUNITYHEALTHCENTERS† !TMIDWIVESHOUSES† 0HARMACIES † !NYSHOPWHEREDRUGSAREEXPENDED† 3CHOOLS † 6ENDINGMACHINES † /THER† 3PECIFY???????????????  7HOSHOULDPROVIDEIT 2EADANDCHECKTHOSEMETHODSMENTIONED $OCTORS † .URSES† 3OCIALWORKERS † 3EX#OUNSELORS† #OMMUNITYHEALTHWORKERS † 0SYCHOLOGISTS† -IDWIVES† 0HARMACISTS† /THER† 3PECIFY???????????????

%  4OOLS

 &ROMWHATYOUHAVELEARNTABOUTEMERGENCYCONTRACEPTION DOYOUTHINKYOUWOULD

EVERUSEITORRECOMMENDITTOAFRIENDORRELATIVEINCASEOFNEED -ODULE% 9ES† .O† .OTSURE †  $OYOUBELIEVEYOURPARTNERWOULDACCEPTTHATYOUUSETHISMETHOD /RWOULDYOU ACCEPTTHATYOURPARTNERUSESIT 9ES† .O† .OTSURE †  !CCORDINGTOYOU WHICHWOULDBETHEBESTWAYSTOINFORMPEOPLEABOUTEMERGENCY CONTRACEPTION 2EADANDCHECKTHOSEMETHODSMENTIONED !TTHECLINIC † 'ROUPTALKS † "ROCHURES † 0OSTERS † 2ADIO † 4ELEVISION † -AGAZINESNEWSPAPERS† 3CHOOLS † 4ELEPHONELINE † )NTERNETPAGE† /THER† 3PECIFY??????????????? $OESNOTKNOW†

6))$ISTRIBUTION )NSOMECOUNTRIES PROVIDERSSUPPLYWOMENINADVANCEWITHKITSCONTAININGEMERGENCY CONTRACEPTIVEPILLS4HUS WOMENCANEASILYRESORTTOTHEMINCASEOFNEED WITHOUTHAVINGTO RETURNTOTHECLINIC  7HATDOYOUTHINKABOUTTHISIDEA !DEQUATE† (ASDOUBTS† )NADEQUATE †

 7HY ?????????????????????????????????????????????????????????

%   3OMEPHARMACEUTICALCOMPANIESHAVEDEVELOPEDSOMETHINGCALLEDhADEDICATED PRODUCTvFOREMERGENCYCONTRACEPTIVEPILLS4HISDEDICATEDPRODUCTCONTAINS THEEXACTDOSE BUTITCONSISTSOFTWOPILLSONLYANDHASFEWERSIDEEFFECTSTHECOSTOFTHE PRODUCT HOWEVER ISHIGHERTHANTHATOFUSINGREGULARORALCONTRACEPTIVEPILLSFOR

-ODULE% EMERGENCYCONTRACEPTION7OULDYOUPREFERTHISDEDICATEDPRODUCT 9ES† .O†

4OOLS )TDEPENDS † $OESNOTKNOW†

 7HY ?????????????????????????????????????????????????????????  (OWMUCHWOULDYOUBEWILLINGTOPAYFORTHISPRODUCT 53??????????? 53  † 53  † 53  † 53  † 53  † 53  † -ORETHAN53 † $OESNOTKNOWRESPOND†

%  4OOLS

7EHAVECOMETOTHEEND"UTBEFOREWElNISH -ODULE% 7EWOULDLIKETOMENTIONTHATEMERGENCYCONTRACEPTIVEPILLSDONOTPROTECTAGAINSTSEXUALLY TRANSMITTEDINFECTIONS INCLUDING()6 THEVIRUSWHICHCAUSES!)$3#ONDOMSAREBELIEVEDTO BETHEMOSTEFFECTIVEMETHODTOPROTECTAGAINSTTHESEDISEASES $OYOUHAVEANYFURTHERDOUBTSABOUTEMERGENCYCONTRACEPTION 5SERSQUESTIONS  ???????????????????????????????????????????????????????????????????????? ???????????????????????????????????????????????????????????????????????? ???????????????????????????????????????????????????????????????????????? ????????????????????????????????????????????????????????????????????????  ???????????????????????????????????????????????????????????????????????? ???????????????????????????????????????????????????????????????????????? ???????????????????????????????????????????????????????????????????????? ????????????????????????????????????????????????????????????????????????  ???????????????????????????????????????????????????????????????????????? ???????????????????????????????????????????????????????????????????????? ???????????????????????????????????????????????????????????????????????? ????????????????????????????????????????????????????????????????????????  ???????????????????????????????????????????????????????????????????????? ???????????????????????????????????????????????????????????????????????? ???????????????????????????????????????????????????????????????????????? ???????????????????????????????????????????????????????????????????????? 7RITETHETIMETHEINTERVIEWlNISHED???(OURS???-INUTES 7RITETHISSAMETIMEONTHElRSTPAGEOFTHEQUESTIONNAIRE

4HANKSAGAINFORPARTICIPATINGINTHISPROJECT

4HISSURVEYWASORIGINALLYDEVELOPEDIN3PANISHBYTHE0OPULATION#OUNCILOF-EXICO)TWASTRANSLATEDAND ADAPTEDWITHPERMISSIONFROMTHE0OPULATION#OUNCILOF-EXICOBY0!4(

%  -ODULE% 4OOLS

%  4OOLS

0ROVIDER+NOWLEDGE !TTITUDES AND0RACTICES -ODULE% 3URVEYON%MERGENCY#ONTRACEPTIVE0ILLS /URORGANIZATION ????????????? ISSEEKINGTOLEARNABOUTMEDICALPROVIDERSKNOWLEDGE OFANDPERCEPTIONSOFTHENEEDFOREMERGENCYCONTRACEPTIVEPILLS%#0S ASWELLASBARRIERS TOPROVIDINGHIGH QUALITY%#0SERVICES4HEINFORMATIONYOUPROVIDEWILLBEUSEDTODESIGN TRAININGCURRICULAANDMATERIALSABOUT%#0SANDOTHERCONTRACEPTIVEMETHODS9OURANSWERS WILLNOTBERELEASEDTOANYONEANDWILLREMAINANONYMOUS9OURNAMEWILLNOTBEWRITTENON THEQUESTIONNAIREORBEKEPTINANYOTHERRECORDS0LEASERETURNTHESURVEYBY????TO??? 4HANKYOUFORYOURHELP ???????????????????????????????????????????????????????????????????????? 0LEASECHECKBELOW /BSTETRICIAN'YNECOLOGIST† .URSE † 0SYCHOLOGIST † /THER???????????????? 0LEASECHECKBELOW &EMALE † -ALE† 2EGIONWHEREYOUWORK 5RBAN† 2URAL† $OYOUAGREETHATUNINTENDEDPREGNANCIESAND ASARESULT INDUCEDABORTIONSARESERIOUS PROBLEMSINOURCOUNTRY 9ES† .O† (OWLONGDOESATYPICALAPPOINTMENTWITHYOURCLIENTLAST ,ESSTHANMIN †  MIN †  MIN † -ORETHANMIN † $OESATYPICALAPPOINTMENTINCLUDEADISCUSSIONOFFAMILYPLANNING 0LEASECHECKONE !LWAYS† -OSTOFTHETIME † 3OMETIMES † 7HENTHECLIENTREQUESTSINFORMATION† .EVER † %  7HATARETHECONTRACEPTIVEMETHODSAVAILABLEATYOURCLINICORHEALTHCENTER 0LEASECHECKALLTHATAPPLY (ORMONALMETHODS

-ODULE% /RALCONTRACEPTIVEPILLS † %MERGENCYCONTRACEPTIVEPILLS † #ONTRACEPTIVEINJECTION† #ONTRACEPTIVEIMPLANT † 4OOLS "ARRIERMETHODS -ALECONDOM† &EMALECONDOM † $IAPHRAGM† /THERMETHODS 6AGINAL† 3AFEPERIODRHYTHM † 7ITHDRAWAL † 3TERILIZATION † )5$† $OYOUHAVECONCERNSABOUTTHEMETHODSLISTEDBELOW #HECKONLYWHEREYOUHAVE ACONCERN .OTEFFECTIVE 5NSAFE /THER (ORMONALMETHODS /RALCONTRACEPTIVEPILLS † † † %MERGENCYCONTRACEPTIVEPILLS † † † #ONTRACEPTIVEINJECTION † † † #ONTRACEPTIVEIMPLANT † † † "ARRIERMETHODS -ALECONDOM † † † &EMALECONDOM † † † $IAPHRAGM † † † /THERMETHODS 6AGINALSPERMICIDES † † † 3AFEPERIODRHYTHM † † † 7ITHDRAWAL † † † 3TERILIZATION † † † )5$ † † †

%  4OOLS

)FFORANYMETHODYOUCHECKEDhOTHER vPLEASEEXPLAIN -ODULE%

????????????????????????????????????????????????????????????????????????????????

????????????????????????????????????????????????????????????????????????????????

7HATCONTRACEPTIVEMETHODSWOULDYOULIKETOLEARNMOREABOUT

????????????????????????????????????????????????????????????????????????????????

????????????????????????????????????????????????????????????????????????????????

????????????????????????????????????????????????????????????????????????????????

7HATADVICETREATMENTWOULDYOUGIVETOAWOMANWHOCAMETOYOUWITHAHISTORYOFA MISSEDORDELAYEDPERIOD

????????????????????????????????????????????????????????????????????????????????

????????????????????????????????????????????????????????????????????????????????

????????????????????????????????????????????????????????????????????????????????

7HATADVICEORTREATMENTWOULDYOUGIVETOAWOMANWHOCAMETOYOUWITHCONCERNSABOUT CONTRACEPTIVEFAILURECONDOMBREAKAGE MISSEDPILLS MISSEDINJECTION

????????????????????????????????????????????????????????????????????????????????

????????????????????????????????????????????????????????????????????????????????

????????????????????????????????????????????????????????????????????????????????

$OYOUAGREEORDISAGREEWITHTHEFOLLOWINGSTATEMENT h%#0SAREPRIMARILYAFORMOF CONTRACEPTIONv !GREESKIPTOQUESTION † $ISAGREEGOTOQUESTION † $OYOUAGREEORDISAGREEWITHTHEFOLLOWINGSTATEMENT h%#0SAREPRIMARILYAFORMOF ABORTIONv !GREE † $ISAGREE†

%  7HENYOUORSOMEONEATYOURCLINICDISCUSSFAMILYPLANNING DOYOUINCLUDEADISCUSSIONOF EMERGENCYCONTRACEPTION 0LEASECHECKONE !LWAYS†

-ODULE% -OSTOFTHETIME † 3OMETIMES † 7HENTHECLIENTREQUESTSINFORMATION† .EVER † 4OOLS (AVEYOUEVERPRESCRIBED%#0S 9ES† .OSKIPTOQUESTION † )FYES PLEASECHECKONEOFTHEFOLLOWING )NTHELASTYEAR HOWMANYTIMESHAVEYOUPRESCRIBED%#0S TIMES †  TIMES†  TIMES†  TIMES† -ORETHANTIMES† (OWFAMILIARAREYOUWITHTHEUSEOF%#0S 6ERYFAMILIAR† 3OMEWHATFAMILIAR † .OTATALLFAMILIAR † 7HATADVANTAGESDOYOUBELIEVETHISMETHODHAS .ONE † 0REVENTSUNINTENDEDPREGNANCY† )DEALWHENNOCONTRACEPTIONWASUSED† !CCESSIBLE† %ASYTOMANAGEDOSE † .OTNECESSARYTOUSEAROUTINECONTRACEPTIVE † 7OMENCANSELF PRESCRIBE † ,OWCOST † %FFECTIVE † &EWCONTRAINDICATIONS † .OIMPORTANTSIDEEFFECTS † #ANBEMANAGEDBYTHEWOMANWITHOUTTHE MANSPARTICIPATION † /THERPLEASEDESCRIBE ??????????????????????????????

%  4OOLS

7HATCONCERNSDOYOUHAVEABOUT%#0S 0LEASECHECKALLTHATAPPLY

.OCONCERNS† -ODULE% -ORALORRELIGIOUSOBJECTION† 7OMENWILLRELYON%#0SASAREGULARFORM OFCONTRACEPTION† 3IDEEFFECTSˆNAUSEAANDVOMITING † )NEFFECTIVEINPREVENTINGPREGNANCY † 3AFETYOFFETUSIF%#0SARENOTEFFECTIVEIN PREVENTINGPREGNANCY † .OTSAFE † $OESNOTPROTECTAGAINSTSEXUALLYTRANSMITTEDINFECTIONS † )NSUFlCIENTTIMEFORADEQUATEPATIENT COUNSELINGEDUCATION† %NCOURAGESIRRESPONSIBLEBEHAVIOR† /THERPLEASEDESCRIBE ?????????????????????????????? 7HATWOULDYOULIKETOLEARNMOREABOUTEMERGENCYCONTRACEPTION 0LEASECHECKALLTHATAPPLY 4YPESOFEMERGENCYCONTRACEPTION† -ECHANISMOFACTIONOFEMERGENCYCONTRACEPTION† %FFECTIVENESS† )5$ASEMERGENCYCONTRACEPTION † 3AFETYOF%#ANDHORMONALCONTRACEPTIVES † 0OSSIBLESIDEEFFECTS † !DVANCEDISTRIBUTION† /THERPLEASEDESCRIBE ?????????????????????????????

7HEREDOYOUBELIEVE%#0SSHOULDBEOFFERED 0LEASECHECKALLTHATAPPLY 'OVERNMENTHOSPITALS† 0RIVATEHOSPITALS † 'OVERNMENTHEALTHCENTERS† 0RIVATECLINICS † #OMMUNITYHEALTHCENTERS† -IDWIVES† 0HARMACIES † 3UPERMARKETS† 3CHOOLS † 6ENDINGMACHINES † /THERPLEASEDESCRIBE ??????????????????????????????

%  7HODOYOUTHINKSHOULDOFFER%#0S 0LEASECHECKALLTHATAPPLY $OCTORS † .URSES†

-ODULE% 3OCIALWORKERS † #OMMUNITYHEALTHPROMOTERS† 0SYCHOLOGISTS†

4OOLS -IDWIVES† 0HARMACISTS† /THERPLEASEDESCRIBE ????????????????????????????? (OWSATISlEDAREYOUWITHCURRENTGUIDELINESGOVERNING%#0USEINTHISCOUNTRY 6ERYSATISlEDSKIPTOQUESTION † 3OMEWHATSATISlEDSKIPTOQUESTION † .OTATALLSATISlED† )FYOUANSWERED h.OTATALLSATISlEDvTOTHEPREVIOUSQUESTION WHATOFlCIAL DOCUMENTATIONWOULDMAKEITEASIERFORYOUTOPROVIDE%#INFORMATIONTOWOMEN 0LEASECHECKALLTHATAPPLY (EALTHAUTHORITIESGUIDELINES† 0ROFESSIONALASSOCIATIONRECOMMENDATIONS† /THERPLEASEDESCRIBE ????????????????????????????? 0LEASECHECKTHESTATEMENTTHATBESTDESCRIBESYOURCLIENTS h!LLOFMYCLIENTSKNOWTHATTHERE ISACONTRACEPTIVEMETHODTHATCAN PREVENTPREGNANCYAFTERUNPROTECTEDSEXv † h3OMEOFMYCLIENTSKNOWTHATTHERE ISACONTRACEPTIVEMETHODTHATCAN PREVENTPREGNANCYAFTERUNPROTECTEDSEXv † h&EWOFMYCLIENTSKNOWTHATTHERE ISACONTRACEPTIVEMETHODTHATCAN PREVENTPREGNANCYAFTERUNPROTECTEDSEXv †

4OWHICHCLIENTSDOYOUOFFERTHEMETHOD 0LEASECHECKALLTHATAPPLY !DOLESCENTS† -ARRIEDORPARTNEREDWOMEN† 2APECASES † #LIENTSWHOUSEDACONTRACEPTIVEMETHOD † #OMMERCIALSEXWORKERS† /THERPLEASEDESCRIBE ?????????????????????????????

%  4OOLS

$OYOUHAVEANYMATERIALSFORCLIENTSTHATDISCUSSEMERGENCYCONTRACEPTION

9ES † -ODULE% .O† $ONOTKNOW † !RETHEREANYWRITTENGUIDELINESTHATYOUUSEFOREMERGENCYCONTRACEPTION 9ES† .O† $ONOTKNOW † 7HATINFORMATIONWOULDMAKEITEASIERFORYOUTOPROVIDE%#INFORMATIONTOWOMEN 0LEASECHECKALLTHATAPPLY 7RITTENMATERIALSANDRESOURCESDESIGNED FORMEDICALPROVIDERS † 7RITTENMATERIALSANDRESOURCESFORWOMEN† $ATASTUDIESONEMERGENCYCONTRACEPTION EFFECTIVENESSANDSAFETY† #OMPREHENSIVEEMERGENCYCONTRACEPTIONTRAINING † /THERPLEASEDESCRIBE ????????????????????????????? 7HATARETHEOBSTACLESTOINCREASEDACCESSTOTHISMETHODINTHISCOUNTRYINGENERAL 0LEASECHECKALLTHATAPPLY .ONE † 2ELIGIOUSOPPOSITION† (EALTHCENTERPOLITICS† /PPOSITIONFORHEALTHREASONS† /PPOSITIONFROMCIVILGROUPS † /PPOSITIONFROMMEDICALPERSONNEL † ,ACKOFAWARENESSONTHEPARTOFCLIENTS † #OST † !VAILABILITY † ,EGALRESTRICTIONS † /THERPLEASEDESCRIBE ?????????????????????????????

%  $OYOUHAVEANYIDEASABOUTHOWTOOVERCOMETHESEOBSTACLES 0LEASECHECKALLTHATAPPLY 4RAININGCOURSES † #LARIFYINGERRONEOUSPRECONCEPTIONS †

-ODULE% 'OVERNMENTNORMS† )NFORMATIONTOTHEGENERALPOPULATION† )NCORPORATIONINTOCOUNSELINGONFAMILY PLANNINGMETHODS † 4OOLS /FFERITATALOWCOST † 0ROVISIONINAPPROPRIATEDOSES † $EDICATEDPRODUCT † /VER THE COUNTERPROVISION † %ASYACCESSTOTHEMETHOD† /THERPLEASEDESCRIBE ?????????????????????????????? 7HATBARRIERSEXISTFORYOURCLIENTSTOACCESSEMERGENCYCONTRACEPTION 0LEASECHECKALLTHATAPPLY ,ACKOFAWARENESSABOUT%#0S † &EAROFSIDEEFFECTS † &EAROFEFFECTSONFETUSIFALREADYPREGNANT† #ULTURALBARRIERS† #OST † /THERPROVIDERSRELUCTANCETOREFERCLIENTSFOR%#0S† #LINICORPHARMACYHOURS † 4RANSPORTATION † #LIENTFEAROREMBARRASSMENTABOUTDISCUSSING THENEEDFOR%#0S† /THERPLEASEDESCRIBE ????????????????????????????? )NYOURCOMMUNITY ISEMERGENCYCONTRACEPTIONINFORMATIONEASILYAVAILABLEFORWOMEN 9ES† .O† )NYOURCOMMUNITY WHATORGANIZATIONSORINFORMATIONSOURCESCANMOSTEFFECTIVELYREACH WOMENWITHINFORMATIONONHEALTHANDLIFESTYLEISSUES 0LEASECHECKTHREE -EDICALINSTITUTIONS† -EDIARADIO 46 NEWSPAPERS † .ONGOVERNMENTAL/RGANIZATIONS† 7OMENSORGANIZATIONSPLEASESPECIFY ???????????????? 0RINTEDMATERIALSPOSTERS BROCHURES BOOKLETS † (OTLINE† /THERPLEASEDESCRIBE ????????????????????????????? %  4OOLS

7HICHHEALTHPROVIDERSDOYOUCONSIDERAREMOSTIMPORTANTTOREACHWITHINFORMATION

ABOUTEMERGENCYCONTRACEPTION 0LEASENUMBERINORDERFROMMOSTIMPORTANT TOLEAST -ODULE% IMPORTANT /BSTETRICIANSGYNECOLOGISTS .URSES (OSPITALEMERGENCYROOMS /THERMEDICALPROVIDERSPLEASESPECIFY ????????????????? &AMILYPLANNINGCOUNSELORS

This material was adapted from provider surveys developed by PATH, Population Council of Mexico, and the Family Planning Association of Sri Lanka.

%  -ODULE% 4OOLS

%  4OOLS

)N $EPTH)NTERVIEW'UIDEFOR+EY2EPRODUCTIVE -ODULE% (EALTH!UTHORITIES $ATEDAYMONTHYEAR ???????????????????????4IMEINTERVIEWBEGAN?????????? .AMEOFFACILITATOR??????????????????????????4IMEINTERVIEWENDED??????????

)NTRODUCTION )NTRODUCEYOURSELFANDEXPLAINTHEPURPOSEOFTHEINTERVIEW)FANOTETAKERISPRESENT INTRODUCETHENOTETAKERITISOFTENHELPFULTOHAVEANOTETAKERWORKINGINCOLLABORATIONWITH THEINTERVIEWER  /URORGANIZATION;INSERTTHENAMEOFORGANIZATIONHERE=ISSEEKINGTOLEARNABOUT REPRODUCTIVEHEALTHAUTHORITIESATTITUDESTOWARDEMERGENCYCONTRACEPTIVEPILLS%#0S THEIRPERCEPTIONSOFTHENEEDFOR%#0SANDBARRIERSTOPROVIDINGHIGH QUALITY%#0 SERVICES ANDTHEIROPINIONONTRAININGNEEDSOFTHEIRSTAFFANDTHEBESTMECHANISMTO EXPAND%#0INFORMATION4HEINFORMATIONYOUPROVIDEWILLBEUSEDTODESIGNTRAINING CURRICULAANDMATERIALSONEMERGENCYCONTRACEPTIONANDOTHERCONTRACEPTIVEMETHODS ,ETTHEINTERVIEWEEKNOWTHATIFATANYTIMEHESHEDOESNOTFEELCOMFORTABLEWITHATOPIC HESHEISNOTREQUIREDTORESPOND4HEREARENOWRONGORRIGHTANSWERS !SKINTERVIEWEETOCOMPLETETHEBACKGROUNDINFORMATIONFORM THENPROCEEDWITHTHE INTERVIEWGUIDE

%  "ACKGROUND)NFORMATION&ORMFOR+EY2EPRODUCTIVE(EALTH -EDICAL!UTHORITIES

-ODULE% 4HISFORMISTOBElLLEDOUTBYTHEREPRODUCTIVEHEALTHMEDICALAUTHORITYBEFORE THEINTERVIEWBEGINS  0LEASECHECK&EMALE† -ALE†  (OWMANYSTAFFAREEMPLOYEDBYYOURINSTITUTION ???????? 4OOLS  (OWMANYSTAFFDOYOUDIRECTLYSUPERVISE ????????  7HICHCONTRACEPTIVEMETHODSDOESYOURSTAFFRECOMMENDMOSTOFTEN #HECKUPTOlVEMETHODS (ORMONALMETHODS /RALCONTRACEPTIVEPILLS † %MERGENCYCONTRACEPTIVEPILLS † #ONTRACEPTIVEINJECTION† #ONTRACEPTIVEIMPLANT † "ARRIERMETHODS -ALECONDOM† &EMALECONDOM † $IAPHRAGM† /THERMETHODS 6AGINALSPERMICIDES† 3AFEPERIODRHYTHM † 7ITHDRAWAL † 3TERILIZATION † )5$†

 $OYOUHAVECONCERNSABOUTTHEMETHODSLISTEDBELOW #HECKONLYWHEREYOUHAVEACONCERN   1RWHIIHFWLYH  8QVDIH 2WKHU (ORMONALMETHODS /RALCONTRACEPTIVEPILLS ††† %MERGENCYCONTRACEPTIVEPILLS ††† #ONTRACEPTIVEINJECTION ††† #ONTRACEPTIVEIMPLANT †††   1RWHIIHFWLYH  8QVDIH 2WKHU "ARRIERMETHODS -ALECONDOM ††† &EMALECONDOM ††† $IAPHRAGM ††† %  4OOLS

  1RWHIIHFWLYH  8QVDIH 2WKHU

/THERMETHODS -ODULE% 6AGINALSPERMICIDES ††† 3AFEPERIODRHYTHM ††† 7ITHDRAWAL ††† 3TERILIZATION ††† )5$ †††

)FFORANYMETHODYOUCHECKEDhOTHERv PLEASEEXPLAIN BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB   7HATCONCERNSDOYOUHAVEABOUT%#0S 0LEASECHECKALLTHATAPPLY .OCONCERNS† -ORALORRELIGIOUSOBJECTION† 7OMENWILLRELYON%#0SASAREGULAR FORMOFCONTRACEPTION† 3IDEEFFECTSˆNAUSEAANDVOMITING † )NEFFECTIVEINPREVENTINGPREGNANCY † 3AFETYOFFETUSIF%#0SARENOTEFFECTIVEIN PREVENTINGPREGNANCY † .OTSAFE † $OESNOTPROTECTAGAINSTSEXUALLYTRANSMITTEDINFECTIONS † )NSUFlCIENTTIMEFORADEQUATEPATIENT COUNSELINGEDUCATION† %NCOURAGESIRRESPONSIBLEBEHAVIOR† /THERPLEASEDESCRIBE ?????????????????????????????

 )NYOUROPINION WHATASPECTSRELATEDTOEMERGENCYCONTRACEPTIONSHOULDBEINCLUDEDIN THETRAININGFORMEDICALPROVIDERS 0LEASECHECKALLTHATAPPLY 4YPESOFEMERGENCYCONTRACEPTION† -ECHANISMOFACTIONOFEMERGENCYCONTRACEPTION† %FFECTIVENESS† )5$ASEMERGENCYCONTRACEPTION † 3AFETYOFEMERGENCYCONTRACEPTION ANDHORMONALCONTRACEPTIVES† 0OSSIBLESIDEEFFECTS † !DVANCEDISTRIBUTION † /THERPLEASEDESCRIBE ?????????????????????????????

%  )NTERVIEW'UIDEFOR+EY2EPRODUCTIVE(EALTH -EDICAL!UTHORITIES .OTE7HENPOSSIBLEITISBESTTOHAVETWOPEOPLEATTENDTHEINTERVIEW ANINTERVIEWERANDA -ODULE% NOTETAKER4HEINTERVIEWERSHOULDBEGINBYSAYING 4ODAY)WOULDLIKETODISCUSSWITHYOUSOMEISSUESTHATAREIMPORTANTTOWOMENIN ;INSERTYOURCOUNTRYHERE=!SAKEYMEDICALAUTHORITY YOUROPINIONSANDEXPERIENCE

4OOLS AREIMPORTANTTOUSANDWILLHELPUSTODESIGNTRAININGCURRICULUMANDMATERIALSFOR MEDICALPROVIDERS

%MERGENCY#ONTRACEPTION3ERVICE0ROVISION 0ERCEPTIONS AND!TTITUDES 7HATDOYOUTHINKABOUTTHERATEOFUNINTENDEDPREGNANCIESANDABORTIONRATE 0ROBE $OYOUTHINKSOMETHINGSHOULDBEDONETOLOWERTHOSERATES 7HATDOYOUANDYOURSTAFFDOTOMAKEITHAPPEN 7HATDOWOMENDOIFTHEYNEEDTOGETHELPWITHPREVENTINGPREGNANCYAFTERUNPROTECTEDSEX 0ROBE $OMEDICALPROVIDERSOFYOURMEDICALINSTITUTIONOFFEREMERGENCY CONTRACEPTIONTOTHEWOMEN )FYES WHOARETHEIRPOTENTIALEMERGENCYCONTRACEPTIONCLIENTS 7HENISEMERGENCYCONTRACEPTIONISOFFERED (OWOFTENDOTHEYDISCUSSEMERGENCYCONTRACEPTIONWITHTHEIRCLIENTS )SEMERGENCYCONTRACEPTIONINFORMATIONCURRENTLYAVAILABLETOWOMENINYOUR MEDICALINSTITUTION )NWHATFORM 7HATDOYOUTHINKABOUTEMERGENCYCONTRACEPTION 0ROBE )NYOUROPINION ARE%#0SPRIMARILYAFORMOFCONTRACEPTIONORAFORMOF ABORTION 7HY 7HATAREYOURCONCERNSABOUT%#0S 7HATISTHECURRENTOVERALLKNOWLEDGEAMONGPROVIDERSREGARDING%#0S )NYOURMEDICALINSTITUTIONS WHATAREMEDICALPROVIDERSPERCEPTIONSOFA NEEDFOR%#0S

%  4OOLS

"ARRIERSTO0ROVIDING(IGH 1UALITY%MERGENCY#ONTRACEPTION3ERVICES -ODULE% 7HATBARRIERS IFANY MIGHTPREVENTYOURSTAFFFROMROUTINELYPROVIDINGEMERGENCY CONTRACEPTIONINFORMATIONANDSERVICESTOWOMEN 7HY DONTREADLIST s 0ERSONAL MORAL ORRELIGIOUSOBJECTION s 7OMENWILLRELYON%#0SASAREGULARFORMOFCONTRACEPTION s 3IDEEFFECTSˆNAUSEAANDVOMITING s )NEFFECTIVEINPREVENTINGPREGNANCY s 3AFETYOFFETUSIF%#0SISNOTEFFECTIVEINPREVENTINGPREGNANCY s .OTSAFE s $OESNOTPROTECTAGAINSTSEXUALLYTRANSMITTEDINFECTIONS s )NSUFlCIENTTIMEFORADEQUATEPATIENTCOUNSELINGEDUCATION s %NCOURAGESIRRESPONSIBLEBEHAVIOR s ,ACKOFSUPPORTOROPPOSITIONFROMLOCALBOARDOFHEALTH 7HATSTANDARDSOFCAREMIGHTAFFECTPROVISIONOFEMERGENCYCONTRACEPTION 0ROBE !REYOUSATISlEDWITHCURRENTGUIDELINESGOVERNING%#0USEINTHISCOUNTRY 7HATPOLITICALOROTHERCONCERNSMIGHTLIMITMOREEXTENSIVEDEVELOPMENTOF %MERGENCYCONTRACEPTIONSERVICESORINFORMATIONDISSEMINATIONINTHE COMMUNITIESYOUSERVE 7HATlNANCIALORSTAFFCONSTRAINTSCOULDLIMITTHEEXPANSIONOFEMERGENCY CONTRACEPTIONINFORMATIONPROVISIONANDSERVICESINYOURMEDICALINSTITUTION 7HATDOYOUSEEASTHEMOSTEFFECTIVEMECHANISMSTOEXPANDEMERGENCYCONTRACEPTION INFORMATIONANDSERVICESTOWOMENINYOURMEDICALINSTITUTIONS DONTREADLIST s 3TAFFTRAINING s -ATERIALS s &UNDING s %#0PRODUCTAVAILABILITY s !UTHORITYFORSTAFFTOPROVIDE%#0S s /THER 7HATISTHECAPACITYOFNONFAMILYPLANNINGREPRODUCTIVEHEALTHPERSONNELPHARMACISTS FELDSHERS TEACHERS ETC TOSUPPLY%#0INFORMATION 0ROBE 7HOARETHEMOSTIMPORTANTPROVIDERSTOBEREACHEDWITH%#0INFORMATION

%  #ONTRACEPTION0ROVISION 7HICHCONTRACEPTIVEMETHODSARERECOMMENDEDTOWOMENMOSTOFTENINYOURMEDICAL INSTITUTION 7HY DONTREADLIST

-ODULE% s (ORMONALMETHODS s "ARRIERMETHODS s /THERMETHODS 4OOLS )NFORMATION4RAINING.EEDS 7HATINFORMATIONWOULDBEMOSTHELPFULINENABLINGYOUANDYOURSTAFFTOPROVIDEEMERGENCY CONTRACEPTIONINFORMATIONANDSERVICESTOWOMEN DONTREADLIST s 7RITTENMATERIALSANDRESOURCESDESIGNEDFORMEDICALPROVIDERS s 7RITTENMATERIALSANDRESOURCESFORCLIENTS s $ATASTUDIESON%#0EFFECTIVENESSANDSAFETY s #OMPREHENSIVE%#0TRAININGFORSERVICEPROVIDERS s /THER )NYOURMEDICALINSTITUTIONS WHATAREMEDICALPROVIDERTRAININGNEEDSINFAMILYPLANNINGAND CONTRACEPTION 7HY (OWWOULDYOUORGANIZETHISTRAINING (OWLONGSHOULDITBE 7HATISSUESON%#0SANDOTHERCONTRACEPTIVEMETHODSSHOULDBEINCLUDEDINTHETRAINING )NYOUROPINION WHICHMEDICALPROVIDERSSHOULDBETRAINEDON%#0SlRSTOFALL 7HEREDOYOUFEELMOSTWOMENGETINFORMATIONABOUTFAMILYPLANNING DONTREADLIST s &RIENDSORCOWORKERS s &AMILYMEMBERSORSPOUSE s -EDICALPROVIDER s 46 s 2ADIO s "ILLBOARDS s -AGAZINES s .EWSPAPERS s "ROCHUREORPRINTEDMATTER s /THER

%  4OOLS

7HATSOURCEOFINFORMATIONDOYOUTHINKWOMENCANTRUSTTHEMOST ANDWHY

)NYOUROPINION WHATINFORMATIONALMATERIALSDOWOMENNEEDlRSTOFALL -ODULE% 0ROBE )FYOUWERETOHAVEEDUCATIONALMATERIALSON%MERGENCY#ONTRACEPTIONOROTHER CONTRACEPTIVEMETHODSTOGIVETOWOMEN WHATWOULDMAKETHEMINTERESTING &ROMWHATSOURCEWOULDYOULIKEWOMENTOLEARNMOREABOUT%MERGENCY #ONTRACETPIONANDOTHERCONTRACEPTIVES )FMEDIA WHATKINDOFMEDIA )FPEOPLE WHATPEOPLE )FPRINTEDMATERIALS WHATKIND DESCRIBE 7HYDOYOUPREFERTHISSOURCEOFINFORMATION 7HATMAKESTHISSOURCE TRUSTWORTHY 7HATMESSAGESON%#0SAREMOSTIMPORTANTTOPASSTOTHEWOMEN

#ONCLUSION 7EWILLCLOSETODAYSINTERVIEWWITHSOMElNALTHOUGHTS7EWANTTOTHANKYOUFORSHARING YOURIDEASANDOPINIONSTODAY$OYOUHAVEANYTHINGYOUWOULDLIKETOADD (OWDOYOUFEELABOUTOURDISCUSSION $OYOUHAVEANYSUGGESTIONSFORIMPROVINGTHE INTERVIEWPROCESS (EREISCONTACTINFORMATIONINCASEYOUHAVEANYMOREQUESTIONSORCOMMENTSYOUWISHTO SHAREAFTERTHEINTERVIEW 4HEINTERVIEWERSHOULDTHANKTHEINTERVIEWEEANDTELLTHEMTHATTHEIRCONTRIBUTIONHAS BEENVERYVALUABLE%MPHASIZETHATTHISINFORMATIONISBEINGUSEDDEVELOPTRAININGAND INFORMATIONMATERIALSON%#0SANDOTHERCONTRACEPTIVES

!FTERTHE)NTERVIEW )MMEDIATELYAFTERTHEDISCUSSION s &ACILITATORANDNOTETAKERDEBRIEFTOGETHER s -AKEANOTEOFSUGGESTEDCHANGESINTHEWAYTHEINTERVIEWISCONDUCTEDORINTHETECHNICAL ASPECTSOFTHELOGISTICS s 2EVISE EDIT ANDCOMPLETENOTES 4HATAFTERNOONOREVENINGNOTETAKERANDORFACILITATOR ˆDONOTDELAYTHISSTEP s 2EVIEWTHENOTESMAKECLARIlCATIONNOTESASNECESSARY s #OMPLETEANDCORRECTTHENOTESINACCORDANCEWITHTHERECORDING s 3UMMARIZEIMPORTANTTHEMESORPOINTSMADEINTHESUMMARYSECTIONOFTHEINTERVIEW s 3ENDTHETAPEANDTHECLARIlCATIONNOTESTOBETRANSCRIBED s -EETWITHTHEOTHERPROJECTSTAFFTODISCUSSHOWTHEINTERVIEWSAREGOING3HARESUGGESTIONS FORCHANGESTOTHEGUIDEORABOUTTHEINTERVIEWS

4HISMATERIALDEVELOPEDBY0!4( %  -ODULE% 4OOLS

%  4OOLS

-YSTERY3HOPPER3URVEY -ODULE%

'UIDELINES .OTE4HISPAGEISFORUSEINPREPARINGFORTHEPHARMACYVISIT)TSHOULDNOTBEUSEDWHILEIN THEPHARMACY 4HEFOLLOWINGARETWOSCENARIOSONEFORAFEMALESHOPPER ONEFORAMALESHOPPER FORUSE INTHEPHARMACY4HEATTACHEDPAGEISTOBEUSEDBYTHEINTERVIEWERWHOWILLINTERVIEWTHE MYSTERYSHOPPERAFTERHESHEHASlNISHEDHISHERVISIT

Female Mystery Shopper: 9ESTERDAY)HADSEXANDDIDNTUSEANYMETHODOF CONTRACEPTION)AMWORRIEDABOUTGETTINGPREGNANTAND )WOULDLIKETOKNOWIFTHEREISSOMETHING)CANDOTO PREVENTPREGNANCY

Male Mystery Shopper: )HADSEXTWODAYSAGO7EALWAYSUSECONDOMS BUT THISTIMETHECONDOMBROKE)AMWORRIEDTHATMY GIRLFRIENDWILLGETPREGNANT)STHEREANYTHINGWECANDO TOPREVENTTHIS

)FTHECOUNTERSTAFFPERSONORPHARMACISTSAYS9%3 !FTERTHEEMPLOYEEHASTOLDYOUABOUTWHATYOUCANDOTOPREVENTPREGNANCY ASKTHE FOLLOWINGTWOQUESTIONSTOHELPINITIATEADISCUSSIONABOUTSEXUALLYTRANSMITTEDINFECTIONSAND ONGOINGCONTRACEPTION)FTHEPHARMACYSTAFFMEMBERPROVIDESTHISINFORMATIONWITHOUTBEING ASKED THEREISNONEEDTOASKTHEPROMPTINGQUESTIONS s 7HATELSECANHAPPENTOMEORMYGIRLFRIEND IFMYSTERYSHOPPERISMALE s )STHEREANYTHINGELSE)NEEDTOKNOW

)FTHECOUNTERSTAFFPERSONORPHARMACISTSAYS./ CONTINUEBYSAYING )HADAFRIENDWHOSAIDTHEREWEREPILLS)MYGIRLFRIEND COULDTAKEDOYOUKNOWANYTHING ABOUTTHAT /R)SEETHEPOSTERINYOURWINDOWTHATSAYSSOMETHINGABOUTEMERGENCYCONTRACEPTION 7HATISTHAT

)FTHEFRONTLINESTAFFMEMBERORPHARMACIST34),,SAYS./ ASK $OYOUKNOWFROMWHOMORWHERE)MAYGETINFORMATIONHELP .OTE-YSTERYSHOPPERSHOULDBESURETOEMPHASIZEHESHEISINTERESTEDIN02%6%.4).' PREGNANCY TOAVOIDANYPOTENTIALCONFUSIONWITH

%  -YSTERY3HOPPER2ECORDING3HEET

.AMEOFMYSTERYSHOPPER?????????????????????? $ATE??????????????????????

-ODULE% .AMEOFINTERVIEWER?????????????????????????????????????????????????????????

 1DPHRISKDUPDF\

4OOLS  $GGUHVVRISKDUPDF\

 6H[RISHUVRQVSRNHQWRLQSKDUPDF\ 0DOH  )HPDOH

 7HATWASTHEGENERALATTITUDEOFTHEPERSONWHO 0OSITIVEFRIENDLY WELCOMING ATTENTIVE ATTENDEDYOUATTHE"%')..).'OFTHEVISIT )NDIFFERENT

.EGATIVEJUDGMENTAL IMPATIENT RUDE  7HATWASTHEGENERALATTITUDEOFTHEPERSONWHO 0OSITIVEFRIENDLY WELCOMING ATTENTIVE ATTENDEDYOUATTHE%.$OFTHEVISIT )NDIFFERENT

.EGATIVEJUDGMENTAL IMPATIENT RUDE  )FTHESTAFFPERSONHADAPOORATTITUDEARETHERE /THERCUSTOMERS REASONSORTHINGSYOUOBSERVEDTHATMIGHTHAVE AFFECTEDHISHERATTITUDE -ANYCUSTOMERS

#IRCLEALLTHATAREMENTIONED %MBARRASSED

4OOMANYQUESTIONS

$IDNTKNOWHOWTOANSWERQUESTIONS

"ORED

/THER???????????????????????????????? 3PECIFY

$ONTKNOW

.OTAPPLICABLE  +RZORQJZDVWKHLQWHUDFWLRQZLWKWKHVWDII SHUVRQ" BBBBBBBBBBPLQXWHV 7EREYOUASKEDWHENYOUHADYOURYOUR

%  4OOLS

 7EREYOUASKEDWHETHERTHEPERIODWASNORMAL

INLENGTHANDTIMING 1R -ODULE%

 :HUH\RXRIIHUHGDQ\WUHDWPHQWVRUPHGLFDWLRQV"

7HATWEREYOUOFFERED %MERGENCYCONTRACEPTIONDEDICATEDPRODUCT;INSERT SITESPECIlCNAME= ???????????????????????????????????????

/RALCONTRACEPTIVESFORUSEASEMERGENCY CONTRACEPTION /THER???????????????????????????????? 3PECIFYBRANDNAME

 (OWMUCHDIDITCOST BBBBBBBBBB

$IDTHESTAFFPERSONEXPLAINWHATTHEPRODUCTWAS

 $IDTHESTAFFPERSONEXPLAINHOWEFFECTIVETHE

 $IDTHESTAFFPERSONDISCUSSSIDEEFFECTS

9RPLWLQJ

,UUHJXODUEOHHGLQJ

/THER???????????????????????????????? 3PECIFY

%   'LG\RXREVHUYHDQ\SULQWHGPDWHULDOVDERXW

??????????????????????????????? ??????????????????????????????? 4OOLS ???????????????????????????????

 'LGWKHVWDIISHUVRQWDONWR\RXDERXWVH[XDOO\

'LGWKHVWDIISHUVRQUHFRPPHQGWKHXVHRID

 :K\ZHUH\RXUHIHUUHG" 'LGQ¶WKDYHWKHSURGXFWRULQIRUPDWLRQ

3UHJQDQF\WHVW

6H[XDOO\WUDQVPLWWHGLQIHFWLRQH[DP

/THER???????????????????????????????? 3PECIFY  :KHUHZHUH\RXUHIHUUHG" $QRWKHUSKDUPDF\

6SHFL¿FGRFWRU¶VRI¿FHRUFOLQLF

+RVSLWDO

'RFWRUDI¿OLDWHGZLWKSKDUPDF\

&RXQVHOLQJFHQWHU

/THER???????????????????????????????? 3PECIFY 'LGWKHSKDUPDF\VWDIISHUVRQDVN\RXLI\RXKDG

%  4OOLS

 'LGWKHSKDUPDF\VWDIISHUVRQJLYH\RXDQ\RWKHU

LQIRUPDWLRQRUDGYLFH" 1R -ODULE%

3OHDVHGHVFULEHEHORZ ??????????????????????????????? ??????????????????????????????? ??????????????????????????????? ???????????????????????????????

Content and format for this tool were adapted from mystery shopper surveys developed by PATH and the Reproductive Health Research Unit of the University of Witwatersrand, South Africa.

% 

-ODULE&

2EGULATION 0ROCUREMENT AND $ISTRIBUTIONOFA0ROGESTIN /NLY%#0

/BJECTIVE 4OSECUREANDDISTRIBUTEANADEQUATESUPPLYOFAHIGH QUALITYPROGESTIN ONLYEMERGENCY CONTRACEPTIVEPILL%#0 PRODUCT

4HEFOLLOWINGTOPICSAREDISCUSSEDINTHISMODULE s 0ROJECT2EGULATION n.ATIONALREGULATORYAUTHORITY.2! n0RODUCTREGISTRATION s 0RODUCT0ROCUREMENT n%STIMATINGINITIALQUANTITYOF%#0S n/NGOINGMONITORINGOF%#0DEMAND n2OLEOFPROGRAMSTAFFINPROCUREMENTCYCLE n-ANAGINGTHEPROCUREMENTPROCESS n%NSURINGPRODUCTQUALITY n-ONITORINGSUPPLIERPERFORMANCE s $ISTRIBUTION n$ISTRIBUTIONSYSTEMS n3ERVICEDELIVERYOPTIONS

4OOLS0ROVIDEDATTHE%NDOF4HIS-ODULE

„ 0OTENTIAL-ARKETFOR%#0S!"ASIC$EMAND-ODEL „ LNFORMATIONTO)NCLUDEINA,EVONORGESTREL /NLY%#00ACKAGE)NSERT „ 3AMPLE0ROCUREMENT3PECIlCATION,EVONORGESTREL /NLY%#0S „ 0REFERENTIAL0RICINGFOR0UBLIC 3ECTOR!GENCIES „ 0ROCUREMENT4HROUGH)NTERNATIONAL0ROCUREMENT3ERVICES

&  &  -ODULE& 0RODUCT2EGULATION !PPROVALOFPRODUCTLABELING THEPACKAGEINSERT ANDUSEINS s 2EGISTRATIONOFDRUGS MEDICINES ANDOTHERHEALTHPRODUCTSF s /VERSIGHTOFPRODUCTMANUFACTURER IMPORTER ANDDISTRIBUTOR s ANDENFORCED)NGENERAL MAJOR.2!AUTHORITYTYPICALLYINCLUDE ADMINISTRATIVEAGENCY TOENSURETHATREGULATORYREQUIREMENTSA )NMOSTCOUNTRIES AN.2!ISESTABLISHEDBYNATIONALLEGISLATIO .ATIONALREGULATORYAUTHORITY.2! THERESOURCESAVAILABLE LEGISLATIVEREQUIREMENTS)NADDITION THEDEGREEOFOVERSIGHT ANDPROCESSESINANYSPECIlCCOUNTRYTHEYWILLVARY ACCORDING PROCESS7HATISPRESENTEDHEREISTHEGENERALLYACCEPTEDMODEL ISABRIEFSUMMARYOFTHEREGULATORYFUNCTION FOLLOWEDBYADE ENSURETHESAFETY EFlCACY ANDQUALITYOFALLMEDICINESPROVID WITHWHICHPRODUCTSMUSTCOMPLY4HEOVERALLPURPOSEOFREGULAT IDENTIlESTHEREGISTRATION LICENSING MARKETAUTHORIZATION AN REGULATORYREQUIREMENTS4HESEREQUIREMENTSAREBASEDONNATION )NMOSTCOUNTRIES ALLMEDICINES INCLUDINGCONTRACEPTIVES ARE EVENT THEDOSEWOULDBEONEMGTABLET -ANUFACTURERSMAYINTRODUCEASINGLEDOSETABLETFOREMERGENCY ORALCONTRACEPTIVEETHINYLESTRADIOLLEVONORGESTREL MGLEVONORGESTRELFOREMERGENCYCONTRACEPTIONINSTEADOFTW /RGANIZATION7(/ REVISEDTHE%SSENTIAL$RUGS,ISTTORECOMMEN FEWERSIDEEFFECTSTHANCOMBINEDESTROGENPROGESTIN%#0S)N PLANNINGPROGRAMSBECAUSETHEYAREMOREEFFECTIVE CANBETAKEN 0ROGESTIN ONLY%#0SCONTAININGLEVONORGESTRELARETHEPREFERRED HIGHQUALITYOFTHE%#0PRODUCTTHEYPLANTOPROVIDE UNDERSTANDANDSUPPORTTHESESTEPSTOENSURETIMELYPROVISION PROCESSOFINCORPORATINGEMERGENCYCONTRACEPTIONINTOAPROGRAM APROGESTIN ONLY%#0S2EGULATION PROCUREMENT ANDDISTRIBUTIO WELLASSPECIlCTOOLS TOHELPAFAMILYPLANNINGPROGRAMPREPAR PRODUCTTOENSURETHEYAREACCURATE COMPLETE ANDBALANCED ,.'MG &ORMULATION PERPILL 0ROGESTIN /NLY$EDICATED%#0S 0LAN" 0OSTINOR  6IKELA OMN"AD.MS3INGLE$OSE #OMMON"RAND.AMES ,EVONELLE  .OR,EVO  4HISMODULEPROVIDESINFORMATION AS DINSPECTIONREQUIREMENTS ANDENFORCEMENTDEPENDSON EDTOTHEPUBLIC&OLLOWING SUBJECTTONATIONAL NTOSERVEASAN REPROPERLYIMPLEMENTED ADEQUATEQUANTITIES AND SCRIPTIONOFTHEREGISTRATION TONATIONALPOLICYAND EFORROUTINEPROVISIONOF FORTHESEFUNCTIONS PRODUCTFORFAMILY ORUSEINCOUNTRY NARECRITICALSTEPSINTHE S TRUCTIONSTHATACCOMPANYA ODOSESOFTHECOMBINED LICENSES INONEDOSE ANDHAVE  THE7ORLD(EALTH ALLEGISLATIONTHAT ORYREQUIREMENTSISTO 0ROGRAMPLANNERSMUST CONTRACEPTIONINTHIS DASINGLEDOSEOF NUMBEROFTABLETS  -ODULE& s $ETERMINATIONOFWHETHERAPRODUCTWILLBEPROVIDEDBYPHYSICIANPRESCRIPTIONONLY OR WILLBEWIDELYAVAILABLEOVER THE COUNTERIE WITHNOPRESCRIPTIONREQUIRED  s 0OSTMARKETINGSURVEILLANCETOMONITORPROBLEMSWITHADVERSEREACTIONSANDPRODUCT QUALITY

0RODUCTREGISTRATION 0RODUCTREGISTRATIONISONEOFTHECRITICALFUNCTIONSTHATALMOSTALL.2!SPERFORM4HE PROCESSOFREGISTERINGAPRODUCTVARIESACCORDINGTONATIONALREQUIREMENTS BUTCERTAIN CLINICAL MANUFACTURING ANDDISTRIBUTIONINFORMATIONISTYPICALLYREQUIRED4HEMOST COMMONLYREQUIREDINFORMATIONISCONTAINEDINTHEMANUFACTURERSPRODUCTDOSSIER WHICH COVERS s 0RODUCTFORMULATION s -ANUFACTURINGPROCESS s 0ACKAGINGREQUIREMENTS s #LINICALRESEARCHRESULTS s 0RODUCTQUALITYTESTS s /THERPRODUCT SPECIlCINFORMATION )NMOSTCASES THEPRODUCTMANUFACTURER WORKINGWITHITSLOCALDISTRIBUTOR ISRESPONSIBLE FORREGISTERINGITSPRODUCTWITHTHE.2!ANDWILLSUBMITTHEREQUIREDDOCUMENTSTOTHE .2!FORPRODUCTREGISTRATION

&ACILITATIONOFTHE2EGISTRATION0ROCESS

0ROGRAMPLANNERSINTERESTEDININTRODUCINGANEW%#0INTOAFAMILYPLANNING PROGRAMCANHELPFACILITATETHEREGISTRATIONPROCESSBY s #ONTACTINGTHEMANUFACTURERANDITSIN COUNTRYDISTRIBUTORORHELPINGTOIDENTIFY ADISTRIBUTORWHERENONEEXISTS TODEMONSTRATETHATAMARKETFORTHE%#0 PRODUCTEXISTS s "UILDINGSUPPORTAMONGTHOSEWHOINmUENCEPOLICY SUCHASCOMMUNITYLEADERS ANDMEDICALPROVIDERSANDTHOSEWHOINmUENCEREGISTRATIONOFNEWDRUGSˆIN PARTICULAR DECISIONMAKERSATTHEMINISTRYOFHEALTHANDTHE.2!ˆBYINCLUDING THEMININITIALADVOCACYANDPLANNINGACTIVITIES4HEIRPARTICIPATIONISCRITICAL ASTHEIRADVICEANDCOLLABORATIONCANHELPENSURETIMELYPROGRESSTHROUGHTHE REGISTRATIONPROCESS s 0ROVIDINGKEYINFORMATIONABOUT%#0STOLEADERSANDDECISIONMAKERSFOR EXAMPLE THEROLE%#0SCANPLAYINPREVENTINGUNINTENDEDPREGNANCYAND ABORTION THEMECHANISMOFACTIONOF%#0S EVIDENCE BASEDINFORMATIONONTHE SAFETYANDEFlCACYOF%#0S ANDTHEFACTTHATPROGESTIN ONLY%#0SAREINCLUDED IN7(/S%SSENTIAL$RUGS,IST4HISINFORMATIONISPROVIDEDIN-ODULE! )NFORMATIONFOR0OLICY-AKERS

&  &  -ODULE& 4HEINSERTSHEETUSUALLYCONTAINSTHEFOLLOWINGINFORMATION MANUFACTURERTHEREFOREPROVIDESAPACKAGEINSERTSHEETWITHEAC FORCONSUMERUSECONTAINPRINTEDMATERIALSWITHINFORMATIONABO 2EGULATORYAUTHORITIESREQUIRETHATDRUGS MEDICINES ANDCONTR 0ACKAGEINSERTSHEETANDCLIENTUSEINSTRUCTIONS #ONTENTSANDQUANTITY s -ANUFACTURERSNAMEORSYMBOL s $ATEOFMANUFACTURE s %XPIRATIONDATEMONTHANDYEAR s ,OTBATCHNUMBER s 0RODUCTBRANDNAME s FOLLOWING COMMONLABELINGINFORMATIONREQUIREDFORTHEINDIVIDUALBLISTER REQUIREMENTSWILLVARYFROMCOUNTRYTOCOUNTRYHOWEVER FOR%# BEFOREITCANBEAPPROVEDFORREGISTRATIONANDIN COUNTRYUSE 2EGULATORYAUTHORITIESREQUIREAPRODUCTSPRIMARYPACKAGETOB 0RODUCTLABELING )FAWOMANWHOWASALREADYPREGNANTTOOK%#0S ITWOULDNOTH s #ONTRAINDICATIONSRELEVANTTOFREQUENT LONG TERMUSELISTED s -EDICALINTERVENTIONISNOTNECESSARYTOENSURESAFEANDCORR s 3TUDIESHAVESHOWNTHATWOMENAREABLETOFOLLOWTHEINSTRUCT s %#0SARESAFEFORSELF MEDICATION ASTHEREARENOSERIOUSSI s CONTRACEPTIVEMETHOD SPECIlCALLYINREGARDTOTHEFOLLOWINGKE FACTTHAT%#0SHAVEGAINED/4#STATUSINMANYCOUNTRIESˆSPEAKT $RUG!DMINISTRATION4HECRITERIATHATDETERMINE/4#STATUSFOC PROGESTIN ONLYDEDICATED%#0ISCURRENTLYUNDERCONSIDERATIONB FOR/4#STATUSˆIE EXEMPTIONFROMPRESCRIPTION DISPENSINGREQ INCLUDING"ELGIUM &RANCE )TALY .ORWAY ANDTHE5NITED+INGDO ONLY%#0SAREAVAILABLEWITHOUTPRESCRIPTIONINMANYCOUNTRIES AVAILABLE/4#INPHARMACIESHASBEENDECIDEDDIFFERENTLYINVAR 4HEISSUEOFWHETHERADEDICATED%#0PRODUCTSHOULDBEPROVIDED 0RESCRIPTIVEOROVER THE COUNTER/4# STATUS WOMENCANINDEPENDENTLYDETERMINEWHETHERTHEYNEEDTOUSE%#0S INAPPROPRIATEUSECOULDNOTCAUSESERIOUSHARM HAVENOIMPORTANTDRUGINTERACTIONS WITHOUTJUSTIlCATION AS%#0TREATMENTISOFSHORTDURATION %# OFREGULARORALCONTRACEPTIVESARESOMETIMESINCLUDEDON%#0PA THEREARENODOCUMENTEDMEDICALCONTRAINDICATIONSFOREMERGENCY TREATMENTCORRECTLY     0RODUCTPACKAGELABELING ACEPTIVESPACKAGED DEEFFECTS YISSUES INTHEPACKAGELABELING EPROPERLYLABELED PACKSHOULDINCLUDETHE HCONSUMERUNITPACKAGE INTHE%UROPEAN5NION IOUSCOUNTRIES0ROGESTIN USONSAFETYˆANDTHE YTHE53&OODAND ECTUSEOF%#0SBECAUSE UTTHEPRODUCT4HE 0PRODUCTSTHEMOST UIREMENTSˆFORA M!NAPPLICATION IONSANDSELF ADMINISTERTHE BYPRESCRIPTIONONLYOR 0SARENOTTOXIC ANDTHEY OTHESAFETYOFTHIS ARMTHEFETUS CKAGINGˆBUTTHISIS CONTRACEPTION    ANDANOVERDOSEOR   AND -ODULE&

s !CTIVEINGREDIENT s /THERINGREDIENTSEXCIPIENTS s 0RECAUTIONSANDCONTRAINDICATIONSFORUSE s 5SEINSTRUCTIONS s 3IDEEFFECTS s 3TORAGEINSTRUCTIONS 4HEPACKAGEINSERTSHEETSHOULDBEEASYFORCLIENTSTOREADANDUNDERSTAND)NFORMATION THATSHOULDBEINCLUDEDINALEVONORGESTREL ONLY%#0PACKAGEINSERTISPROVIDEDINTHE TOOLSSECTIONOFTHISMODULE

0RODUCT0ROCUREMENT 0ROCUREMENTISTHEPROCESSBYWHICH%#0PRODUCTSAREREQUESTEDANDOBTAINEDFROM MANUFACTURERSANDDISTRIBUTORS2EGARDLESSOFWHETHERTHEREQUESTINGINSTITUTIONISA NONGOVERNMENTALORGANIZATIONORAGOVERNMENTAGENCY THESTANDARDPROCUREMENTPROCESS ISTRADITIONALLYMANAGEDBYDEDICATEDPROCUREMENTPERSONNELANDINCLUDES #ONlRMINGTHEQUANTITYREQUIRED -ANAGINGTHEPROCUREMENTPROCESS %NSURINGPRODUCTQUALITY -ONITORINGSUPPLIERPERFORMANCE 0ROGRAMPLANNERSSUPPORTTHISPROCESSBYPROVIDINGINFORMATIONONPROGRAM REQUIREMENTS SUCHASQUANTITIES DELIVERYSCHEDULE ANDOTHERSPECIlCPROGRAMNEEDS 4HISMODULEPROVIDESEXTENSIVEINFORMATIONABOUTPROCUREMENT-UCHOFTHISINFORMATION WILLACTUALLYBEUSEDONLYBYTHOSEINVOLVEDINTHEPROCUREMENTPROCESS(OWEVER THIS INFORMATIONALSOCANBEUSEFULASANOVERVIEWFORDECISIONMAKERSOFWHATISINVOLVEDIN SUPPLYINGAPROGRAMWITHTHISCONTRACEPTIVEMETHOD WHICHDIFFERSFROMOTHERMETHODS DUETOITSIRREGULARUSEBYCLIENTS

%STIMATINGINITIALQUANTITYOF%#0S "ECAUSE%#0SARENOTINTENDEDFORREGULARUSE TRADITIONALTECHNIQUESFORESTIMATING DEMANDARELIKELYNOTTOBEAPPROPRIATE4HERECURRENTLYDOESNOTAPPEARTOBEA CONSISTENTLYUSEDMETHODFORFORECASTINGDEMAND PARTLYDUETOTHEFACTTHATDEDICATED %#0PRODUCTSHAVEONLYRECENTLYBEGUNTOBEWIDELYAVAILABLE 7HENINITIATINGPROVISIONOF%#0S THEEXPERIENCEOFASOCIALMARKETINGORGANIZATION HASINDICATEDTHATASIMPLECALCULATIONCANBEUSEFUL4HEORGANIZATIONPURCHASES INITIALSUPPLIESOF%#0SBASEDONANESTIMATEOFTOPERCENTOFTHEVOLUMEOFORAL CONTRACEPTIVESREGULARLYSOLDINTHECOUNTRYˆADJUSTINGTOWARDTHELOWORHIGHEND DEPENDINGONHOWWELL KNOWN%#0SAREINTHECOUNTRYANDTHECOUNTRYSSTATISTICSON CONTRACEPTIVEPREVALENCEBYMETHOD!STHISINITIALSUPPLYOF%#0SISUSED STAFFRECORD DATAONTHENUMBEROFCLINICSORPHARMACIESSUPPLIEDANDTHENUMBEROF%#0PACKETSIN THEDISPENSERSSOLDTOTHESELOCATIONS4HESESALESDATAARETHENUSEDFORFORECASTINGFUTURE DEMAND &  &  -ODULE& DISCUSSEDBELOW 3OMEOFTHEKEYFACTORSTHATDETERMINETHEPROCUREMENTMETHODT WITHPROCUREMENTPERSONNELTOOBTAINACCURATEESTIMATESOFTHE PRODUCT)TISTHEREFOREIMPORTANT FORPLANNINGPURPOSES FOR ENTIREPROCUREMENTCYCLE FROMINITIALIDENTIlCATIONOFREQUIRE PRODUCTISNEEDED 4HESEFACTORSALSOAFFECTTHELENGTHOFTIM NUMBEROFMANUFACTURERS ANDTHEPROGRAMDELIVERYSCHEDULEREQU GOVERNINGUSEOFFUNDSEG WHETHERITISDONOR PROVIDEDORG SUPPLYDEPENDSONSEVERALFACTORS INCLUDINGTHEFUNDINGSOURCE 4HEPROCUREMENTPROCESSAFAMILYPLANNINGPROGRAMWILLUSETOE -ANAGINGTHEPROCUREMENTPROCESS RESPONSIBLEFOR%#0PROCUREMENT MAINTAINACONTINUOUS COLLABORATIVEWORKINGRELATIONSHIPWITH CYCLEOFPROCUREMENT&ORTHESEREASONS ITISIMPORTANTFORPR ANDUSEITINEVALUATINGSUPPLIERPERFORMANCEASTHEYCONSIDER PROBLEMSENCOUNTEREDINTHElELD4HEPROCUREMENTUNITWILLDOC CHANGESREQUESTEDBYTHESUPPLIER0ROGRAMSTAFFALSOPROVIDEI INASSISTINGPROCUREMENTSTAFFTOPROMPTLYRESPONDTOPRODUCTA PROGRAMREQUIREMENTSANDDELIVERYSCHEDULENEEDS THEYALSOSER 0ROGRAMSTAFFPLAYANIMPORTANTROLEINTHEPROCUREMENTCYCLE 2OLEOFPROGRAMSTAFFINPROCUREMENTCYCLE NEEDED PROGRAMMANAGERSARERESPONSIBLEFORPROVIDINGTHEMWITHAFORE NEXTPROCUREMENTCYCLE!STHEPROCUREMENTUNITPLANSFORTHEN CONSUMPTIONANDEXTRAPOLATIONSOFTHOSEPATTERNSFORTHETIMEP ANDFACTOREDINTOTHERESUPPLYPROCESS0ROJECTIONSCANBEBASE TOCAMPAIGNSFORINCREASEDAWARENESSOFTHEMETHODTHESETREND REQUIREMENTS-ONITORINGUSESHOULDINCLUDENOTINGTRENDS SUCH USEOVERONEYEARWILLESTABLISHDEMANDDATATHATCANBEUSEDI THEINITIALSUPPLYWASINADEQUATEANDASTOCKOUTISPOSSIBLE- %#0PRODUCTSHOULDBEREORDEREDEVENBEFORETHENEXTCYCLEIFM MAKEREORDERINGBEFORETHENEXTPROCUREMENTCYCLEDIFlCULTHOW ANDCOMPILINGDATATHATCANBEUSEDTOFORECASTFUTUREDEMAND STOCKDEPLETIONOVERTIME#AREFULMONITORINGISCRITICALFORB /NCEANINITIALSUPPLYOF%#0SHASBEENRECEIVED ITISIMPORTA /NGOINGMONITORINGOF%#0DEMAND SUPPLYREQUIREDFORANINITIALORDER BENEEDEDANDTHENTORElNETHISlRSTESTIMATETOPRODUCEAMOR -ODEL 4HESPREADSHEETENABLESTHEUSERTOCALCULATEANESTIMA INCLUDEDINTHETOOLSSECTIONOFTHISMODULE0OTENTIAL-ARKET !SPREADSHEETFORESTIMATINGTHEQUANTITYOF%#0SAPROGRAMSHO )NITIALDEMANDESTIMATION PROGRAMSTAFFTOWORKCLOSELY OTHAVOIDINGSTOCKOUTS EITWILLTAKETOCOMPLETETHE OGRAMSTAFFTOESTABLISHAND MENTSTOlNALDELIVERYOF FOR%#0S!"ASIC$EMAND OVERNMENTFUNDED THE SUPPLIERSFORTHENEXT ONITORINGANDRECORDING NTTOMONITORUSEAND DONTHEPATTERNSOF%#0 NFORMATIONONPRODUCT NFORECASTINGFUTURE NDDELIVERYSCHEDULE )NADDITIONTOIDENTIFYING ERIODCOVEREDBYTHE &UNDINGCYCLESMAY PROCUREMENTPERSONNEL PROCUREMENTCYCLETIME EREALISTICESTIMATEOF%#0 ANDRELEVANTREQUESTS TEDMAXIMUMTHATCOULD EXTPROCUREMENTCYCLE SSHOULDBEQUANTIlED VEASATECHNICALRESOURCE ASINCREASEDUSEDUE ONITORINGINDICATESTHAT ULDINITIALLYPURCHASEIS OBEUSEDAREBRIEmY UMENTTHISINFORMATION EVER IFITISFEASIBLE CASTOF%#0PRODUCT NSUREAN%#0PRODUCT IREMENTSWHENTHE -ODULE&

&UNDINGSOURCE

$ONOR PROVIDED7HEN%#PRODUCTSAREDIRECTLYPROVIDEDBYADONOR THEPROCUREMENT PROCESSISSHORTENED BECAUSESEVERALSTEPSINTHEPROCESSAREELIMINATEDREQUESTING QUOTES NEGOTIATINGCONTRACTSWITHSUPPLIERS ETC )FTHEDONORPROVIDESDIRECTFUNDING TOTHERESPONSIBLEGOVERNMENTPROCUREMENTAGENCY THESESTEPSWILLHAVETOBEINCLUDED THEPROCESSWILLTAKEMORETIME ANDANYSPECIALPROCUREMENTREQUIREMENTSIMPOSEDBY THEDONORMUSTBECOMPLIEDWITH$ONORAGENCIESVARYINTHEIRAPPROACHTOEMERGENCY CONTRACEPTION ASSEENINTHEPOLICIESOFTWOOFTHEMAJORCONTRACEPTIVEDONORAGENCIES THE5NITED3TATES!GENCYFOR)NTERNATIONAL$EVELOPMENT53!)$ ANDTHE5NITED.ATIONS 0OPULATION&UND5.&0! "OTH53!)$AND5.&0!ENDORSECOUNTRYPROGRAMSROUTINE PROVISIONOF%#0SASONEOFTHECONTRACEPTIVEOPTIONSOFFEREDINTHEMETHODMIX4HROUGH  53!)$ HOWEVER HASNOTPROVIDEDADEDICATEDPROGESTIN ONLY%#0PRODUCTTO COUNTRYPROGRAMS5.&0!PROVIDESDEDICATED%#0STOREQUESTINGCOUNTRIES-ODULE !)NFORMATIONFOR0OLICY-AKERSDISCUSSESTHE%#0SUPPORTAVAILABLETHROUGHTHESE AGENCIES5.&0!ALSOOFFERSASERVICEUNDERWHICHTHEYPROCUREANDSHIPDEDICATED%#0S TOSUPPORTACOUNTRYPROGRAMFORAFEE)NFORMATIONON5.&0!PROCUREMENTSERVICESIS PROVIDEDINTHETOOLSSECTIONOFTHISMODULE 'OVERNMENT FUNDED'OVERNMENT FUNDEDPROCUREMENTMUSTCOMPLYWITHNATIONAL PROCUREMENTREQUIREMENTS WHICHINMOSTCASESFOLLOWATRADITIONALPUBLIC SECTORPROCESS THATINCLUDESIDENTIFYINGREQUIREMENTSOBTAININGBUDGETAPPROVALPREPARINGBIDDING DOCUMENTSWHICHINCLUDESPECIlCATIONS QUALITYASSURANCEANDINSPECTIONREQUIREMENTS PROPOSEDTERMSANDCONDITIONS REQUESTINGBIDSORQUOTESEVALUATINGBIDSORQUOTES NEGOTIATINGANDAWARDINGCONTRACTARRANGINGFORSHIPMENTANDPRODUCTINSPECTION !SMENTIONEDABOVE PROGRAMPLANNERSSUPPORTTHISPROCESSBYPROVIDINGPROCUREMENT MANAGERSWITHSPECIlCINFORMATIONONPROGRAMREQUIREMENTS

.UMBEROFPRODUCTMANUFACTURERS

7HENTHEREAREMULTIPLEMANUFACTURERSOFAPRODUCT THEREISACOMPETITIVE ENVIRONMENTˆWHICHCANRESULTINALOWERPRICE)NACOMPETITIVEENVIRONMENT ASISTHE CASEFORCOMBINEDORALCONTRACEPTIVES DONORSANDNATIONALPROCUREMENTPOLICYOFTEN WILLREQUIREOPENORLIMITEDINTERNATIONALBIDDINGˆAFORMALPROCESSREQUIRINGALEADTIME OFSEVERALMONTHS)NTHECASEOFPROGESTIN ONLYDEDICATED%#0PRODUCTS THENUMBEROF SUPPLIERSCURRENTLYISLIMITED4HETWOPHARMACEUTICALCOMPANIESTHATARETHEDOMINANT SUPPLIERSOFDEDICATED PROGESTIN ONLY%#0PRODUCTSIE PRODUCTSPACKAGEDANDLABELED SPECIlCALLYFOREMERGENCYCONTRACEPTION ARE'EDEON2ICHTER,TDAND,ABORATOIRE(2! 0HARMA4HEIR%#0PRODUCTS 0OSTINOR 'EDEON2ICHTER,TD AND.OR,EVO,ABORATOIRE (2!0HARMA AREREGISTEREDINMANYCOUNTRIES4HEREAREOTHERMANUFACTURERSOF LEVONORGESTREL PRINCIPALLYIN#HINAAND)NDIA THATHAVESIGNIlCANTLOCALMARKETSHARES ANDTHATCOULDBECOMESUPPLIERSOFADEDICATEDLEVONORGESTREL ONLY%#0INTHEFUTURE 0RODUCTANDCONTACTINFORMATIONOFADDITIONALSUPPLIERSWILLBEMADEACCESSIBLEON THEWEBSITEOFTHE)NTERNATIONAL#ONSORTIUMFOR%MERGENCY#ONTRACEPTION WHENTHEY ENTERTHEINTERNATIONALMARKET!SOF HOWEVER BECAUSE'EDEON2ICHTER,TDAND ,ABORATOIRE(2!0HARMAARETHEONLYTWOMAJORSUPPLIERS THEPROCUREMENTAGENCYCAN ISSUEAREQUESTFORQUOTEDIRECTLYTOEACHMANUFACTURER RATHERTHANREQUESTINGBIDSFROM MULTIPLEMANUFACTURERS WHICHWILLSTREAMLINETHEPROCUREMENTPROCESSANDSHORTENTHE PROCUREMENTCYCLE#ONTACTINFORMATIONFORBOTH'EDEON2ICHTER,TDAND,ABORATOIRE (2!0HARMAISCONTAINEDINTHETOOLSSECTIONOFTHISMODULE &  &  -ODULE& -INIMIZINGTHENUMBEROFSHIPMENTSFORTHEORDER4HEMOREFR s ,IMITINGSPECIALREQUESTS!NYTIMEAMANUFACTURERHASTOCHA s -AXIMIZINGTHEVOLUMEOFASINGLEORDER4HEVOLUMEOFPRODUC s ORDER!PROGRAMCANREALIZESAVINGSBY FAVORABLEPRICESBYTRYINGTOMINIMIZETHECOSTSINCURREDBYTH #OSTIMPACTONTHESUPPLIER &ACTORSTHATAFFECTTHEPROCUREMENTPRICEOFAPRODUCT HTTPWWWCECINFOORGlLESECSTATUSAVAILABILITYPDF STATUSOFDEDICATED%#0PRODUCTS4HELIST WHICHISUPDATEDAN PROVIDESALISTOFCOUNTRIESIN!FRICA !SIA AND,ATIN!MERICA PRODUCT)NADDITION THE)NTERNATIONAL#ONSORTIUMFOR%MERGENC BEUSEDFOREMERGENCYCONTRACEPTION4HEDATABASECANBESEARCH BOTHCOMBINEDORALCONTRACEPTIVEPILLSANDPROGESTIN ONLYCONTR 4HISWEBSITEPROVIDESASEARCHABLEDATABASEOFORALCONTRACEPTI ONTHEWEBSITEHTTPECPRINCETONEDUWORLDWIDEDEFAULTASP 0ARENTHOOD&EDERATION)00& $IRECTORYOF(ORMONAL#ONTRAC )NFORMATIONABOUTTHEAVAILABILITYOF%#0PRODUCTS DRAWNFROM 0RODUCTAVAILABILITY ITSPRODUCTIN COUNTRYBEFOREITCANBECONSIDEREDFORACONTRA BIDDOCUMENTSBYINCLUDINGAREQUIREMENTTHATTHESUPPLIERBER .2!AREPURCHASEDFORUSEINCOUNTRY4HISISTRADITIONALLYADD 4HEPROCUREMENTAGENCYSHOULDALWAYSENSURETHATONLYPRODUCTS PRODUCTSPECIlCATION ATTHEENDOFTHISMODULE4HEPROCUREMENTAGENCYCANUSETHIS PROCUREMENTSPECIlCATIONFORLEVONORGESTREL ONLY%#0SCANBEFO BRANDNAME)FUSINGPROCUREMENTSPECIlCATIONSTOREQUESTQUOTE 2EQUESTSFORAQUOTECANBEBASEDONPROCUREMENTSPECIlCATIONS FORMOFHIGHERPRICES PURCHASER4HISINCREASEINADMINISTRATIVECOSTSCANBEPASSED SHIPMENTSTHEPURCHASERREQUESTS THEGREATERTHEADMINISTRATIV INCURREDAREMOSTOFTENPASSEDONASHIGHERPRICESTOTHEPURCH ORDERDIFFERENTSIZEBOXESANDADJUSTITSSTANDARDPACKAGINGPR REQUESTINGFOURPRODUCTSPERBOXWHENTHENORMISSIXPERBOX &OREXAMPLE IFAPURCHASERREQUESTSSPECIALPACKAGINGREQUIREM PROCESSTOACCOMMODATEAPURCHASERSSPECIALREQUEST ANADDITI PRODUCT 4HESESAVINGSAREOFTENTHENPASSEDONTOTHEPURCHASERBYOFFE MAYBEABLETOACHIEVETHROUGHSUCHMEASURESASBULKPROCUREMEN CUSTOMER4HEGREATERTHEVOLUMEOFPRODUCTORDERED THEGREATE THATMOSTMANUFACTURERSWILLCONSIDERWHENDETERMININGTHEPRIC 4HEPURCHASERCANIMPROVETHECHANCESOFOBTAINING CTAWARD WITHINFORMATIONABOUTTHE ESUPPLIERINlLLINGTHE RESSEDINTHEREQUESTFOR VESAVAILABLEWORLDWIDEˆ NUALLY CANBEACCESSEDAT ESPONSIBLEFORREGISTERING ACEPTIVEPILLSˆTHATCAN SAMPLETODEVELOPITSOWN Y#ONTRACEPTIONWEBSITE THE)NTERNATIONAL0LANNED S ASAMPLEGENERIC ORTHEMANUFACTURERS EDBYCOUNTRYORBY UNDINTHETOOLSSECTION NGEORADAPTASTANDARD OCESS4HEADDITIONALCOSTS ONTOTHEPURCHASERINTHE ECOSTINCURREDBYTHE REGISTEREDTHROUGHTHE ASER RINGALOWERPRICEFORTHE EQUENTTHENUMBEROF ONALCOSTISINCURRED RSAVINGSAMANUFACTURER THEMANUFACTURERMUST EPTIVES ISACCESSIBLE TORDEREDISAFACTOR ENTSFOREXAMPLE ETHEYWILLCHARGEA TOFRAWMATERIALS -ODULE&

0REFERENTIALPRICING)FAGOVERNMENTALORPUBLIC SECTORAGENCYISCONDUCTINGTHE PROCUREMENT ITISPOSSIBLETOREQUESTPREFERENTIALPUBLICSECTORPRICINGDIRECTLYFROMTHE MANUFACTURER"OTH'EDEON2ICHTER,TDAND,ABORATOIRE(2!0HARMAOFFERPUBLIC SECTORPRICINGSEE0REFERENTIAL0RICINGFOR0UBLIC3ECTOR!GENCIESINTHETOOLSSECTIONFOR THESEMANUFACTURERSCONTACTINFORMATIONANDMOREDETAILS

%NSURINGPRODUCTQUALITY !SMENTIONEDINTHESECTIONABOVEONPRODUCTREGULATION THE.2!HASTHERESPONSIBILITY OFENSURINGTHEQUALITYOFDRUGSANDMEDICINESBYESTABLISHINGINSPECTIONANDQUALITY ASSURANCETESTINGREQUIREMENTS(OWEVER ITISTHERESPONSIBILITYOFTHEPROCUREMENTUNIT TOENSURECOMPLIANCEWITHTHESEREQUIREMENTS4HISISTRADITIONALLYACCOMPLISHEDBY INCLUDINGAPPROPRIATECERTIlCATION INSPECTION ANDTESTINGREQUIREMENTSINTHETECHNICAL SPECIlCATIONSANDSPECIALCONDITIONSOFCONTRACTSISSUEDTOSUPPLIERS #OMMONLYREQUESTEDCERTIlCATIONREQUIREMENTSFORPHARMACEUTICALCONTRACEPTIVES CANBEFOUNDINSECTIONSTHROUGHOFTHE3AMPLE0ROCUREMENT3PECIlCATION ,EVONORGESTREL /NLY%#0SCONTAINEDINTHE4OOLSSECTIONOFTHISMODULE#OMMON INSPECTIONANDTESTINGREQUIREMENTSAREALSOINCLUDEDINTHISSAMPLEPROCUREMENT SPECIlCATION

-ONITORINGSUPPLIERPERFORMANCE /NCETHEELEMENTSDESCRIBEDABOVEHAVEBEENCONSIDEREDANDTHEPROCESSFORPROCURING ANEMERGENCYCONTRACEPTIONPRODUCTHASBEENDETERMINED THEPROCUREMENTPROCESS CANBESETINMOTION-ANAGINGTHISPROCESSINVOLVESPREPARINGAPPROPRIATEDOCUMENTS ESTABLISHINGCONTRACTTERMSTHATENSUREPRODUCTQUALITY ARRANGINGFORPRODUCTSHIPMENT ENSURINGADHERENCETOCONTRACTTERMS ANDMONITORINGTHESUPPLIERSPERFORMANCE )NFORMATIONTHATWILLHELPINCARRYINGOUTTHISPROCESSISFOUNDINTHE3AMPLE0ROCUREMENT 3PECIlCATION,EVONORGESTREL /NLY%#0SINTHETOOLSSECTIONOFTHISMODULE4HIS DOCUMENTISPROVIDEDTOILLUSTRATETHELEVELOFDETAILTHATISREQUIREDFORASPECIlCATIONTHAT ADDRESSESPRODUCTQUALITY INSPECTION ANDTESTINGISSUES4HEPROCUREMENTSPECIlCATION ISANIMPORTANTCOMPONENTOFMANAGINGTHEPROCESSBECAUSE ALONGWITHAPPROPRIATE CONTRACTTERMSANDCONDITIONS ITHELPSTOENSURETHATPRODUCTSPROVIDEDTOTHEPROGRAMARE OFACCEPTABLEQUALITY

$ISTRIBUTION "ECAUSE%#0SAREMOSTEFFECTIVEWHENTAKENASSOONASPOSSIBLEAFTERUNPROTECTED SEX ANDSHOULDBETAKENWITHINHOURS EASYACCESSTOTHISMETHODISOFPARTICULAR IMPORTANCE "ARRIERSTO%#0ACCESSHAVEINCLUDED s #LIENTEMBARRASSMENTINREQUESTING%#0SBECAUSETHEYHAVETOADMITTHATTHEYHADSEX WITHOUTPROTECTION  s 0ROVIDERBIASESAGAINST%#0SORCERTAINUSERS s 2ESTRICTIVEHOURSOFSERVICEDELIVERY

&  &  -ODULE& &AMILYPLANNING.'/S FRANCHISING 3OCIALMARKETINGSOCIAL #OMMERCIALPHARMACIES TRANSMITTEDINFECTIONS ASSAULTORSEXUALLY SERVICESFORSEXUAL CLINICS HOSPITALS SPECIAL 0UBLICSECTOR ITIUIN3SE DATGS$ISADVANTAGES !DVANTAGES $ISTRIBUTION3YSTEM FRANCHISING NONGOVERNMENTALORGANIZATIONS COMMERCIALPHARMACIES ANDSOCIA WITHTHREEBROADCATEGORIESOFDISTRIBUTIONSYSTEMSPUBLICSEC 4HETABLEBELOWDESCRIBESSOMEOFTHEADVANTAGESANDDISADVANTA $ISTRIBUTIONSYSTEMS ,OWORNOCOSTTOCLIENTS s 0OTENTIALFORLINKINGCLIENTSTOOTHER s /RGANIZATIONALSTRUCTUREMAYPROVIDE s ,ARGECLIENTELE s -AYPROVIDELOW COSTSERVICESTO s 0OTENTIALFORLINKINGCLIENTSTOOTHER s /RGANIZATIONALSTRUCTUREMAYPROVIDE s 3PECIALIZEDFAMILYPLANNINGSERVICES s #ANMAKE%#0DISTRIBUTIONSELF s 4YPICALLYUSESTRAININGTOIMPROVE s )NCLUDESADVERTISINGANDAWARENESS s 0OTENTIALFORLOWCOSTTOCLIENT s #ANMAKE%#0DISTRIBUTIONSELF s !TTRACTIVETOYOUTHANDOTHER s %ASYACCESS OPENLONGHOURS s REPRODUCTIVEHEALTHSERVICES SERVICESANDCOUNSELING FOREFFECTIVEQUALITYCONTROLOF CLIENTS REPRODUCTIVEHEALTHSERVICES SERVICESANDCOUNSELING FOREFFECTIVEQUALITYCONTROLOF INTOSYSTEMS MAYMAKEITEASIERTOINTEGRATE%#0S SUSTAINING SERVICEQUALITY RAISING SUSTAINING CLINICS POPULATIONSLESSCOMFORTABLEWITH WEEKENDS -AYBEDIFlCULTTOINCORPORATE%#0S s -AYPRESENTCHALLENGESFORYOUTHOR s ,OCATIONSMAYNOTBEEASILYACCESSIBLETO s -AYNOTHAVETHEmEXIBILITYTORESPOND s -AYHAVERESTRICTEDHOURS s ,OCATIONSMAYNOTBEEASILYACCESSIBLETO s -AYHAVERESTRICTEDHOURS s $OESNOTALWAYSPROVIDEALINKTOOTHER s $ISTRIBUTIONSTAFFMAYNOTHAVECORRECT s /FTENREQUIRESONGOINGSUBSIDYFOR s $ONOTALWAYSPROVIDEALINKTOOTHER s 0HARMACIESTHATLACKSEPARATECOUNSELING s 0HARMACYSTAFFPROVIDING%#0STOCLIENTS s 0RICINGGENERALLYHIGHERTHANTHROUGH s PROVIDEDFAMILYPLANNING INTOPROGRAMSTHATHAVENOTTRADITIONALLY %#0S UNMARRIEDWOMENORCOUPLESREQUESTING CLIENTS QUICKLYTO%#0NEEDS CLIENTS NEEDEDSERVICES DOSAGE INFORMATIONABOUTINDICATIONSFORUSEOR PRODUCTANDORADVERTISING NEEDEDSERVICES POTENTIALUSERS SETTINGMAYBEINTIMIDATINGTOSOME INDICATIONSFORUSEORDOSAGE MAYNOTHAVECORRECTINFORMATIONABOUT CLIENTS THEREFORELESSACCESSIBLETOLOW INCOME PUBLICDISTRIBUTIONMECHANISMSAND TOR FAMILYPLANNING GESASSOCIATED LMARKETINGOR -ODULE&

3ERVICEDELIVERYOPTIONS 'IVENTHETIME SENSITIVENATUREOF%#0USE PROGRAMPLANNERSSHOULDDEVELOPAWARENESS RAISINGSYSTEMSTOENSURETHATWOMENKNOWABOUT%#0SANDWHERETOACCESSTHEM )NFORMATIONABOUT%#0SCANBEDELIVEREDINAVARIETYOFVENUES INCLUDINGPUBLIC SECTORCLINICS WHEREPROVIDERSCANROUTINELYMENTION%#0SDURINGFAMILYPLANNING VISITS ANDSOCIALSERVICEANDOTHERPUBLIC SECTOROR.'/NONCLINICALSERVICEPOINTS -ASSMEDIACAMPAIGNSAREANOTHERMECHANISMFORRAISINGAWARENESS3EE-ODULE# 2AISING0UBLIC!WARENESSFORMOREDETAILEDDISCUSSIONOFTHESEISSUES /NEAPPROACH FORENSURINGTIMELYACCESSTO%#0SISTOPROVIDEWOMENWITHANADVANCESUPPLYALONG WITHINSTRUCTIONSFORUSE ORANADVANCEPRESCRIPTIONTHATCANBElLLEDIFNEEDED!DVANCE PROVISIONOF%#0SHASBEENFOUNDTOREDUCEUNINTENDEDPREGNANCIESWITHOUTINCREASING REPEATEDUSEORENCOURAGINGWOMENTOABANDONOTHERMETHODSOFCONTRACEPTION )TMAYBEPOSSIBLETOINTEGRATE%#0PRODUCTS ASWELLASINFORMATIONANDCOUNSELING INTO SPECIALIZEDSERVICEDELIVERYOPTIONSBEYONDTHECATEGORIESDESCRIBEDABOVE4HESEMIGHT INCLUDE s #OMMUNITY BASEDDISTRIBUTIONPROGRAMS s 3CHOOLNURSES s 5NIVERSITYHEALTHCENTERS s .'/PROGRAMS s 3OCIALSERVICES s &ACTORIESWITHMANYYOUNGFEMALEWORKERS s 0RIVATE SECTORMEDICALPROVIDERS s 3EXUALASSAULTSERVICES 2EGARDLESSOFTHEDISTRIBUTIONSYSTEMIMPLEMENTED ITISIMPORTANTTOENSUREACONSISTENT SUPPLYOFTHE%#0PRODUCT

2EFERENCES HTTPWWWWHOINTMEDICINESORGANIZATIONPAREDLEXPCOMMEM?REPRODDOC

7(/4ASK&ORCEON0OSTOVULATORY-ETHODSOF&ERTILITY2EGULATION2ANDOMISEDCONTROLLEDTRIALOF LEVONORGESTRELVERSUSTHE9UZPEREGIMENOFCOMBINEDORALCONTRACEPTIVESFOREMERGENCYCONTRACEPTION ,ANCET  

'RIMES $! 2AYMOND %' AND3COTT*ONES "%MERGENCYCONTRACEPTIONOVER THE COUNTERTHE MEDICALANDLEGALIMPERATIVES/BSTETRICSAND'YNECOLOGY  

!UGENY %#ANHORMONALEMERGENCYCONTRACEPTION%# BEAVAILABLEWITHOUTMEDICALPRESCRIPTION %UROPEAN*OURNALOF#ONTRACEPTIONAND2EPRODUCTIVE(EALTH#ARE3UPPL ABSTRACT 

7ORLD(EALTH/RGANIZATION)MPROVING!CCESSTO1UALITY#AREIN&AMILY0LANNING-EDICAL%LIGIBILITY #RITERIAFOR#ONTRACEPTIVE5SENDEDITION7(/&2(&00'ENEVA7(/ 

'RIMES $!3WITCHINGEMERGENCYCONTRACEPTIONTOOVER THE COUNTERSTATUS.EW%NGLAND*OURNALOF -EDICINE  

&  &  -ODULE&   'LASIER!AND"AIRD$4HEEFFECTSOFSELF ADMINISTERINGEME OFTHEPROSPECTIVESTUDIES "RACKEN -"/RALCONTRACEPTIONANDCONGENITALMALFORMATIONS /BSTETRICSAND'YNECOLOGY    RGENCYCONTRACPETION INOFFSPRINGAREVIEWANDMETA ANALYSIS .%*-   -ODULE&4OOLS,IST

„ 0OTENTIAL-ARKETFOR%#0S!"ASIC$EMAND-ODEL "ECAUSE%#0SAREUSEDONANIRREGULARANDUNEXPECTEDBASIS FORECASTINGTHENEEDAND PLANNINGTHESUPPLYPROCESSWILLDIFFERFROMREGULARCONTRACEPTIVEPILLS4HISTOOLWILLHELP PROGRAMMANAGERSPLANFORANINITIALSUPPLYOF%#0S

„ )NFORMATIONTO)NCLUDEINA,EVONORGESTREL /NLY%#0 0ACKAGE)NSERT 2EGULATORYAUTHORITIESREQUIRETHATDRUGS MEDICINES ANDCONTRACEPTIVESPACKAGEDFOR CONSUMERUSECONTAINPRINTEDMATERIALSWITHINFORMATIONABOUTTHEPRODUCT)TISIMPORTANTTO ENSURETHATTHISINFORMATIONSHEETUSESCLEARLANGUAGEANDISEASYFORCLIENTSTOUNDERSTAND 4HEPACKAGEINSERTSHOULDBEDESIGNEDTOMEETREGULATORYREQUIREMENTSANDPROVIDECLIENTS WITHKEYINFORMATIONTHATTHEYWILLNEEDFORUSINGTHEPILLS4HISTOOLPROVIDESESSENTIAL INFORMATIONFORPILLUSERSASWELLASOPTIONALADDITIONALINFORMATIONTHATCANBECONSIDERED IFSPACEPERMITS

„ 3AMPLE0ROCUREMENT3PECIlCATION ,EVONORGESTREL /NLY%#0S 0ROCUREMENTUNITSCANUSETHISSAMPLEFORMATASAGUIDE ADDINGCOUNTRY SPECIlCINFORMATION WHEREAPPROPRIATE4HESAMPLESPECIlCATIONISDESIGNEDTOBEUSEDINCONJUNCTIONWITH BIDDINGANDCONTRACTDOCUMENTS4HESPECIlCATIONALSOCANBEUSEFULASANOVERVIEWOFTHE KINDOFINFORMATIONTHATWILLBENEEDEDFORPROCUREMENTPURPOSES

„ 0REFERENTIAL0RICINGFOR0UBLIC 3ECTOR!GENCIES #ONTACTINFORMATIONISPROVIDEDFORTWOMANUFACTURERSOFADEDICATEDLEVONORGESTREL ONLY %#0WHOOFFERPUBLIC SECTORPRICING

„ 0ROCUREMENT4HROUGH)NTERNATIONAL0ROCUREMENT3ERVICES /RGANIZATIONSWITHLIMITEDPROCUREMENTCAPACITYORWANTINGTOPROCURESMALLQUANTITIES OF%#0SMAYlNDTHATORDERINGTHROUGHAREPUTABLEINTERNATIONALPROCUREMENTAGENCYIS ADVANTAGEOUS)NFORMATIONABOUTTHISOPTIONISPROVIDED

& 

4OOLS

0OTENTIAL-ARKETFOR%#0S!"ASIC$EMAND-ODEL -ODULE& 4HISMODELISATOOLTOHELPPROGRAMMANAGERSUSEGENERALLYAVAILABLESTATISTICSANDDATATO DElNETHEPOTENTIALMARKETFOR%#0SINTHEIRSERVICEAREAˆBOTHTHEMAXIMUMDEMANDPER YEARANDTHEREALISTICDEMANDPERYEAR4HEMAXIMUMDEMANDISTHETOTALNUMBEROF%#0S THATCOULDPOTENTIALLYBENEEDEDBYTHETARGETPOPULATIONBASEDONESTIMATESOFUNPROTECTED SEXACTS4HEREALISTICDEMANDREDUCESTHISESTIMATEBYTAKINGINTOACCOUNTISSUESOF%#0 KNOWLEDGE ACCESSIBILITY ANDWOMENSABILITYTOPAYFORTHEPILLS )NTHEBEGINNING WHEN%#0SAREJUSTBEINGINTRODUCED THEMAXIMUMDEMANDWILLBEMUCH HIGHERTHANTHEREALISTICDEMAND"UTOVERTIME BYINCREASINGCLIENTAWARENESSANDPROVIDER TRAINING THETOTALREALISTICDEMANDWILLGROWBECAUSEOFINCREASEDKNOWLEDGEANDINCREASED ACCESS ANDWILLTHEREFOREMORECLOSELYMATCHTHEMAXIMUMDEMAND

-ODEL$ESCRIPTION $ATA AND!SSUMPTION -AXIMUMDEMANDPERYEAR 4HElRSTSECTIONOFTHEMODELESTIMATESTHEMAXIMUMDEMANDPERYEARFOR%#0S4HISIS CALCULATEDBYCOMBININGESTIMATESOFTHEMAXIMUMNUMBEROFCOITALACTSTHATCOULDREQUIRE %#0SFORWOMENUSINGCONTRACEPTIVESANDWOMENNOTUSINGANYCONTRACEPTION4HEESTIMATE FORWOMENUSINGCONTRACEPTIONISCALCULATEDBYCOMPUTINGTHETOTALNUMBEROFWOMENOF REPRODUCTIVEAGEUSINGTRADITIONALMETHODS MALECONDOMS ANDORALCONTRACEPTIVEPILLS ESTIMATINGTHETOTALNUMBEROFTHEORETICALLYPROTECTEDCOITALACTSPERYEARANDTHEN BASEDON OBSERVEDDEPARTUREFROMEFFECTIVEUSEOFCONTRACEPTION CALCULATINGTHENUMBEROFCOITALACTS THATREQUIREPREGNANCYPREVENTION 4RADITIONALMETHODS CONDOMS ANDPILLSARETHEONLYCONTRACEPTIVESINCLUDEDINTHEMODEL BECAUSETHEYARETHEMETHODSFORWHICHAWOMANWOULDBEAWAREOFADEPARTUREFROM EFFECTIVEUSEANDWOULDPERCEIVETHENEEDFOR%#0SSEXUALRELATIONSOUTSIDEOFTHESAFE PERIOD PARTNERFAILINGTOWITHDRAW INCONSISTENTCONDOMUSE ORMISSEDORALCONTRACEPTIVE PILLS 5SERSOFOTHERMETHODSOFCONTRACEPTIONSUCHASANDINTRAUTERINEDEVICES ARENOTLIKELYTONEED%#0S4OCALCULATETHETOTALNUMBEROFCOITALACTSINTHISPOPULATION THEMODELUSESTHEWORLDAVERAGEOFCOITALACTSPERYEAR4HEOBSERVEDDEPARTUREFROM EFFECTIVEUSEOFCONTRACEPTIONISINCLUDEDINTHEMODELASAlXEDRATEOFPERCENT BASED ONESTIMATESOFOBSERVEDDEPARTUREFROMEFFECTIVEUSEOFCONTRACEPTIONTHEPERCENTAGEOF COITALACTSTHATCONTRACEPTIVEUSERSWOULDKNOWTHEYDIDNOTACTUALLYUSETHEIRCONTRACEPTION EFFECTIVELY 4HEPERCENTESTIMATEISBASEDONDATAINDICATINGTHATANAVERAGEOFPERCENT OFWOMENKNOWINGLYMISSMORETHANPILLSPERCYCLEAPPROXIMATELYPERCENTOFCOITAL ACTSBYCONDOMUSERSAREKNOWINGLYUNPROTECTEDANDFAILURERATESOFWITHDRAWALANDRHYTHM METHODSAREPERCENTANDPERCENT RESPECTIVELY7HILETHEFAILURERATEOFTRADITIONAL METHODSISNOTPARALLELTOTHEDATAFORCONDOMSORPILLS THEASSUMPTIONISTHATMOSTFAILURE OFTRADITIONALMETHODSWOULDBECLEARLYOBSERVEDEITHERBECAUSEWOMENFOLLOWINGTHEIR CYCLEHADINTERCOURSEDURINGTHEIRFERTILEPERIODORTHEIRPARTNERDIDNOTWITHDRAWINTIME  &URTHERMORE SINCEUNPROTECTEDACTSDONOTALWAYSLEADTOPREGNANCY THEOBSERVEDRATEWOULD NOTBEANYLOWERTHANACTUALFAILURERATE

&  4HEESTIMATEFORWOMENNOTUSINGANYCONTRACEPTIONISCALCULATEDBYCOMPUTINGTHETOTAL NUMBEROFSEXUALLYACTIVEWOMENOFREPRODUCTIVEAGENOTUSINGCONTRACEPTION ESTIMATING THETOTALNUMBEROFUNPROTECTEDCOITALACTSPERYEAR ANDTHENˆBASEDONTHEESTIMATEOFTHE PROPORTIONOFWOMENWHOWOULDPREFERTOAVOIDAPREGNANCYˆCALCULATINGTHETOTALNUMBER

-ODULE& OFCOITALACTSAMONGWOMENNOTUSINGANYCONTRACEPTIONTHATWOULDREQUIREPREGNANCY PREVENTION 4HEPROPORTIONOFWOMENNOTUSINGCONTRACEPTIONWHOWOULDPREFERTOAVOIDPREGNANCYIS BASEDONDATAINDICATINGTHATABOUTPERCENTOFMARRIEDWOMENINTHEDEVELOPINGWORLD 4OOLS WOULDPREFERTOAVOIDAPREGNANCYBUTARENOTUSINGANYFORMOFCONTRACEPTION

2EALISTICDEMANDPERYEAR 4HESECONDSECTIONOFTHEMODELESTIMATESAMOREREALISTICDEMANDFOR%#0SBYCALCULATINGA SUBSETOFTHEMAXIMUMDEMANDBYDETERMININGTHENUMBEROFTHOSEWOMENWHOWOULDHAVE KNOWLEDGEOF%#0S LIVEINANAREAWHERE%#0SAREACCESSIBLE ANDHAVETHEABILITYTOPAY 4HESEPERCENTAGESAREESTIMATEDBASEDONLOCALKNOWLEDGEOFTHEPOPULATIONANDWILLVARYBY COUNTRY

2EFERENCES -AC+AY *4HE0ENGUIN!TLASOF(UMAN3EXUAL"EHAVIOR.EW9ORK0ENGUIN2EFERENCE 

2OSENBERG -* 7AUGH -3 AND"URNHILL -3#OMPLIANCE COUNSELINGANDSATISFACTIONWITHORAL CONTRACEPTIVESAPROSPECTIVEEVALUATION&AMILY0LANNING0ERSPECTIVES    

-YER , -ATHEWS # AND,ITTLE &#ONDOMUSEANDSEXUALBEHAVIORSAMONGINDIVIDUALSPROCURINGFREEMALE CONDOMSIN3OUTH!FRICAAPROSPECTIVESTUDY3EXUALLY4RANSMITTED$ISEASES   

(ATCHER 2! 4RUSSELL * 3TEWARD & ETAL#ONTRACEPTIVE4ECHNOLOGY THREVISEDEDITION.EW9ORK )RVINGTON0UBLISHERS 

2OSS *!AND7INFREY 7,5NMETNEEDFORCONTRACEPTIONINTHEDEVELOPINGWORLDANDTHEFORMER3OVIET 5NIONANUPDATEDESTIMATE)NTERNATIONAL&AMILY0LANNING0ERSPECTIVES   

#ONTENTANDFORMATFORTHISTOOLWEREADAPTEDFROMAFORECASTINGMODELDEVELOPEDBY!LTA#ARE0!4(GREATLY APPRECIATESCONTRIBUTIONSMADETOTHEMODELBYTHE$ELIVER0ROJECTAT*OHN3NOW )NCAND0OPULATION 3ERVICES)NTERNATIONAL

&  4OOLS

0OTENTIAL-ARKETFOR%#0S!"ASIC$EMAND-ODEL

-!8)-5-$%-!.$0%29%!2 -ODULE&

-AXIMUMNUMBEROFCOITALACTSFORWHICHWOMENMAYQUESTIONTHEIRPREGNANCYSTATUSIMMEDIATELYAFTERINTERCOURSE

7OMEN5SING#ONTRACEPTION A 4OTALPOPULATION B 0ERCENTAGEOFWOMENOFREPRODUCTIVEAGE C 4OTALNUMBEROFWOMENOFREPRODUCTIVEAGEA XB D #ONTRACEPTIVEPREVALENCERATEˆTRADITIONALMETHODSWITHDRAWAL RHYTHM  E #ONTRACEPTIVEPREVALENCERATEˆMALECONDOMS F #ONTRACEPTIVEPREVALENCERATEˆORALCONTRACEPTIVEPILLS G 4OTALCONTRACEPTIVEPREVALENCERATEOFTRADITIONALMETHODS CONDOMSANDPILLS D E F H 4OTALNUMBEROFWOMENOFREPRODUCTIVEAGEUSINGTRADITIONALMETHODS CONDOMS ORPILLSC XG I !VERAGENUMBEROFCOITALACTSPERYEAR  J 4OTALNUMBEROFTHEORETICALLY02/4%#4%$COITALACTSYEARH XI K /BSERVEDDEPARTUREFROMEFFECTIVEUSEOFCONTRACEPTION   IE MISSEDORALCONTRACEPTIVEPILLS UNPROTECTEDCOITALACTSBYCONDOMUSERS

L 4OTALNUMBEROFCOITALACTSAMONGWOMENUSINGTRADITIONALMETHODS CONDOMS ANDPILLSREQUIRINGPREGNANCYPREVENTIONYEARJ XK

7OMEN./45SING!NY#ONTRACEPTION M 4OTALNUMBEROFSEXUALLYACTIVEWOMENOFREPRODUCTIVEAGE N 2ATEOFNON CONTRACEPTIVEUSE

O 4OTALNUMBEROFSEXUALLYACTIVEWOMENOFREPRODUCTIVEAGENOTUSINGCONTRACEPTIONM XN

P !VERAGENUMBEROFCOITALACTSPERYEAR  Q 4OTALNUMBEROFTHEORETICALLY5.02/4%#4%$COITALACTSYEARO XP R 0ROPORTIONOFWOMENNOTUSINGANYCONTRACEPTIONWHOPREFERTOAVOIDPREGNANCY  S 4OTALNUMBEROFCOITALACTSAMONGWOMENNOTUSINGANYCONTRACEPTIONREQUIRING PREGNANCYPREVENTIONYEARQ XR -AXIMUMOPPORTUNITY

T 4/4!,-!8)-5-$%-!.$0%29%!2L S 

2%!,)34)#$%-!.$0%29%!2 3UBSETOFCOITALACTSFROMMAXIMUMOPPORTUNITYOFWOMENTHATHAVEKNOWLEDGEOF%#0S LIVEINAREAWHERE%#0SARE ACCESSIBLE ANDHAVEABILITYTOPAY U 4OTALNUMBEROFCOITALACTSREQUIRINGPREGNANCYPREVENTIONPERYEAR  TOTALMAXIMUMDEMANDFROMT ABOVE V OFWOMENWITHKNOWLEDGEOF%#0S

W OFWOMENWHOLIVEINAREASWHERE%#0SAREACCESSIBLE

X OFWOMENWHOHAVEABILITYTOPAYFOR%#0S Y 4OTALOFWOMENWHOMAYSEEK%#0SV XW XX 

Z 4/4!,2%!,)34)#$%-!.$0%29%!2  .UMBEROFCOITALACTSFORWHICHWOMENMAYSEEK%#0SU XY

4HESHADEDBOXESARECALCULATEDAUTOMATICALLYINTHEELECTRONICVERSIONOFTHISDOCUMENT 2EFERENCESINCLUDEDINMODELDESCRIPTION &  -ODULE& 4OOLS

&  4OOLS

)NSTRUCTIONSFOR5SINGTHE"ASIC$EMAND-ODELTO -ODULE& !SSESSTHE0OTENTIAL-ARKETFOR%#0S

-AXIMUM$EMANDPER9EAR 7OMENUSINGCONTRACEPTION A %NTERTHETOTALNUMBEROFWOMENINTHEPOPULATION)NDIVIDUALCOUNTRYDATAISAVAILABLEONLINE FROMTHE0OPULATION2EFERENCE"UREAUWEBSITEKWWSZZZZRUOGSRSRUJGDWD¿QGHUKWP THE 5NITED.ATIONS7ORLD#ONTRACEPTIVE5SEWEBSITEKWWSZZZXQRUJHVDSRSXODWLRQ SXEVDUFKLYHZFXZFXKWP ANDTHE-EASURE$EMOGRAPHICAND(EALTH3URVEYSWEBSITE KWWSZZZPHDVXUHGKVFRPFRXQWULHVVWDUWFIP B %NTERTHEPERCENTAGEOFWOMENOFREPRODUCTIVEAGE#OUNTRY SPECIlCDATAMAYBEAVAILABLE ONTHEWEBSITESDESCRIBEDINA ABOVE C -ULTIPLYA XB TOlNDTHETOTALNUMBEROFWOMENOFREPRODUCTIVEAGE D %NTERTHECONTRACEPTIVEPREVALENCERATESFORTRADITIONALMETHODSIE WITHDRAWALANDRHYTHM ASAPERCENTAGE #OUNTRYSPECIlCDATAMAYBEAVAILABLEONTHEWEBSITESDESCRIBEDINA ABOVE E %NTERTHECONTRACEPTIVEPREVALENCERATESFORMALECONDOMSASAPERCENTAGE #OUNTRY SPECIlCDATAMAYBEAVAILABLEONTHEWEBSITESDESCRIBEDINA ABOVE F %NTERTHECONTRACEPTIVEPREVALENCERATESFORORALCONTRACEPTIVEPILLSASAPERCENTAGE  #OUNTRY SPECIlCDATAMAYBEAVAILABLEONTHEWEBSITESDESCRIBEDINA ABOVE G !DDD E F FORTHETOTALCONTRACEPTIVEPREVALENCERATEOFTRADITIONALMETHODS CONDOMS ANDPILLS H -ULTIPLYC XG TOlNDTHETOTALNUMBEROFWOMENOFREPRODUCTIVEAGEUSINGTRADITIONAL METHODS CONDOMS ORPILLSASTHEIRCONTRACEPTIVEMETHOD I 4HEREISNONEEDTOENTERANYTHINGHERE4HEAVERAGENUMBEROFCOITALACTSPERYEARAROUND THEWORLDISESTIMATEDTOBE4HISISAlXEDNUMBER(OWEVER ITCANBESUBSTITUTEDWITHA NUMBERMOREREmECTIVEOFLOCALCONDITIONS IFLOCALDATAAREAVAILABLE J -ULTIPLYH XI FORTHETOTALNUMBEROFTHEORETICALLY02/4%#4%$COITALACTSPERYEARFOR TRADITIONALMETHODS CONDOMS ANDPILLS K 4HEREISNONEEDTOENTERANYTHINGHERE4HISISAlXEDRATEOFPERCENTBASEDON ESTIMATESOFOBSERVEDDEPARTUREFROMEFFECTIVEUSEOFCONTRACEPTIONTHEPERCENTAGEOFCOITAL ACTSTHATCONTRACEPTIVEUSERSWOULD+./7THEYDIDNOTACTUALLYUSETHEIRCONTRACEPTION EFFECTIVELY  L -ULTIPLYJ XK FORTHETOTALNUMBEROFCOITALACTSUSINGTRADITIONALMETHODS CONDOMS AND PILLSREQUIRINGPREGNANCYPREVENTIONPERYEAR

7OMEN./4USINGANYCONTRACEPTION M %NTERTHETOTALNUMBEROFSEXUALLYACTIVEWOMENOFREPRODUCTIVEAGE#OUNTRY SPECIlCDATA MAYBEAVAILABLEONTHEWEBSITESDESCRIBEDINA ABOVE

&  N %NTERTHERATEOFNONCONTRACEPTIVEUSE&INDTHISRATEBYSUBTRACTINGTHETOTALPERCENTOF CONTRACEPTIVEUSEFROMTOGETTHENONCONTRACEPTIVEUSERATE4HETOTALCONTRACEPTIVE USERATECANBEFOUNDATTHE0OPULATION2EFERENCE"UREAU THE5NITED.ATIONS7ORLD #ONTRACEPTIVE5SE ORTHE-EASURE$EMOGRAPHICAND(EALTH3URVEYSWEBSITES

-ODULE& DESCRIBEDINA ABOVE O -ULTIPLYM XN FORTHETOTALNUMBEROFWOMENNOTUSINGCONTRACEPTION P 4HEREISNONEEDTOENTERANYTHINGHERE4HEAVERAGENUMBEROFCOITALACTSPERYEARAROUND

4OOLS THEWORLDISESTIMATEDTOBE4HISISAlXEDNUMBER(OWEVER ITCANBESUBSTITUTEDWITHA NUMBERMOREREmECTIVEOFLOCALCONDITIONS IFLOCALDATAAREAVAILABLE Q -ULTIPLYO XP FORTHETOTALNUMBEROFTHEORETICALLY5.02/4%#4%$COITALACTSPERYEAR R 4HEREISNONEEDTOENTERANYTHINGHERE4HISNUMBERISBASEDONTHEESTIMATETHAT PERCENTOFMARRIEDWOMENINTHEDEVELOPINGWORLDWOULDPREFERTOAVOIDAPREGNANCYBUTARE NOTUSINGANYFORMOFCONTRACEPTION4HISISAlXEDNUMBER S -ULTIPLYQ XR FORTHETOTALNUMBEROFCOITALACTSREQUIRINGPREGNANCYPREVENTIONPERYEAR T !DDL S FORTHETOTALMAXIMUMDEMANDPERYEAR

5HDOLVWLFGHPDQGSHU\HDU U %NTERTHETOTALNUMBEROFCOITALACTSREQUIRINGPREGNANCYPREVENTIONPERYEAR4HISISTHETOTAL MAXIMUMDEMANDPERYEARFROMT ABOVE V %STIMATETHEPERCENTAGE OFWOMENWITHKNOWLEDGEOF%#0S+NOWLEDGE ATTITUDES AND PRACTICESSTUDIESABOUT%#0SPERFORMEDLOCALLYMAYPROVIDETHISINFORMATION W %STIMATETHEPERCENTAGE OFWOMENWHOLIVEINAREASWHERE%#0SAREORWILLBE ACCESSIBLE&OREXAMPLEIF%#0SAREONLYAVAILABLEINURBANAREAS USETHEPERCENTAGEOFTHE POPULATIONLIVINGINURBANSETTINGS X %STIMATETHEPERCENTAGE OFWOMENWITHTHEABILITYTOPAYFOR%#0S4HISESTIMATEMAY DEPENDONWHETHER%#0SAREAVAILABLEATASUBSIDIZEDPRICE Y -ULTIPLYV XW XX FORTHETOTALPERCENTAGE OFWOMENWHOMAYSEEK%#0S Z -ULTIPLYU XY FORTHETOTALNUMBEROFCOITALACTSFORWHICHWOMENMAYSEEK%#0S4HISIS THEREALISTICDEMANDPERYEAR

#ONTENTANDFORMATFORTHISTOOLWEREADAPTEDFROMAFORECASTINGMODELDEVELOPEDBY!LTA#ARE0!4(GREATLY APPRECIATESCONTRIBUTIONSMADETOTHEMODELBYTHE$ELIVER0ROJECTAT*OHN3NOW )NCAND0OPULATION3ERVICES )NTERNATIONAL

&  4OOLS

)NFORMATIONTO)NCLUDEINA,EVONORGESTREL /NLY -ODULE& %#00ACKAGE)NSERT

%SSENTIALINFORMATIONFORCLIENTS s "RIEFINSTRUCTIONS ¥ %#0SAREMEDICINETOPREVENTPREGNANCYAFTERUNPROTECTEDSEXUALINTERCOURSE5SE%#0S IFYOUDONOTWANTTOBECOMEPREGNANT IFYOUTHINKYOURCONTRACEPTIVEMETHODFAILED OR IFYOUWERERAPED ¥ 4AKEASINGLEDOSEOFMGLEVONORGESTRELASSOONASPOSSIBLEWITHINHOURSAFTER UNPROTECTEDSEX%#0SAREMOREEFFECTIVETHESOONERTHEYARETAKEN ¥ %#0SCANBEUSEDANYTIMEINTHEMENSTRUALCYCLE s "RIEFINFORMATIONABOUTSIDEEFFECTS ¥ -OSTWOMENDONOTFEELANYTHINGAFTERTAKING%#0S3OMEWOMENHAVESOREBREASTSAND HEADACHES3OMEWOMENHAVETHEIRPERIODALITTLELATERORALITTLEEARLIERTHANUSUAL3OME WOMENFEELSICKTOTHEIRSTOMACH ANDSOMEWOMENEVENVOMITAFTERTAKING%#0S ¥ )FYOUVOMITWITHINHOURAFTERTAKING%#0SITMAYMEANYOUHAVEVOMITEDUPTHE %#0S YOUSHOULDTRYTOTAKEANOTHERDOSEIMMEDIATELY ¥ )FYOUVOMITMORETHANONEHOURAFTERTAKING%#0S YOUDONOTNEEDTOTAKEEXTRAPILLS ¥ 4HESE%#0SIDEEFFECTSMAYBEUNCOMFORTABLE BUTTHEYARENOTHARMFULANDUSUALLYLAST FORONLYONEDAYORLESS ¥ )TISNORMALFORYOURNEXTPERIODTOBEGINAFEWDAYSEARLIERORLATERTHANEXPECTED s 3EXUALLYTRANSMITTEDINFECTIONS34)S %#0SDONOTPROTECT34)SOR()6)FYOUTHINKYOU MAYHAVECONTRACTEDAN34)OR()6 VISITYOURHEALTHOR34)CLINIC

/PTIONALADDITIONALINFORMATION s %#0SDONOTWORKIFYOUAREALREADYPREGNANT s %#0SAREEFFECTIVECONTRACEPTION BUTTHEYDONOTWORKEVERYTIME)FYOURPERIODDOESNOT STARTWITHINWEEKSAFTERTAKING%#0S YOUMAYBEPREGNANT(AVEAPREGNANCYTESTTOKNOW FORSURE s !SSOONASPOSSIBLE BEGINUSINGABIRTHCONTROLMETHODYOUWILLBEABLETOUSEONANONGOING BASIS%#0SAREINTENDEDFOREMERGENCYPROTECTION4HEYARENOTASEFFECTIVEASOTHERFORMS OFBIRTHCONTROL s !FTERUSING%#0S  5SEABARRIERMETHOD LIKEACONDOM EACHTIMEYOUHAVESEXUNTILYOUBEGINYOURNEXT MENSTRUALPERIOD!FTERTHATTIMEYOUMAYCONTINUEUSINGYOURBIRTHCONTROLMETHODOR BEGINANEWONE

&  /R  )FYOUWEREUSINGORALCONTRACEPTIVESPILLS YOUSHOULDCONTINUETAKINGTHETABLETSSTARTING ONTHEDAYAFTERYOUTOOKTHE%#0SUNTILTHEENDOFTHECYCLE9OUSHOULDTHENUSEA CONDOMOROTHERBARRIERCONTRACEPTIVEMETHODFORATLEASTSEVENDAYSAFTERRESTARTINGORAL -ODULE& CONTRACEPTIVEPILLS 4OOLS

4HISMATERIALWASDEVELOPEDBY0!4(

&  4OOLS

3AMPLE0ROCUREMENT3PECIlCATION -ODULE& ,EVONORGESTREL /NLY%#0S 4HEFOLLOWINGSAMPLEFORMATCANBEUSEDINDEVELOPINGPROCUREMENTSPECIlCATIONSFOR EMERGENCYCONTRACEPTIVES)NDEVELOPINGAPROCUREMENTSPECIlCATIONITISIMPORTANTTO THOROUGHLYREVIEWNATIONALREGULATORYANDREGISTRATIONREQUIREMENTSFORTHEPRODUCTTOENSURE THATAPPROPRIATEPRODUCTREQUIREMENTSAREINCORPORATEDINTOTHESPECIlCATION)NTHISSAMPLE EXAMPLESOFPRODUCTSPECIlCATIONSAREINITALICSWHENPREPARINGAPROCUREMENTSPECIlCATION APPROPRIATEPRODUCTSPECIlCATIONSCANBESUBSTITUTEDFORTHEITALICIZEDEXAMPLES4HESAMPLE PROCUREMENTSPECIlCATIONISDESIGNEDTOBEUSEDINCONJUNCTIONWITHBIDDINGANDCONTRACT DOCUMENTS

.OTESFORSUBMISSIONOFSAMPLEOFPRODUCT  4HESAMPLEEMERGENCYCONTRACEPTIVESPILLSSUBMITTEDBYTHEBIDDERINRESPONSETOTHIS SOLICITATIONMUSTBEEXACTLYTHESAMEASWOULDBESUPPLIEDIFACONTRACTWEREAWARDEDTOTHE BIDDER)NOTHERWORDS SAMPLESSHOULDHAVESAMETABLETSHAPE COLOR WEIGHT INGREDIENTS ANDIDENTIlCATIONIMPRINTSAMEBLISTERPACKSIZE MATERIAL TEXT ANDIDENTIlCATIONMARKINGS SAMEINNERBOXSIZE MATERIAL TEXT ANDIDENTIlCATIONMARKINGS

 2EQUIREMENTS

%MERGENCY#ONTRACEPTIVE4ABLETSIN!CCORDANCEWITHTHE&OLLOWING3PECIlCATIONS

4WO TABLETPACKAGECONSISTINGOFTWOEMERGENCYCONTRACEPTIVELEVONORGESTREL ONLYTABLETS %ACHTABLETSHALLCONTAINMILLIGRAMSOFLEVONORGESTREL

0RODUCTAND"RAND.AMES 0RODUCT.AME????????????????????? "RAND.AMES??????????????????????

2AW-ATERIALS

%MERGENCYCONTRACEPTIVESOFFEREDUNDERTHISPURCHASEDESCRIPTIONSHALLBEPRODUCEDFROM VALIDATEDRAWMATERIALSOBTAINEDFROMALICENSEDMANUFACTURERORITSAUTHORIZEDDISTRIBUTOR! TYPICALVALIDATIONINCLUDES BUTISNOTLIMITEDTO THESEAREAS

s -ANUFACTURINGRECORDSANDPROCEDURESFORTHERAWMATERIALSYNTHESIS PROCESSING PACKING ANDSTORAGE s 1UALITYCONTROLRECORDSANDPROCEDURESFORTHERAWMATERIAL IN PROCESS ANDlNALPRODUCT s 0LANTCERTIlCATIONBYLOCALREGULATORYAUTHORITIESSUCHAS#OMMERCE )NDUSTRY (EALTH %NVIRONMENT ASREQUIRED

%HFDXVHWKHUDZPDWHULDOVWKDWPDNHXSERWKDFWLYHDQGLQDFWLYHLQJUHGLHQWVDUHRIJUHDWLPSRUWDQFHIRU¿QDO SURGXFWELRDYDLODELOLW\DQGVWDELOLW\JRRGPDQXIDFWXULQJSUDFWLFHVUHTXLUHWKDWPDQXIDFWXUHUVYDOLGDWHYHQGRUV IRUDOOUDZPDWHULDOV

&  x #ERTIlCATIONOFWORKERSTRAININGINGOODMANUFACTURINGPRACTICESANDSAFETYPROTECTION x 2ECORDSDEMONSTRATINGRAWMATERIALSWITHTHEREQUIREDPHYSICALANDCHEMICALCHARACTERISTICS

2EGISTRATION2EQUIREMENTS -ODULE& %MERGENCYCONTRACEPTIVESOFFEREDUNDERTHISPURCHASEDESCRIPTIONSHALLBECURRENTLY REGISTEREDINTHECOUNTRYOFDESTINATIONANDAPPROVEDBY????????????????LOCALREGULATORY AUTHORITY  4OOLS #ERTIlCATEOF,ICENSING3TATUS

%MERGENCYCONTRACEPTIVESOFFEREDUNDERTHISPURCHASEDESCRIPTIONSHALLBELICENSEDFOR MARKETINGBYTHEDRUGREGULATORYAUTHORITYOFTHECOUNTRYOFORIGIN0RIORTOAWARDOFTHE #ONTRACT THESUCCESSFULOFFERORS MAYBEREQUIREDTOSUBMITAhSTATEMENTOFLICENSINGSTATUS OFPHARMACEUTICALPRODUCTS vASPROVIDEDUNDERTHE7ORLD(EALTH/RGANIZATION7(/ #ERTIlCATION3CHEME

.O/BJECTION#ERTIlCATE

)NTHECASEOFGOODSOFFOREIGNORIGIN EMERGENCYCONTRACEPTIVESOFFEREDUNDERTHISPURCHASE DESCRIPTIONSHALLHAVEBEENAWARDEDA.O/BJECTION#ERTIlCATEBY?????????LOCAL REGULATORYAUTHORITY ONBEHALFOFANYLOCALMANUFACTURERS OFTHEIMPORTINGCOUNTRY

#OMPLIANCEWITH'OOD-ANUFACTURING0RACTICES

4HE3UPPLIERMUSTBEABLETOPROVIDECERTIlCATIONTHATTHEEMERGENCYCONTRACEPTIVESARE MANUFACTUREDACCORDINGTO7(/GOODMANUFACTURINGPRACTICES'-0 3UCHCERTIlCATION CANBEFOUNDINTHE7(/#ERTIlCATION3CHEMEh#ERTIlCATEOFA0HARMACEUTICAL0RODUCTv 3UPPLIERALSOMUSTBEABLETOPROVIDECOPIESOFITSANNUAL'-0AUDITREPORTS

7(/#ERTIlCATIONˆ-OVEMENTIN)NTERNATIONAL#OMMERCE

4HE3UPPLIERMUSTBEABLETOPROVIDEDOCUMENTATIONINDICATINGMANUFACTUREROFTHEPRODUCT HASRECEIVEDCONlRMATIONFROMTHE-INISTRYOF(EALTHOFTHECOUNTRYOFMANUFACTURETHATTHE PHARMACEUTICALMEETSTHEREQUIREMENTSINTHE7(/#ERTIlCATION3CHEME

3HAPEAND$IMENSIONS

4ABLETSSHALLBEOFTHESHAPEANDDIMENSIONSOFTHE"IDDERSNORMAL STANDARDCOMMERCIAL TABLET

#OLORS

%MERGENCYCONTRACEPTIVETABLETSSHALLBESIMILARTO"IDDERSNORMAL STANDARDCOMMERCIAL TABLETS

:+2&HUWL¿FDWLRQ6FKHPHIRUWKH4XDOLW\RI3KDUPDFHXWLFDO3URGXFWV0RYLQJLQ,QWHUQDWLRQDO&RPPHUFH)RU DGGLWLRQDOLQIRUPDWLRQVHHZZZZKRLQWPHGLFLQHVOLEUDU\TVPZKRHGPTVPFHUWLIVFKHPHVKWPO

&  4OOLS

4ABLET-ARKING -ODULE& %ACHTABLETSHALLBEARTHEIDENTIFYINGIMPRINTOFITSMANUFACTURERIFSUCHIMPRINTISPROVIDED ONTHE"IDDERSNORMAL STANDARDCOMMERCIALTABLET

0ACKAGING

0RESENTATION %ACHINDIVIDUALTABLETSHALLBEENCLOSEDINATRANSPARENTBLISTERPACKOFTHERMOFORMED POLYMERWITHAFOILBACKING4HESUPPLIERSHALLBEABLETOPROVIDETOTHESATISFACTIONOFTHE REGISTRATIONNATIONALQUALITYCONTROLAUTHORITIESTHEMANUFACTURERSSTABILITYTESTDATATO VALIDATETHEPRODUCTSSTATEDSHELFLIFEATAMBIENTTEMPERATUREDEGREES#ORABOVEAND RELATIVEHUMIDITYOFPERCENT6ARIATIONSMUSTBEPROVENSCIENTIlCALLYCOMPARABLEBY MEANSOFSTABILITYDATA 4HESIZEOFTHEPACKAGESHALLNOTBELESSTHANMMINCHES XMMINCHES  4HICKERPOLYMERORFOILORTHEADDITIONOFACARDTOEITHERTHEFRONTORBACKOFTHEPACKAGE INADDITIONTOTHEMINIMUMPOLYMERORFOIL ISACCEPTABLE

-OUNTING 4ABLETSSHALLBEMOUNTEDTWO TABLETSPERPACKAGE

)DENTIlCATION-ARKINGSON)NDIVIDUAL"LISTER0ACKS

%ACHINDIVIDUALBLISTERPACKSHALLHAVETHEFOLLOWINGINFORMATION s 0RODUCTBRANDNAME s ,OTBATCHNUMBER s %XPIRATIONDATEMONTHANDYEAR s $ATEOFMANUFACTURE s -ANUFACTURERSNAMEORSYMBOL s #ONTENTSANDQUANTITY s 0RODUCTUSEANDSTORAGEINSTRUCTIONSACCOMPANYINGTHEBLISTERPACK

0RINTINGANDLAYOUT /NTHEBACKOFEACHBLISTERPACKAGETHETRADEORBRANDNAMEOFTHEPRODUCTSHALLBE PRINTEDINPRECISIONFULLREGISTRATION 4HEMONTHANDYEAROFEXPIRATION ANDTHELOTBATCHCONTROLNUMBERSHALLBESHOWNON EACHINDIVIDUALBLISTERPACK$EBOSSINGISACCEPTABLEFORTHESENUMBERS 4HETABLETFORMULATIONANDORTHEINTERNATIONALNONPROPRIETARYNAMESHALLBEPRINTEDON THEINDIVIDUALPACKETANDMAYBEPRINTEDONTHEREVERSESIDESMALLESTTYPENOLESSTHAN ONEMMHIGH 

&  7ORKMANSHIP

0RODUCTSANDPACKAGINGSHALLBEFREEOFDEFECTSTHATIMPAIRTHEIRSERVICEABILITY AFFECTTHEIR DURABILITY ORDETRACTFROMTHEIRAPPEARANCE -ODULE& ,OTS0ER/RDER

4HE3UPPLIERSHALLlLLTHEORDERUSINGTHEFEWESTNUMBEROFMANUFACTURINGLOTSPOSSIBLE

4OOLS 3HELF,IFE

4HESHELFLIFEOFTHEPRODUCTPROVIDEDUNDERTHISSOLICITATIONSHALLBE???? YEARSFROM THEDATEOFMANUFACTUREWHENSTOREDUNDERTROPICALCONDITIONSSUCHASTHOSEPREVAILING IN????????????RECIPIENTCOUNTRYNAME 4HE3UPPLIERSHALLBEABLETOPROVIDETOTHE SATISFACTIONOFREGISTRATIONNATIONALQUALITYCONTROLAUTHORITIESMANUFACTURERSSTABILITYTEST DATASUBSTANTIATINGTHIS???YEARSHELFLIFEATAMBIENTTEMPERATURESDEGREES#ORABOVEAND RELATIVEHUMIDITYOFPERCENTINTHEPROPOSEDBLISTERPACKAGE !TTHETIMEOFINSPECTIONORACCEPTANCEFORDELIVERYTOTHECOUNTRYOFDESTINATION NOMORE THAN????? MONTHSSHALLHAVEEXPIREDSINCETHEDATEOFMANUFACTURESHOWNONTHEBATCH RELEASEOR#ERTIlCATEOF!NALYSIS

4EST$ATA

#HEMICALANDPHYSICALTESTDATAFORRAWMATERIALS COMPONENTS IN PROCESS ANDlNISHED PRODUCTTESTINGMUSTBEONRECORDFOREACHLOTSHIPPEDANDMUSTBEAVAILABLETO0URCHASERS REPRESENTATIVESWHENREQUESTED

1UALITY!SSURANCE0ROVISIONS

#OMPLIANCE

4HE3UPPLIERSHALLGUARANTEETHATTHEPRODUCTSASPACKEDFORSHIPMENTCOMPLYWITHALL PROVISIONSOFTHESPECIlCATIONANDRELATEDDOCUMENTS

$OCUMENTATION

 4HE3UPPLIERSHALLPROVIDEEVIDENCEOFTHESATISFACTIONOFTHETECHNICALSPECIlCATION REQUIREMENTSFORWHICHSPECIlCINSPECTIONINSTRUCTIONSORPROTOCOLSHAVENOTBEEN PROVIDED3UCHEVIDENCEISCONTAINEDINTHEh-ANUFACTURERS"ATCH#ERTIlCATEvUNDERTHE 7(/#ERTIlCATION3CHEME

,QFOXGLQJTXDOLW\FRQWURODQGPDQXIDFWXULQJUHFRUGVLQSURFHVVFRQWUROUHFRUGVDQG¿QDOSURGXFWFHUWL¿FDWHRIDQDO\VLV

&  4OOLS



4HE3UPPLIERSHALLPROVIDEACOPYOFTHEMANUFACTURINGRECORDANDPROCEDURESTOTHE -ODULE& 0URCHASERFOREACHLOTINTENDEDFORSHIPMENT

 4HE3UPPLIERSHALLPROVIDEACOPYOFTHE#ERTIlCATEOF!NALYSISTOTHE0URCHASERFOREACH LOTINTENDEDFORSHIPMENT

 4HE3UPPLIERSHALLPROVIDETOTHE0URCHASERACOPYOFTHEAPPROVALOFEACHCOMPONENTFOR EACHLOTINTENDEDFORSHIPMENT

)NSPECTIONBYTHE0URCHASER

4HE0URCHASERRESERVESTHERIGHTTOPERFORMORCAUSETOBEPERFORMEDANYOFTHEINSPECTIONS ANDTESTSSETFORTHINTHE3PECIlCATIONAND3PECIAL#ONDITIONSOF#ONTRACTTOENSURETHAT THEGOODSCONFORMTOPRESCRIBEDREQUIREMENTS4HE0URCHASERRESERVESTHERIGHT AND ORMAYASSIGNTHERIGHTTOAREPRESENTATIVE TOENTERANDINSPECTTHEPRODUCTIONFACILITY PRIORTOSHIPMENTOFTHEGOODSANDTODRAWSAMPLESFROMTHE3UPPLIERSFACTORYANDOR WAREHOUSE%XCEPTASOTHERWISESPECIlEDINTHECONTRACTORPURCHASEORDER PRIORTOSHIPMENT THE0URCHASERWILLSAMPLEORCAUSETOBESAMPLEDTHEPRODUCTASPACKEDININNERBOXES PREPARATORYTOPACKINGINEXTERIORSHIPPINGCARTONS4HESAMPLINGSHALLBEACCORDINGTO RECOGNIZEDSTANDARDS 4HE0URCHASERMAYHAVESOMEORALLOFTHETESTSSPECIlEDIN3ECTION??????????OFTHE CONTRACTPERFORMEDBYALABORATORYSUITABLYEQUIPPEDANDQUALIlEDTOCONDUCTQUALITY ASSURANCETESTSONPHARMACEUTICALPRODUCTSACCORDINGTO????????????0HARMACOPOEIA

3AMPLING0ROCEDURES

4HE0URCHASERORTHE0URCHASERSREPRESENTATIVESHALLSELECTTHEREQUIREDSAMPLESFROMTHELOT ACCORDINGTO3ECTION????OFTHE3PECIAL#ONDITIONSOF#ONTRACT)FTHEORDERISTOBElLLED USINGMORETHANONEPRODUCTIONLOT EACHPRODUCTIONLOTSHALLBESEPARATELYSAMPLEDAND TESTED 7HEREANINSPECTIONLOTISSMALLERTHAN UNITS ITWILLBEDEEMEDTOBE FOR DETERMINATIONOFSAMPLESIZES 4HENORMAL TIGHTENED ANDREDUCEDINSPECTIONPROVISIONSOF)3/)NSPECTIONBY !TTRIBUTES MAYBEUSEDFORVISUALINSPECTION3AMPLINGFORANALYTICALTESTINGSHALLBEDONEIN ACCORDANCEWITHPHARMACOPOEIALREQUIREMENTS !LLSAMPLEDBOXESANDSHIPPINGCARTONSSHALLBESOMARKEDANDSHALLINCLUDETHEDATEAND INITIALSOFSAMPLER

)NSOMECASES 3PECIAL#ONDITIONSOF#ONTRACTAREADDEDTOTHEGOVERNINGCONTRACT4HESETERMSACCOMMODATEANYSPECIALNEEDSNOT OTHERWISECOVERED SUCHASREQUIREMENTSTOREMEDYNON CONFORMINGPRODUCT TIMELIMITATIONSONINSPECTIONS ORTHEUSEOFSPECIlC INSPECTIONAGENCIES $EPENDINGONTHETESTSREQUIRED SAMPLINGMAYBECONDUCTEDACCORDINGTOTHESTANDARDSOFTHE)NTERNATIONAL/RGANIZATIONFOR 3TANDARDIZATION)3/)NSPECTIONBY!TTRIBUTES ORASDICTATEDBYLOCALORINTERNATIONALPHARMACOPOEIAE&OLLOWINGRECOGNIZED SAMPLINGPROCEDURESHELPSTOENSURETHATTHEPRODUCTSTESTEDAREREPRESENTATIVEOFTHEWHOLE&ORINFORMATIONONOBTAINING)3/ )NSPECTIONBY!TTIBUTES SEEZZZLVRFKLVRHQ&DWDORJXH'HWDLO3DJH &  3AMPLE2ETENTION

4HE3UPPLIERSHALLRETAINASAMPLEOFTENBLISTERPACKAGES ORTHEEQUIVALENTREQUIREDTO PERFORMTHREECOMPLETECHEMICALASSAYS FROMEACHLOTSHIPPED FORAPERIODOFONEYEARAFTER

-ODULE& THEPRINTEDEXPIRATIONDATE

 0ACKING

)NNER"OXES 4OOLS  0RODUCTSSEALEDININDIVIDUALPACKAGESASSPECIlEDIN3ECTIONSHALLBEPACKED ININNERBOXESOF????? PACKAGESPERINNERBOX)NNERBOXESSHALLBEMADEOFLIGHT lBERBOARDWHITE OFASIZESUFlCIENTTOCONTAINTHESPECIlEDNUMBEROFPACKAGES 4HEOVERALLDIMENSIONSSHOULDBESUCHTHATTHEPRODUCTDOESNOTGETDAMAGEDDURING TRANSPORTATIONANDSTORAGE

 &ORINNERBOXES THE"IDDERSHALLlLLINTHEBLANKSPROVIDEDBELOW 4HEPRODUCTSINEACHINNERBOXWILLBE????? INDIVIDUALPACKAGESTHEOVERALL DIMENSIONOFABOXWILLBE???CMX???CMX???CM

%XTERIOR3HIPPING#ARTONS

 0RODUCTANDPRINTEDMATERIALS PACKAGEDANDPACKEDASSPECIlEDABOVE SHALLBE CONTAINEDINEXTERIORSHIPPINGCARTONSOFSTRONG EXPORTQUALITYMATERIALABLETOWITHSTAND ROUGHHANDLINGANDTHEPREVAILINGCLIMATICCONDITIONSDURINGTRANSPORTANDSTORAGE

 4HE"IDDERSHALLlLLINTHEFOLLOWINGBLANKS 4HEEXTERIORSHIPPINGCARTONWILLCONTAIN????INNERBOXESTHEOVERALLDIMENSIONSOFA CARTONWILLBE?CM X??CMX??CMANDTHEGROSSWEIGHTOFONESHIPPINGCARTONWILLBE ???KG !STANDARDFOOTMETER CONTAINERWILLACCOMMODATE??????EXTERIORSHIPPING CARTONS

 -ARKINGS

)NNER"OXES

4HEINNERBOXESSHALLBEMARKEDWITHTHEFOLLOWINGINFORMATIONINACLEARLYLEGIBLEMANNER THATISACCEPTABLETOTHE0URCHASER

7KHVPDOOHVWW\SHVKDOOEHQROHVVWKDQPPKLJKXQOHVVRWKHUZLVHVSHFL¿HGE\WKHFRPPHUFLDOODZVRIWKHFRXQWU\LI LPSRUWDWLRQ

&  4OOLS

s 3URGXFWEUDQGQDPH

s /RWEDWFKQXPEHU -ODULE& s ([SLUDWLRQGDWH PRQWKDQG\HDU s 'DWHRIPDQXIDFWXUH s 0DQXIDFWXUHU¶VQDPHDGGUHVV s &RQWHQWVDQGTXDQWLW\ s 'UXJUHJLVWUDWLRQQXPEHUV LIDSSOLFDEOH s ,QVWUXFWLRQVIRUVWRUDJHDQGKDQGOLQJ

%XTERIOR3HIPPING#ARTONS

4HEFOLLOWINGINFORMATIONSHALLBESTENCILEDORLABELEDONTHEEXTERIORSHIPPINGCARTONSON TWOOPPOSINGSIDESINBOLDLETTERSATLEAST??MMHIGHWITHWATERPROOFINKINACLEARLYLEGIBLE MANNERTHATISACCEPTABLETOTHE0URCHASER 2EGULATORY)NFORMATIONONTWOOPPOSINGSIDESOFCARTON s 3URGXFWEUDQGQDPH s /RWEDWFKQXPEHU s ([SLUDWLRQGDWH PRQWKDQG\HDU s 'DWHRIPDQXIDFWXUH s 0DQXIDFWXUHU¶VQDPHDGGUHVV s &RQWHQWVDQGTXDQWLW\ s 'UXJUHJLVWUDWLRQQXPEHUV LIDSSOLFDEOH s ,QVWUXFWLRQVDQGV\PEROV VHHEHORZ IRUVWRUDJHDQGKDQGOLQJ s 1RWLFHRIQHHGWRSURWHFWIURPH[SRVXUHWRZDWHUDQGH[WUHPHKHDWRUH[WUHPHFROG #USTOMS3HIPPING)NFORMATIONONTWOOPPOSINGSIDESOFCARTON s 0DGHLQBBBBBBBBBBBBBBBBBBB s 6XSSOLHU¶VQDPHDQGDGGUHVV LIGLIIHUHQWIURPPDQXIDFWXUHU s &RQVLJQHH¶VDGGUHVVLQIXOO s *URVVZHLJKWRIHDFKFDUWRQ LQNJ s 3RUWRIHQWU\ s &RQWUDFWQXPEHU s 4XDQWLW\RIJRRGV s &DUWRQBBBRIBBB

7KHVPDOOHVWW\SHVKDOOEHQROHVVWKDQWHQPPKLJKXQOHVVRWKHUZLVHVSHFL¿HGE\WKHFRPPHUFLDOODZVRIWKHFRXQWU\ RILPSRUWDWLRQ

&   0RINTED-ATERIALSˆ0RODUCT)NFORMATION3HEETS

#ONSUMERINFORMATIONANDDIRECTIONSFORUSESHALLBEPRINTEDIN%NGLISHANDORIN???? ???ANDPROVIDEDASPACKAGEINSERTS ONECOPYFOREACHCONSUMERUNIT -ODULE& )NFORMATIONFOR0HYSICIANS5SESHALLBEPRINTEDIN%NGLISHANDORIN???????4WO COPIESOFSUCHINFORMATIONSHALLBEPROVIDEDFOREACHBLISTERPACKAGESANDSHALLBE PLACEDINEACHEXTERIORSHIPPINGCARTON 4OOLS

4HISMATERIALWASDEVELOPEDBY0!4(

&  4OOLS

0REFERENTIAL0RICINGFOR0UBLIC 3ECTOR!GENCIES -ODULE& )NCONSIDERATIONOFTHENEEDANDTHEPUBLICGOOD MANUFACTURERSMAYDECIDETOOFFERA PREFERENTIALPRICETOPUBLIC SECTORORNONPROlTPROGRAMS 'EDEON2ICHTER,TD0OSTINOR  AND,ABORATOIRE(2!0HARMA.ORLEVO THETWO MAJORINTERNATIONALPHARMACEUTICALCOMPANIESTHATCURRENTLYMANUFACTUREANDDISTRIBUTE LEVONORGESTREL ONLYPRODUCTSPACKAGEDANDLABELEDSPECIlCALLYFOREMERGENCYCONTRACEPTION HAVEBOTHINDICATEDAWILLINGNESSTOPROVIDETHEIRPRODUCTTOQUALIlEDGOVERNMENTAL ORGANIZATIONSANDPUBLIC SECTORAGENCIESATPREFERENTIALPRICES2EQUESTSFORPREFERENTIAL PUBLIC SECTORPRICINGSHOULDBEISSUEDDIRECTLYTOTHECOMPANIESATTHEFOLLOWINGADDRESSES *HGHRQ5LFKWHU/WG %XGDSHVW *\RPURLX +XQJDU\ $WWHQWLRQ 0V$JQHV+D]VOLQV]N\$UHD0DQDJHU,QWHUQDWLRQDO'RVDJH)RUP3URGXFWV DKD]VOLQV]N\#UL FKWHUKX 7HO)D[ $OWD&DUHRQEHKDOIRI/DERUDWRLUH+5$3KDUPD UXH)UHGHULFN/HPDLWUH 3DULV)UDQFH $WWHQWLRQ 0U6DDG+DUWL0DQDJLQJ'LUHFWRU VDDGKDUWL#DOWDFDUHIU 0UV6RSKLH*RGHIUR\%UDQG0DQDJHU JRGHIUR\#DOWDFDUHIU 7HO)D[ 4HECOMPANIESMAYREQUESTINFORMATIONTHATCONlRMSTHEORGANIZATIONISABONAlDE GOVERNMENTALORGANIZATIONORPUBLIC SECTORAGENCY4HEYMAYREQUESTINFORMATIONONTHE PLANSFORSUCCESSFULLYINTRODUCINGEMERGENCYCONTRACEPTIONINTOTHEEXISTINGFAMILYPLANNING REPRODUCTIVEHEALTHPROGRAM/THERINFORMATIONTHATTHECOMPANIESMAYREQUESTINCLUDES

x 1UANTITYOF%#0DOSAGESREQUIRED x $ELIVERYDATEFORSHIPMENT x 3HIPPINGINSTRUCTIONSANDSHIPPINGDOCUMENTREQUIREMENTS x )NSPECTIONORTESTINGREQUIREMENTS x 2EGISTRATION LICENSING ANDQUALITYASSURANCEDOCUMENTATIONREQUIREDTOREGISTERANDIMPORT PRODUCT x .AMEANDCONTACTINFORMATIONFORFOLLOW UPQUESTIONS 3INCEPROCUREMENTPERSONNELARETRADITIONALLYRESPONSIBLEFORCONTACTINGMANUFACTURERSAND SUPPLIERSTOREQUESTPRICINGANDDETAILEDPRODUCTINFORMATION PROGRAMPLANNERSSHOULDWORK CLOSELYWITHTHEIRPROCUREMENTSTAFFTOPROVIDETHEINFORMATIONTHATTHEMANUFACTURERSMAY REQUEST

&  -ODULE& 4OOLS

&  4OOLS

0ROCUREMENT4HROUGH)NTERNATIONAL -ODULE& 0ROCUREMENT3ERVICES !NORGANIZATIONWOULDWANTTOUSETHESERVICESOFAREPUTABLEINTERNATIONALPROCUREMENT AGENCYTOOBTAINLEVONORGESTREL ONLYEMERGENCYCONTRACEPTIVEPILLSIFTHEORGANIZATIONHAS LIMITEDPROCUREMENTCAPACITYORTHEVALUEOFANORDERISSMALL4WOINTERNATIONALAGENCIES WITHEXPERIENCEINPROCURINGANDPROVIDINGLEVONORGESTREL ONLY%#0SARE5.&0!AND)00& WHICHHAVEPROVIDEDTHEGENERALORDERINGANDCONTACTINFORMATIONBELOW

5.&0! 5.&0!HASCONSIDERABLEEXPERIENCEINTHEINTERNATIONALPROCUREMENTANDSHIPMENTOF DEDICATED%#0SANDITSPROCUREMENTSERVICESAREAVAILABLETOGOVERNMENTMINISTRIES MULTILATERALANDBILATERALAGENCIES AND.'/S'ENERALORDERINGREQUIREMENTSFOR5.&0! PROCUREMENTSERVICESAREASFOLLOWS &ORORDERSOF PACKSORMOREOFLEVONORGESTREL ONLY%#0 DELIVERYTIMEISANAVERAGEOF TWOTOTHREEMONTHSAFTERTHEPURCHASEORDERISISSUED 5.0&!ISCURRENTLYABLETOlLLORDERSOFFEWERTHAN PACKS4HEDELIVERYTIMEFORSMALL ORDERSISAPERIODOFSEVERALDAYS 5.&0!PAYMENTTERMSARENETDAYSANDTHEREISASERVICEFEECHARGEOFPERCENTOFTHE COSTOFINSURANCEANDFREIGHTVALUEOFTHEGOODSTOCOVER5.&0!EXPENSESTOPROCESSTHE ORDER 2EQUESTSFOR5.&0!PROCUREMENTSERVICESANDGENERALINQUIRIESSHOULDBEISSUEDDIRECTLYTO 5.&0!ATTHEFOLLOWINGADDRESS 0V1DQD(VVDK6U3URFXUHPHQW2I¿FHU 3URFXUHPHQW6HUYLFHV6HFWLRQ 8QLWHG1DWLRQV3RSXODWLRQ)XQG 81)3$ (DVWQG6WUHHW 1HZ

&ORPLANNINGPURPOSES THEAPPROXIMATEORDERVALUEOF PACKSIS53 ATACURRENTPRICEOF53PERPACKOFTWO TABLETS4HEGROSSWEIGHTOFASHIPMENTOF PACKSOF0OSTINORISAPPROXIMATELYKILOGRAMS

&  )NTERNATIONAL0LANNED0ARENTHOOD&EDERATION)00& )00& WORKINGTHROUGHASUBSIDIARY %.%4 PROVIDESINTERNATIONALPROCUREMENTANDSHIPMENT OFDEDICATEDLEVONORGESTREL ONLY%#0STOITSMEMBERASSOCIATIONSANDTHIRD PARTYCUSTOMERS -ODULE& /RGANIZATIONSPLACINGORDERSTHROUGH)00&MUSTGUARANTEETHATTHEIRLEVONORGESTREL ONLY %#0PRODUCTSEXAMPLESOFWHICHARE0OSTINOR AND.ORLEVO WILLBEEXCLUSIVELYDISTRIBUTED THROUGHFAMILYPLANNINGCLINICSANDYOUTHCENTERS WHERETHEENDUSERSWILLRECEIVETHE %#0SEITHERFREEOFCHARGEORFORAMINIMALFEETOCOVERCOSTS-EMBERASSOCIATIONSANDTHIRD 4OOLS PARTYCUSTOMERSWHOCANCOMPLYWITHTHISREQUIREMENTMUSTSUBMITANOFlCIALLETTERTO)00& CONlRMINGTHATTHEPRODUCTWILLBEDISTRIBUTEDTHROUGHTHEPUBLICSECTORORAN.'/4HE LETTERSHOULDALSOIDENTIFYTHEANNUALQUANTITYOF%#0SREQUIRED7ITHINTWOWEEKSOFRECEIPT OFTHEABOVELETTER )00&WILLSTUDYTHEPOSSIBILITIESOFSUPPLYINGWITHINTHATCOUNTRYANDA DECISIONWILLBETAKEN)00&SABILITYTOSUPPLYTHEPRODUCTISCONDITIONEDBYSEVERALFACTORS INCLUDINGWHETHERORNOTTHEPRODUCTISREGISTEREDINACOUNTRYAND)00&SAGREEMENTWITH %#0MANUFACTURERS)00&WILLNOTIFYTHEREQUESTINGPARTYOFITSABILITYTOSUPPLYPRODUCT INCLUDINGINFORMATIONONANYCONDITIONSOFPROVISIONTHATWOULDBEREQUIRED &ORTHOSEREQUESTSFOR%#0THATHAVEBEENAPPROVED )00&CURRENTLYHASAMINIMUMORDER QUANTITYREQUIREMENTOF PACKSOFLEVONORGESTREL ONLY%#0S4HEAPPROXIMATEPRICE FOR%#0RANGESFROM53TO53 DEPENDINGUPONTHEMANUFACTURERSUPPLYINGTHE PRODUCT4HETIMEREQUIREDTOPROCESSANORDERFOR%#0SISAPPROXIMATELYTOMONTHSAFTER THEPURCHASEORDERHASBEENRECEIVEDBY)00&)00&PAYMENTTERMSAREDAYSANDTHEREIS ASERVICEFEECHARGEOFOFTHE#)&COSTOFINSURANCEANDFREIGHT VALUEOFTHEGOODSTO COVER)00&EXPENSESTOPROCESSTHEORDER 2EQUESTSFOR)00&PROCUREMENTSERVICESSHOULDBEISSUEDDIRECTLYTO)00&ATTHEFOLLOWING ADDRESS 0UV9DQHVVD*HUEURQ6HUYLFHV3URYLGHU % MAILVGERBRON IPPFORG OR #ARL&OISSEY "USINESS!NALYST % MAILCFOISSEY IPPFORG )NTERNATIONAL0LANNED0ARENTHOOD&EDERATION)00& 2EGENTS#OLLEGE )NNER#IRCLE 2EGENTS0ARK ,ONDON.7.3 5NITED+INGDOM 4ELEPHONE   &AX  

4HISMATERIALWASDEVELOPEDBY0!4(

&  -ODULE'

4HE/PTIONOF0ROVIDING#OMBINED /RAL#ONTRACEPTIVES#/#S AS .ON $EDICATED%MERGENCY #ONTRACEPTIVE0ILLS%#0S

/BJECTIVE 4OGUIDEDECISIONMAKINGANDPROGRAMPLANNINGWHENPROVISIONOFCOMBINEDORAL CONTRACEPTIVESFOREMERGENCYCONTRACEPTIONISBEINGCONSIDERED

4HEREARETWOTYPESOF%#0SPROGESTIN ONLYPILLSCONTAININGLEVONORGESTRELAND#/#S4HIS MODULEBRIEmYDISCUSSESISSUESTOCONSIDERWHENLOOKINGATTHEOPTIONOFPROVIDING#/#SFOR EMERGENCYCONTRACEPTION4HEFOLLOWINGTOPICSAREDISCUSSED s 0ROVISIONOF#/#SFOR%MERGENCY#ONTRACEPTION s !PPROACHESFOR0ROVIDING#/#SAS.ON $EDICATED%#0S s 0ROSAND#ONSOF0ROVIDING#/#SAS.ON $EDICATED%#0S s 0LANNINGFOR0RODUCT3UPPLY

4OOLS0ROVIDEDATTHE%NDOF4HIS-ODULE „ 0ROTOTYPE0ACKAGE&ORMAT „ #/#SFOR%MERGENCY#ONTRACEPTION%XAMPLEOFTHE2EPACKAGING&ORMAT5SEDBY THE&AMILY'UIDANCE!SSOCIATIONOF%THIOPIA „ )NFORMATIONTO)NCLUDE7HEN0ROVIDING#/#SFOR%MERGENCY#ONTRACEPTION „ 0ROVISIONOFA/NE -ONTH3UPPLYOF#/#SFOR%MERGENCY#ONTRACEPTION

0ROVISIONOF#/#SFOR%MERGENCY#ONTRACEPTION !SDESCRIBEDINTHE7ORLD(EALTH/RGANIZATION7(/ PUBLICATION%MERGENCY #ONTRACEPTION!'UIDEFOR3ERVICE$ELIVERY THEREARETWOKINDSOFPRODUCTSTHATCANBEUSED ASEMERGENCYCONTRACEPTIVEPILLS PROGESTIN ONLYPILLSCONTAININGLEVONORGESTRELAND #/#S CONTAININGPROGESTINANDESTROGEN WHICHAREWIDELYUSEDFORREGULARCONTRACEPTION 4HEPROGESTIN ONLYPILLSHAVEAHIGHEREFFECTIVENESSRATEFOREMERGENCYCONTRACEPTIONAND HAVEFEWERSIDEEFFECTSTHAN#/#SWHENTAKENFOREMERGENCYCONTRACEPTION)NADDITION PROGESTIN ONLYPILLSCANBETAKENINONEDOSE&ORTHESEREASONS PROGESTIN ONLYPILLSARE CONSIDEREDTHEPREFERREDEMERGENCYCONTRACEPTIVEPRODUCTFORFAMILYPLANNINGPROGRAMS '  '  -ODULE' $ISTRIBUTIONOFA0ROGESTIN /NLY%#0 'EDEON2ICHTER,TDAND,ABORATOIRE(2!0HARMA#ONTACTINFORM OMLTO #OMMON"RAND.AMES &ORMULATION %MERGENCY#ONTRACEPTION/CTOBER P 3OURCE!DAPTEDFROM%XPANDING'LOBAL!CCESSTO%MERGENCY#ONTR HOURS ANDTHESECONDDOSESHOULDBETAKENHOURSAFTERT &ORALLREGIMENS THElRSTDOSESHOULDBETAKENASSOONASPOSS !BBREVIATIONS%%ETHINYLESTRADIOL,.'LEVONORGESTREL %%MCG .'MG OR %%MCG ,.'MG %%MCG ,.'MG OR %%MCG ,.'MG EMERGENCYCONTRACEPTION4HEDATABASECANBESEARCHEDBYCOUNTR WORLDWIDEˆBOTH#/#SANDPROGESTIN ONLYCONTRACEPTIVEPILLSˆTHAT DEFAULTASP4HISWEBSITEPROVIDESASEARCHABLEDATABASEOFOR #ONTRACEPTIVES ISACCESSIBLEONTHEWEBSITEHTTPECPRINCET FROMTHE)NTERNATIONAL0LANNED0ARENTHOOD&EDERATION$IREC !DDITIONALINFORMATIONABOUTTHEAVAILABILITYOF#/#AND%#0PR MOSTCOMMONBRANDNAMESOFTHE#/#STHATAREUSEDFOREMERGENCY MEANSOFFERINGALESSEFFECTIVEPRODUCT4HETABLEBELOWSHOWS THEREARETRADE OFFSWITHREGARDTOCOSTANDQUALITY-OSTIMPO EMERGENCYCONTRACEPTIVEUSE!LTHOUGHTHESEAPPROACHESHAVEBEE EMERGENCYCONTRACEPTIONORBYPROVIDINGANENTIRECYCLEOFPILL BYCUTTINGUPREGULAR#/#PACKETSANDREPACKAGINGTHEPILLSIN VIABLEWAYTOROUTINELYOFFEREMERGENCYCONTRACEPTIONTOCLIENT PLANNINGPROGRAMSINTHISSITUATIONHAVEFOUNDTHATPROVIDING# NOTFEASIBLEORPROGESTIN ONLYPILLSMAYBEREGISTEREDBUTACCE )NSOMECOUNTRIES HOWEVER THEOPTIONOFPROVIDINGADEDICATED SPECIlCALLYFOREMERGENCYCONTRACEPTION WIDELYDISTRIBUTEADEDICATEDPROGESTIN ONLY%#0ˆTHATIS AN%# PROGESTIN ONLYPILLSFOREMERGENCYCONTRACEPTION4HEREARETWO )N THE7(/-ODEL,ISTOF%SSENTIAL-EDICINESWASREVISED  #OMBINED/RAL#ONTRACEPTIVES .ORDETTE /VRAL, 2IGEVIDON ,O&EMENAL -ICROGYNON /VRAN 0#  0REVEN .ORAL .ORDIOL /VIDON /VRAL %UGYNON &ERTILAN .EOGYNON

ATIONISPROVIDEDIN-ODULE&2EGULATION 0ROCUREMENT AND .'NORGESTREL IBLEAFTERINTERCOURSE BUTOPTIMALLYWITHIN HElRSTDOSE ACEPTION)NTERNATIONAL#ONSORTIUMFOR ONEDUWORLDWIDE SSMAYBELIMITED&AMILY RTANTLY OFFERING#/#S ALCONTRACEPTIVESAVAILABLE .UMBEROF S4HEYHAVEDONETHIS SWITHINSTRUCTIONSFOR THEFORMULATIONSAND &IRSTDOSE /#SMAYBETHEONLY THECORRECTDOSAGEFOR PROGESTIN ONLY%#0IS MANUFACTURERSTHAT TABLETS 0LABELEDANDPACKAGED ODUCTS DRAWN TORYOF(ORMONAL YORBYPRODUCT NUSEDSUCCESSFULLY TOINCLUDEONLYTHE   CANBEUSEDFOR CONTRACEPTION 3ECONDDOSE .UMBEROF TABLETS -ODULE'

!PPROACHESFOR0ROVIDING#/#SAS.ON $EDICATED%#0S "ECAUSE#/#SGENERALLYCOMEINONE MONTHSUPPLYPACKETS PROVIDERSDISTRIBUTING #/#SFOREMERGENCYCONTRACEPTIONDEVELOPVARIOUSAPPROACHESFORDELIVERINGTHEPILLSTO CLIENTS&REQUENTLYUSEDAPPROACHESFORDELIVERING#/#SASNONDEDICATED%#0SINCLUDE THEFOLLOWING s 0ROVIDINGAMONTHSCYCLEOFPILLSTOTHECLIENTWITHVERBALINSTRUCTIONSONHOWTOTAKETHEM s #UTTINGUPCYCLESASNEEDEDANDGIVINGTHEPILLSTOTHECLIENTSWITHVERBALINSTRUCTIONS s #UTTINGUP#/#SINADVANCEONSITEATAHEALTHCAREFACILITY ANDINSERTINGTHEMIN ENVELOPESALONGWITHSOMEFORMOFWRITTENINSTRUCTIONS s 2EPACKAGING#/#SINACENTRALIZED SUPERVISEDFACILITYANDINSERTINGPRINTEDINSTRUCTIONS !LTHOUGHEACHOFTHESEAPPROACHESHASADVANTAGES THEREAREALSODISADVANTAGES WHICH MEANSTHEREISATRADE OFFASTOSAFETYRISKORCOSTSAVINGSINCREASEDEXPENSE ASDISCUSSED BELOW

0ROSAND#ONSOF0ROVIDING#/#SAS.ON $EDICATED%#0S 4HEREARESEVERALFACTORSTOADDRESSWHENCONSIDERINGWHETHERPROVISIONOF#/#SASNON DEDICATED%#0SISANAPPROPRIATECHOICE4HESEINCLUDETHEPOLITICALSITUATIONREGARDING EMERGENCYCONTRACEPTION REGULATORYREQUIREMENTS THESCALEOFTHEPROGRAM COST SAVINGOPPORTUNITIES DONORPROVISIONOFAPPROPRIATE#/#PRODUCTSANDPOSSIBLEDONOR RESTRICTIONSONUSEOFTHOSEPRODUCTS ANDCOSTSOFREPACKAGINGANDQUALITYASSURANCE 0ROGRAMPLANNERSMUSTEVALUATEALLOFTHESEELEMENTSCAREFULLYBEFOREMAKINGADECISION ABOUTREPACKAGING#/#SFOR%#

2EASONSWHYPROGRAMSWOULDCHOOSETHEOPTIONOFPROVIDING#/#SAS NONDEDICATED%#0S 0OTENTIALOPPOSITION)FTHEREARESECTORSORGROUPSINACOUNTRYWHOSESENSITIVITIESTOWARD EMERGENCYCONTRACEPTIONMIGHTDELAYREGISTRATION PROCUREMENT ANDDISTRIBUTIONOFA PROGESTIN ONLY%#0 PROVISIONOF#/#SFOREMERGENCYCONTRACEPTIONˆALOW PROlLE APPROACHˆMAYBETHEBESTALTERNATIVE HELPINGAVOIDCONTROVERSYANDMAKINGITPOSSIBLE TOMOVEAHEADANDINCORPORATEEMERGENCYCONTRACEPTIONINTOAPROGRAMINATIMELYWAY 0ROVISIONOFAMONTHSCYCLEOFPILLS INPARTICULAR HASTHEPOTENTIALADVANTAGEOFBEING MOREANONYMOUS INTHATNOONEWILLKNOWHOWTHECLIENTINTENDSTOUSETHEPILLS !VAILABILITY"ECAUSE#/#SAREWIDELYUSEDFORREGULARCONTRACEPTION THEYAREREGISTERED ANDEASILYAVAILABLEINMOSTCOUNTRIES !CCESS)F#/#SAREDONOR PROVIDED ITMAYBEEASIERFORAPROGRAMTOUSESOMEOFTHE PRODUCTFOREMERGENCYCONTRACEPTION RATHERTHANTOPROCUREANADDITIONALPRODUCT #OST0ROVIDINGAMONTHSCYCLEOFPILLSORCUTTINGUPCYCLESASNEEDEDANDGIVINGTHEMTO THECLIENTWITHVERBALINSTRUCTIONSONHOWTOTAKETHEMWOULDBEALOW COSTAPPROACH

'  '  -ODULE' 0LANNINGFOR0RODUCT3UPPLY  -IXINGOFDIFFERENTPACKETSANDBATCHES#/#PACKETSMAYNOT  0OTENTIALFORINCORRECTADMINISTRATION7HENPROVIDINGAMON  #OST4HECOSTOFCUTTINGUP#/#SINADVANCEANDINSERTINGT  1UALITYCONTROL4HEFARTHERONEGETSFROMACENTRALIZEDPRO  2EGULATORYCONSTRAINTS4HEREMAYBEREGULATORYBARRIERSTO  NUMBEROFPACKETSTOORDER WASTINGPILLFROMEACHCYCLE4HEWASTAGESHOULDBEFACTORED THEREARE%#CYCLESOFPILLSEACH INONEPACKETOF-ICR TOPROVIDE%#INSEGMENTSOFPILLS ASSMALLERSEGMENTSCOULD CYCLES)N:AMBIA WHERE PILLPACKETSOF-ICROGYNONAREUSED DETERMINEHOWMANYPACKETSOF#/#SWILLBENEEDEDTOYIELDTHE 7HENCUTTINGUP#/#PACKETSFOREMERGENCYCONTRACEPTION ITWIL %FFECTIVENESS#/#SARELESSEFFECTIVEFOREMERGENCYCONTRAC  NONDEDICATED%#0S 2EASONSWHYPROGRAMSWOULDNOTCHOOSETOPROVIDE#/#SAS PROVIDINGADEDICATED LEVONORGESTREL ONLY%#0 SOMEFORMOFWRITTENINSTRUCTIONSCOULD DEPENDINGONTHESCALE INACCURATEEXPIRYDATEORDIFlCULTYINTRACINGPILLSIFAPRODU MANUFACTURINGBATCHESORLOTSCOULDBEREPACKAGEDTOGETHER4HI NUMBEROF%#0DOSES WHICHMEANSTHATPILLSFROMDIFFERENTPACK FORLOW LITERATECLIENTS CORRECTADMINISTRATIONISPLACEDENTIRELYONTHECLIENT4HERI INSTRUCTIONSONTHENUMBEROFPILLSTOTAKEFOREMERGENCYCONTR COULDUNDERMINEANEMERGENCYCONTRACEPTIONPROGRAM CENTRALIZED SUPERVISEDFACILITYANDINSERTINGPRINTEDINSTRUCT INSERTINGTHEMINENVELOPESALONGWITHWRITTENINSTRUCTIONSOR RISKOFERRORANDLACKOFQUALITYCONTROLTHANCUTTINGUP#/#S CYCLESASNEEDEDANDGIVINGTHEMTOTHECLIENTWITHVERBALINST THATPROTECTEACHPILLCOULDBEDESTROYED0ROVIDINGAMONTHS PACKSBYHANDATMULTIPLESITES!PARTICULARRISKISTHATTHE INCORRECTORINCOMPLETEINSTRUCTIONS1UALITYCONTROLCANBEDI FORERRORINCLUDEPROVISIONOFTHEWRONGPRODUCT THEINCORRECT GREATERTHERISKSFORERRORINPACKAGINGORINPROVIDINGINSTRU SEEKINGSPECIAL.2!APPROVAL ORGANIZATIONSINFORMALLYCUTUP#/#PACKETSFOREMERGENCYCONTR THEREISNOTADEDICATEDEMERGENCYCONTRACEPTIONPRODUCT HOWEV BUTREQUIRESAMANUFACTURERSLICENSEFORLARGE SCALEREPACKAGI ALLOWSAREPACKAGINGRELABELINGPROCESSWHENITISDONEONANI .2! REQUIREMENTS)NTHE5NITED3TATES FOREXAMPLE THE&OOD PROGRAMCONSIDERINGTHISAPPROACHSHOULDBEAWAREOFTHE.ATION USINGTHEPILLSFORANYPURPOSEOTHERTHANTHATFORWHICHTHEY FORMULATIONS ANDTHEYHAVEMORESIDEEFFECTS OGYNON THISPRACTICEMEANS INTEGRITYOFTHEBLISTERPACKS DUCTQUALITYCONTROLSYSTEM THE CUTTINGUP#/#PACKETSAND SKOFERRORISHIGH ESPECIALLY CTRECALLWERENECESSARY IONS1UALITYCONTROLPROBLEMS CTIONSFORUSE0OSSIBILITIES TOOEASILYBELOST3INCE INWHENDECIDINGONTHE HEMINENVELOPESALONGWITH EPTIONTHANPROGESTIN ONLY WEREORIGINALLYREGISTERED! THSCYCLEOF#/#SWITH FlCULTWHENCUTTINGUPPILL NUMBEROFPILLS AND INADVANCEONSITEAND RUCTIONSWOULDENTAILGREATER NG)NMANYCOUNTRIESWHERE REPACKAGINGTHE#/#SINA CYCLEOFPILLSORCUTTINGUP THEPRACTICEISALWAYS ACEPTION THEBURDENFOR DIVIDEINTOTHECORRECT NDIVIDUALBASISFORCLIENTS DESIREDNUMBEROF%# LBENECESSARYTO BEASHIGHASTHECOSTOF SCOULDRESULTINAN ER FAMILYPLANNING AND$RUG!DMINISTRATION ETSANDPERHAPSDIFFERENT AL2EGULATORY!UTHORITY ACEPTION WITHOUT -ODULE'

2EFERENCES 7ORLD(EALTH/RGANIZATION%MERGENCY#ONTRACEPTION!'UIDEFOR3ERVICE$ELIVERY7(/&2(&00 'ENEVA7(/ 

7(/4ASK&ORCEON0OSTOVULATORY-ETHODSOF&ERTILITY2EGULATION2ANDOMIZEDCONTROLLEDTRIALOF LEVONORGESTRELVERSUSTHE9UZPEREGIMENOFCOMBINEDORALCONTRACEPTIVESFOREMERGENCYCONTRACEPTION ,ANCET  

VON(ERTZEN (ETAL,OWDOSEMIFEPRISTONEANDTWOREGIMENSOFLEVONORGESTRELFOREMERGENCY CONTRACEPTIONA7(/MULTICENTRERANDOMISEDTRIAL,ANCET   

0!4(GREATFULLYACKNOWLEDGESTHECONTRIBUTIONSOF*OHN3KIBIAKOFTHE0OPULATION#OUNCIL.AIROBITOTHE DEVELOPMENTANDTHECONTENTOFTHISMODULE

'  '  -ODULE' -ODULE'4OOLS,IST

„0ROTOTYPE0ACKAGE&ORMAT !PACKAGEFORMATTHATCANBEADAPTEDASNEEDED

„#/#SFOR%MERGENCY#ONTRACEPTION%XAMPLEOF THE2EPACKAGING&ORMAT5SEDBYTHE&AMILY'UIDANCE !SSOCIATIONOF%THIOPIA !NILLUSTRATIONOFAREPACKAGINGFORMATUSEDFORREPACKAGED#/#SFOREMERGENCY CONTRACEPTION

„)NFORMATIONTO)NCLUDE7HEN0ROVIDING#/#SFOR %MERGENCY#ONTRACEPTION %SSENTIALINFORMATIONTHATSHOULDBEPROVIDEDEITHERONTHEPACKAGEORONAPACKAGEINSERT ANDADDITIONAL OPTIONALINFORMATION

„0ROVISIONOFA/NE -ONTH3UPPLYOF#/#SFOR%MERGENCY #ONTRACEPTION 3UGGESTEDINSTRUCTIONSTOPROVIDEWHENDISPENSINGAMONTHSSUPPLYOFORALCONTRACEPTIVES FORTHEINDICATIONOFEMERGENCYCONTRACEPTION

'  -ODULE' 4OOLS

'  4OOLS -ODULE'

([SLU\GDWH%DWFK

'  -ODULE' 4OOLS

'  4OOLS

#/#SFOR%MERGENCY#ONTRACEPTION %XAMPLEOFTHE2EPACKAGING&ORMAT5SEDBYTHE -ODULE' &AMILY'UIDANCE!SSOCIATIONOF%THIOPIA

'  -ODULE' 4OOLS

4HE&AMILY'UIDANCE!SSOCIATIONOF%THIOPIADEVELOPEDTHISPACKAGEFORMATINCOLLABORATIONWITHTHE-ODERN #ENTERFOR"USINESS3ERVICESIN$UBAIANDWITHTHE0OPULATION#OUNCIL)TWASREPRINTEDWITHPERMISSION

'  4OOLS

)NFORMATIONTO)NCLUDE7HEN0ROVIDING#/#S -ODULE' FOR%MERGENCY#ONTRACEPTION %SSENTIAL)NFORMATION 4HEREARETWOKINDSOFESSENTIALINFORMATIONPRODUCTINFORMATIONANDINFORMATIONFORTHE USER4HISINFORMATIONSHOULDBEPROVIDEDEITHERONTHEPACKAGEORONAPACKAGEINSERT

0RODUCTINFORMATION

s ,ABEL%MERGENCY#ONTRACEPTIVE0ILLSOR%#0S  s %XPIRYDATEOFPILLS INCLUDINGMONTH DAY ANDYEAR s -ANUFACTURERSBATCHORLOTNUMBER s ,OCALLYMANDATEDINFORMATIONREQUIREDBYGOVERNMENTAGENCIES 

)NFORMATIONFORTHEUSER

s "RIEFINSTRUCTIONS  %#0SCANPREVENTPREGNANCYAFTERUNPROTECTEDSEXUALINTERCOURSE5SE%#0SIFYOUDO NOTWANTTOBECOMEPREGNANT IFYOUTHINKYOURCONTRACEPTIVEMETHODHASFAILED ORIFYOU WERERAPED  4HElRSTDOSESHOULDBETAKENASSOONASPOSSIBLEAFTERSEX BUTCANBETAKENUPTODAYS HOURS AFTERSEX%#0SAREMOREEFFECTIVETHESOONERTHEYARETAKEN  4HESECONDDOSESHOULDBETAKENHOURSAFTERTHElRSTDOSE  4RYTOTAKETHElRSTDOSESOTHATTHETIMINGOFTHESECONDDOSEHOURSLATER ISPRACTICAL FORYOUIE DURINGWAKINGHOURS   %#0SCANBEUSEDANYTIMEINTHEMENSTRUALCYCLE s "RIEFINFORMATIONABOUTSIDEEFFECTS  3OMEWOMENHAVESOREBREASTS HEADACHES ORFEELNAUSEOUS3OMEWOMENEVENVOMIT AFTERTAKING%#0S  )FYOUVOMITWITHINONEHOURAFTERTAKING%#0S TAKEANOTHERDOSEIMMEDIATELY  )FYOUVOMITMORETHANONEHOURAFTERTAKING%#0S YOUDONOTNEEDTOREPEATTHEDOSE  4HESIDEEFFECTSOF%#0SMAYBEUNCOMFORTABLE BUTTHEYARENOTHARMFULANDUSUALLYLAST FORONLYONEDAYORLESS  )TISNORMALFORYOURNEXTPERIODTOBEGINAFEWDAYSEARLIERORLATERTHANEXPECTED s 3EXUALLYTRANSMITTEDINFECTIONS34)S %#0SDONOTPROTECTAGAINST34)SOR()6)FYOUTHINK YOUMAYHAVECONTRACTEDAN34)OR()6 VISITYOURHEALTHOR34)CLINIC s ,OCALLYMANDATEDINFORMATIONREQUIREDBYGOVERNMENTAGENCIES 

'  /PTIONAL!DDITIONAL)NFORMATION )FTHEPROGRAMISPROVIDINGAPACKAGEINSERT THEFOLLOWINGADDITIONALINFORMATIONCOULDBE INCLUDED

-ODULE' s %#0SDONOTWORKIFYOUAREALREADYPREGNANT s %#0SAREEFFECTIVECONTRACEPTION BUTTHEYDONOTWORKEVERYTIME)FYOURPERIODDOESNOT STARTWITHINWEEKSAFTERTAKING%#0S YOUMAYBEPREGNANT(AVEAPREGNANCYTESTTOKNOW FORSURE 4OOLS s !SSOONASPOSSIBLE BEGINUSINGABIRTHCONTROLMETHODYOUWILLBEABLETOUSEONANONGOING BASIS%#0SAREINTENDEDFOREMERGENCYPROTECTION4HEYARENOTASEFFECTIVEASOTHERFORMS OFBIRTHCONTROL s !FTERUSING%#0S  5SEABARRIERMETHOD LIKEACONDOM EACHTIMEYOUHAVESEXUNTILYOUBEGINYOURNEXT MENSTRUALPERIOD!FTERTHATTIMEYOUMAYCONTINUEUSINGYOURCONTRACEPTIVEMETHODOR BEGINANEWONEOR  )FYOUWEREUSINGORALCONTRACEPTIVESPILLS YOUSHOULDCONTINUETAKINGTHETABLETSSTARTING ONTHEDAYAFTERYOUTOOKTHE%#0SUNTILTHEENDOFTHECYCLE9OUSHOULDTHENUSEA CONDOMOROTHERBARRIERCONTRACEPTIVEMETHODFORATLEASTSEVENDAYSAFTERRESTARTING CONTRACEPTIVEPILLS

%#0SAND#ONDOMS0ACKAGINGFOR$UAL0ROTECTION %#0SARESOMETIMESPACKAGEDWITHCONDOMSASDUALPROTECTION SINCE%#0SDONOTPROTECT AGAINST34)S INCLUDING()6!)$3)NSUCHCASES THEREWILLBETWOEXPIRYDATESˆONEFOR THEPILLSANDONEFORTHECONDOM)TWILLBEIMPORTANT WHENPLANNINGDISTRIBUTION TOUSE THEEARLIEROFTHETWOEXPIRYDATES4HEREALSOMAYBESOMEADDITIONALCLIENTINFORMATION PROVIDEDWITHTHEPACKAGEWHENTWOPRODUCTSAREPROVIDED

4HISMATERIALWASDEVELOPEDBY0!4(

'  4OOLS

0ROVISIONOFA/NE -ONTH3UPPLYOF#/#S -ODULE' FOR%MERGENCY#ONTRACEPTION

)NAFEWCOUNTRIES PROGRAMSHAVECHOSENTODISTRIBUTETHEENTIREONE MONTHSUPPLYOF#/#S ALONGWITHINSTRUCTIONSONTHENUMBEROFPILLSTOTAKEFOR%#7HILEITMAYBEEASIERTO DISPENSE%#USINGTHISAPPROACH OFTHEFOURAPPROACHESOUTLINEDINTHISMODULE THISONE ENTAILSTHEMOSTRISKBECAUSEITPLACESTHEBURDENFORCORRECTDOSAGESQUARELYONTHECLIENT 4HERISKOFINCORRECTDOSAGEISGREATLYENHANCEDIFLITERACYISLOW IFTHEREISNOWAYTO CONlRMTHATTHECLIENTTHOROUGHLYUNDERSTANDSTHEINSTRUCTIONSSHEHASBEENGIVEN IFMULTIPLE PILLBRANDSAREAVAILABLEINTHECOUNTRY ANDORIFTHEPACKCONTAINSIRONPILLSORPLACEBOSIN ADDITIONTOTHEBIRTHCONTROLPILLS4HEFOLLOWINGINSTRUCTIONSCOULDBEGIVENTOCLIENTSWHEN PROVIDINGTHEMWITHAMONTHSSUPPLYFOR%# INADDITIONTOPROVIDINGUSEINSTRUCTIONSSUCH ASTHOSEPRINTEDONTHEPROTOTYPEPACKAGEINTHETOOLSSECTIONOFTHISMODULE s &OREMERGENCYCONTRACEPTION PILLSCANBETAKENFROMAWHOLEPACKETOFREGULARORAL CONTRACEPTIVEPILLS$ONOTMIXBRANDS4AKETHETWODOSESFROMTHESAMEPACKET s )FYOUHAVEACOMPLETEPACKETOFREGULARORALCONTRACEPTIVEPILLS THELASTPILLSSHOULDNOT BEUSED%#DOSESSHOULDBETAKENUSINGPILLSFROMTHElRSTPILLSINTHEPACKET

4HISMATERIALWASDEVELOPEDBY0!4(

' 

-ODULE(

0ROVIDER4RAINING

/BJECTIVE 4OPROVIDETECHNIQUESANDMATERIALSFORTRAININGMEDICALANDNONMEDICALPERSONNELWHO WILLBEDISTRIBUTINGEMERGENCYCONTRACEPTIONTOCLIENTS

4RAININGHEALTHCAREPROVIDERSTOSCREENANDCOUNSELCLIENTSFOREMERGENCYCONTRACEPTIVE PILLS%#0S WILLHELPENSURESUCCESSFULINTRODUCTIONOFTHEMETHODANDITSCORRECTUSE4HE SUBSTANCEOFTHISMODULEISAPROTOTYPETRAININGCURRICULUMTHATCANBEADAPTEDTODIFFERENT KINDSOFHEALTHPROVIDERS!SANINTRODUCTIONTOTHECURRICULUM THEFOLLOWINGTOPICSARE DISCUSSED

s 0ROVIDER4RAINING s 4ARGET!UDIENCESFOR4RAINING s (OWTO5SETHE%MERGENCY#ONTRACEPTION#URRICULUM

4OOLS0ROVIDEDATTHE%NDOF4HIS-ODULE

„ %MERGENCY#ONTRACEPTION#URRICULUM „ 0RE AND0OST 3ESSION1UESTIONNAIRE „ (ANDOUT+EY-ESSAGESFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTS „ (ANDOUT3AMPLE%MERGENCY#ONTRACEPTIVE0ILL3CREENING#HECKLIST „ (ANDOUT#OUNSELINGFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTS „ (ANDOUT#OUNSELING3KILLS/BSERVER#HECKLIST „ 4RAINING!ID'RAB"AGˆ+EY-ESSAGESFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTS „ 4RAINING!ID$EMONSTRATION2OLE 0LAY „ 4RAINING!ID%MERGENCY#ONTRACEPTIVE0ILL#LIENT3ITUATION2OLE 0LAYS

0ROVIDER4RAINING &ORMORETHANYEARS EMERGENCYCONTRACEPTIONHASBEENKNOWNTOBEANEFFECTIVEMETHOD FORPREVENTINGPREGNANCYAFTERUNPROTECTEDSEXUALINTERCOURSE(OWEVER ITISONLYWITHIN THEPASTTENYEARSTHATEMERGENCYCONTRACEPTIONHASRECEIVEDWIDESPREADATTENTIONASA CONTRACEPTIVEOPTION ANDDEDICATED%#0SHAVEONLYRECENTLYBECOMEAVAILABLE!SARESULT INFORMATIONABOUTSCREENINGANDCOUNSELING%#0CLIENTSISNOTYETINCLUDEDINMANYTRAINING PROGRAMSFORHEALTHPROVIDERS%MERGENCYCONTRACEPTIONISUNIQUEINTHATITISAPOSTCOITAL METHOD WOMENNEEDITDUETOUNEXPECTEDCIRCUMSTANCES ANDITMUSTBETAKENWITHINASHORT TIMEFRAME0ROVIDERTRAININGCANHELPENSUREQUALITYOFSERVICES0RE SERVICETRAINING AS (  (  -ODULE( HOWEVER THEYDONOTTYPICALLYDISTRIBUTE%#0SORPROVIDETHEK 0EEREDUCATORSCANPLAYACRITICALROLEINRAISINGAWARENESS (OWTO5SETHE%MERGENCY#ONTRACEPTION#URRICULUM 4ARGET!UDIENCESFOR4RAINING ASWELLASCONTINUINGEDUCATIONPROGRAMSOFHEALTHPROFESSIONAL 6ARIOUSADAPTATIONSHAVEBEENINCORPORATEDINTOTHECURRICULUMS GROUPS4HISCURRICULUMHASBEENADAPTEDANDUSEDSUCCESSFULLY SPENTONINTERACTIVEEXERCISESCANBEMODIlEDANDADAPTEDTOME LEVELSOFKNOWLEDGE&OREXAMPLE THEEMPHASISONTECHNICALINF 4HISTRAININGCURRICULUMCANBEADAPTEDANDUSEDFORARANGEOF s s s s s DETERMININGPARTICIPANTSFORTRAININGINCLUDE !SSESSMENTWORKCANHELPGUIDETRAINING3OMEIMPORTANTQUESTIO 4RAININGSHOULDBEADAPTEDTOMEETTHESPECIlCNEEDSOFTHETRA s s s s s s s SERVICESTOWOMENINCLUDE THATHAVEBEENINSTRUMENTALINPROVIDINGEMERGENCYCONTRACEPTIO REGULATIONS ANDTHESOCIOCULTURALSITUATIONS'ROUPSINBOTHT 0ROVIDERSOFEMERGENCYCONTRACEPTIONWILLDIFFERINEACHCOUNTR OFSTUDIES #AMBODIAˆINTEGRATED0!4(SPHARMACYPERSONNELTRAININGCURRICUL &ACULTYOF0HARMACYADAPTEDANDˆINCOLLABORATIONWITHTHE0HARM HASBEENINSTITUTIONALIZEDBYTHE5NIVERSITYOF(EALTH3CIENCE TERMSUSTAINABILITYOFPROVIDERTRAINING&OREXAMPLE IN#AMBO PARTOFTHECURRICULUMINUNIVERSITYSCHOOLSOFMEDICINEANDPH :KLFK 7HICHPROVIDERGROUPSWILLBEABLETOREACHTHELARGESTNUMBER CONTRACEPTION 7HICHPROVIDERGROUPSAREMOSTACCESSIBLETOPOTENTIALUSERSOF 7HATISTHEEDUCATIONALBACKGROUNDOFPARTICIPANTS !TWHATSTAGEOFINTRODUCTIONISEMERGENCYCONTRACEPTIONCURREN $OMESTICANDSEXUALABUSEANDRAPESURVIVORCOUNSELORSANDADVO 0EEREDUCATORSSUCHASYOUTHLEADERSATFACTORIES 0HARMACISTSANDPHARMACYCOUNTERSTAFF #OMMUNITY BASEDDISTRIBUTORS 4RAINEDHEALTHWORKERS SUCHASCOMMUNITYHEALTHVOLUNTEERSAND 0HYSICIANS .URSES PROVIDER JURXSVDUHWKHPRVWPRWLYDWHG" AMONGWOMENWHOMIGHTNOTOTHERWISERECEIVEINFORMATION INDOFTECHNICALINFORMATIONCONTAINEDINTHISMODULE

HEPUBLICANDPRIVATESECTORS &ACULTYOF0HARMACY4HE ARMACY CANENSURELONG ININGPARTICIPANTS Y DEPENDINGONTHELAWS DIA PROVIDERTRAINING PROVIDERSWITHDIFFERING ORGANIZATIONS%FFORTSTO ORMATIONORTHETIME OFSCHOOLSOFPHARMACY INSEVERALCOUNTRIES ETTHENEEDSOFSPECIlC NINFORMATIONAND NSTOASKWHEN EMERGENCY ACISTS!SSOCIATIONOF OFWOMEN TLY UMINTOTHElNALYEAR MIDWIVES CATES -ODULE(

INCLUDEEMERGENCYCONTRACEPTIONINTHECURRICULUMSOFHEALTHPROVIDERTRAININGPROGRAMS CANHELPTOENSUREWIDESPREADPROVIDERKNOWLEDGEABOUTEMERGENCYCONTRACEPTION 0ROVIDERSWHOAREALREADYTRAINEDINEMERGENCYCONTRACEPTIONWILLBENElTFROMPERIODIC hREFRESHERvTRAININGSESSIONSTHATEMPHASIZEKEYELEMENTSOF%#0SERVICEDELIVERYASWELL ASUPDATEDSERVICEDELIVERYGUIDELINESBASEDONCURRENTMEDICALEVIDENCE 4HECURRICULUMGUIDESTHETRAINERTHROUGHESSENTIALINFORMATIONABOUT%#0S RELATED REPRODUCTIVEHEALTHISSUESSUCHASSEXUALLYTRANSMITTEDINFECTIONS34)S ANDCOUNSELING ISSUESSUCHASCONTINUEDCONTRACEPTIONANDREFERRAL)TISIMPORTANTFORTHETRAINERTO BECOMEFAMILIARWITHALLOFTHEMATERIALINTHISCURRICULUMHOWEVER ITISNOTINTENDED TOBEREADALOUDORUSEDASALECTURESCRIPT4HECURRICULUMISFORMATTEDTOCREATEAN INTERACTIVELEARNINGENVIRONMENT ANDQUESTIONSANDACTIVITIESAREINCLUDEDTOPROMOTE DISCUSSION4HEACTIVITIESAIMTOHELPTHETRAINEESIMPROVETHEIRSKILLSINPROVIDING%#0S ANDOTHERREPRODUCTIVEHEALTHSERVICES4HECURRICULUMANDTRAININGMATERIALSPRESENTED HEREWEREDRAWNFROMANUMBEROFEXISTINGCURRICULAANDTRAININGRESOURCES 4RAININGTECHNIQUESUSEDTHROUGHOUTTHECURRICULUMINCLUDE s 3MALLANDLARGEGROUPDISCUSSIONS s 0RESENTATIONOFMATERIALBYTHETRAINER s 2OLE PLAY s "RAINSTORMING s 'AMES s 7ORKINGINSMALLGROUPSORPAIRS 4HETRAININGTOOLSAREDESIGNEDASAGENERICMODELFORTRAININGVARIOUSTYPESOFPROVIDERS INCLUDINGCLINICIANSANDPHARMACISTS#ONSIDERINCLUDINGADDITIONALINFORMATIONSPECIlC TOTHELEVELOFPROVIDERTHATWILLBETRAINEDANDTHESETTINGINWHICHTHEYWILLBEPROVIDING %#0STOCLIENTS3OMETOPICSFORCONSIDERATIONINCLUDE #LINICIANS s 0ROVIDINGINFORMATIONBOTHVERBALANDWRITTENDEPENDINGONTHEWOMANSNEED ABOUT OTHERONGOINGFAMILYPLANNINGMETHODSINCLUDINGTHEINTRAUTERINEDEVICE s 0ROVIDINGINFORMATIONABOUT34)SINCLUDING()6!)$3MANAGEMENTANDTREATMENT s 0ROVIDINGINFORMATIONTOWOMENINACLINICSETTINGENSURINGAPRIVATEANDSUPPORTIVE ENVIRONMENT s 0ROVIDING%#0SINADVANCEOFNEEDTOWOMENATRISKOFUNINTENDEDPREGNANCY 0HARMACISTS s %NSURINGPRIVACYINPHARMACYSETTINGS s 0ROVIDINGWOMENWITHAPPROPRIATEVERBALANDPRINTEDINSTRUCTIONSFORUSING%#0S s 2EFERRINGWOMENTOOTHERHEALTHCAREPROVIDERSFORFAMILYPLANNINGMETHODSAND34) MANAGEMENTTREATMENT

(  (  -ODULE( !DDITIONAL2ESOURCESFOR$EVELOPING4RAINING3ESSIONS HTTPWWWPATHORGlLES2(?00)+?PDF INTERNETAT REPRODUCTIVEHEALTHPHARMACYPROGRAM 0ROGRAM)MPLEMENTATION+IT'UIDELINESANDTOOLSFORIMPLEMENTI KWWSZZZFHFLQIRRUJKWPOUHVGRZQORDGDEOHPWUOVKWP FOUNDINTHEAPPENDIX)TISALSOAVAILABLEON LINEAT SERVEASASTANDARDOFCAREFORIMPLEMENTINGASERVICEPROTOCOL 0ILLS-EDICALAND3ERVICE$ELIVERY'UIDELINES 4HE)NTERNATIONAL#ONSORTIUMFOR%MERGENCY#ONTRACEPTIONS HTTPWWWPATHORGlLES2(?00)+?PDF HTTPWWWPATHORGlLES2(?00)+?PDF /NCEPARTICIPANTSHAVECOMPLETEDTHETRAINING CERTIlCATESOFC CURRICULUM TOCONDUCTINGTHETRAININGWORKSHOP4ECHNICALREFERENCESAREL MODULE4HETRAINERSHOULDCOLLECTTHISINFORMATIONANDINSERT 4HETRAINERISALSOPROVIDEDWITHALISTOFCOUNTRY SPECIlCINF OFEACHSESSION THETRAINERISPROVIDEDWITHALISTOF4!SAND ASANYOTHERMATERIALSDEEMEDAPPROPRIATEBYTHETRAINERORPRE OFHANDOUTS(/S ANDREFERENCEMATERIALSINCLUDEDINTHECURRI KEYPOINTSCOVEREDINTHETRAINING4HEPACKETOFMATERIALSSHO 4RAINERSSHOULDPROVIDEEACHTRAININGPARTICIPANTWITHAPACKET 4!S WHICHAREREFERENCEDTHROUGHOUTTHECURRICULUM MESSAGESARECOVEREDDURINGTHETRAINING4HETRAININGCURRICUL +EYPOINTSAREINCLUDEDATTHEENDOFEACHSECTION4HETRAINER EXPERIENCESTHROUGHOUTTHETRAINING TECHNIQUESUSED PARTICIPANTSSHOULDBEENCOURAGEDTOSHARETHE CERTAINACTIVITIESORSECTIONSTHATMIGHTONLYBEUSEDFORCERT CHANGEDTOAPRESENTATION)NADDITION DEPENDINGONLOCALREAL FOREACHSECTIONACCORDINGTOTHEAUDIENCEˆFORINSTANCE AGROU ISALSOINCLUDEDAFTERTHESECTIONTITLE4HETRAINERMAYCHANG 4HETYPEOFTRAININGTECHNIQUEEG ROLE PLAYORGROUPDISCUS AREALSOPROVIDED BUTTHETRAINERSHOULDADJUSTTHETIMEASAP COUNTRYSITUATION ANDMODIFYTHETRAININGCURRICULUMTOBESTMEETTHENEEDSOFTH %ACHSECTIONBEGINSONANEWPAGE DEPENDINGONHOWMANYBREAKSAREINCLUDED 4HETRAININGSESSIONISSCHEDULEDTOLASTFORAPPROXIMATELYlVE WWWPATHORGRESOURCESEC?DIVERSE COMMUNITIES PROJHTMNOTEBOOK !RESOURCEFORDEVELOPINGTRAININGSESSIONSFORPHARMACISTSIS 2ESOURCESFORDEVELOPINGCLINICIANFOCUSEDTRAININGSESSIONSCA 3UGGESTIONSFORTHEAMOUNTOFTIMENEEDEDTOCONDUCTEACHSESSI 4HETRAINERPRESENTERISENCOURAGEDTOADAPT 0!4(  4HISISALSOAVAILABLEONTHE  HTTPWWWPATHORGlLES2(?00)+?PDF HTTPWWWPATHORGlLES2(?00)+?PDF PROVIDESMEDICALGUIDELINESTHATCAN  AINGROUPS2EGARDLESSOFTHE ETHEMETHODOLOGYUSED (/SUSEDFORTHATMODULE PROPRIATEFORTHEAUDIENCE ORMATIONNEEDEDFOREACH SION USEDFOREACHSECTION SHOULDENSURETHATTHESE ITINTOTHECURRICULUMPRIOR ULDINCLUDEPHOTOCOPIES %MERGENCY#ONTRACEPTION ITIESANDNEEDS THEREARE OMPLETIONSHOULDBEGIVEN OFMATERIALSTOREINFORCE ANDAHALFHOURS UMINCLUDESTRAININGAIDS AROUND%#0S)TCANBE SENTER!TTHEBEGINNING ISTEDATTHEENDOFTHE NBEFOUNDATHTTP CULUMNOTEBOOKASWELL IRTHOUGHTS IDEAS AND 9OUTH &RIENDLY0HARMACY PDISCUSSIONCOULDBE NGAYOUTH FRIENDLY EAUDIENCEAND  ON   -ODULE(4OOLS,IST

„ %MERGENCY#ONTRACEPTION#URRICULUM !CURRICULUMFORTRAININGPROVIDERSOFEMERGENCYCONTRACEPTIONWITHINFORMATIONON UNINTENDEDPREGNANCY BACKGROUNDONEMERGENCYCONTRACEPTION REGIMENEFFECTIVENESS MECHANISMOFACTION SAFETYANDUSE COMMONSIDEEFFECTS COUNSELING SCREENINGAND EDUCATION FOLLOW UP ANDAWARENESSANDINCREASINGAWARENESSOF%#0S4HETOOLSLISTED BELOWARETOBEUSEDINCONJUNCTIONWITHTHECURRICULUM

„ 0RE AND0OST 3ESSION1UESTIONNAIRE 1UESTIONNAIRESTOBEUSEDBOTHBEFOREANDAFTERTHETRAININGTOHELPTHETRAINERUNDERSTANDAND MEASUREPARTICIPANTKNOWLEDGELEVELANDAWARENESS

„ (ANDOUT+EY-ESSAGESFOR%MERGENCY#ONTRACEPTIVE0ILL #LIENTS 4HISTOOLHASALISTOFKEYTOPICSANDISSUESTHATSHOULDBEDISCUSSEDWITHTHECLIENTWHEN PROVIDING%#0S!LTERNATIVELY IFPRIVACYCANNOTBEASSURED THEHANDOUTCANBEGIVENTOTHE CLIENTTOTAKEHOME

„ (ANDOUT3AMPLE%MERGENCY#ONTRACEPTIVE0ILL 3CREENING#HECKLIST 4HISTOOLISDESIGNEDTOHELPPROVIDERSREMEMBERWHATTOASKACLIENTWHENSCREENINGHERFOR %#0PROVISION

„ (ANDOUT#OUNSELINGFOR%MERGENCY#ONTRACEPTIVE0ILL #LIENTS 4HISTOOLHELPSTRAINPROVIDERSTOCOUNSELWOMENINAMANNERTHATISRESPECTFULOFTHECLIENT ANDRESPONSIVETOHERNEEDSFORINFORMATIONANDCOUNSELING

„ (ANDOUT#OUNSELING3KILLS/BSERVER#HECKLIST 4HISTOOLCANBEUSEDBOTHINTRAININGANDASAREMINDERFORPROVIDERSONTHEBESTWAYSTO COUNSELWOMENFOR%#0USE

(  „ 4RAINING!ID'RAB"AGˆ+EY-ESSAGESFOR%MERGENCY #ONTRACEPTIVE0ILL#LIENTS 4HESESTATEMENTSAREINTENDEDTOBEUSEDASTRAININGTOOLSFORPROVIDERS4HEPIECESCANBE

-ODULE( DRAWNFROMABAGORHATANDACTASPROMPTSFORWHATAPROVIDERSHOULDTELLACLIENTABOUT %#0S

„ 4OOLS 4RAINING!ID$EMONSTRATION2OLE 0LAY 4HISROLE PLAYISATOOLTHATCANHELPPROVIDERSPREPAREFORAVARIETYOFSITUATIONSINWHICH MANYDIFFERENTTYPESOFWOMENMAYREQUEST%#0S

„ 4RAINING!ID%MERGENCY#ONTRACEPTIVE0ILL#LIENT 3ITUATION2OLE 0LAYS 4HESEROLE PLAYSARETOOLSTHATCANHELPPROVIDERSPREPAREFORTHEMANYDIFFERENTTYPESOF SITUATIONSANDWOMENTHATMAYREQUEST%#0S

(  4OOLS

%MERGENCY#ONTRACEPTION#URRICULUM -ODULE( FOR[INSERTGROUP]IN[INSERTCOUNTRY]

/VERVIEW ,EARNINGOBJECTIVES

"YTHEENDOFTHISTRAINING PARTICIPANTSWILLBEABLETO Ŷ $ESCRIBETHEHISTORYANDEXPANDINGROLEOFEMERGENCYCONTRACEPTIONINPREGNANCYPREVENTION Ŷ $ESCRIBEKEYFACTSABOUTEMERGENCYCONTRACEPTIONINCLUDINGDIFFERENTREGIMENS EFFECTIVENESS MECHANISMOFACTION SAFETY ANDSIDEEFFECTS Ŷ %XHIBITGOODEMERGENCYCONTRACEPTIVECOUNSELINGSKILLS Ŷ )DENTIFYMECHANISMSFORRAISINGAWARENESSOFEMERGENCYCONTRACEPTIONWITHINTHECLIENTPOPULATION Ŷ )NCREASETHEIRAWARENESSOFEMERGENCYCONTRACEPTIONRESOURCESIN;INSERTCOUNTRY= 4IME

!PPROXIMATELYHOURSANDMINUTESDEPENDINGONLENGTHANDFREQUENCYOFBREAKS  !GENDA  )NTRODUCTIONAND0RE 3ESSION1UESTIONNAIREMIN  5NINTENDED0REGNANCYMIN  "ACKGROUNDON%MERGENCY#ONTRACEPTIONMIN  %FFECTIVENESSOF4WO%MERGENCY#ONTRACEPTIVE0ILL2EGIMENSMIN  $ESCRIPTIONOF%MERGENCY#ONTRACEPTIVE0ILL2EGIMENSMIN  %MERGENCY#ONTRACEPTIVE0ILL-ECHANISMOF!CTIONMIN  %MERGENCY#ONTRACEPTIVE0ILL3AFETYAND5SEMIN  #OMMON3IDE%FFECTSMIN  %MERGENCY#ONTRACEPTION3CREENINGAND#OMMUNICATIONMIN  #OUNSELINGFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTSMIN  &OLLOW 5PAND2EFERRALFOR#LIENTSMIN  )NCREASING!WARENESSOF%MERGENCY#ONTRACEPTIONMIN  2EVIEW #ONCLUSION AND0OST 3ESSION1UESTIONNAIREMIN (ANDOUTSANDTRAININGAIDS 0RE AND0OST 3ESSION1UESTIONNAIRE (/ +EY-ESSAGESFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTS (/ 3AMPLE%MERGENCY#ONTRACEPTIVE0ILL3CREENING#HECKLIST (/ #OUNSELINGFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTS

(  (/ #OUNSELING3KILLS/BSERVER#HECKLIST 4! 'RAB"AGˆ+EY-ESSAGESFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTS 4! $EMONSTRATION2OLE PLAY 4! %MERGENCY#ONTRACEPTIVE0ILL#LIENT3ITUATION2OLE 0LAYS -ODULE( 0REPARATION

9OUWILLNEEDTHEFOLLOWINGMATERIALS

4OOLS Ŷ &LIPCHART OVERHEAD ORCHALKBOARD Ŷ -ARKERSORCHALK ,OCALDATAONTHEFOLLOWINGISSUESCANBEUSED Ŷ .UMBEROFUNINTENDEDPREGNANCIESBYYEARFORTHEPASTSEVERALYEARS Ŷ .UMBEROFPREGNANCIESINGIRLSUNDERYEARSOFAGEFORTHEPASTSEVERALYEARS Ŷ .UMBEROFABORTIONSBYYEAR Ŷ .UMBEROFABORTIONSTOGIRLSUNDERYEARSOFAGEBYYEAR Ŷ %MERGENCYCONTRACEPTIONAVAILABILITY Ŷ 3TATUSOFDEDICATEDEMERGENCYCONTRACEPTIVEPILLPRODUCT Ŷ %MERGENCYCONTRACEPTIONAWARENESSORUSE Ŷ ,OCALBRANDSOFANTIEMITICSIE ANTINAUSEADRUGS  #ONTENTANDFORMATFORTHISCURRICULUMWEREADAPTEDFROM s $IVERSE!UDIENCES%MERGENCY#ONTRACEPTION#LINICAL0ROVIDER4RAINING#URRICULUM3EATTLE 7! 0!4(  s #OMPREHENSIVE2EPRODUCTIVE(EALTHAND&AMILY0LANNING4RAINING#URRICULUM-ODULE %MERGENCY#ONTRACEPTIVE0ILLS 7ATERTOWN -!0ATHlNDER)NTERNATIONALREVISED  s 3PECIAL2EPORTON%MERGENCY#ONTRACEPTION4HE0HARMACISTS2OLE!MERICAN0HARMACEUTICAL !SSOCIATION  s %XPANDING'LOBAL!CCESSTO%MERGENCY#ONTRACEPTION!#OLLABORATIVE!PPROACHTO-EETING 7OMENS.EEDS3EATTLE 7!)NTERNATIONAL#ONSORTIUMFOR%MERGENCY#ONTRACEPTION 

(  4OOLS

)NTRODUCTIONAND0RE 3ESSION1UESTIONNAIRE -INUTES -ODULE(

 )NTRODUCETRAINERANDPARTICIPANTS  2EVIEWOBJECTIVESOFTHISSESSIONWRITEOUTONmIPCHARTPAPER OVERHEAD ORCHALKBOARD   %STABLISHTIMEFRAMEFORTHISSESSION

3EE/VERVIEWFOROBJECTIVES%MPHASIZEPRACTICALAPPROACHOFTRAINING 4HISTRAININGISDESIGNEDTOBUILDKNOWLEDGEOFEMERGENCYCONTRACEPTION%# BYPROVIDING ACCURATE UP TO DATEINFORMATION4HESESSIONISSCHEDULEDTOLASTFORAPPROXIMATELYlVEHOURSAND THIRTYMINUTES$URINGTHESESSIONPARTICIPANTSWILLSHARETHEIRTHOUGHTS IDEAS ANDEXPERIENCESIN DISCUSSIONS SMALLGROUPWORK ROLE PLAYS ANDLARGEGROUPDISCUSSIONS%NCOURAGEPARTICIPANTSTOASK QUESTIONSWHENTHEYHAVETHEM

 $ISTRIBUTEPRE SESSIONQUESTIONNAIRE!LLOWPARTICIPANTSAPPROXIMATELYTENMINUTESTOCOMPLETE THEQUESTIONNAIRE

(  5NINTENDED0REGNANCY -INUTES

$ISCUSSION PRESENTATION PAIRWORK ANDBRAINSTORMING -ODULE(

 !SKPARTICIPANTSh7HATISUNINTENDEDPREGNANCY (OWCOMMONISIT v,ISTPARTICIPANTS RESPONSESONAmIPCHART OVERHEAD ORCHALKBOARD  5SINGTHEPARTICIPANTRESPONSES DElNEUNINTENDEDPREGNANCYANDITSCONSEQUENCES0RESENT 4OOLS INFORMATIONBELOWIFNECESSARY  ,INKTHISINFORMATIONTOTHENEEDFOR%# CITINGDATAONNEEDFROM;INSERTCOUNTRY=

$ElNITION5NINTENDEDPREGNANCYIShAPREGNANCYTHATISUNWANTEDORMISTIMEDATCONCEPTIONv 5NINTENDEDPREGNANCYDOESNOTMEANUNWANTEDBIRTHSORUNLOVEDCHILDREN(OWEVER ITDOESMEAN LESSOPPORTUNITYTOPREPAREANDLESSTIMEFOR s 0REPREGNANCYRISKIDENTIlCATION s -ANAGEMENTOFPREEXISTINGCONDITIONS s #HANGESINDIETANDVITAMINS s !VOIDANCEOFALCOHOL TOXICEXPOSURE ANDSMOKING s %NSURINGTHElNANCIALRESOURCESNEEDEDTODELIVERANDSUPPORTANEWCHILD %ACHYEARINTHEWORLD s 3EVENTY lVEMILLIONWOMENEXPERIENCEANUNINTENDEDPREGNANCY s 4HIRTYMILLIONWOMENEXPERIENCECONTRACEPTIVEFAILURE s !PPROXIMATELYMILLIONABORTIONSOCCUR OFWHICHTWENTYMILLIONAREUNSAFE 

 !SKPARTICIPANTSTOWORKINPAIRSFORlVEMINUTES%ACHPAIRSHOULDMAKEALISTOFTHEIR RESPONSESTOTHEQUESTIONh7HATARETHECONSEQUENCESOFUNINTENDEDPREGNANCY v  !SKSEVERALVOLUNTEERSTOOFFERITEMSFROMTHEIRLIST0RESENTINFORMATIONBELOWASSUMMARY

#ONSEQUENCESOFUNINTENDEDPREGNANCIESCANBESIGNIlCANT 0OSSIBLERESPONSESINCLUDE s (EALTHRISKSTOMOTHER s 2ELIANCEONABORTIONTOENDPREGNANCY s $ISCONTINUATIONOFSCHOOLINGFORADOLESCENTS  s %MOTIONALDISTRESS s %CONOMICHARDSHIP s $ISAPPROVALFROMTHECOMMUNITY ESPECIALLYFORYOUNG UNMARRIEDWOMEN s 0OSSIBLEHEALTHRISKSTOINFANTS INCLUDINGBIRTHINJURIES LOWERBIRTHWEIGHT ANDALOWERCHANCEOF SURVIVAL 7HEREABORTIONISILLEGALORRESTRICTEDBYAGE WOMENMAYSEEKANILLEGALPROVIDERWHOMAY BEUNSKILLEDORMAYPRACTICEUNDERUNSANITARYCONDITIONS5NSAFEABORTIONREPRESENTSAHIGH

(  4OOLS

PROPORTIONOFTHEMATERNALDEATHS.EARLYPERCENTOFALLMATERNALDEATHSARETHERESULTOFABORTION COMPLICATIONS;)NSERTCOUNTRY SPECIlCDATAONUNSAFEABORTION= -ODULE(

 "RIEmYINTRODUCE%#USINGTHEINFORMATIONBELOW

%MERGENCYCONTRACEPTIONISTHEONLYCURRENTLYAVAILABLECONTRACEPTIVEMETHODTHATPREVENTS PREGNANCYAFTERSEXUALINTERCOURSEANDBEFOREIMPLANTATION"ECAUSETHEREISNOPERFECTFORMOF CONTRACEPTIONANDTHEREAREVERYFEWPERFECTCONTRACEPTIVEUSERS ITISIMPORTANTTOREMEMBERTHATEVEN THOSECOUPLESUSINGCONTRACEPTIONFAITHFULLYANDCORRECTLYCANEXPERIENCECONTRACEPTIVEFAILURE

 !SKPARTICIPANTSh7HYORWHENWOULDSOMEONENEED%# v,ISTPARTICIPANTSRESPONSESONA mIPCHART OVERHEAD ORCHALKBOARD  $ISCUSSANDCOMPLEMENTPARTICIPANTRESPONSESWITHTHEINFORMATIONBELOW

4HEREAREDIFFERENTREASONSACLIENTMIGHTNEED%#4HOSEREASONSARE s )FACOUPLERECENTLYHADSEXWITHOUTUSINGCONTRACEPTION s )FACONDOMBROKEORSLIPPED s )FAWOMANUSINGORALCONTRACEPTIVEPILLSMISSEDTHREEORMOREPILLS s )FAWOMANUSINGCONTRACEPTIVEINJECTIONSWASLATEFORHERSHOT s )FAWOMANTHINKSTHATHERDIAPHRAGMORCERVICALCAPSLIPPED s )FAWOMANEXPERIENCEDAN)5$EXPULSION s )FSEXWASFORCEDRAPE  3UMMARYOFKEYPOINTS

Ŷ ;)NSERTCOUNTRY SPECIlCDATATODEMONSTRATETHEMAGNITUDEOFTHEPROBLEMOFUNINTENDEDPREGNANCY= Ŷ %#HASAVERYSTRONGPOTENTIALROLEINREDUCINGUNINTENDEDPREGNANCY Ŷ 4HEHEALTHANDSOCIALCONSEQUENCESOFUNINTENDEDPREGNANCYARESIGNIlCANT Ŷ 5SEOF%#AFTERCONTRACEPTIVEFAILUREORWHENNOCONTRACEPTIONWASUSEDREPRESENTSARESPONSIBLE CHOICETOPREVENTPREGNANCY

(  "ACKGROUNDON%MERGENCY#ONTRACEPTION -INUTES

"RAINSTORMINGANDPRESENTATION -ODULE(

!SKPARTICIPANTSh7HATDOYOUKNOWORWHATHAVEYOUHEARDABOUT%# v ,ISTPARTICIPANTSRESPONSESONmIPCHART OVERHEAD ORCHALKBOARD4ELLPARTICIPANTSTHAT WHILESOMEOFTHETHINGSTHEYHAVEHEARDORBELIEVEABOUT%#MAYNOTBECOMPLETELY 4OOLS CORRECT THETRAININGSESSIONTODAYWILLCLARIFYPOINTSOFCONFUSIONANDCORRECTANY MISINFORMATION (IGHLIGHTTHEHISTORYOF%#INTRODUCTIONWITHSPECIlCINFORMATIONABOUT%#INTRODUCTION ANDAVAILABILITYIN;INSERTCOUNTRY=

%MERGENCYCONTRACEPTIONISNOTNEW s (IGH DOSEWEREUSEDFOR%#INTHES s )NTHEMID S $R!LBERT9UZPESRESEARCHONHIGH DOSEESTROGENREGIMENSLEDTOTHECURRENT REGIMENUTILIZINGAVAILABLECOMBINEDORALCONTRACEPTIVEPRODUCTS!LSOINTHES RESEARCH BEGANONTHEUSEOFPROGESTIN ONLYPILLS s 2EGULATORYAUTHORITIESTHROUGHOUTTHEWORLDINCLUDING&RANCE THE5NITED+INGDOM ANDTHE 5NITED3TATES HAVEAPPROVED%#PRODUCTS%MERGENCY#ONTRACEPTIVE0ILLS%#0S AREONTHE 7ORLD(EALTH/RGANIZATION-ODEL%SSENTIAL-EDICINE,IST3EETHEAPPENDIXFORALISTOFWEBSITE RESOURCESANDALINKTOTHE7(/%SSENTIAL-EDICINE,IST4HISLISTALSOPROVIDESALINKTOTHE )NTERNATIONAL#ONSORTIUMFOR%MERGENCY#ONTRACEPTIONSLISTOFOTHERCOUNTRIESWITHREGISTERED %#PRODUCTS s ;)NSERTRELEVANTCOUNTRY SPECIlCDATAON%#INTRODUCTIONANDAVAILABILITY= s 7ITHTHESEDEVELOPMENTS THEUSEOF%#ISINCREASINGANDLIKELYWILLCONTINUETOEXPAND)TIS IMPORTANTTHATPROVIDERSBEPREPAREDTOHELPWOMENUSEITEFFECTIVELY

 %XPLAINTHETWOTYPESOF%#

4HEREARETWOTYPESOF%#%#0SAND)5$INSERTION %#0S

%#0SAREHIGHERDOSESOFTHESAMEHORMONESFOUNDINORDINARYBIRTHCONTROLPILLS%#0SSHOULD BEINITIATEDASSOONASPOSSIBLEWITHINDAYSHOURS AFTERUNPROTECTEDSEX%#0SAREMORE EFFECTIVETHESOONERTHEYARETAKEN7OMENSHOULDBEENCOURAGEDTOTAKETHE%#0SASSOONAS POSSIBLEWITHINHOURS BUTTHEYSHOULDUNDERSTANDTHATTHEEFFECTIVENESSOFTHEPILLSISLESSENED THELONGERONEWAITSAFTERINTERCOURSETOTAKETHEM %#0SARESOMETIMESREFERREDTOASTHEhMORNINGAFTERPILL vDESPITETHELONGERWINDOWOF OPPORTUNITYFORTHEIRUSE2ECOMMENDEDDOSINGDIFFERSDEPENDINGONTHETYPEOF%#0THATIS TAKEN %#0SARENOTTHESAMEASMISOPROSTOL MIFEPRISTONE OR25THE&RENCHABORTIONPILL ANDTHEYCANNOTCAUSEANABORTION %#0SCANBEPROVIDEDTOWOMENBEFORETHEYNEEDTHEM7EKNOWTHATCONTRACEPTIVESFAILAND SOMETIMESWOMENAREUNABLETOUSEACONTRACEPTIVEMETHOD4HEREFORE ITMAYBEIMPORTANTFOR

(  4OOLS

WOMENTOHAVE%#0SAVAILABLEATHOMEINTHEEVENTTHATTHEYHAVEUNPROTECTEDINTERCOURSEANDDONOT WANTTOGETPREGNANT(AVING%#0SATHOMEWILLHELPENSURETHATTHEYAREEASILYAVAILABLEANDCANBE -ODULE( USEDSOONAFTERINTERCOURSEWHENTHEYAREMOSTEFFECTIVE )5$)NSERTION

)5$INSERTIONWITHINDAYSOFUNPROTECTEDSEXALSOISANEFFECTIVEFORMOF%#ANDHASTHEADDED BENElTOFPROVIDINGTHECLIENTWITHALONG TERMCONTRACEPTIVEMETHOD0ROVIDERSNOTTRAINEDIN)5$ INSERTIONCANREFERWOMENTOHEALTHCAREPROVIDERSFORTHISPROCEDURE(OWEVER THISMUSTOCCUR WITHINTHETIMEFRAMEABOVE $FRSSHU7,8'XVHGIRU(&UHGXFHVWKHULVNRISUHJQDQF\DIWHUXQSURWHFWHGLQWHUFRXUVHE\ SHUFHQW )FINSERTEDFOR%# )5$SCANBERETAINEDFORUPTOYEARSORREMOVEDDURINGTHECLIENTSNEXT MENSTRUATION 3CREENINGFORAN)5$ASAN%#METHODSHOULDFOLLOWREGULAR)5$SCREENINGCRITERIA)NADDITION THEPROVIDERSHOULDASCERTAINTHATTHEUNPROTECTEDINTERCOURSEOCCURREDWITHINDAYSOFSEEKING TREATMENT ./4%)FASKEDABOUTTHEMECHANISMOFACTION THETRAINERMAYEXPLAINTHATTHECOPPERONTHE)5$ CANPREVENTFERTILIZATIONORINHIBITIMPLANTATION

 .OTETOPARTICIPANTSTHATTHETRAININGWILLFOCUSON%#0SBECAUSETHEYAREACCESSIBLETHROUGHA VARIETYOFPROVIDERS WHEREAS)5$SCANONLYBEINSERTEDBYPHYSICIANS

3UMMARYOFKEYPOINTS

Ŷ %#HASBEENINUSEFOROVERYEARSANDMANYINTERNATIONALREGULATORYBODIESAPPROVEIT Ŷ 4HEREARETWOTYPESOF%#%#0SAND)5$INSERTION%#0SARETHEFOCUSOFTHETRAININGSINCETHEYARE THEMOSTEASILYACCESSIBLEANDAVAILABLE Ŷ %#ISINCREASINGLYBEINGRECOGNIZEDASASTANDARDOFCAREFORPREVENTIONOFPREGNANCYAFTER UNPROTECTEDINTERCOURSE

(  %FFECTIVENESSOF4WO%MERGENCY#ONTRACEPTIVE0ILL2EGIMENS -INUTES

0RESENTATION -ODULE( )NTRODUCETHETWOTYPESOF%#0REGIMENS REVIEWTHEIREFFECTIVENESS ANDDISCUSSTHEDOSAGE REQUIREMENTS5SETHEINFORMATIONBELOW

4HEREARETWOTYPESOF%#0SCURRENTLYINUSETHATWILLBEDISCUSSEDINTHISTRAINING%ACHTYPEOR 4OOLS REGIMENISDElNEDBYTHETYPEOFHORMONEORACTIVEINGREDIENTSUSED s 4HEPROGESTIN ONLYREGIMENCONSISTSOFMGLEVONORGESTRELORNORGESTREL TAKENINASINGLE DOSEASSOONASPOSSIBLEAFTERUNPROTECTEDINTERCOURSE)TCANBETAKENUPTOHOURSORlVEDAYS AFTERUNPROTECTEDINTERCOURSE)TISIMPORTANTTOTAKETHEPILLSASSOONASPOSSIBLEBECAUSETHEIR EFFECTIVENESSDECREASESOVERTIME s %STROGENANDPROGESTINTHECOMBINEDREGIMEN ORTHE9UZPEREGIMEN ISETHINYLESTRADIOLPLUS LEVONORGESTRELORNORGESTREL 4AKETHElRSTDOSEASSOONASPOSSIBLEAFTERUNPROTECTEDINTERCOURSE ANDTHESECONDDOSEHOURSLATER)TCANBETAKENUPTOHOURSORlVEDAYSAFTERUNPROTECTED INTERCOURSE)TISIMPORTANTTOTAKETHEPILLSASSOONASPOSSIBLEBECAUSETHEIREFFECTIVENESSDECREASES OVERTIME .OTE4HETWODOSESOFTHECOMBINED%#0REGIMENSHOULD./4BETAKENATONETIMEBECAUSEOFTHE INCREASEDRISKOFNAUSEAANDVOMITING 4HEDIFFERENCESINBOTHEFFECTIVENESSANDSIDEEFFECTSBETWEENTHETWOMETHODSARESIGNIlCANTAND SUBSTANTIAL4HEPROGESTIN ONLYMETHODISBOTHMOREEFFECTIVEANDPRODUCESFEWERSIDEEFFECTS

2EGIMEN %FFECTIVENESS 6LGHHIIHFWV 2EDUCESTHERISKOFPREGNANCY .AUSEAINPERCENTOFWOMENANDVOMITING 0ROGESTIN ONLY BYPERCENT INPERCENT #OMBINEDESTROGEN 2EDUCESTHERISKOFPREGNANCY .AUSEAPRESENTINPERCENTOFWOMENUSING PROGESTIN BYPERCENT THISREGIMENANDVOMITINGINPERCENT

)FVOMITINGOCCURSWITHINONEHOURAFTERTAKINGADOSE TAKEANOTHERDOSEASSOONASPOSSIBLE)F VOMITINGOCCURSMORETHANONEHOURAFTERTAKING%#0S YOUDONOTNEEDTOREPEATTHEDOSE 1HLWKHUPHWKRGZLOOZRUNLIDZRPDQLVDOUHDG\SUHJQDQW 5HVHDUFKKDVGHPRQVWUDWHGWKDWWKHHI¿FDF\RI(&3VGHFUHDVHVDVWKHWLPHLQFUHDVHVEHWZHHQ LQWHUFRXUVHDQGXVHRI(&3V7KLVPHDQVWKDWZRPHQPXVWKDYHUHDG\DFFHVVWR(&3VLQRUGHUWR PD[LPL]HWKHLUHIIHFWLYHQHVV !LMOSTALLOTHERCONTRACEPTIVEMETHODSAREMOREEFFECTIVETHAN%#0SFORREGULARONGOINGUSE%#0S ARENOTPERCENTEFFECTIVE7OMENWHOUSETHEMONAREGULARBASISREPEATEDLYEXPOSETHEMSELVES TOTHERISKOFMETHODFAILURE%#0SREDUCETHERISKOFPREGNANCYBYTOPERCENT4HATISTOSAY THAT IFWOMENHAVEUNPROTECTEDINTERCOURSEDURINGTHEIRMOSTFERTILETIMESOFTHEMONTHANDTAKE s !PROGESTIN ONLY%#REGIMEN THENWILLBECOMEPREGNANT APERCENTREDUCTIONINPREGNANCYRISK s !COMBINEDESTROGENPROGESTIN%#REGIMEN THENWILLBECOMEPREGNANT APERCENTREDUCTIONIN PREGNANCYRISK 7KHVHHVWLPDWHVRIUHGXFWLRQLQWKHULVNRISUHJQDQF\IROORZLQJ(&3XVHDUHEDVHGRQVWXGLHVWKDWHYDOXDWHG(&3XVHZLWKLQD KRXUWLPHIUDPH

(  4OOLS

4HEMORETIMESAWOMANUSESTHEMETHOD THEMORETIMESSHEEXPOSESHERSELFTOPREGNANCYRISK !DDITIONALLY REGULAR%#0USEFOURORMORETIMESAMONTH CAUSESBLEEDINGIRREGULARITY7HILENOT -ODULE( NECESSARILYAHEALTHRISK IRREGULARBLEEDINGISUNACCEPTABLETOMOSTWOMEN 3UMMARYOFKEYPOINTS

Ŷ 4HEREARETWO%#0REGIMENSPROGESTIN ONLYANDCOMBINEDESTROGENANDPROGESTIN Ŷ 4HEPROGESTIN ONLYREGIMENISMOREEFFECTIVEANDHASFEWERSIDEEFFECTS Ŷ "OTH%#0REGIMENSAREMOREEFFECTIVETHESOONERTHEYARETAKEN Ŷ 4HEPROGESTIN ONLYREGIMENMGDOSEOFLEVONORGESTREL CANBESAFELYANDEFFECTIVELYTAKENATONE TIME RATHERTHANHOURSAPART Ŷ %#0SARENOTINTENDEDFORREGULARUSEALMOSTALLOTHERCONTRACEPTIVEMETHODSAREMOREEFFECTIVE

(  $ESCRIPTIONOF%MERGENCY#ONTRACEPTIVE0ILL0RODUCT 2EGIMENS -INUTES -ODULE( 0RESENTATIONANDDISCUSSION

%XPLAINTHAT%#0SAREAVAILABLEINMANYCOUNTRIESASADEDICATEDSPECIlCALLYPACKAGED PRODUCT$ISCUSSTHEAVAILABILITYOFADEDICATEDPRODUCTIN;INSERTCOUNTRY= 4OOLS

"OTHTHEPROGESTIN ONLYANDCOMBINEDREGIMENSAREAVAILABLEINSOMECOUNTRIESASDEDICATED%#0 PRODUCTSˆTHOSEPACKAGEDANDLABELEDSPECIlCALLYFORUSEAS%#0S)FITISAVAILABLEANDAFFORDABLE THEPROGESTIN ONLYREGIMENISRECOMMENDEDOVERTHECOMBINEDREGIMEN4HEPROGESTIN ONLYREGIMEN ISMOREEFFECTIVEANDHASFEWERSIDEEFFECTS4HECOMBINEDREGIMEN HOWEVER ISBETTERTHANNO%#0S ATALL ;)NSERTCOUNTRY SPECIlCDATAONSTATUSOFDEDICATEDPRODUCT)NCLUDEINFORMATIONONTHEBRANDNAME THECOSTANDWHETHERTHEPRODUCTISAVAILABLEINPHARMACIES=

!SKPARTICIPANTSIFTHEYHAVEHEARDOFREGULARORALCONTRACEPTIVEPILLPACKETSBEINGUSEDFOR%# !SK h(OWCANREGULARORALCONTRACEPTIVEPILLSBEUSEDAS%# v %XPLAINTHEDIFFERENTWAYS%#MAYBEPROVIDEDWITHREGULARORALCONTRACEPTIVEPILLSUSINGTHE INFORMATIONPROVIDEDBELOW(AVEPARTICIPANTSFOLLOWTHEDISCUSSIONUSINGTHETABLEIN(/ +EY-ESSAGESFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTS

2EGULARORALCONTRACEPTIVEPILLSCANBEUSEDFOR%#4HEDOSESOFCOMBINEDORALCONTRACEPTIVES APPROXIMATETHEAMOUNTOFTHEESTROGENANDTHEPROGESTINUSEDINTHE9UZPEREGIMEN-OSTOFTHE BRANDSLISTEDINTHETABLEONTHETHIRDPAGEOF(/+EY-ESSAGESFOR%MERGENCY#ONTRACEPTIVE0ILL #LIENTSANDTHENEXTPAGE REQUIRETAKINGORPILLSFORTHElRSTDOSEANDORPILLSFORTHESECOND DOSE"ECAUSETHESEARECOMBINEDESTROGENANDPROGESTIN PILLS THEYCANNOTBETAKENINASINGLE DOSE

(  4OOLS

%#0&ORMULATIONS -ODULE(

3ECOND &IRST$OSE $OSE &ORMULATION NUMBEROF NUMBEROF PERPILL #OMMON"RAND.AMES TABLETS TABLETS

0ROGESTIN ONLY ,.'MG ,EVONELLE  .OR,EVO   2EGIMEN 0LAN" 0OSTINOR  6IKELA 3INGLE$OSE

#OMBINED %%MCG ,.'MG %UGYNON &ERTILAN 2EGIMEN OR .EOGYNON .ORAL  %%MCG .'MG .ORDIOL /VIDON /VRAL /VRAN 0#  0REVEN

%%MCG ,.'MG ,O&EMENAL -ICROGYNON OR .ORDETTE /VRAL, 2IGEVIDON   %%MCG .'MG

!BBREVIATIONS%%ETHINYLESTRADIOL,.'LEVONORGESTREL.'NORGESTREL

&ORALLREGIMENS THElRSTDOSESHOULDBETAKENASSOONASPOSSIBLEAFTERINTERCOURSE BUTOPTIMALLYWITHIN HOURS4HESECONDDOSEOFTHECOMBINEDREGIMENSHOULDBETAKENHOURSAFTERTHElRSTDOSE4HE PROGESTIN ONLYREGIMENDOSESMAYBETAKENALLATONETIME

!DAPTEDFROM%XPANDING'LOBAL!CCESSTO%MERGENCY#ONTRACEPTION)NTERNATIONAL#ONSORTIUMFOR %MERGENCY#ONTRACEPTION/CTOBER P

)NFORMATIONINTHISTABLEHASBEENUPDATEDTOREmECTCURRENTRESEARCH VON(ERTZEN (ETAL,OWDOSEMIFEPRISTONEANDTWOREGIMENSOFLEVONORGESTRELFOREMERGENCY CONTRACEPTIONA7(/MULTICENTRERANDOMIZEDTRIAL,ANCET   

7RKHOSWKHFOLHQWDYRLGPLVWDNHVLQWDNLQJWKHUHJLPHQWKHSURYLGHURUVWDIIVKRXOGFXWXSRUDO FRQWUDFHSWLYHSLOOSDFNHWVDQGJLYHRQO\WKHVSHFL¿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¿HGFOHDUO\DQGWKDW WKHZRPHQDUHLQVWUXFWHGFDUHIXOO\DERXWWKHQXPEHUDQGFRORURIWKHWDEOHWVUHTXLUHGIRUHDFKGRVH 7RKHOSHQVXUHFRPSOLDQFHZLWKWKHUHJLPHQZKHQXVLQJUHJXODURUDOFRQWUDFHSWLYHVSURYLGHZULWWHQ LQIRUPDWLRQ0DQXIDFWXUHUVRIRUDOFRQWUDFHSWLYHVGRQRWSURYLGHSDWLHQWLQIRUPDWLRQDERXW(&

(  (IGH DOSEORALCONTRACEPTIVECOMBINATIONSPILLSCONTAININGMORETHAN—GOFESTROGEN AND TRIPHASICFORMULATIONS SHOULDNOTBEUSEDAS%#0S 3UMMARYOF+EY0OINTS Ŷ 4HEREAREDEDICATED%#0PRODUCTSINMANYCOUNTRIES -ODULE( Ŷ $EDICATED%#0PRODUCTSAREPREFERREDBECAUSETHEYAREPACKAGEDANDLABELEDSPECIlCALLYFORUSEAS %#0SANDBECAUSETHEREISLESSCHANCEFORERROR Ŷ 7HERENODEDICATEDPRODUCTISAVAILABLE REGULARORALCONTRACEPTIVEPILLSCANBEUSEDFOR%#

4OOLS Ŷ 7HEN#/#SAREREPACKAGEDAS%#0S PROVIDECLEARPRODUCTIDENTIlCATIONANDCLIENTINSTRUCTIONS Ŷ %#0AVAILABILITYIN;INSERTCOUNTRY=

7ULSKDVLFIRUPXODWLRQRI2&VDOWHUWKHGRVDJHRIHVWURJHQDQGSURJHVWLQWKURXJKRXWWKHPRQWKO\UHJLPHQWRDOWHUVWHURLGOHYHOVLQDQ HIIRUWWRPLQLPL]HPHWDEROLFHIIHFWVDQGEUHDNWKURXJKEOHHGLQJDQGDPHQRUUKHD7KH\VKRXOGQRWEHXVHGDV(&3V

(  4OOLS

%MERGENCY#ONTRACEPTIVE0ILL-ECHANISMOF!CTION -INUTES -ODULE(

"RAINSTORMING DISCUSSION ANDPRESENTATION

.OTETO4RAINER9OUMAYWISHTOHAVEAPHYSICIANOROTHERCLINICIANPRESENTDURINGTHEDISCUSSIONON %#0MECHANISMOFACTIONTOHELPEXPLAINTHEPROCESSOFPREGNANCYANDHOWHORMONALCONTRACEPTIVES WORK

!SKPARTICIPANTSh(OWDO%#0SPREVENTPREGNANCY v#ONlRMORCORRECTPARTICIPANTS RESPONSES .OTETHECONTENTOFPARTICIPANTSRESPONSESRELATEDTO%#0SMECHANISMOFACTIONONAmIP CHART OVERHEAD ORCHALKBOARD 0ROVIDETHEINFORMATIONBELOWIFITISNOTCOVEREDTHROUGHTHEQUESTIONANDANSWERS

%#0SWORKTHESAMEWAYREGULARORALCONTRACEPTIVEPILLSWORK4HESEPILLSMAYWORKINMORE THANONEWAY7ECLEARLYUNDERSTANDSOMEOFTHESEWAYSOTHERSAREPOSSIBLEBUTNOTYETPROVEN s 6WDWLVWLFDOHYLGHQFHVXJJHVWVWKDW(&3VPXVWZRUNWKURXJKPRUHWKDQRQHPHFKDQLVPRIDFWLRQRU WKH\FRXOGQRWEHDVHIIHFWLYHDVWKH\DUH s 5HVHDUFKKDVVKRZQWKDW(&3VFDQLQKLELWRUGHOD\RYXODWLRQ s (&3VPD\SUHYHQWLPSODQWDWLRQ LHWKHLPSODQWLQJRIWKHIHUWLOL]HGHJJLQWKHOLQLQJRIWKHXWHUXV E\ DOWHULQJWKHHQGRPHWULXP WKHOLQLQJRIWKHXWHUXV +RZHYHUWKHHYLGHQFHIRUHQGRPHWULDOHIIHFWVRI (&3WUHDWPHQWLVPL[HGDQGLWLVQRWFOHDUWKDWWKHHQGRPHWULDOFKDQJHVZRXOGLQKLELWLPSODQWDWLRQ 

s ,WLVSRVVLEOHWKDW(&3VLQKLELWIHUWLOL]DWLRQ²WKURXJKWKLFNHQLQJRIWKHFHUYLFDOPXFRXVUHVXOWLQJLQ WUDSSLQJRIVSHUPRUDOWHUDWLRQVLQWKHWXEDOWUDQVSRUWRIVSHUPRUHJJ²EXWQRGDWDH[LVWUHJDUGLQJ FRQ¿UPDWLRQRIWKLVSRVVLEOHPHFKDQLVPRIDFWLRQ 4IMINGPLAYSAKEYROLEINHOW%#0SWORK/FPARTICULARIMPORTANCEIS s &\FOHGD\RQZKLFKLQWHUFRXUVHRFFXUUHG s &\FOHGD\RQZKLFKWUHDWPHQWLVXVHG %#0SROLEINPREVENTINGPREGNANCY s ,WWDNHVDERXWGD\VDIWHURYXODWLRQIRUDIHUWLOL]HGHJJWREHJLQWRLPSODQW7KHUHIRUHLQWHUYHQWLRQ ZLWKLQKRXUVRUXSWRGD\VFDQQRWUHVXOWLQDERUWLRQ s $VPHQWLRQHGHDUOLHU(&3VZLOOQRWZRUNLILPSODQWDWLRQKDVRFFXUUHGDQGDZRPDQLVDOUHDG\ SUHJQDQW (&3VGRQRWLQWHUIHUHZLWKDQHVWDEOLVKHGSUHJQDQF\6WXGLHVRIRUDOFRQWUDFHSWLYHVWDNHQ LQDGYHUWHQWO\LQHDUO\SUHJQDQF\VKRZQRLQFUHDVHGULVNRIPLVFDUULDJHRUFRQJHQLWDO DEQRUPDOLWLHV :RPHQPD\ZDQWWRNQRZKRZ(&3VZRUNLQRUGHUWRPDNHDQLQIRUPHGFKRLFHDERXW(&3XVH 7KHUHIRUHLWLVLPSRUWDQWWKDWWKHSURYLGHUXQGHUVWDQGDQGEHDEOHWRGHVFULEHKRZ(&3VZRUN ,PSRUWDQWSRLQWVWRFRPPXQLFDWHWRFOLHQWVDERXWWKHPHFKDQLVPRIDFWLRQDUHWKDW(&3V s :RUNWKURXJKYDULRXVPHFKDQLVPV s :LOOQRWLQWHUUXSWRUKDUPDQHVWDEOLVKHGSUHJQDQF\ LHLWLV127DPHGLFDODERUWLRQ 

(  s $UHQRWWKHVDPHDVPLIHSULVWRQH 58WKH³$ERUWLRQ3LOO´ ZKLFKLVXVHGWRWHUPLQDWHDQ HVWDEOLVKHGSUHJQDQF\ 3UMMARYOF+EY0OINTS Ŷ %#0SARETHOUGHTTOWORKINSEVERALWAYS7EHAVEMORECLINICALEVIDENCEONSOMEOFTHESEWAYS -ODULE( THANONOTHERS%#0SWORKTHESAMEWAYREGULARORALCONTRACEPTIVEPILLSWORK Ŷ %#0SWILLNOTCAUSEANABORTION Ŷ 4IMINGPLAYSAKEYROLEINHOW%#0SWORK

4OOLS Ŷ )FAWOMANTAKES%#0SANDSTILLBECOMESPREGNANT THEPREGNANCYWILLNOTBEHARMEDBYTHE%#0USE Ŷ %#0SWILLNOTAFFECTAWOMANSABILITYTOBECOMEPREGNANTINTHEFUTURE

(  4OOLS

%MERGENCY#ONTRACEPTIVE0ILL3AFETYAND5SE -INUTES -ODULE(

"RAINSTORMING DISCUSSION ANDPRESENTATION

!SKPARTICIPANTSh$OYOUTHINK%#0SARESAFE vANDh!RETHEREHEALTHCONDITIONSTHATWOULD PREVENTYOUFROMPROVIDING%#0STOAWOMAN v#ONlRMORCORRECTPARTICIPANTSRESPONSES 5SEAmIPCHARTTORECORDRESPONSES (IGHLIGHTTHEPOINTSONSAFETYPROVIDEDBELOW

!CCORDINGTOTHE7ORLD(EALTH/RGANIZATIONANDTHE)NTERNATIONAL0LANNED0ARENTHOOD&EDERATION THEREARENOCONTRAINDICATIONSFOR%#0SBECAUSETHEAMOUNTOFHORMONEISTOOSMALLTOHAVEA CLINICALLYSIGNIlCANTIMPACTANDTHEDURATIONOFUSEISVERYSHORT  -ANYOFTHECONTRAINDICATIONSFORDAILYORALCONTRACEPTIVESAREBASEDONTHEPRESUMPTIONOFLONG TERMUSE4HE7ORLD(EALTH/RGANIZATIONSTATESTHAT%#0SHAVENOCLINICALLYSIGNIlCANTIMPACTON CONDITIONSSUCHASCARDIOVASCULARDISEASE ANGINA ACUTEFOCALMIGRAINE ORSEVERELIVERDISEASE 2EPEATEDUSEOF%#0SISNOTHARMFULFORMOSTWOMEN&ORSOMEWOMENWHOHAVESEXUALINTERCOURSE INFREQUENTLYDElNEDASFOURORLESSTIMESPERMONTH ANDWHOARENOTATRISKOFSEXUALLYTRANSMITTED INFECTIONS34)S OR()6 %#0SMAYBEANAPPROPRIATEMETHOD&ORAWOMANWHOHASREGULAR INTERCOURSEMULTIPLETIMESWITHINACYCLE FREQUENTUSEOF%#0SISNOTRECOMMENDEDBECAUSE OTHERMETHODSAREMOREEFFECTIVEATPREVENTINGPREGNANCY!DDITIONALLY FREQUENT%#0USEMAYBE MOREEXPENSIVETHANUSINGREGULARCONTRACEPTIVEMETHODS!SMENTIONEDEARLIER REPEATEDUSEOF %#0SWITHINTHESAMECYCLEMAYCAUSEBLEEDINGDISTURBANCES WHICHWHILENOTHARMFUL ARELIKELY TOBEUNACCEPTABLETOAWOMAN(OWEVER AWOMANSHOULDNOTBEDENIED%#0SERVICESBECAUSESHE ISAREPEATUSER UNLESSSHEISSOMEONEFORWHOMORALCONTRACEPTIVESARECONTRAINDICATED)NTHIS SITUATION NONJUDGMENTALCOUNSELINGABOUTOTHERMETHODSISANIMPORTANTPARTOFGOODSERVICE)FA WOMANREGULARLYUSES%#0S ITISIMPORTANTTOTRYTODETERMINEWHYTHEWOMANISNOTUSINGREGULAR CONTRACEPTIONANDTOCOUNSELHERABOUTONGOINGCONTRACEPTION 4HEREARENOKNOWNDRUGINTERACTIONSWITH%#0S'IVENTHESHORTDURATIONOFTREATMENT ITISUNLIKELY THATDRUGINTERACTIONSTHATAFFECTORALCONTRACEPTIVEUSEALSOAFFECT%#0USE(OWEVER WOMEN TAKINGDRUGSTHATMAYREDUCETHEEFlCACYOFORALCONTRACEPTIVESINCLUDING2IFAMPINANDCERTAIN ANTICONVULSANTDRUGS SHOULDBEADVISEDTHATTHEEFlCACYOF%#0SMAYBEREDUCED 3UMMARYOFKEYPOINTS

Ŷ %#0SCANBESAFELYUSEDBYWOMEN Ŷ &REQUENT%#0USEMULTIPLETIMESWITHINONECYCLE DOESNOTPRESENTAHEALTHRISK BUTISNOT RECOMMENDEDBECAUSEITISNOTASEFFECTIVEASOTHERMETHODS

(  &RPPRQ6LGH(IIHFWV -INUTES

"RAINSTORMING DISCUSSION ANDPRESENTATION -ODULE(

!SKPARTICIPANTSh7HATARETHECOMMONSIDEEFFECTSOF%#0SANDHOWCANTHEYBEMANAGED v 7RITERESPONSESONAmIPCHART

4OOLS #ONlRMORCORRECTRESPONSESUSINGTHEINFORMATIONBELOW

(&3VVRPHWLPHVFDXVHVLGHHIIHFWVVXFKDVQDXVHDYRPLWLQJKHDGDFKHVGL]]LQHVVFUDPSLQJIDWLJXH RUEUHDVWWHQGHUQHVV7KHVHVLGHHIIHFWVXVXDOO\JRDZD\ZLWKLQWRGD\VDIWHUWDNLQJWKH(&3V (&3VDOVRPD\FDXVHLUUHJXODUEOHHGLQJXQWLOWKHZRPDQ¶VQH[WSHULRGDQGKHUSHULRGPD\FRPH HDUO\RUODWH+RZHYHULQPRUHWKDQSHUFHQWRIFDVHVPHQVHVZLOOEHRIQRUPDOGXUDWLRQIRUWKH ZRPDQ$VPHQWLRQHGHDUOLHUWKHSURJHVWLQRQO\UHJLPHQFDXVHVIHZHURIWKHVHVLGHHIIHFWV ,IDZRPDQ¶VSHULRGKDVQRWUHVXPHGZLWKLQZHHNVDIWHUWDNLQJWKH(&3VVKHPD\EH SUHJQDQW,WLVLPSRUWDQWWKDWZRPHQXQGHUVWDQGWKLVDQGHLWKHUUHWXUQWRWKH(&3SURYLGHUIRU UHIHUUDOLQIRUPDWLRQRUJRWRDFOLQLF7KLVLVHVSHFLDOO\LPSRUWDQWIRUZRPHQZKRWDNH(&3VPRUH WKDQKRXUVDIWHUXQSURWHFWHGLQWHUFRXUVH s 7KHSURJHVWLQRQO\UHJLPHQLVSUHIHUUHGEHFDXVHLWKDVIHZHUVLGHHIIHFWVWKDQWKHFRPELQHGUHJLPHQ s 1DXVHDDQGYRPLWLQJDUHFRPPRQVLGHHIIHFWVRIWKHFRPELQHGUHJLPHQ

2EGIMEN .AUSEA 6OMITING 2ECOMMENDATIONS

3URJHVWLQRQO\ 2FFXUVLQDERXW 2FFXUVLQRQO\ 2OUTINEUSEOFANANTIEMETICISNOT SHUFHQWRI DERXWSHUFHQW RECOMMENDEDBEFOREWOMENTAKEA ZRPHQ RIZRPHQ DOSEOFTHEPROGESTIN ONLYREGIMEN

&RPELQHG 2FFXUVLQDERXW 2FFXUVLQ 3URSK\ODFWLFXVHRIDQDQWLHPHWLFVXFK HVWURJHQSURJHVWLQ SHUFHQWRI DERXW DVGLPHQK\GULQDWH 'UDPDPLQHŠRU ZRPHQ SHUFHQWRI >LQVHUWORFDOEUDQGQDPH@ LVURXWLQHO\ XVHUV UHFRPPHQGHGWRUHGXFHWKHULVNRI QDXVHDDQGYRPLWLQJZLWKWKHFRPELQHG UHJLPHQ

s ,IYRPLWLQJRFFXUVZLWKLQRQHKRXUDIWHUWDNLQJDGRVHWKHZRPDQVKRXOGUHSHDWWKHGRVH7KLVPHDQV VKHPD\QHHGWRUHWXUQWRWKH(&3SURYLGHURUSKDUPDF\IRUDQRWKHUGRVH,IYRPLWLQJRFFXUVPRUH WKDQRQHKRXUDIWHUWDNLQJDGRVHWKHSLOOVDOUHDG\KDYHEHHQDEVRUEHGDQGWKHZRPDQGRHVQRWQHHG WRUHSHDWWKHGRVH )NSERTSIDEEFFECTINFORMATIONFORLOCALLYAVAILABLEDEDICATEDPRODUCT IFAPPLICABLE 3UMMARYOFKEYPOINTS

Ŷ .AUSEAANDSOMETIMESVOMITINGAREPOTENTIALSIDEEFFECTSOF%#0USE4HEYARENOTDANGEROUSANDARE FARMORECOMMONAMONGWOMENWHOUSETHECOMBINED%#0REGIMEN Ŷ 4HEPROGESTIN ONLYREGIMENISBETTERTOLERATED Ŷ )FAWOMANVOMITSWITHINONEHOURAFTERTAKING%#0S SHESHOULDREPEATTHEDOSE

(  4OOLS

Ŷ !NTIEMETICSCANREDUCETHEFREQUENCYOFNAUSEAANDVOMITINGWITHTHECOMBINEDREGIMEN

Ŷ )FAWOMANSMENSTRUALPERIODISMORETHANWEEKSLATE SHEMAYBEPREGNANTANDMAYNEEDFURTHER -ODULE( COUNSELINGORREFERRALSERVICES)TISESPECIALLYIMPORTANTTHATWOMENWHOTAKE%#0SMORETHAN HOURSAFTERINTERCOURSEBEINFORMEDABOUTTHEPOSSIBILITYOFPREGNANCYOR%#0FAILURE

(  %MERGENCY#ONTRACEPTION3CREENINGAND#OMMUNICATION -INUTES

"RAINSTORMING PAIRWORK PRESENTATION ANDDISCUSSION -ODULE(

!SKPARTICIPANTSh7HATKEYSCREENINGQUESTIONSSHOULDAWOMANBEASKEDWHENPROVIDINGHER WITH%#0SFORRECENTUNPROTECTEDINTERCOURSE v ,ISTRESPONSESONAmIPCHART OVERHEAD ORCHALKBOARD#ORRECTORCOMPLEMENTPARTICIPANTS 4OOLS RESPONSESWITHTHEQUESTIONSLISTEDBELOW4HISINFORMATIONISALSOPROVIDEDIN(/3AMPLE %MERGENCY#ONTRACEPTIVE0ILL3CREENING#HECKLIST-AKESUREPARTICIPANTSUNDERSTANDTHAT %#0SALSOCANBEPROVIDEDBEFOREAWOMANNEEDSTHEM&OREXAMPLE CONDOMUSERSMAYWISH TOKEEPAPACKETOF%#0SATHOMEINCASEOFCONDOMBREAKAGE

4HEIMPORTANTSCREENINGQUESTIONSFOR%#0USEFOLLOWINGRECENTUNPROTECTEDINTERCOURSEARE s $OYOUWANTTOPREVENTPREGNANCY s (AVEYOUHADUNPROTECTEDSEXDURINGTHELASTDAYSHOURS s )FhYESvTHENTHECLIENTMAYBEELIGIBLEFOR%#0S%FFECTIVENESSWILLBELOWERTHELONGERAWOMAN TAKESTOTAKE%#0S s 7ASTHELASTMENSTRUALPERIODLESSTHANWEEKSAGO s 7ASTHISPERIODNORMALINBOTHITSLENGTHANDTIMING s )FhYESvTOTHEPREVIOUSTWOQUESTIONS %#0SMAYBEPROVIDED s )STHEREREASONTOBELIEVEYOUMAYBEPREGNANT s )FTHECLIENTISNOTPREGNANT %#0SMAYBEGIVEN)FTHECLIENTSPREGNANCYSTATUSISUNCLEAR %#0SMAY STILLBEGIVEN WITHTHEEXPLANATIONTHATTHEMETHODWILLNOTWORKIFSHEISALREADYPREGNANT

 4ELLPARTICIPANTSWEWILLNOWDOANEXERCISETOHELPTHEMANSWERCOMMONQUESTIONSCLIENTSWHO SEEK%#0SMAYHAVE  #UTUPACOPYOF4!'RAB"AGˆ+EY-ESSAGESFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTSSO THATEACHQUESTIONISONASEPARATESTRIPOFPAPER 0LACEFOLDEDQUESTIONSINABAGANDSHAKETODISTRIBUTETHEMWITHINTHEBAG  )NVITEONEPARTICIPANTATATIMETOPICKAQUESTIONFROMTHEBAG READITALOUD ANDANSWERIT)F THEPARTICIPANTISUNABLETOANSWERTHEQUESTION ITCANBEPASSEDTOANOTHERPARTICIPANT  )FTHEQUESTIONCANNOTBEANSWEREDBYTHESECONDPARTICIPANT ANSWERTHEQUESTIONANDASSIST PARTICIPANTSTOUNDERSTANDIT#ONlRMORCORRECTANSWERSUSINGTHEINFORMATIONBELOWANDIN (/+EY-ESSAGESFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTS

!FTERAWOMANISSCREENEDFOR%#0SANDGIVENINSTRUCTIONSONHOWTOUSETHEM ITISIMPORTANTTOASK IFSHEHASANYFURTHERQUESTIONSABOUT%#0S3OMEWOMENWILLHAVEMANYQUESTIONSWHILEOTHERS WILLHAVEFEW IFANY BUTITISIMPORTANTTOBEABLETOANSWERWOMENSQUESTIONSWHENASKED"ECAUSE NOTALLWOMENWILLNEEDORWANTALLOFTHEINFORMATIONPROVIDEDBELOWINTHEKEYMESSAGES ITIS RECOMMENDEDTHATITBEUSEDONLYWHENWOMENASKFORIT4HESEMESSAGESAREPROVIDEDBELOWANDIN (/+EY-ESSAGESFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTS

(  4OOLS

7HATAREEMERGENCYCONTRACEPTIVEPILLS

%#0SAREPILLSTHATYOUCANTAKEAFTERSEXTOPREVENTPREGNANCY%#0SAREUSEFULIFYOUHAVEHADSEX -ODULE( WITHOUTUSINGCONTRACEPTIONORIFYOUHADACONTRACEPTIVEFAILURESUCHASABROKENCONDOM  %#0SCONTAINTHESAMEINGREDIENTSASPILLSUSEDFORREGULARCONTRACEPTION BUTINHIGHERAMOUNTS 4HEYAREEFFECTIVEANDSAFE (OWDOEMERGENCYCONTRACEPTIVEPILLSWORK $EPENDINGONWHENYOUUSE%#0SDURINGYOURMONTHLYCYCLE %#0SMAY s 3TOPORDELAYANEGGFROMBEINGRELEASEDFROMTHEOVARY s 3TOPAFERTILIZEDEGGFROMATTACHINGTOYOURUTERUS s 0REVENTTHESPERMFROMGETTINGTOTHEEGG %#0SWILLNOTWORKONCEAPREGNANCYHASSTARTEDAFERTILIZEDEGGHASIMPLANTED  (OWEFFECTIVEAREEMERGENCYCONTRACEPTIVEPILLS %#0SPREVENTMOSTPREGNANCIES BUTTHEYARENOTPERCENTEFFECTIVE 7HENCAN)USE%#0S %#0SCANBEUSEDWITHINlVEDAYSOFUNPROTECTEDINTERCOURSEBUTAREMOSTEFFECTIVETHESOONERTHEY AREUSED 7HATIF)HADUNPROTECTEDSEXMORETHANDAYSAGO )FMORETHANDAYSHAVEPASSEDSINCEYOUHADUNPROTECTEDSEX THE%#0SMAYSTILLHAVESOMEEFFECT BUTITISIMPORTANTTOTAKETHEMASSOONASPOSSIBLE $OEMERGENCYCONTRACEPTIVEPILLSCAUSESIDEEFFECTS %#0SSOMETIMESCAUSENAUSEA VOMITING ANDLESSFREQUENTLY HEADACHES DIZZINESS CRAMPING FATIGUE ORBREASTTENDERNESS4HESESIDEEFFECTSUSUALLYGOAWAYWITHINAFEWDAYSAFTERYOUTAKETHE%#0S %#0SALSOMAYCAUSEIRREGULARBLEEDINGUNTILYOURNEXTPERIOD ANDYOURPERIODMAYCOMEEARLYOR LATE 7HATSHOULD)DOAFTERUSINGEMERGENCYCONTRACEPTIVEPILLS 9OUWILLNOTSEEANYIMMEDIATESIGNSSHOWINGWHETHERTHE%#0SWORKED9OURMENSTRUALPERIODMAY COMEONTIME ORITMAYBEEARLYORLATE)FYOURPERIODHASNOTSTARTEDWITHINWEEKSOFTAKING%#0S YOUMIGHTBEPREGNANT)FYOUAREPREGNANT YOUNEEDTOCONSIDERWHATYOUROPTIONSARE)FYOUHAVE ANYCAUSEFORCONCERN SEEYOURHEALTHCAREPROVIDERORPHARMACIST )FTHEEMERGENCYCONTRACEPTIVEPILLSDONOTWORKAND)BECOMEPREGNANT WILLTHEPREGNANCYBE NORMAL "ASEDONAVAILABLEEVIDENCE THEREISNOREASONTOBELIEVETHATTHEPREGNANCYWOULDBEABNORMALOR THATTHEFETUSWOULDBEHURTINANYWAY 7HATIF)HAVEUNPROTECTEDSEXAGAINAFTERTAKINGTHEEMERGENCYCONTRACEPTIVEPILLS )FYOUHAVEUNPROTECTEDSEXAFTERUSING%#0S THEYWILLNOTPROTECTYOU5SEAREGULARCONTRACEPTIVE METHODTOPREVENTPREGNANCYINTHEFUTURE

(  #AN)USEEMERGENCYCONTRACEPTIVEPILLSEVERYTIME)HAVESEX .O%#0SSHOULDNOTBEUSEDROUTINELYTOPREVENTPREGNANCYBECAUSETHEYARELESSEFFECTIVEAND FREQUENTLYMOREEXPENSIVETHANOTHERFAMILYPLANNINGMETHODSANDMAYCAUSEIRREGULARBLEEDING $OEMERGENCYCONTRACEPTIVEPILLSPREVENTSEXUALLYTRANSMITTEDINFECTIONS -ODULE( .O%#0SDONOTPROTECTAGAINST()6!)$3OROTHER34)SLIKESYPHILIS GONORRHEA CHLAMYDIA AND HERPES)FYOUAREWORRIEDABOUTWHETHERYOUHAVEANINFECTION TALKTOYOURHEALTHCAREPROVIDEROR PHARMACISTABOUTYOURCONCERNS ANDASKHOWYOUCANGETTREATMENTANDPROTECTYOURSELFINTHEFUTURE

4OOLS 7HATIF)HADSEXMULTIPLETIMESBEFORETAKINGEMERGENCYCONTRACEPTIVEPILLS %#0SAREMOREEFFECTIVETHESOONERAFTERSEXTHEYARETAKEN0ROTECTIONISGREATESTIFSEXOCCURRED WITHINHOURS5SETHEMOSTRECENTACTOFUNPROTECTEDINTERCOURSETODETERMINEIFYOUSHOULDTAKE %#0S7HILEYOUMAYBEPREGNANTFROMAPREVIOUSACTOFUNPROTECTEDINTERCOURSE TAKING%#0SWILL NOTHARMADEVELOPINGFETUS ANDIFYOUARENOTPREGNANT USING%#0SMAYSTILLPREVENTPREGNANCY FROMTHEMOSTRECENTACTOFUNPROTECTEDINTERCOURSE #AN)HAVEAPACKETOFEMERGENCYCONTRACEPTIVEPILLSTOKEEPATHOMEINCASE)NEEDTHEM 9ES%#0SAREMOREEFFECTIVETHESOONERTHEYAREUSED)TMAYBEAPPROPRIATEFORSOMEPEOPLE CONDOMUSERSFOREXAMPLE TOKEEPAPACKETOF%#0SATHOMETOUSEINTHEEVENTOFUNPROTECTEDSEX 4HISWILLHELPENSUREYOUCANUSE%#0SASSOONASPOSSIBLEAFTERSEXWHENTHEYAREMOSTEFFECTIVE (OWDO)USEEMERGENCYCONTRACEPTIVEPILLS ;4HISSECTIONWILLVARYDEPENDINGONCOUNTRYCONTEXTANDPRODUCTAVAILABILITY= &ORTHEPROGESTIN ONLYREGIMEN TAKEASINGLEDOSEOFMGLEVONORGESTRELASSOONASPOSSIBLEWITHIN HOURSAFTERUNPROTECTEDINTERCOURSE &ORTHEESTROGENANDPROGESTINREGIMEN TAKETHElRSTDOSEASSOONASPOSSIBLEWITHINHOURSAFTER UNPROTECTEDINTERCOURSEANDTAKETHESECONDDOSEHOURSLATER 3UMMARYOFKEYPOINTS Ŷ +EYSCREENINGQUESTIONSDETERMINEWHETHER%#0SAREANAPPROPRIATEMETHODFORACLIENT Ŷ 0ROVIDERSSHOULDBEPREPAREDTOANSWERCLIENTSQUESTIONSABOUT%#0SANDPROVIDETHEMWITHKEY INFORMATIONTOUSE%#0SCORRECTLY Ŷ %#0SCANBEPROVIDEDTOWOMENANDCOUPLESBEFORETHEYARENEEDED ASABACKUPTOCONDOMUSEFOR EXAMPLE

(  4OOLS

#OUNSELINGFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTS -INUTES -ODULE(

0RESENTATION DEMONSTRATION ROLE PLAYING ANDDISCUSSION

 2EMINDPARTICIPANTSTHATCOUNSELINGISANIMPORTANTPARTOF%#0SERVICEDELIVERY2EFER PARTICIPANTSTO(/#OUNSELINGFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTSANDREVIEWTHEKEY POINTSDESCRIBEDTHEREALSOPROVIDEDBELOW 

$VZLWKDQ\FRQWUDFHSWLYHPHWKRG(&3VVKRXOGEHSURYLGHGLQDPDQQHUWKDWLVUHVSHFWIXORIWKH FOLHQWDQGUHVSRQVLYHWRKHUQHHGVIRULQIRUPDWLRQDQGFRXQVHOLQJ7KLVLVHVSHFLDOO\WUXHIRU\RXQJ ZRPHQ$VQRWHGLQ+2.H\0HVVDJHVIRU(PHUJHQF\&RQWUDFHSWLYH3LOO&OLHQWVWKLVPHDQV PDLQWDLQLQJDVXSSRUWLYHUHDVVXULQJSDUWLFLSDWRU\DQGFRQ¿GHQWLDOHQYLURQPHQW 5HDVVXUHDOOFOLHQWVUHJDUGOHVVRIDJHRUPDULWDOVWDWXVWKDWDOOLQIRUPDWLRQZLOOEHNHSWFRQ¿GHQWLDO

%HVXSSRUWLYHRIWKHFOLHQW¶VFKRLFHVDQGUHIUDLQIURPPDNLQJMXGJPHQWDOFRPPHQWVRULQGLFDWLQJ GLVDSSURYDOWKURXJKERG\ODQJXDJHRUIDFLDOH[SUHVVLRQVZKLOHGLVFXVVLQJ(&3VZLWKFOLHQWV 6XSSRUWLYHDWWLWXGHVZLOOKHOSVHWWKHVWDJHIRUIROORZXSFRXQVHOLQJDERXWUHJXODUFRQWUDFHSWLYHXVH DQG67,SUHYHQWLRQ $FWLYHO\LQYROYHWKHFOLHQWLQWKHFRXQVHOLQJSURFHVV7KLVPD\EHPRUHHIIHFWLYHLQHQVXULQJ FRPSOLDQFHWKDQVLPSO\SURYLGLQJKHUZLWKLQIRUPDWLRQ7KLVDFWLYHLQYROYHPHQWPD\LQFOXGH s $VNLQJKHUZKDWVKHKDVKHDUGDERXW(&3V s 'LVFXVVLQJKHUH[SHULHQFHZLWKRWKHUFRQWUDFHSWLYHPHWKRGV s 9DOLGDWLQJRUFRUUHFWLQJKHULGHDVDVDSSURSULDWH -AINTAINPRIVACYBYENSURINGTHATCOUNSELINGISCONDUCTEDINAPRIVATEANDSUPPORTIVEENVIRONMENT TOTHEGREATESTEXTENTPOSSIBLE7HENITISDIFlCULTTOMAINTAINPRIVACY GIVETHEMETHODTOTHE CLIENTWITHAPPROPRIATEVERBALANDPRINTEDINSTRUCTIONSABOUTBOTH%#0SANDOTHERFORMSOFREGULAR CONTRACEPTIVEMETHODS)FINANONCLINICSETTING ADVISEHERTOATTENDACLINICORCONTACTAHEALTHCARE ORFAMILYPLANNINGPROVIDERFORCOUNSELINGABOUTREGULARCONTRACEPTIVEMETHODS2EASSURETHEWOMAN THATALLINFORMATIONWILLBEKEPTCONlDENTIAL INCLUDINGTHEFACTTHATSHEHASRECEIVED%#0S

 )NTRODUCETHECOUNSELINGSTEPSOF'!4(%2DESCRIBEDBELOW%XPLAINTHATTHISISAWAYOF REMEMBERINGTHEESSENTIALSTEPSINCOUNSELING

'REET !SKQUESTIONS 4ELLCLIENTABOUTSPECIlCREPRODUCTIVEHEALTHTOPICS (ELPCLIENTMAKEDECISIONTHATISBESTFORHERHIM %XPLAINWHATTODO 2EFERORSCHEDULERETURNVISIT IFAPPROPRIATE

 !SKFORAVOLUNTEERTOPLAYTHEPARTOFCLIENTINAROLE PLAYTODEMONSTRATEEFFECTIVECOUNSELING 4HETRAINERPLAYSTHEROLEOFTHEPROVIDER'IVETHEPARTICIPANT4!$EMONSTRATION2OLE 0LAY TOREADQUICKLY

(   4HEOTHERPARTICIPANTSWILLOBSERVE lLLINGOUTACHECKLISTTOTAKENOTEOFWHATEFFECTIVE BEHAVIORSHAVEBEENDEMONSTRATEDBYTHETRAINER$ISTRIBUTE(/#OUNSELING3KILLS/BSERVER #HECKLIST0ARTICIPANTSSHOULDALSOREFERBACKTO(/3AMPLE%MERGENCY#ONTRACEPTIVE0ILL 3CREENING#HECKLISTFORADDITIONALQUESTIONSTOASKWHENSCREENINGCLIENTSFOR%#0S

-ODULE(  $ISCUSSION!SKSEVERALPARTICIPANTSTOSUMMARIZEWHATCOUNSELINGSTEPSTHEYOBSERVEDINTHE ROLE PLAY0ROCESSTHEACTIVITYWITHTHEFOLLOWINGQUESTIONSh7HATDIDYOULIKEABOUTTHEWAY THEPROVIDERDEALTWITHTHISCLIENT vh7HATCOULDHESHEHAVEDONETOMAKETHEINTERACTION MOREEFFECTIVE vh7HATHAVEYOULEARNEDFROMTHISEXERCISE v  'OOVERTHESUMMARYOFTHEBASICSTEPSOFTHECLIENT PROVIDERINTERACTIONASPROVIDEDBELOW 4OOLS

)NTHEROLE PLAY THETRAINERSHOULDBESURETOSHOWARESPECTFULATTITUDE!SKOPEN ENDEDQUESTIONS TOINVITETHECLIENTSTOCOMMUNICATETHEIRNEEDSOPENLY3CREENBRIEmYANDCONlRMTHECONlDENTIAL NATUREOFTHESESERVICES!SKIFCLIENTSHAVEQUESTIONS ANDLISTENTOTHEIRCONCERNS 3UMMARYOFTHEBASICSTEPSOFTHECLIENT PROVIDERINTERACTION s 'REETCLIENT INTRODUCEYOURSELF ANDASKWHATSHENEEDS s !SKQUESTIONS SCREENCLIENT s 4ELLCLIENTABOUT%#0SGIVECLEARINFORMATIONABOUTUSE SIDEEFFECTS ANDFOLLOW UP s (ELPCLIENTMAKEDECISIONS0ROVIDEWRITTENORPICTORALINSTRUCTIONS IFAVAILABLE s %XPLAINWHATTHEOPTIONSARE WHATTHECLIENTSHOULDDO$ISCUSSOPTIONSFORON GOINGCONTRACEPTION WITHCLIENT s 2EFERTOOTHERHEALTHCAREPROVIDERIFNECESSARY

 !SKPARTICIPANTSTOWORKINPAIRS%ACHPAIRWILLWORKFORTENMINUTESTOPREPAREASHORTROLE PLAYTODEMONSTRATECLIENTCOUNSELING  'IVEEACHPAIRONEOFTHECASESTUDIESON4!%MERGENCY#ONTRACEPTIVE0ILL#LIENT3ITUATION 2OLE 0LAYS2EQUESTTHATPARTICIPANTSDOTHEIRBESTTODEMONSTRATEEFFECTIVECLIENTSERVICESKILLS INTHEROLE PLAY  !SKEACHPAIRTOPRESENTTHEIRROLE PLAY4HEOTHERPARTICIPANTSWILLOBSERVE  7HENALLTHEGROUPSHAVEPRESENTED PROCESSTHEACTIVITYWITHTHEFOLLOWINGQUESTIONS A h7HATDIDYOULIKEABOUTTHEWAYTHEHESHEDEALTWITHTHISCLIENT v B h$IDHESHEPROVIDECORRECTINFORMATIONABOUT%#0SANDTHEIRUSE v C h7HATCOULDHESHEHAVEDONETOMAKETHEINTERACTIONMOREEFFECTIVE v D h7HATHAVEYOULEARNEDFROMTHISEXERCISE v  !SKPARTICIPANTSWHATCHALLENGESTHEYMIGHTENCOUNTERINPROVIDINGGOOD QUALITYSERVICES!SK THEGROUPTOBRAINSTORMWAYSTOMEETTHESECHALLENGES

3UMMARYOFKEYPOINTS

Ŷ 4REATMENTOFCLIENTS REGARDLESSOFAGEORMARITALSTATUS SHOULDALWAYSBECOURTEOUS RESPECTFUL NONJUDGMENTAL ANDHELPFUL Ŷ 7HENPOSSIBLE THEREGULARUSEOFCONTRACEPTIVEMETHODSSHOULDBEEMPHASIZED Ŷ 7HENAPPROPRIATE ASSESSMENTOF34)RISKSHOULDBEMADE Ŷ 7HENPHARMACISTSANDOTHERNONCLINICALSTAFFAREPROVIDING%#0S THEYSHOULDREFERCLIENTSTO HEALTHCARECLINICSFORFURTHERTREATMENTEG FOR34)SORPOSSIBLEPREGNANCY ANDINFORMATIONAND COUNSELINGABOUTREGULARCONTRACEPTIVEMETHODS Ŷ 7OMENSHOULDNEVERBEDENIEDACCESSTO%#0STOPREVENTPREGNANCY (  4OOLS

&OLLOW 5PAND2EFERRALFOR#LIENTS -INUTES -ODULE(

0RESENTATIONANDBRAINSTORMING

 !SKPARTICIPANTSh)NWHATINSTANCESWOULDITBEGOODFORAPROVIDERTOFOLLOWUPWITHACLIENT AFTER%#0PROVISION vANDh)NWHATINSTANCESWOULDITBEGOODFORAPROVIDERTOREFERA CLIENT v  #OMPLEMENTPARTICIPANTSRESPONSESWITHTHEINFORMATIONPROVIDEDBELOW

)NSOMECASES ITISIMPORTANTTOPROVIDEFOLLOW UPCAREEVALUATIONAFTERPROVIDING%#0S4HE SITUATIONSBELOWREPRESENTPOSSIBILITIESFORFOLLOW UPANDREFERRAL s ,IWKHFOLHQWUHSRUWVQRPHQVHVZLWKLQZHHNVRI(&3XVHVKHPD\EHSUHJQDQW,WLVQRUPDOIRUD ZRPDQ¶VPHQVHVWREHJLQDIHZGD\VHDUOLHURUODWHUWKDQXVXDODIWHUWDNLQJ(&3V,IDZRPDQGRHV QRWKDYHDSHULRGZLWKLQZHHNVVKHVKRXOGEHUHIHUUHGWRDKHDOWKFDUHSURYLGHUWRGLVFXVVKHUQH[W RSWLRQV s $FOLHQWVKRXOGEHHQFRXUDJHGWRUHWXUQWRKHUSURYLGHURUWKHQHDUHVWKHDOWKFDUHIDFLOLW\LIVKHKDV FRQFHUQVRUSUREOHPV s 3URYLGHUVZKRRIIHUURXWLQHFRQWUDFHSWLYHPHWKRGVFDQGLVSHQVHWKHVHDWWKHWLPHRI(&3VHUYLFHRULI XQDYDLODEOHWKHFOLHQWPD\EHUHIHUUHGWRDSKDUPDF\RURWKHUKHDOWKFDUHSURYLGHU s $VVHVVLQJ67,ULVNDQGSURYLGLQJRUUHIHUULQJWKHFOLHQWIRUGLDJQRVLVRUWUHDWPHQWLVDFULWLFDOSDUWRI (&VHUYLFHV s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

 (IGHLIGHTNEEDFORONGOINGCONTRACEPTIVEMANAGEMENTANDEXPLAINWHENTHISISAPPROPRIATE ACCORDINGTOTHELISTBELOW

7HENEVERPOSSIBLE %#0COUNSELINGSHOULDINCLUDEDISCUSSIONOFALONG TERMCONTRACEPTIVEPLAN4HE FOLLOWINGTABLECLARIlESTHETIMELINEFORINITIATINGREGULARCONTRACEPTIVEUSEAFTER%#0USEDEPENDING ONTHEMETHODSELECTED

(  #ONTRACEPTIVEMETHOD )NITIATEUSE

#ONDOM IMMEDIATELY

-ODULE( $IAPHRAGM IMMEDIATELY

/RALCONTRACEPTIVES IMMEDIATELYORAFTERNEXTMENSES

)NJECTABLEIMPLANT WITHINDAYSAFTERNEXTMENSES 4OOLS  5SEBACK UPMETHODUNTILMENSESOCCURS

%#0SDONOTPROTECTAGAINST34)SOR()60EOPLEREQUESTING%#MAYHAVEBEENEXPOSEDTOAN34) 0ROVIDERSPLAYAPIVOTALROLEHELPINGCLIENTSDETERMINEWHETHERTHEYAREATRISKOFAN34) ANDIFSO REFERRINGTHECLIENTTOACLINICFORACHECK UPORPROVIDINGSERVICESASNECESSARY+EYQUESTIONSTHAT HELPCLIENTSASSESSTHEIRRISKINCLUDE s 'R,KDYHDQHZVH[XDOSDUWQHU" s 'R,KDYHPRUHWKDQRQHVH[XDOSDUWQHU" s 'RHVP\SDUWQHUKDYHPRUHWKDQRQHSDUWQHU" s +DVP\SDUWQHUEHHQGLDJQRVHGZLWKD67," s 'R,XVHLQWUDYHQRXVGUXJV" s 'R,KDYHDQ\V\PSWRPVRI67,V"6RPHFRPPRQV\PSWRPVLQFOXGH  $EQRUPDOYDJLQDOGLVFKDUJH  *HQLWDOVRUHVRUXOFHUV  6ZROOHQQRGHV  $FXWHRUFKURQLFORZHUDEGRPLQDOSDLQ  )HYHU 'IVENTHESENSITIVENATUREOFTHESEQUESTIONS ITMAYBEMOREAPPROPRIATETOPROVIDECLIENTSWITHALIST OFTHESEQUESTIONS 3UMMARYOFKEYPOINTS

Ŷ &OLLOW UPANDREFERRALARECRITICALTOGOODSERVICE Ŷ 7OMENMAYHAVEBEENEXPOSEDTO34)SANDNEEDTOASSESSTHEIRRISKANDBEDIAGNOSEDANDTREATEDOR REFERRED ASAPPROPRIATE Ŷ 7OMENWHOHAVEBEENSEXUALLYASSAULTEDANDABUSEDSHOULDBEREFERREDTOVIOLENCEORRAPERELIEF RESOURCES Ŷ %#0DISCUSSIONSCANLEADTOALONG TERMCONTRACEPTIVEPLAN Ŷ %#0S$/./4PROTECTAGAINST34)S0ROVIDERSSHOULDASSESS34)RISKANDMAKEREFERRALSASPARTOF %#0PROVISION

(  4OOLS -ODULE( )NCREASING!WARENESSOF%MERGENCY#ONTRACEPTION -INUTES

3MALLGROUPWORKANDDISCUSSION

!SKPARTICIPANTSTOWORKINGROUPSOFlVEANDANSWERTWOQUESTIONS A h7HATARETHEGREATESTBARRIERSTO%#USE v B h7HATCANYOUDOSPECIlCALLYTOINCREASEAWARENESSOF%#INYOURCOMMUNITY v  ,ETPARTICIPANTSDISCUSSINSMALLGROUPSFORTENMINUTES!SKEACHGROUPTOPREPARETHEIRLIST OFANSWERSONAmIPCHART OVERHEAD ORCHALKBOARDANDPRESENTTOTHEGROUP  %NCOURAGEPARTICIPANTSTOINCLUDEIDEASABOUTRAISINGAWARENESSWITHINTHEIRCOMMUNITIES ORAMONGTHEIRCOLLEAGUES !FTERALLTHEGROUPSHAVEPRESENTED ALLOWTIMEFORLARGEGROUPDISCUSSION  (IGHLIGHTLACKOFAWARENESSOF%#IN;INSERTCOUNTRY=BASEDONINFORMATIONBELOWAND GATHEREDINBASELINEASSESSMENT

,Q>LQVHUWFRXQWU\@RQHRIWKHJUHDWHVWEDUULHUVWRWKHXVHRI(&LVODFNRIDZDUHQHVV%HFDXVHWKH SXEOLFLVODUJHO\XQLQIRUPHGDERXWWKHPHWKRGWKHUHDUHREVWDFOHVWRWKHZLGHVSUHDGSURYLVLRQRI(& ;)NSERTCOUNTRY SPECIlCDATAON%#AWARENESSFROMASSESSMENTIFTHEREISONE = 7OMENSESPECIALLYYOUNGWOMENS AWARENESSOF%#REMAINSLOWTHEREFORE THEMETHODREMAINS UNDERUSED3OMEOFTHEREASONSCLIENTSlNDITDIFlCULTTODISCUSS%#ARE s 6KDPHDERXWLPSURSHUXVHRIRUODFNRIXVHRIFRQWUDFHSWLRQ s $ISCOMFORTDISCUSSINGTOPICSRELATEDTOSEXUALITY s &XOWXUDOLVVXHVUHODWHGWRSURYLGHUFOLHQWUHODWLRQVKLS s )HDUVDERXWFRQ¿GHQWLDOLW\ SDUWLFXODUO\ZLWKDGROHVFHQWV  7ITHOUTKNOWLEDGEABOUT%# CLIENTSAREUNABLETOMAKEINFORMEDCONTRACEPTIVECHOICES)TIS IMPORTANTTHATCLIENTSHAVEACCESSTOTHISINFORMATIONFROMAHIGHLYVALUEDSOURCE!SPROVIDERS YOUPLAYAPIVOTALROLEINEXPANDINGWOMENSAWARENESSOF ANDACCESSTO THISCRITICALCONTRACEPTIVE OPTION%DUCATIONABOUT%#ISIMPORTANTBOTHFORCOUPLESWHODONOTUSEACONTRACEPTIVEMETHODAT ALLANDFORTHOSEWHOUSEAMETHODTHATFAILS BECAUSE%#CANACTASABACKUP4HEKNOWLEDGETHAT ABACKUPEXISTSMAYENCOURAGECOUPLESTOADOPTTHEUSEOFCONDOMSASAMETHODOFPREVENTING()6 INFECTIONAND34)S0ROVIDERSCANPLAYANUMBEROFIMPORTANTROLESINTHEPROVISIONOF%# 4HESEINCLUDE s #OUNSELINGCLIENTSTOEXPLAINORREINFORCEKEYPOINTSABOUT%#USE s %DUCATINGCLIENTSABOUT%# s #REATINGANENVIRONMENTTHATENCOURAGESPEOPLETOSEEK%#0SERVICES

(  !LLPROVIDERSSHOULDBEAWAREOFKEYISSUESINVOLVING%# SUCHASTHENEEDTOBEGINTHERAPYASSOON ASPOSSIBLE PREFERABLYWITHINHOURSAFTERUNPROTECTEDINTERCOURSE 4HUSFAR TRAININGHASFOCUSEDONPROVIDING%#0SAFTERUNPROTECTEDSEXUALINTERCOURSE(OWEVER ADVANCEDISTRIBUTIONANDPRESCRIBINGOF%#0SCANGREATLYIMPROVETHECONVENIENCEOFTHE

-ODULE( METHODANDHELPENSURETHATWOMENHAVEACCESSTOTREATMENTASSOONASTHEYNEEDIT4HISIS PARTICULARLYIMPORTANTINVIEWOFRESEARCHTHATDEMONSTRATESIMPROVEDEFlCACYWITHEARLIER%#0USE 4RANSPORTATIONCANBEASIGNIlCANTBARRIERFORACCESSTO%#0SADVANCEPRESCRIBING WHENAPPROPRIATE HELPSTOCONTROLFORTHISBARRIER0ROVIDERSSHOULDDISPENSE%#0STOWOMENWHOMAYWISHTOKEEP THEMATHOMETOUSEINTHEEVENTOFUNPROTECTEDINTERCOURSE 4OOLS 3OMEPROVIDERSRAISECONCERNSABOUTWHETHERPROVIDING%#0STOWOMENAHEADOFTIMEWILLMAKE THEMMORELIKELYTOUSETHEMIRRESPONSIBLY2ESEARCHHASNOTFOUNDTHISTOBETRUE 3UMMARYOFKEYPOINTS

Ŷ -ANYWOMENARENOTINFORMEDABOUT%# Ŷ 0ROVIDERSCANHELPEXPANDKNOWLEDGEANDUSEOFTHISIMPORTANTCONTRACEPTIVEMETHOD Ŷ !DVANCEDISTRIBUTIONCANIMPROVECLIENTACCESSTOANDEFFECTIVEUSEOF%#0S

(  4OOLS

2EVIEW #ONCLUSION AND0OST 3ESSION1UESTIONNAIRE -INUTES -ODULE(

0RESENTATIONANDDISCUSSION

 2EVIEWTHESESSIONSOBJECTIVESANDASKFORlNALQUESTIONSANDCOMMENTS  -AKERECOMMENDATIONSONHOWPROVIDERSCANHELPINCREASEAWARENESSOF%#USINGTHE INFORMATIONBELOW

4HEMOSTIMPORTANTTHINGPROVIDERSCANDOTOIMPROVETHECONSISTENTANDAPPROPRIATEUSEOF%#ISTO TALKABOUTITWITHCLIENTS0ROVIDERSHAVEACRUCIALROLETOPLAYINREDUCINGUNINTENDEDPREGNANCYBY EDUCATINGCLIENTSABOUT%#ANDPROVIDINGITWHENAPPROPRIATE 2EACHINGWOMENWITH%#INFORMATIONANDSERVICESPOSESSPECIALCHALLENGES3OMEWOMENMAYlND ITDIFlCULTTOACCESSRELIABLEINFORMATIONANDSERVICESBECAUSETHEY s $UHXQDZDUHRIWKHDYDLODELOLW\RI(&3V s /DFNFRQ¿GHQFHRUDUHHPEDUUDVVHGWRDVNIRU(&3V s $UHXQDZDUHWKDWVRPHSURYLGHUVFDQKHOSWKHP s $UHDQ[LRXVDERXWMXGJPHQWDODWWLWXGHVRISURYLGHUV 4HEFOLLOWINGRECOMMENDATIONSCANHELPINCREASEADOLESCENTCLIENTSAWARENESSOF%# s 2OUTINELYADVISECLIENTSABOUT%#0SASABACKUPTOCONTRACEPTIVEACCIDENTS s -AKE%#INFORMATIONALMATERIALSAVAILABLEANDACTIVELYREFERCLIENTSTOTHEM s %NCOURAGECLIENTSTOOBTAINADVANCE OF NEED%#0S IFAPPROPRIATE s $ISPLAYYOUTH FRIENDLYPOSTERS SIGNS OROTHERLOGOS

 $ISTRIBUTEPOST SESSIONQUESTIONNAIRE!LLOWPARTICIPANTSAPPROXIMATELYTENMINUTESTO COMPLETETHEQUESTIONNAIRE  #OLLECTTHEPOST SESSIONQUESTIONNAIREANDTHENGOOVERIT ASKINGPARTICIPANTSTOCALLOUTTHE CORRECTANSWERS  4HANKEVERYONEFORTHEIRPARTICIPATIONINTHETRAINING

2EFERENCES

5NITED.ATIONS0OPULATION&UND4HE3TATEOF7ORLD0OPULATION.EW9ORK5.&0! 

3EGAL 3* ,A'UARDIA +$4ERMINATIONOFPREGNANCYˆAGLOBALVIEW"AILLIERES#LIN/BSTET'YNAECOL  

0ROGRAMFOR!PPROPRIATE4ECHNOLOGYIN(EALTH0!4( .EWAPPROACHESTOEARLYABORTION/UTLOOK /CTOBER 

'LOBAL(EALTH#OUNCIL0ROMISESTO+EEP4HE4OLLOF5NINTENDED0REGNANCIESON7OMENS,IVESINTHE$EVELOPING7ORLD.EW 9ORK'LOBAL(EALTH#OUNCIL 

!LAUDDIN -AND-AC,AREN ,2EACHINGNEWLYWEDANDMARRIEDADOLESCENTS)N&OCUS*ULY 

VON(ERTZEN (ETAL,OWDOSEMIFEPRISTONEANDTWOREGIMENSOFLEVONORGESTRELFOREMERGENCYCONTRACEPTIONA7(/MULTICENTRE RANDOMISEDTRIAL,ANCET   

4RUSSELL *AND%LLERTSON #%FlCACYOFEMERGENCYCONTRACEPTION&ERTILITY#ONTROL2EVIEWS   

(  7(/4ASK&ORCEON0OSTOVULATORY-ETHODSOF&ERTILITY2EGULATION2ANDOMIZEDCONTROLLEDTRIALOFLEVONORGESTRELVERSUSTHE9UZPE REGIMENOFCOMBINEDORALCONTRACEPTIVESFOREMERGENCYCONTRACEPTION,ANCET  

)NTERNATIONAL#ONSORTIUMFOR%MERGENCY#ONTRACEPTION%XPANDINGGLOBALACCESSTOEMERGENCYCONTRACEPTION/CTOBER 

4RUSSELL *AND2AYMOND %3TATISTICALEVIDENCEABOUTTHEMECHANISMOFACTIONOFTHE9UPZEMETHODOFEMERGENCYCONTRACEPTION

-ODULE( /BSTETRICSAND'YNECOLOGY   

3WAHN -ETAL%FFECTOFPOST COITALCONTRACEPTIVEMETHODSONTHEENDOMETRIUMANDTHEMENSTRUALCYCLE!CTA/BSTETRICIAET 'YNECOLOGICA3CANDINAVICA  

,ING 7ETAL-ODEOFACTIONOFDL NORGESTRELANDETHINYLESTRADIOLCOMBINATIONINPOSTCOITALCONTRACEPTION&ERTILITYAND3TERILITY

4OOLS   

2OWLANDS 3ETAL!POSSIBLEMECHANISMOFACTIONOFDANAZOLANDETHINYLESTRADIOLNORGESTRELCOMBINATIONUSEDASAPOSTCOITAL CONTRACEPTIVEAGENCY#ONTRACEPTION  

,ING 7ETAL-ODEOFACTIONOFDL NORGESTRELANDETHINYLESTRADIOLCOMBINATIONINPOSTCOITALCONTRACEPTION)))%FFECTOF PREOVULATORYADMINISTRATIONFOLLOWINGTHELUTEINIZINGHORMONESURGEONOVARIANSTEROIDOGENESIS&ERTILITYAND3TERILITY   

+UBBA !ETAL4HEBIOCHEMISTRYOFHUMANENDOMETRIUMAFTERTWOREGIMENSOFPOSTCOITALCONTRACEPTIONADL NORGESTREL ETHINYLESTRADIOLCOMBINATIONORDANAZOL&ERTILITYAND3TERILITY  

4ASKIN /ETAL(IGHDOSESOFORALCONTRACEPTIVESDONOTALTERENDOMETRIALDANDDQEINTEGRINSINTHELATEIMPLANTATIONWINDOW &ERTILITYAND3TERILITY  

VON(ERTZEN ( AND6AN,OOK 02ESEARCHONNEWMETHODSOFEMERGENCYCONTRACEPTION&AMILY0LANNING0ERSPECTIVES    

53$EPARTMENTOF(EALTHAND(UMAN3ERVICES &OODAND$RUG!DMINISTRATION0RESCRIPTIONDRUGPRODUCTS CERTAINCOMBINEDORAL CONTRACEPTIVESFORUSEASPOST COITALEMERGENCYCONTRACEPTION.OTICE&EDERAL2EGISTER  

'RIMES $ETAL%MERGENCY#ONTRACEPTION!NNALSOF)NTERNAL-EDICINE  

7ORLD(EALTH/RGANIZATION)MPROVING!CCESSTO1UALITY#AREIN&AMILY0LANNING-EDICAL%LIGIBILITY#RITERIAFOR#ONTRACEPTIVE 5SE3ECOND%DITION7(/2(2'ENEVA7(/ 

)NTERNATIONAL0LANNED0ARENTHOOD&EDERATION3TATEMENTON%MERGENCY#ONTRACEPTION,ONDON)00& !VAILABLEONLINEAT HTTPMIRRORIPPFORGMEDICALIMAPSTATEMENTSENG?BHTM !CCESSED$ECEMBER

!MERICAN0HARMACEUTICAL!SSOCIATION3PECIAL2EPORTON%MERGENCY#ONTRACEPTION4HE0HARMACISTS2OLE 

(  4OOLS

0RE AND0OST 3ESSION1UESTIONNAIRE -ODULE( %MERGENCY#ONTRACEPTIVE0ILLS%#0S

2ESPONDENT"ACKGROUND ,DP BBB 0DOH   BBB )HPDOH ,DP BBB 3KDUPDFLVW BBB 'RFWRU BBB 1XUVH BBB 0LGZLIH BBB2WKHUVSHFLI\BBBBBBBBBBB

-ARKTHEFOLLOWINGSTATEMENTSASTRUEORFALSE 4RUE &ALSE

 0ROGESTIN ONLYEMERGENCYCONTRACEPTIONPILLS%#0S REDUCETHE RISKOFPREGNANCYBYPERCENT

 %#0SMAYBEUSEDUPTOHOURSDAYS AFTERUNPROTECTED INTERCOURSE

 4HEREARENOCONTRAINDICATIONSTO%#0USE

 %#0SPROVIDEPROTECTIONAGAINST()6!)$3ANDOTHERSEXUALLY TRANSMITTEDINFECTIONS

 $EPENDINGONLOCALREGULATIONS %#0SCANBEPROVIDEDSAFELYBY PROPERLYTRAINEDDOCTORS NURSES PHARMACISTS ANDPHARMACYSTAFF

 %#0SAREANEFFECTIVE REGULARCONTRACEPTIVEMETHOD

 #ONDOMSANDOTHERBARRIERMETHODSMAYBESTARTEDIMMEDIATELY FOLLOWING%#0USE

 %#0SCANNOTCAUSEANABORTION

 4HEMOSTCOMMONSIDEEFFECTSOF%#0SARENAUSEAANDVOMITING

 !LLCLIENTSSHOULDUNDERGOAFULLPELVICEXAMBEFORERECEIVING %#0S

 %#0SCANBEUSEDSAFELYBYADOLESCENTGIRLS

 %#0SAREMOREEFFECTIVETHESOONERTHEYARETAKENAFTER INTERCOURSE

 %#0SSHOULDNOTBEPROVIDEDTOCLIENTSBEFORETHEYNEEDTHEM

 2EGULARORALCONTRACEPTIVEPILLSCANNOTBEUSEDFOR%#

(  0RE AND0OST 3ESSION1UESTIONNAIRE %MERGENCY#ONTRACEPTIVE0ILLS%#0S

-ODULE( !NSWER+EY

-ARKTHEFOLLOWINGSTATEMENTSASTRUEORFALSE 4RUE &ALSE

4OOLS  0ROGESTIN ONLYEMERGENCYCONTRACEPTIONPILLS%#0S REDUCETHE 8 RISKOFPREGNANCYBYPERCENT

 %#0SMAYBEUSEDUPTOHOURSDAYS AFTERUNPROTECTED 8 INTERCOURSE

 4HEREARENOCONTRAINDICATIONSTO%#0USE 8

 %#0SPROVIDEPROTECTIONAGAINST()6!)$3ANDOTHERSEXUALLY 8 TRANSMITTEDINFECTIONS

 $EPENDINGONLOCALREGULATIONS %#0SCANBEPROVIDEDSAFELYBY 8 PROPERLYTRAINEDDOCTORS NURSES PHARMACISTS ANDPHARMACYSTAFF

 %#0SAREANEFFECTIVE REGULARCONTRACEPTIVEMETHOD 8

 #ONDOMSANDOTHERBARRIERMETHODSMAYBESTARTEDIMMEDIATELY 8 FOLLOWING%#0USE

 %#0SCANNOTCAUSEANABORTION 8

 4HEMOSTCOMMONSIDEEFFECTSOF%#0SARENAUSEAANDVOMITING 8

!LLCLIENTSSHOULDUNDERGOAFULLPELVICEXAMBEFORERECEIVING 8 %#0S

%#0SCANBEUSEDSAFELYBYADOLESCENTGIRLS 8

%#0SAREMOREEFFECTIVETHESOONERTHEYARETAKENAFTER 8 INTERCOURSE

%#0SSHOULDNOTBEPROVIDEDTOCLIENTSBEFORETHEYNEEDTHEM 8

2EGULARORALCONTRACEPTIVEPILLSCANNOTBEUSEDFOR%# 8

4HISMATERIALWASDEVELOPEDBY0!4(

(  4OOLS

(ANDOUT -ODULE( +EY-ESSAGESFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTS

7HATAREEMERGENCYCONTRACEPTIVEPILLS s %MERGENCYCONTRACEPTIVEPILLS%#0S AREPILLSTHATYOUCANTAKEAFTERSEXTOPREVENTPREGNANCY %#0SAREUSEFULIFYOUHADSEXWITHOUTUSINGCONTRACEPTIONORIFYOUHADACONTRACEPTIVEFAILURE SUCHASABROKENCONDOM  s %#0SCONTAINTHESAMEINGREDIENTSASSOMEPILLSUSEDFORREGULARCONTRACEPTION BUTINHIGHER AMOUNTS4HEYAREEFFECTIVEANDSAFEFORALMOSTALLWOMEN

(OWDOEMERGENCYCONTRACEPTIVEPILLSWORK $EPENDINGONWHENYOUUSE%#0SDURINGYOURMONTHLYCYCLE %#0SMAY s 3TOPORDELAYANEGGFROMBEINGRELEASEDFROMTHEOVARY s 3TOPAFERTILIZEDEGGFROMATTACHINGTOYOURUTERUS s 0REVENTTHESPERMFROMGETTINGTOTHEEGG %#0SWILLNOTWORKONCEAPREGNANCYHASSTARTED

(OWEFFECTIVEAREEMERGENCYCONTRACEPTIVEPILLS s %#0SPREVENTMOSTPREGNANCIES BUTTHEYARENOTPERCENTEFFECTIVE

7HENCAN)USE%#0S s %#0SCANBEUSEDWITHINlVEDAYSOFUNPROTECTEDTERCOURSEBUTAREMOSTEFFECTIVETHESOONERTHEY AREUSED

7HATIF)HADUNPROTECTEDSEXMORETHANDAYSAGO s )FMORETHANDAYSHAVEPASSEDSINCEYOUHADUNPROTECTEDSEX THE%#0SMAYSTILLHAVESOME EFFECTBUTITISIMPORTANTTOTAKETHEMASSOONASPOSSIBLE

$OEMERGENCYCONTRACEPTIVEPILLSCAUSESIDEEFFECTS s %#0SSOMETIMESCAUSENAUSEA VOMITING HEADACHES DIZZINESS CRAMPING FATIGUE ORBREAST TENDERNESS4HESESIDEEFFECTSUSUALLYGOAWAYWITHINAFEWDAYSAFTERYOUTAKETHE%#0S%#0S ALSOMAYCAUSEIRREGULARBLEEDINGUNTILYOURNEXTPERIOD ANDYOURPERIODMAYCOMEEARLYORLATE

7HATSHOULD)DOAFTERUSINGEMERGENCYCONTRACEPTIVEPILLS s 9OUWILLNOTSEEANYIMMEDIATESIGNSSHOWINGWHETHERTHE%#0SWORKED9OURMENSTRUALPERIOD MAYCOMEONTIME ORITMAYBEEARLYORLATE)FYOURPERIODHASNOTSTARTEDWITHINWEEKSOF TAKING%#0S YOUMIGHTBEPREGNANT)FYOUAREPREGNANT YOUNEEDTODISCUSSYOUROPTIONS WITHAHEALTHCAREPROVIDER)FYOUHAVEANYCAUSEFORCONCERN SEEYOURHEALTHCAREPROVIDEROR PHARMACIST

(  )FTHEEMERGENCYCONTRACEPTIVEPILLSDONOTWORKAND)BECOMEPREGNANT WILLTHE PREGNANCYBENORMAL

s "ASEDONAVAILABLEINFORMATION THEREISNOREASONTOBELIEVETHATTHEPREGNANCYWOULDBE ABNORMALORTHATTHEFETUSWOULDBEHURTINANYWAY -ODULE(

7HATIF)HAVEUNPROTECTEDSEXAGAINAFTERTAKINGTHEEMERGENCYCONTRACEPTIVE PILLS 4OOLS s )FYOUHAVEUNPROTECTEDSEXAFTERUSING%#0S THEYWILLNOTPROTECTYOU9OUWILLNEEDTOREPEAT THETREATMENT5SEAREGULARCONTRACEPTIVEMETHODTOPREVENTPREGNANCYINTHEFUTURE

#AN)USEEMERGENCYCONTRACEPTIVEPILLSEVERYTIME)HAVESEX

s .O%#0SSHOULDNOTBEUSEDROUTINELYTOPREVENTPREGNANCYBECAUSETHEYARELESSEFFECTIVEAND FREQUENTLYMOREEXPENSIVETHANOTHERFAMILYPLANNINGMETHODSANDMAYCAUSEIRREGULARBLEEDING

$OEMERGENCYCONTRACEPTIVEPILLSPREVENTSEXUALLYTRANSMITTEDINFECTIONS

s .O%#0SDONOTPROTECTAGAINST()6!)$3OROTHERSEXUALLYTRANSMITTEDINFECTIONS34)S LIKESYPHILIS GONORRHEA CHLAMYDIA ANDHERPES)FYOUAREWORRIEDABOUTWHETHERYOUHAVEAN INFECTION TALKTOYOURHEALTHCAREPROVIDERORPHARMACISTABOUTYOURCONCERNSANDASKHOWYOU CANGETTREATMENTANDPROTECTYOURSELFINTHEFUTURE

7HATIF)HADSEXMULTIPLETIMESBEFORETAKINGEMERGENCYCONTRACEPTIVEPILLS

s 9OUCANSTILLUSE%#0SIFTHELASTTIMEYOUHADSEXISWITHINDAYS)FYOUAREALREADYPREGNANT FROMANEARLIERACTOFUNPROTECTEDSEX THE%#0SWILLNOTHAVEANYEFFECT%#0SAREMORE EFFECTIVETHESOONERAFTERSEXTHEYARETAKEN

#AN)HAVEAPACKETOFEMERGENCYCONTRACEPTIVEPILLSTOKEEPATHOMEINCASE) NEEDTHEM

s 9ES%#0SAREMOREEFFECTIVETHESOONERTHEYAREUSED)TMAYBEAPPROPRIATEFORSOMEPEOPLE CONDOMUSERSFOREXAMPLE TOKEEPAPACKETOF%#0SATHOMETOUSEINTHEEVENTOFUNPROTECTED SEX4HISWILLHELPENSUREYOUCANUSE%#0SASSOONASPOSSIBLEAFTERSEXWHENTHEYAREMOST EFFECTIVE

(OWDO)USEEMERGENCYCONTRACEPTIVEPILLS

s &ORTHEPROGESTIN ONLYREGIMEN TAKEASINGLEDOSEOFMGLEVONORGESTRELASSOONASPOSSIBLE WITHINHOURSAFTERUNPROTECTEDSEX s &ORTHEESTROGENANDPROGESTINREGIMEN TAKETHElRSTDOSEASSOONASPOSSIBLEWITHINHOURS AFTERUNPROTECTEDSEXANDTAKETHESECONDDOSEHOURSLATER

(  4OOLS

3PECIlCINFORMATIONABOUTTHE%#0FORMULATIONSISPROVIDEDINTHETABLEBELOW -ODULE( ;4HISSECTIONDEPENDSONCOUNTRYCONTEXTANDPRODUCTAVAILABILITY=

%#0&ORMULATIONS

&IRST$OSE 3ECOND$OSE &ORMULATION #OMMON"RAND NUMBEROF NUMBEROF PERPILL .AMES TABLETS TABLETS

0ROGESTIN ONLY ,.'MG ,EVONELLE  .OR,EVO   2EGIMEN 0LAN" 0OSTINOR  6IKELA 3INGLE$OSE

#OMBINED2EGIMEN %%MCG ,.'MG %UGYNON &ERTILAN OR .EOGYNON .ORAL %%MCG .'MG .ORDIOL /VIDON  /VRAL /VRAN 0#  0REVEN

%%MCG ,.'MG ,O&EMENAL OR -ICROGYNON  %%MCG .'MG .ORDETTE /VRAL, 2IGEVIDON

!BBREVIATIONS%%ETHINYLESTRADIOL,.'LEVONORGESTREL.'NORGESTREL

&ORALLREGIMENS THElRSTDOSESHOULDBETAKENASSOONASPOSSIBLEAFTERINTERCOURSE BUTOPTIMALLYWITHIN HOURS4HESECONDDOSEOFTHECOMBINEDREGIMENSHOULDBETAKENHOURSAFTERTHElRSTDOSE4HE PROGESTIN ONLYREGIMENDOSESMAYBETAKENALLATONETIME

!DAPTEDFROM%XPANDING'LOBAL!CCESSTO%MERGENCY#ONTRACEPTION)NTERNATIONAL#ONSORTIUMFOR %MERGENCY#ONTRACEPTION/CTOBER P

)NFORMATIONINTHISTABLEHASBEENUPDATEDTOREmECTCURRENTRESEARCH VON(ERTZEN (ETAL,OWDOSEMIFEPRISTONEANDTWOREGIMENSOFLEVONORGESTRELFOREMERGENCY CONTRACEPTIONA7(/MULTICENTRERANDOMIZEDTRIAL,ANCET   

#ONTENTANDFORMATWEREADAPTEDFROM3PECIAL2EPORTON%MERGENCY#ONTRACEPTION4HE0HARMACISTS2OLE !MERICAN0HARMACEUTICAL!SSOCIATION  (  -ODULE( 4OOLS

(  4OOLS

(ANDOUT -ODULE( 3AMPLE%MERGENCY#ONTRACEPTIVE0ILL3CREENING#HECKLIST

 $OYOUWANTTOPREVENTPREGNANCY 9ES .O

 (AVEYOUHADUNPROTECTEDSEXDURINGTHELASTDAYS 9ES .O HOURS )Fh9ESv THENTHECLIENTMAYBEELIGIBLEFOR%#0S)TISIMPORTANTTO TAKETHEMASSOONASPOSSIBLEAFTERUPROTECTEDSEX!FTERHOURS DAYS %#0SCANNOLONGERBECONSIDEREDTOBEEFFECTIVE  7ASTHELASTMENSTRUALPERIODLESSTHANWEEKSAGO 9ES .O

 7ASTHISPERIODNORMALINBOTHITSLENGTHANDTIMING 9ES .O )Fh9ESvTOTHEPREVIOUSTWOQUESTIONS %#0SMAYBEPROVIDED  )STHEREREASONTOBELIEVETHATTHEYOUMAYBEPREGNANT 9ES .O )FTHECLIENTISNOTPREGNANT %#0SMAYBEGIVEN)FTHECLIENTS PREGNANCYSTATUSISUNCLEAR %#0SMAYSTILLBEGIVEN WITHTHE EXPLANATIONTHATTHEMETHODWILLNOTWORKIFSHEISALREADYPREGNANTAND WILLNOTHARMTHEFETUS

#ONTENTANDFORMATFORTHISCHECKLISTWEREADAPTEDFROM#OMPREHENSIVE2EPRODUCTIVE(EALTHAND&AMILY0LANNING 4RAINING#URRICULUM-ODULE%MERGENCY#ONTRACEPTIVE0ILLS 7ATERTOWN -!0ATHlNDER)NTERNATIONALREVISED  

(  -ODULE( 4OOLS

(  4OOLS

(ANDOUT -ODULE( #OUNSELINGFOR%MERGENCY#ONTRACEPTIVE0ILL#LIENTS

!SWITHANYCONTRACEPTIVEMETHOD %#0SSHOULDBEPROVIDEDINAMANNERTHATISRESPECTFULOFTHE CLIENTANDRESPONSIVETOHERNEEDSFORINFORMATIONANDCOUNSELING

$URINGCOUNSELING PROVIDERSSHOULD

2EASSUREALLCLIENTS REGARDLESSOFAGEORMARITALSTATUS THATALLINFORMATIONWILLBEKEPT CONlDENTIAL

"ESUPPORTIVEOFTHECLIENTSCHOICESANDREFRAINFROMMAKINGJUDGMENTALCOMMENTSORINDICATING DISAPPROVALTHROUGHBODYLANGUAGEORFACIALEXPRESSIONSWHILEDISCUSSING%#0SWITHCLIENTS 3UPPORTIVEATTITUDESWILLHELPSETTHESTAGEFORFOLLOW UPCOUNSELINGABOUTREGULARCONTRACEPTIVEUSE AND34)PREVENTION

!CTIVELYINVOLVETHECLIENTINTHECOUNSELINGPROCESS4HISMAYBEMOREEFFECTIVEINENSURING COMPLIANCERATHERTHANSIMPLYPROVIDINGHERWITHINFORMATION4HISACTIVEINVOLVEMENTMAYINCLUDE

s !SKINGHERWHATSHEHASHEARDABOUT%#0S s $ISCUSSINGHEREXPERIENCEWITHOTHERCONTRACEPTIVEMETHODS s 6ALIDATINGORCORRECTINGHERIDEASASAPPROPRIATE

-AINTAINPRIVACYBYENSURINGTHATCOUNSELINGISCONDUCTEDINAPRIVATEANDSUPPORTIVE ENVIRONMENTTOTHEGREATESTEXTENTPOSSIBLE7HENITISDIFlCULTTOMAINTAINPRIVACY GIVETHEMETHOD TOTHECLIENTWITHAPPROPRIATEVERBALANDPRINTEDINSTRUCTIONSABOUTBOTH%#0SANDOTHERFORMS OFREGULARCONTRACEPTIVEMETHODS)FINANONCLINICSETTING ADVISEHERTOATTENDACLINICORCONTACT AHEALTHCAREORFAMILYPLANNINGPROVIDERFORCOUNSELINGABOUTREGULARCONTRACEPTIVEMETHODS 2EASSURETHECLIENTTHATALLINFORMATIONWILLBEKEPTCONlDENTIAL INCLUDINGTHEFACTTHATSHEHAS RECEIVED%#0S

#ONTENTANDFORMATFORTHISHANDOUTWEREADAPTEDFROM#OMPREHENSIVE2EPRODUCTIVE(EALTHAND&AMILY0LANNING 4RAINING#URRICULUM-ODULE%MERGENCY#ONTRACEPTIVE0ILLS 7ATERTOWN -!0ATHlNDER)NTERNATIONALREVISED  

(  -ODULE( 4OOLS

(  4OOLS

(ANDOUT -ODULE( #OUNSELING3KILLS/BSERVER#HECKLIST

#OUNSELINGSKILLOBSERVED 9ES .O #OMMENTS  'REETSCLIENTINFRIENDLYANDHELPFULWAY  )NTRODUCESSELF  !SKSCLIENTWHYHESHEHASCOMETOYOU ORWHATMAKESHIMHERTHINKHESHE NEEDS%#0S  %NSURESCONlDENTIALITY  3CREENSCLIENTFORDATEOFUNPROTECTED SEXANDLASTMENSTRUATION  4ELLSCLIENTABOUT%#0SHOWTHEYWORK EFFECTIVENESS POSSIBLESIDEEFFECTS   !LLOWSCLIENTTOASKQUESTIONSANDASKS CLIENTIFHESHEHASANYQUESTIONS  %XPLAINSCORRECTUSEOF%#0SANDASKS CLIENTTOSUMMARIZEINSTRUCTIONS  3HOWS%#0STOCLIENTANDGIVESCLIENT CORRECTNUMBEROFPILLS  %XPLAINSHOWTOMANAGEPOSSIBLESIDE EFFECTSANDTELLSCLIENTTORETURNORGO TOACLINICORHOSPITALIFTHEREAREANY PROBLEMSORCONCERNS  4ELLSCLIENTTHEMENSTRUALPERIODISLIKELY TOBEWITHINONEWEEKBEFOREORAFTERTHE NORMALEXPECTEDDATE  !SKSCLIENTABOUTONGOINGCONTRACEPTIVE METHOD ANDASKSIFHESHEWOULDLIKETO DISCUSSOTHERCONTRACEPTIONOPTIONS  %XPLAINSTOTHECLIENTTHATHESHEAND HISHERPARTNERMAYBEATRISKOFAN34)  0ROVIDESREFERRALINFORMATIONFOR COMMUNITYHEALTHSERVICES  $EMONSTRATESANONJUDGMENTALATTITUDE ANDRESPECTFORCLIENT

#ONTENTANDFORMATFORTHISCHECKLISTWEREADAPTEDFROM#OMPREHENSIVE2EPRODUCTIVE(EALTHAND&AMILY0LANNING 4RAINING#URRICULUM-ODULE%MERGENCY#ONTRACEPTIVE0ILLS 7ATERTOWN -!0ATHlNDER)NTERNATIONALREVISED  

(  -ODULE( 4OOLS

(  4OOLS

4RAINING!ID -ODULE( 'RAB"AGˆ+EY-ESSAGESFOR%MERGENCY#ONTRACEPTIVE 0ILL#LIENTS

7HATAREEMERGENCYCONTRACEPTIVEPILLS 

(OWDO%#0SWORK 

(OWEFFECTIVEARE%#0S 

7HATIF)HADUNPROTECTEDSEXMORETHANDAYSAGO 

$O%#0SCAUSESIDEEFFECTS 

7HATSHOULD)DOAFTERUSING%#0S 

)FTHE%#0SDONOTWORKAND)BECOMEPREGNANT WILLTHEPREGNANCYBENORMAL 

7HATIF)HAVEUNPROTECTEDSEXAGAINAFTERTAKINGTHE%#0S 

#AN)USE%#0SEVERYTIME)HAVESEX 

$O%#0SPREVENTSEXUALLYTRANSMITTEDINFECTIONS 

7HATIF)HADSEXMULTIPLETIMESBEFORETAKING%#0S 

#AN)HAVEAPACKETOF%#0STOKEEPATHOMEINCASE)NEEDTHEM 

(OWDO)USE%#0S 

#ONTENTANDFORMATFORTHISTRAININGAIDWEREADAPTEDFROM#OMPREHENSIVE2EPRODUCTIVE(EALTHAND&AMILY 0LANNING4RAINING#URRICULUM-ODULE%MERGENCY#ONTRACEPTIVE0ILLS 7ATERTOWN -!0ATHlNDER )NTERNATIONALREVISED 

(  -ODULE( 4OOLS

(  4OOLS

4RAINING!ID -ODULE( $EMONSTRATION2OLE 0LAY

9OUHAVEVOLUNTEEREDTOPLAYTHEPARTOFACLIENTSEEKING%#0SINAROLE PLAYTODEMONSTRATEEFFECTIVE COUNSELINGTECHNIQUES

9OUAREA YEAROLDWOMANWHOISSEEKING%#0STODAY9OUHADUNPROTECTEDSEXWITHYOURNEW BOYFRIENDTHENIGHTBEFORELAST ANDYOURBESTFRIENDTOLDYOUTOGOTOAPROVIDERANDASKABOUTPILLS THATCANPREVENTYOUGETTINGPREGNANT4HElRSTDAYOFYOURLASTMENSTRUALPERIODWASTWOWEEKS AGO9OUAREHEALTHYANDDONOTSMOKE9OUUSUALLYUSECONDOMS BUTTHISTIMEYOUDIDNTHAVEANY AROUNDANDHADNTEXPECTEDTOHAVESEX9OUDLIKETOKNOWIFTHEPROVIDERCANGIVEYOUSOMEOF THESEPILLSTOKEEPATHOMEINCASETHISEVERHAPPENSTOYOUAGAIN

#ONTENTANDFORMATFORTHISTRAININGAIDWEREADAPTEDFROM#OMPREHENSIVE2EPRODUCTIVE(EALTHAND&AMILY 0LANNING4RAINING#URRICULUM-ODULE%MERGENCY#ONTRACEPTIVE0ILLS 7ATERTOWN -!0ATHlNDER)NTERNATIONAL REVISED 

(  -ODULE( 4OOLS

(  4OOLS

4RAINING!ID -ODULE( %MERGENCY#ONTRACEPTIVE0ILL#LIENT3ITUATION2OLE 0LAYS

'2/50 2OLE PLAY

9OUAREAYOUNGWOMAN3EVERALDAYSAGOYOUWEREASSAULTEDANDRAPED ANDYOUTHINKYOU MAYNEED%#TOPREVENTYOUFROMGETTINGPREGNANT9OUGOTOTHEINSERTFAMILYPLANNING CLINIC PHARMACY OROTHERPROVIDERSETTING TOlNDOUTMOREINFORMATION4HEPROVIDERASKS SCREENINGQUESTIONS9OUBEGINTOFEELNERVOUS BUTlNALLYSHAREWITHTHEPROVIDERTHATYOU WERERAPED



'2/50 2OLE PLAY

9OUHAVEHEARDABOUT%#FROMFRIENDSANDTHINKYOUMIGHTNEEDIT BUTYOUARESCAREDTO TRYITBECAUSEYOUTHINKITMIGHTMAKEYOUINFERTILEANDTHATITMIGHTNOTBESAFEBECAUSEYOU SMOKE9OUHADUNPROTECTEDSEXLASTNIGHTYOUWERENOTEXPECTINGTOHAVESEXWITHYOURNEW BOYFRIENDANDDIDNOTHAVEANYCONTRACEPTIVEPROTECTIONNEARBY 9OURLASTMENSTRUALPERIOD ENDEDDAYSAGOANDWASNORMAL9OUAREASMOKERANDHAVEHERPESBUTNOOTHERHEALTH PROBLEMS9OUHAVEBEENPREGNANTONCEBEFOREANDHADANABORTIONANDARESCAREDOFHAVING ANOTHERONE9OUHAVENOTBEENSEXUALLYACTIVEFORAWHILEBUTARESTARTINGANEWRELATIONSHIP 9OUAREINTERESTEDINLEARNINGMOREABOUTTHEPILLFORONGOINGCONTRACEPTION



'2/50 2OLE PLAY

9OUARESEEKING%#0SATYOURLOCALINSERTFAMILYPLANNINGCLINIC PHARMACY OROTHER PROVIDERSETTING 9OUHADUNPROTECTEDSEXYESTERDAYANDKNEWYOUCOULDGETPILLSTHAT WOULDBELIKELYTOPREVENTYOUFROMGETTINGPREGNANT4HEPROVIDERHASASKEDYOUSOME QUESTIONSANDSHOWNYOUHOWTOTAKEBIRTHCONTROLPILLSFOR%#9OUWANTTOPAYFORTHEPILLS BUTYOUDONTHAVEANYMONEYRIGHTNOW9OUAREINTERESTEDINlNDINGOUTABOUTONGOING CONTRACEPTIVEOPTIONS BUTYOUARENOTSUREWHERETOGOFORTHISINFORMATION9OUWOULDALSO LIKETOKNOWIFYOUCANGETCONDOMS



'2/50 2OLE PLAY !MANCOMESTOYOUANDTELLSYOUTHATWHENHEWASHAVINGSEXWITHHISGIRLFRIENDLASTNIGHT THECONDOMBROKE



(  -ODULE( 4OOLS

(  4OOLS

'2/50 2OLE PLAY

!YOUNGWOMANCOMESTOYOUANDTELLSYOUSHEHASMISSEDATLEASTOFHERBIRTHCONTROLPILLS -ODULE( 3HEISWONDERINGWHATSHESHOULDDO



'2/50 2OLE PLAY 9OUHAVEAPATIENTREQUESTING%#9OUHAVENOPRIVATECOUNSELINGAREAANDTHEREAREMANY OTHERPATIENTSWAITINGTOBESERVED9OULOOKCLOSELYATHER ANDSHEAPPEARSTOHAVEABLACK EYE



'2/50 2OLE PLAY !YOUNGWOMANCOMESINREQUESTING%#9OURECOGNIZEHERBECAUSETHISISTHETHIRDTIMESHE HASCOMEINASKINGFOR%#



'2/50 2OLE PLAY !YOUNGWOMANFORWHOMYOUPRESCRIBED%#COMESBACKANDTELLSYOUTHATTHEMETHODDIDNT WORKANDNOWSHEISPREGNANT

#ONTENTANDFORMATFORTHISTRAININGAIDWEREADAPTEDFROM#OMPREHENSIVE2EPRODUCTIVE(EALTHAND&AMILY 0LANNING4RAINING#URRICULUM-ODULE%MERGENCY#ONTRACEPTIVE0ILLS 7ATERTOWN -!0ATHlNDER)NTERNATIONAL REVISED 

( 

-ODULE)

%VALUATION

/BJECTIVE 4OMEASUREACHIEVEMENTOFOBJECTIVESANDTODOCUMENTTHEIMPACTOFINTERVENTIONS

!SYSTEMATICEVALUATIONOFAPROGRAMORPROJECTOBJECTIVELYMEASURESCHANGEˆWHATITHAS ACCOMPLISHEDINTERMSOFPROCESS OUTCOMES ANDLESSCOMMONLY IMPACT4HISMODULEON EVALUATIONDISCUSSESTHEFOLLOWINGTOPICS s 2ELATIONSHIPBETWEEN!SSESSMENTAND%VALUATION s %VALUATION&UNCTIONS s #HARACTERISTICSOF'OOD%VALUATION s #HOICEOF%VALUATION-ETHOD s %VALUATION0LAN$EVELOPMENT s ,INKSTO%VALUATION2ESOURCES

4OOLS0ROVIDEDATTHE%NDOFTHIS-ODULE

„ %XAMPLE2ESULTS&RAMEWORKFORAN%MERGENCY#ONTRACEPTION0ROJECT „ %XAMPLE/UTLINEOFAN%#00ROGRAM%VALUATION2EPORT

2ELATIONSHIP"ETWEEN!SSESSMENTAND%VALUATION 4OMEASURECHANGE ITISNECESSARYTOHAVEASTARTINGPOINT BEFORETHEPROGRAMSACTIVITIESOR INTERVENTIONSBEGIN WHENSPECIlCTARGETSOFTHEPROGRAMINTERVENTIONSˆORINDICATORSˆARE MEASURED4HISSTARTINGPOINT ORBASELINE CANBEDOCUMENTEDASPARTOFASSESSMENTACTIVITIES 0LEASEREFERTO-ODULE%!SSESSMENTANDTHEASSESSMENTTOOLS WHICHARECLOSELYTIEDTO THISMODULEONEVALUATION 4HESAMEINDICATORSUSEDFORTHEBASELINECANBEMONITOREDAND RECORDEDTHROUGHOUTTHEEVALUATIONPERIODˆMAKINGITPOSSIBLE ATTHEENDOFTHEEVALUATION PERIOD TODOCUMENTTHECHANGESTHATHAVETAKENPLACEINTHEINDICATORS

%VALUATION&UNCTIONS %VALUATIONOFEMERGENCYCONTRACEPTIVEPILLPROGRAMSFULlLLSFOURKEYFUNCTIONS  )TENABLESPROGRAMMANAGERSANDSTAFFTOGUIDEANDIMPROVETHEIROWNWORK BYPROVIDING SYSTEMATICANDOBJECTIVEFEEDBACKONWHATISANDISNOTWORKINGANDWHY SOTHATSYSTEMSFOR PROVIDING%#0PRODUCTANDINFORMATIONCANBEIMPROVED

)  )  -ODULE) #HARACTERISTICSOF'OOD%VALUATION #HOICEOF%VALUATION-ETHOD  )T  x x x 4HEMETHODSUSEDTOEVALUATEAPROJECTWILLDEPENDON x x x x x x MINDASANEWEVALUATIONSTRATEGYISDEVELOPED &OLLOWINGISALISTOFCHARACTERISTICSOFASTRONGEVALUATIONP )T  )T  FUTURE PROGRAMSUCCESS REQUESTSFORFUTURESUPPORT INTENDEDPURPOSESˆACRITICALELEMENTOFREPORTSONCOMPLETEDPR 2ESOURCESAVAILABLE WOMENREQUESTING%#0SMAYBEMOREIMPORTANT EDUCATION THENUMBEROFCALLSTOANEMERGENCYCONTRACEPTIONHO MAYBECENTRALTOTHEEVALUATION)FTHEFOCUSOFTHEWORKISO ONPROVIDERTRAINING CHANGESINPROVIDERKNOWLEDGE ATTITUDES 4HENATUREOFTHEWORKTHATISBEINGEVALUATED NUMBEROFSITESWHERE%#0SAREAVAILABLE DISTRIBUTIONRECORDSTODEMONSTRATETHENUMBEROF%#0SDISTRIBU APPROACHESWITHMOREGENERALIZABLERESULTSSUCHASUSINGCONTRA IN-ODULE%!SSESSMENT ,ARGERPROGRAMSMAYALLOWMOREEFFECT EVALUATIONUSINGQUALITATIVEAPPROACHES3EEQUALITATIVEDATA 4HESIZEOFTHEPROGRAM &INDINGSAREAPPLIEDTOFUTUREPROGRAMSORPOLICIES 2ESULTSARESHAREDINATIMELYANDUNDERSTANDABLEMANNERWITHA 2ESOURCESAREPRUDENTLYUSED 3TAKEHOLDERSAREINVOLVEDATALLSTAGESTOENHANCERELEVANCYAN THEINTERESTSANDSAFETYOFALLPARTICIPANTS $ATAARECOLLECTEDANDANALYZEDINASYSTEMATICANDUNBIASEDWA 0ROJECTGOALSANDOBJECTIVES AREWELLDElNEDANDMEASURABLE SIGNIlCANTLYREDUCETHERESOURCESREQUIREDFOROBTAININGINFORM ITISPOSSIBLETOTAPINTOEXISTINGDATACOLLECTIONSYSTEMSTHA OTHERRESOURCESAREAVAILABLE SUCHASEXISTINGSYSTEMSFORGAT ACTIVITIESTOTHESCOPEOFTHEPROJECTACTIVITIES)TWILLBEI #LEARLY%#0INTRODUCTIONEFFORTSWITHLIMITEDBUDGETSMUSTCARE THEM EXPANDINGTHEIMPACTANDREACHOFTHE%#0PROGRAM INTEGRATION INCREASESTHEKNOWLEDGEBASE DEMONSTRATESTODECISIONMAKERSORDONORSTHEEFFECTIVEUSEOF DEMONSTRATESTOOTHERSTHEEFFECTIVENESSOFSTRATEGIESANDAPPR SOTHATPROGRAMMANAGERSCANDECIDEWHETHERANDHOWTOADAPT PROVIDINGDATATHATWILLFACILITATEMAKING%#0SMOREAVAILABL )TISIMPORTANTTOBUILDEVALUATIONACTIVITIESINTOTHEBUDGET 3MALLPILOTPROJECTSMAYLENDTHEMSELVESTOMOREIN DEPTH ABOUTEFFECTIVEINTERVENTIONSANDTHEFACTORSTHATAFFECT &OREXAMPLE IFTHEPROJECTISFOCUSED ROCESSTHATSHOULDBEKEPTIN MPORTANTTODETERMINEWHAT TCOLLECTRELEVANTDATA THISCAN NCLIENTINFORMATIONAND HERINGDATAFORINDICATORS)F COLLECTIONTOOLS PROVIDED DACCURACY ANDPRACTICES+!0 ATION FULLYMATCHEVALUATION TEDMONTHLYANDTHE CEPTIVECOMMODITY OACHESOF%#0 PPROPRIATEPARTIES Y WITHPROPERREGARDFOR TLINE ORNUMBEROF THEIRRESOURCES OJECTS ASWELLASOF IVEUSEOFQUANTITATIVE ORREPLICATE EINTHE FORTHE S -ODULE)

%VALUATION0LAN$EVELOPMENT "UILDINEVALUATIONFROMTHEBEGINNING )TISIMPORTANTTOINCLUDETHEEVALUATIONPLANASPARTOFTHE%#0INTRODUCTIONPROCESSAND TOWORKINCOLLABORATIONWITHPARTNERSANDOTHERSWHOWILLBEINTERESTEDINTHEOUTCOME OFTHEEVALUATIONINORDERTOENSURETHATTHEEVALUATIONRESULTSPROVIDEUSEFUL RELEVANT INFORMATION

,INKYOUREXPECTEDRESULTSTOTHEPLANNEDACTIVITIES )NDEVELOPINGANEVALUATIONPLAN LINKTHEEXPECTEDRESULTSOFTHEPROJECTTOPLANNED ACTIVITIES4ODOTHIS BEEXPLICITABOUTGOALSANDOBJECTIVESOFTHEPROJECTANDDElNE WHERE INTHEPROCESSOFINTEGRATING%#0S DATACOULDBECOLLECTEDTOMEASUREWHETHER THEPROJECTHASBEENSUCCESSFUL$ATATHATAREUSEDTOMEASURESUCCESSCANALSOBECALLED INDICATORS!RESULTSFRAMEWORKCANBEANEFFECTIVEWAYOFDEVELOPINGANEVALUATIONPLAN !NEXAMPLEOFARESULTSFRAMEWORKISINCLUDEDATTHEENDOFTHISMODULETODEMONSTRATE HOWAFRAMEWORKLIKETHISCANAPPLYTOANEMERGENCYCONTRACEPTIONPROGRAMEVALUATION 3ELECTINDICATORSTHATWILLINDICATECHANGEBROUGHTABOUTBYTHE PROJECTINTERVENTIONS 4HEINDICATORSSHOULDBEPARTOFTHEBASELINEDATA PROVIDINGAMEASUREMENTOFTHE STATUSBEFORETHEPROJECT!TTHEENDOFTHEPROJECT LATERDATAONTHESAMEINDICATORSCAN BECOMPAREDWITHTHEBASELINEDATATOSHOWCHANGESTHATMAYHAVERESULTEDFROMTHE PROJECTACTIVITIES&OREACHINDICATOR DETERMINEWHEREORHOWTHEINFORMATIONWILLBE OBTAINED$ATAFORASINGLEINDICATORSHOULDBECOLLECTEDFROMMORETHANONESOURCE #ROSS CHECKINGTHEDATAFROMSEVERALSOURCESWILLINCREASEACCURACYANDCREDIBILITY4HE FOLLOWINGTABLESHOWSTHEINDICATORSTOINCLUDE

!SPECTOF%#0 )NTEGRATION )NDICATOR 0OLICYLEVEL s 3TATEDSUPPORTFOR%#0SFROMMINISTRYOFHEALTHFOREXAMPLERESOURCES ALLOCATEDFOR%#0SORSTANDARDOFCAREGUIDELINES s 3TATEDSUPPORTFROMMEDICALASSOCIATIONLEADERSFOREXAMPLE APUBLISHED STATEMENTORAPUBLICANNOUNCEMENTINSUPPORTOF%#0S s #OMMITMENTTOCOLLABORATEBYLOCALPARTNERORGANIZATIONS 3ERVICEDELIVERY s .UMBEROFWOMENREQUESTING%#0S s .UMBEROF%#0SSOLDDISTRIBUTEDMONTHLY s .UMBEROFPERSONNELAUTHORIZEDTOPROVIDE%#0S s .UMBEROFPEOPLETRAINEDTOPROVIDE%#0S s .UMBEROFSITESWHERE%#0SAREAVAILABLE 3ERVICEQUALITY s 0OSITIVECHANGEINPROVIDERATTITUDESTOWARD%#0S s 0OSITIVECHANGEINCLIENTEXPERIENCEACCESSING%#0S s 0ERCENTAGEOF%#0SCLIENTSALSOCOUNSELEDABOUTSEXUALLYTRANSMITTED INFECTIONS s 0ERCENTAGEOF%#0SCLIENTSALSOREFERREDTOSOURCEOFONGOINGCONTRACEPTIVE METHOD !WARENESSRAISING s .UMBEROFCALLSTOEMERGENCYCONTRACEPTIONHOTLINE s 0ERCENTAGEOFPUBLICWHOKNOWWHAT%#0SAREORWHERETOGETTHEM )  )  -ODULE) ,INKSTO%VALUATION2ESOURCES NECESSARYTODEMONSTRATETHECHANGETHATTHEPROJECTPROGRAMHO THESAMPLESIZEINTHISCASE NUMBEROFPROVIDERSTOINCLUDEI ATTITUDESTOWARD%#0S ITISIMPORTANTTOCONSULTWITHASTATI THEEVALUATIONGOALISTOSHOWASTATISTICALLYSIGNIlCANTCHANG SOFTWAREDEVELOPEDFORENTERINGDATAFORMS)FQUANTITATIVEDAT THEFORMS ANDINCLUDINGMECHANISMSFORCONlRMINGACCURATEDATA PROVIDINGSTANDARDIZEDFORMS TRAININGTHESTAFFTHATWILLCOLL DATAENTRYPROCESSESSHOULDBEINPLACEBEFORETHEDATACOLLECT OFALLPROJECTPROGRAMSITES0LANSFORENSURINGTHEQUALITYOF FRIENDLYTOPROGRAMORGANIZERS ASITISIMPORTANTTHATTHESIT TORANDOMLYSELECTTHESITESRATHERTHANPICKINGSITESTHATARE &OREXAMPLE IFONLYASELECTIONOFSERVICEDELIVERYSITESARE ENSURINGSAMPLESIZESLARGEENOUGHTODETECTTHECHANGESTHEPR ESPECIALLYIMPORTANTTOALSOCONSIDERISSUESOFAVOIDINGBIAS USEDASPARTOFANEVALUATIONTOVERIFYSUCCESSFULRESULTS&OR ASISSUESTOCONSIDERINDATACOLLECTION ENTRY ANDANALYSIS IN DEPTHINTERVIEWS FOCUSGROUPDISCUSSIONS ANDMYSTERYSHOPP BEUSEDFORASSESSMENT INCLUDINGKNOWLEDGE ATTITUDESANDPERC -ODULE%!SSESSMENTPROVIDESGUIDANCEREGARDINGDATACOLLECTIO #HOOSEMETHODSFORDATACOLLECTION )NTERNETATTTPWWWCPCEDUMEASUREMERLINMERLINHTML $EVELOPEDBYTHE53!)$ FUNDED-%!352% RESOURCESTOASSISTINTHEMONITORINGANDEVALUATIONOFHEALTH 4HE-%2,).6IRTUAL,IBRARYISACOMPREHENSIVECOLLECTIONOFBOT %VALUATION 0ROJECT ITISAVAILABLEONTHE 4HESEMETHODSCANALLBE ESSELECTEDBEREPRESENTATIVE EASYTOREACHORTHATARE TOBEEVALUATED ITISBETTER STICIANINDETERMINING EVALUATION HOWEVER ITIS ECTTHEDATAONTHEUSEOF BOTHTHEDATACOLLECTIONAND EFOREXAMPLE INPROVIDER CONTROLLINGQUALITY AND ANDPOPULATIONSERVICES NTHESTUDY THATWILLBE IONBEGINS4HISCANINCLUDE AISTOBECOLLECTEDAND OJECTHOPESTOOBSERVE EPTIONS+!0 SURVEYS PESTOACHIEVE ERTECHNIQUES ASWELL NMETHODSTHATCAN ENTRYINTHECOMPUTER HPRINTANDELECTRONIC -ODULE)4OOLS,IST

„%XAMPLE2ESULTS&RAMEWORKFORAN%MERGENCY #ONTRACEPTION0ROJECT 4HISISAGENERALOVERVIEWCOVERINGKEYELEMENTSOFANINTRODUCTIONSTRATEGY)NAREAL %#0INTEGRATIONEFFORT EACHSECTIONWOULDNEEDTOBEmESHEDOUTMOREFULLY4HISRESULTS FRAMEWORKISINTENDEDSOLELYTODEMONSTRATEHOWAPROGRAMCANLINKRESULTS ACTIVITIES ANDINDICATORS ASWELLASSPECIFYPROSPECTIVELYHOWINFORMATIONWILLBEOBTAINEDTOVERIFY WHETHERRESULTSWEREACHIEVED

„%XAMPLE/UTLINEOFAN%#00ROGRAM%VALUATION2EPORT 4HISOUTLINEPROVIDESANEXAMPLEOFHOWAPROGRAMEVALUATIONREPORTOFAN%#0PROGRAM COULDBESTRUCTURED

)  -ODULE) 4OOLS

)  4OOLS

%XAMPLE2ESULTS&RAMEWORKFORAN%MERGENCY #ONTRACEPTION0ROJECT -ODULE) /VERALL'OAL4OIMPROVEWOMENSAWARENESSOFANDACCESSTOEMERGENCYCONTRACEPTIONTHROUGHPUBLIC SECTORPROGRAMSSOTHATWOMENCANMAKEINFORMEDCHOICESREGARDINGEMERGENCYCONTRACEPTIVEUSE

!SPECT OF%#0 !CTIVITIESAIMINGTO INTEGRATION $ESIREDRESULT ACHIEVETHISRESULT )NDICATORS -EANSOFVERIlCATION

0OLICYLEVEL 3UPPORTFROM s -EETINGSWITHKEY s 3TATEDSUPPORTFROM s -EETINGMINUTES MINISTRYOFHEALTH REPRESENTATIVES -/( s ,ETTEROFCOMMITMENT -/( MEDICAL FROM-/( MEDICAL s 3TATEDSUPPORTFROM ASSOCIATIONS AND ASSOCIATIONS AND s )MPLEMENTATIONOF MEDICALASSOCIATION ACTIONPLAN LOCALPARTNER LOCALPARTNER LEADERS ORGANIZATIONSFOR ORGANIZATIONS INTEGRATING%#0S s #OMMITMENTTO INTOPUBLIC SECTOR COLLABORATEBYLOCAL SYSTEMS PARTNERORGANIZATIONS s $EVELOPMENTOFACTION PLAN

3ERVICE )NCREASEDCAPACITY s 0UBLIC SECTOR s .UMBEROFPUBLIC s 4RAININGRECORDS DELIVERY OFPUBLIC SECTOR CLINICIANTRAINING SECTORCLINICIANSWHO s 0RE ANDPOST TRAINING CLINICIANSTO s 2EGULARMEETINGS ARETRAINEDTOPROVIDE PROVIDER+!0SURVEY PROVIDE%#0 %#0S WITHPROVIDERSTO s -YSTERYCLIENTSURVEYS INFORMATIONAND LEARNFROMONE s 0OSITIVECHANGEIN s #LIENTSATISFACTION PRESCRIPTIONSTO ANOTHERANDOPENLY PROVIDERATTITUDES SURVEYS CLIENTS DISCUSSCONCERNS TOWARD%#0S )NCREASED #ONTRACEPTIVE ANDPROBLEMS s .UMBEROF%#0S PROVISIONOF%#0S COMMODITYDISTRIBUTION s $ISTRIBUTIONOF%#0S DISTRIBUTEDMONTHLY THROUGHPUBLIC RECORDS SECTORSYSTEMS THROUGHPUBLIC s .UMBEROFSITESWHERE SECTORPROGRAMS %#0SAVAILABLE

3ERVICE %#0SPROVIDED s 0UBLIC SECTOR s 0ERCENTAGEOFCLIENTS s 0RE ANDPOST TRAINING QUALITY TOCLIENTSASPART CLINICIANTRAINING PROVIDEDWITH%#0S PROVIDER+!0SURVEY OFANINTEGRATED INCLUDESINFORMATION COUNSELEDONSEXUALLY s -YSTERYCLIENTSURVEYS RESPONSETO ABOUTONGOING TRANSMITTEDINFECTION UNPROTECTEDSEX FAMILYPLANNING s %#0CLIENTSCLINICAL s 0ERCENTAGEOFCLIENTS RECORDS METHODSAND PROVIDEDWITH%#0S SEXUALLYTRANSMITTED REFERREDTOONGOING INFECTIONS CONTRACEPTIVEMETHODS

!WARENESS )NCREASED s "ACKGROUND s .UMBEROFARTICLES s -EDIATRACKING RAISING AWARENESSOF%#0S WORKSHOPFOR ABOUT%#0SIN s (OTLINETRACKING FORWOMENOF JOURNALISTS MAINSTREAMMEDIA REPRODUCTIVEAGE s 3ENTINELCLINICTRACKING s $EVELOPMENT s .UMBEROFCALLSTO%#0 OF%#0REQUESTS OFHOTLINEWITH HOTLINE INFORMATIONABOUT s .UMBEROFWOMEN %#0S REQUESTING%#0S s $EVELOP)%# MATERIALSSUCHAS BROCHURES POSTERS ANDRADIOSPOTS

4HISMATERIALWASDEVELOPEDBY0!4( )  -ODULE) 4OOLS

)  4OOLS

%XAMPLE/UTLINEOFAN%#00ROGRAM%VALUATION2EPORT -ODULE) ))NTRODUCTION ! "ACKGROUNDONEMERGENCYCONTRACEPTIVEPILLS%#0S  %#0SASAUNIQUEFORMOFCONTRACEPTIONTHATCANBEUSEDAFTERSEXTOPREVENT PREGNANCY  )DEALLY%#0SSHOULDBEUSEDWITHINHOURSOFUNPROTECTEDSEXANDARE SIGNIlCANTLYMOREEFFECTIVETHESOONERTHEYARETAKEN " $ESCRIPTIONOFLOCALADVOCACYFRAMEWORK  2ATESOFUNINTENDEDPREGNANCY  .EGATIVECONSEQUENCESOFUNINTENDEDPREGNANCYFORBOTHFAMILYANDCHILD  %#0SCANHELPPREVENTUNINTENDEDPREGNANCY REDUCEABORTIONRATES ANDREDUCE MATERNALMORTALITY # $ESCRIPTIONOFTHEPROGRAMSINTEGRATIONOF%#0SINTOTHEPUBLIC SECTORSYSTEMS  0ROGRAMGOALSANDOBJECTIVES  0ROGRAMIMPLEMENTATION  #OLLABORATINGPARTNERS )) %VALUATION-ETHODS/VERVIEWOF%VALUATION3TRATEGY ! $ESCRIPTIONOFMETHODSFOREXAMPLE +!0SURVEY IN DEPTHINTERVIEW FOCUSGROUP DISCUSSION ANDPARTICIPANTSPOLICYMAKERS PROVIDERS CLIENTS USEDTOEVALUATE PROGRAMSUCCESS  3TUDYPOPULATIONS SETTING ANDLOCATIONSWHEREDATACOLLECTED  0ARTICIPANTRECRUITMENT  3AMPLINGHOWPARTICIPANTSWERESELECTED RATIONALEFORNUMBEROFPARTICIPANTS ANALYSISMETHODSUSED INCLUDINGSTATISTICALTESTSIFAPPLICABLE ))) $ESCRIPTIONOFEVALUATIONRESULTS ! 0OLICYLEVEL  )NDICATIONSOFSUPPORTATTHEPOLICYLEVEL  3ERVICEDELIVERY A #APACITYOFPROVIDERSTOPROVIDE%#0INFORMATIONANDPRESCRIPTION B 0ROVISIONOF%#0STHROUGHPUBLIC SECTORSYSTEM C 0ROVIDERSSATISFACTION  3ERVICEQUALITY A %#0PROVISIONASPARTOFANINTEGRATEDRESPONSETOUNPROTECTEDSEX B #LIENTSATISFACTION  %#0!WARENESSRAISING A )NCREASEINLEVELOFAWARENESSABOUT%#0S B -EDIAREPORTSON%#0S )6 $ISCUSSIONOFTHEEVALUATIONlNDINGSANDTHEIRIMPLICATIONS ! 3UMMARIZECENTRALlNDINGS " $ISCUSSEFFECTIVENESSOFSTRATEGIESANDAPPROACH 6 0ROVISIONOFRECOMMENDATIONS BASEDONEVALUATIONRESULTS FORIMPROVEMENTANDNEXT STEPSPOSSIBLE

4HISMATERIALWASDEVELOPEDBY0!4( ) 

!PPENDIX!

%MERGENCY#ONTRACEPTIVE0ILLS -EDICALAND3ERVICE$ELIVERY 'UIDELINES

Emergency Contraceptive Pills: Medical and Service XDelivery Guidelines

Second Edition • 2003

International Consortium for Emergency Contraception

Emergency Contraceptive Pills: Medical and Service Delivery Guidelines

Second Edition X 2003

International Consortium for Emergency Contraception ACKNOWLEDGEMENTS

The Consortium’s original guidelines were based on the service delivery guidelines of the International Planned Parenthood Federation, Pathfinder International, and PATH. The first edition was printed in October 2000. The following individuals in particular contributed to that edition: Elizabeth Raymond, Yusuf Ahmed, Sharon Camp, Marilyn Edmunds, Douglas Huber, Carlos Huezo-Toledo, Valerie Koscelnik, Suneeta Mittal, Jose David Ortiz, Karen Ostea, Khama Rogo, Jeff Spieler, James Trussell, Paul Van Look, and Helena von Hertzen. For updating the second edition, the Consortium is grateful to: Elizabeth Raymond, Angeles Cabria, David Grimes, Susan McIntyre, Ilze Melngailis, Claudia Morrissey, Raffaela Schiavon, Harris Solomon, Perger Teodora, Fatiha Terki, James Trussell, Andre Ulmann, Helena von Hertzen, Anne Wilson, and Beverly Winikoff.

Emergency Contraceptive Pills: Medical and Service Delivery Guidelines 2003 The International Consortium for Emergency Contraception Washington, DC USA

Printed on recycled paper Original graphic design by Elizabeth Sanders INTERNATIONAL CONSORTIUM FOR EMERGENCY CONTRACEPTION Emergency Contraceptive Pills: X Medical and Service Delivery Guidelines

Second Edition • 2003

CONTENTS

Foreword 4 Summary Service Protocol for Emergency Contraceptive Pills 5 1 Introduction 7 1.1 Definition 7 1.2 Indications 7 2 Emergency Contraceptive Pills 7 2.1 ECP Regimens 7 2.2 Mode of Action 8 2.3 Efficacy 8 2.4 Side Effects, Prevention, and Management 9 2.5 Precautions 9 2.6 Screening 10 2.7 Special Issues 10 2.8 Information for the Client 11 2.9 Counseling 11 2.10 Follow-up 12 2.11 If the Client Becomes Pregnant 12 2.12 Starting or Resuming Regular Contraception after ECP Use 12 3 ECP Service Delivery Systems 13 3.1 Youth 14 3.2 Women Who Have Been Sexually Assaulted 14 Table 1 ECP Formulations 15 Appendix: Use of IUDs for Emergency Contraception 16 References 17 About the International Consortium for Emergency Contraception 19

3 X FOREWORD

Offering emergency contraception is an important way for this important option before they need it. Because the time family planning and other reproductive health programs to frame for treatment is short — efficacy declines with each improve the quality of their services and better meet the day or even hour of delay — women need to be aware that needs of their clients. Emergency contraception is needed emergency contraception is an option, know where they because no contraceptive method is 100 percent effective, can seek services, and understand that treatment should be and few people use their method perfectly every time they started as soon as possible after unprotected or inade- have intercourse. Furthermore, emergency contraception quately protected intercourse. Providing emergency con- is useful in cases of sexual assault. traceptive information and, if practical, supplies of ECPs Emergency contraceptive pills (ECPs), the most com- at the time of a regular family planning or medical visit is monly used and most convenient form of emergency con- one way of ensuring that women have the resources they traception, are not difficult to provide. Specially packaged need to protect themselves from pregnancy in the event of ECPs or supplies of regular oral contraceptives that can be unprotected intercourse or a contraceptive failure. used for ECPs are readily available in most places. The organizations that make up the International Providers can be trained easily in the correct use, counsel- Consortium for Emergency Contraception have compiled ing, and follow-up related to ECPs. Nevertheless, provid- these service delivery guidelines to give family planning ing ECPs does entail unique service delivery issues, such and other reproductive health programs and practitioners as the need to ensure rapid access to the method to maxi- the information they need to provide ECPs safely and mize efficacy and the importance of conveying informa- effectively. The recommendations in these guidelines tion about additional, ongoing methods to prevent both reflect the latest available research on emergency contra- pregnancy and sexually transmitted infections after the ception and have been reviewed by internationally recog- ECPs are used. nized reproductive health experts. Local programs should An essential component of programs providing emer- adapt these guidelines as necessary to comply with national gency contraception is education, informing women about or other requirements.

X 4 SUMMARY SERVICE PROTOCOL FOR EMERGENCY CONTRACEPTIVE PILLS

Emergency contraceptive pills (ECPs) are an important the combined regimen reduces it by 56 percent to 89 per- option for women who recently have had unprotected cent. In direct comparisons, the levonorgestrel regimen has intercourse or a contraceptive failure and who do not want been shown to be substantially more effective than the to become pregnant. ECPs have been shown to be safe and combined regimen. Both regimens appear to be more effective in studies conducted over the past three decades. effective the sooner after intercourse they are used. ECPs are not as effective as consistent and correct use of most Indication modern contraceptive methods. To prevent pregnancy after unprotected or inadequately Side Effects protected intercourse. Side effects of both regimens include nausea, vomiting, Regimens abdominal pain, fatigue, headache, dizziness, breast ten- derness, and irregular vaginal spotting or bleeding. The lev- The two regimens discussed in these guidelines are: onorgestrel-only regimen is associated with a significantly • Levonorgestrel-only regimen: 1.50 mg levonorgestrel lower chance of nausea and vomiting than the combined in a single dose or in two doses of 0.75 mg taken up to regimen. In most women, menses following treatment will 12 hours apart. occur within a week before or after the expected time. • Combined estrogen-progestin regimen: two doses of 100 mcg ethinyl estradiol plus 0.50 mg of levonorgestrel Prevention and Management of Nausea taken 12 hours apart. and Vomiting Treatment with either regimen should be initiated as The best way to minimize nausea and vomiting is to soon as possible after intercourse because data suggest that use the levonorgestrel-only regimen instead of the com- efficacy declines substantially with time. Both regimens bined regimen whenever possible. Pretreatment with the have been shown to be effective through five days (120 antiemetic drugs meclizine or metoclopramide can prevent hours) after intercourse. Longer delays have not been these symptoms in users of the combined regimen. If vom- investigated. iting occurs within two hours after either dose, repeat the In some locations, both regimens are available as prod- dose, if feasible. In cases of severe vomiting, vaginal admin- ucts formulated and labeled specifically for use as ECPs. istration of ECPs may be effective. Alternatively, ECPs can be formulated from a variety of reg- ular oral contraceptive pills (see Table 1 or www.cecinfo.org). Precautions The levonorgestrel-only regimen is preferred because it is more effective and is associated with a lower incidence There are no known medical conditions that preclude of side effects. the use of ECPs. ECPs are not indicated in women with confirmed pregnancy because they will have no effect. Mode of Action However, ECPs may be given without pregnancy testing or when pregnancy status is unclear, as there is no evidence The exact mode of action of ECPs in any given case suggesting harm to a pregnant woman or to her pregnancy. cannot be known. ECPs have been shown to inhibit or delay an egg from being released from the ovary when Screening taken before ovulation. They may also prevent sperm and egg from uniting or stop a fertilized egg from attaching to Because ECPs are not dangerous under any known cir- the uterus. The two ECP regimens discussed in these cumstances, routine screening via examination or labora- guidelines do not interfere with an established pregnancy. tory tests is unnecessary prior to treatment. The client herself can determine whether ECPs are indicated after Effectiveness written or oral instruction. A pregnancy test may be helpful in ruling out pregnancy if the client has missed a menstrual Various studies have shown that the levonorgestrel- period. However, treatment should not be delayed in order only regimen reduces the risk of pregnancy by 60 percent to perform any screening procedures. to 93 percent or more after a single act of intercourse, and

5 X Special Situations Information for Clients

• Breastfeeding: There is no evidence that ECPs will Information about ECPs and related issues may be harm a breastfeeding woman or her infant, although provided in person, over the telephone, in writing, or by a some authorities recommend feeding immediately combination of these approaches. At a minimum, the fol- before taking the pills and then expressing and dis- lowing messages should be conveyed: carding the breast milk for the six hours afterwards. • The client should start treatment as soon as possible • Coital act(s) more than 120 hours in the past: ECPs after intercourse. may be used, but clients should be informed that effi- • Following ECP use, if the client’s menstrual period has cacy has not been studied. Emergency intrauterine not come within a week after it was expected, she device (IUD) insertion should be considered. should seek evaluation and care for possible pregnancy. • More than one prior unprotected act: One ECP • If the client has irregular bleeding and lower abdomi- treatment may be used to cover all unprotected or nal pain, she should contact a health care provider for inadequately protected acts within the past 120 hours. possible evaluation for ectopic pregnancy. • Repeated ECP use: ECPs may be used as frequently • The client should use another form of contraception as requested, but clients should be informed that after using ECPs. ECPs are not suitable for ongoing ongoing, correct use of other contraceptive methods contraception. provides more effective protection over time. • ECPs do not protect against HIV or other sexually • Use of ECPs before intercourse: No data are avail- transmitted infections (STIs). able on how long the contraceptive effect of ECPs per- Ideally, the client should also be given information sists after the pills have been taken. Clients should be about efficacy, side effects, mechanism of action, other encouraged to use a contraceptive method other than contraceptive methods, and methods to prevent STIs. She ECPs whenever possible. should be offered a temporary method, such as condoms, • Unprotected intercourse during the “infertile for use in the immediate future, and referrals to facilities period”: Because it is often difficult to define the infer- where she can obtain any needed follow-up services. All tile period with certainty, ECPs are recommended any counseling should be nonjudgmental and supportive. time that unprotected or inadequately protected inter- course occurs and the client is concerned that she is at Follow-up risk for pregnancy. Advise the client to see a health care provider if she • Concurrent use of other drugs: Clients should be experiences irregular bleeding combined with lower abdom- counseled about the possibility of drug interactions inal pain or if she has any questions or reason for concern. and managed accordingly (see Section 2.7). • Use of other formulations: Combined estrogen- progestin pill formulations containing the progestin norethindrone in place of levonorgestrel can be used when the regimens described herein are not available.

X 6 EMERGENCY CONTRACEPTIVE PILLS: MEDICAL AND SERVICE DELIVERY GUIDELINES

1 Introduction — more than seven days late for a combined estrogen- plus-progestin monthly injection Despite the availability of highly effective methods of — dislodgment, delay in placing, or early removal of a contraception, many pregnancies are unplanned and contraceptive hormonal skin patch or ring unwanted. These pregnancies carry a higher risk of mor- — dislodgment, breakage, tearing, or early removal of bidity and mortality, often due to unsafe abortion. Many of a diaphragm or cap these unplanned pregnancies can be avoided using emer- — failed (e.g., ejaculation in vagina gency contraception.1,2 or on external genitalia) — failure of a spermicide tablet or film to melt before 1.1 Definition intercourse — miscalculation of the periodic abstinence method or Emergency contraceptive pills (ECPs) are hormonal failure to abstain on fertile day of cycle methods of contraception that can be used to prevent — IUD expulsion; or pregnancy after an unprotected or inadequately protected act of intercourse. • in cases of sexual assault when the woman was not ECPs sometimes are referred to as “morning-after” or protected by an effective contraceptive method. “postcoital” pills. The term “emergency contraceptive pills” is preferred because it conveys the important mes- 2 Emergency Contraceptive Pills sage that the treatment should not be used as an ongoing contraceptive method, and it avoids giving the mistaken 2.1 ECP Regimens impression that the pills must be taken on the morning after intercourse. Two ECP regimens are discussed in these guidelines: These guidelines address medical and service delivery • Levonorgestrel-only regimen: 1.50 mg levonorgestrel issues related to two regimens of ECPs, one containing a in a single dose or in two doses of 0.75 mg taken up to progestin only (levonorgestrel), and the other containing a 12 hours apart. combination of a progestin (levonorgestrel) and an estro- • Combined estrogen-progestin (Yuzpe) regimen: gen (ethinyl estradiol). two doses of 100 mcg ethinyl estradiol plus 0.50 mg A brief overview of the use of intrauterine devices (IUDs) of levonorgestrel taken 12 hours apart. for emergency contraception is included in the Appendix. Note that levonorgestrel plus an equal amount of a 1.2 Indications related but inactive compound is called norgestrel; there- fore, these regimens can also be formulated by substitut- ECPs are indicated to prevent pregnancy after unpro- ing double the amount of norgestrel as is indicated for tected or inadequately protected sexual intercourse, levonorgestrel. including: Treatment with either regimen should be initiated as • when no contraceptive has been used; soon as possible after unprotected or inadequately pro- • when there is a contraceptive failure or incorrect use, tected intercourse, because efficacy declines substantially 3,4 including: with time. Early data showed that both regimens are 5,6 — condom breakage, slippage, or incorrect use effective when used up to 72 hours after intercourse. — two or more consecutive missed combined oral Consequently, some product package instructions and contraceptive pills older guidelines advise use only within that time frame. — progestin-only pill (minipill) taken more than three However, more recent studies indicate that the regimens hours late continue to be moderately effective if started between 72 4,7 — more than two weeks late for a progestin-only con- and 120 hours. No data are available on efficacy if treat- traceptive injection (depot-medroxyprogesterone ment is started more than 120 hours after intercourse. acetate or enanthate) Both regimens are available in some locations as products formulated and labeled specifically for use as

7 X ECPs. They also can be made up from a variety of regular expected pregnancies averted by the treatment. Determining oral contraceptive pills (see Table 1 or www.cecinfo.org). this fraction is not straightforward; it involves many assump- The levonorgestrel-only regimen is preferred because it is tions that are difficult to validate. Therefore, the reported more effective and is associated with a lower risk of nausea efficacy figures presented below may not be precise. Yet, pre- and vomiting.5 cise estimates of efficacy may not be highly relevant to many women who have had unprotected intercourse, since ECPs 2.2 Mode of Action are often the only available treatment. A more important consideration for most ECP clients may be the fact that Like all hormonal contraceptives, ECPs may work in a ECPs (specifically, the levonorgestrel regimen) are certainly variety of ways. The precise mechanism of action of ECPs in more effective than nothing.23 a particular case cannot be determined and probably depends Four studies of the levonorgestrel regimen that on the time in a woman’s menstrual cycle when intercourse included a total of almost 5,000 women reported pre- occurred and when ECPs were taken.8,9 Several studies have vented fractions between 60 percent and 93 percent; that provided direct evidence that when taken before ovulation, is, this regimen reduced a woman’s chance of pregnancy both the combined regimen and the levonorgestrel regimen by that amount.4,5,24,25 A meta-analysis of eight studies of can act by preventing or delaying ovulation.10-14 Some studies the combined regimen including more than 3,800 women have shown changes in histologic and biochemical features concluded that the regimen prevents about 74 percent of of the endometrium after treatment with combined ECPs, expected pregnancies; the proportion ranged from 56 per- suggesting that they may act by impairing endometrial recep- cent to 89 percent in the different studies.26 A large ran- tivity to implantation of a fertilized egg.6,14,15 However, other domized trial that directly compared the two regimens studies have shown no such effects with both the combined showed that the levonorgestrel regimen is significantly and levonorgestrel-only regimens,10,11,13,16,17 and it is not clear more effective than the combined regimen. The relative that the observed changes would be sufficient to prevent risk of pregnancy in this study was 0.36, indicating that the implantation. Additional possible mechanisms include inter- chance of pregnancy among women who received the lev- ference with sperm transport or penetration18,19 and interfer- onorgestrel regimen was about one third of the chance ence with corpus luteum function.14,20 To date, no direct among those who received the combined regimen.5 clinical data exist regarding these possibilities. Nevertheless, Multiple studies have indicated that both regimens are statistical evidence on the effectiveness of ECPs suggests that more effective the sooner after intercourse the pills are they could not be as effective as data indicate if they only taken.4,5,25,27 Some older studies of the combined regimen worked by interfering with ovulation.21 did not show this time effect,28 but they may not have been ECPs have often been confused with . as rigorously conducted as more recent research. No data ECPs are effective only in the first few days following inter- are available establishing efficacy if ECPs are taken more course before a pregnancy is established, while medical than 120 hours after intercourse. abortion is a nonsurgical option for terminating a preg- ECPs are inappropriate for regular use as an ongoing nancy. At least five days elapse between intercourse and the contraceptive method for several reasons. First, ECPs are less establishment of a pregnancy, defined as implantation of a effective than most modern methods over the long term. The fertilized egg in the lining of a woman’s uterus. ECPs work prevented fraction statistic used to express efficacy of ECPs in this interval to prevent pregnancy. They are ineffective after a single use cannot be directly compared to published once implantation has begun. Data from studies of high- failure rates of other contraceptives used for prolonged peri- dose oral contraceptives indicate that neither of the two ods of time. However, if ECPs were used as an ongoing ECP regimens discussed here will interrupt an established method, the cumulative risk of pregnancy during a full year of pregnancy or harm a developing embryo.22 use would likely be higher than the risk associated with regu- 2.3 Efficacy lar hormonal contraceptives, male condoms, and other bar- rier methods. In addition, very frequent ECP use would The statistic commonly used to express the efficacy of result in more side effects (such as menstrual irregularities) most contraceptive methods indicates the proportion of and exposure to a higher total hormone dose than would women who become pregnant while using the method over regular use of either combined oral contraceptive pills or a fairly long period of time. This statistic is not meaningful progestin-only pills. Data are not available on the incidence of for ECPs, which are intended for one-time use. Instead, the medical complications (if any) in women who use current contraceptive efficacy of ECPs is commonly expressed in regimens of ECPs frequently over a long period of time. terms of the “prevented fraction,” which is the proportion of

X 8 2.4 Side Effects, Prevention, and tion among ECP users); the menstrual period usually Management occurs within one week before or after the expected time. Management No deaths or serious complications have been causally linked to emergency contraception.29 Side effects that are med- After using ECPs, if the menstrual period has not ically minor but troublesome to clients do occur, however. come by a week after it was expected, the client should be advised to consider the possibility that she may be preg- Nausea and vomiting nant and to seek appropriate evaluation (such as a preg- Nausea occurs in about 18 percent of women and nancy test) and care. vomiting occurs in about 4 percent of women using lev- Irregular vaginal bleeding onorgestrel-only ECPs.4,5,24,25 Nausea and vomiting occur in about 43 percent and 16 percent, respectively, of clients Some women may experience irregular bleeding or using the combined regimen.30 In studies directly compar- spotting after taking ECPs. The proportion with this side ing the two regimens, the levonorgestrel regimen has been effect varies substantially in different studies; for example, shown to cause significantly and substantially less nausea trials of the LNG regimen found that between 0 percent and vomiting than the combined regimen.5,25 If they occur, and 17 percent of women reported non-menstrual bleed- these symptoms are usually limited to the first three days ing in the first week after use. after treatment.31 Management Prevention Irregular bleeding due to ECPs is not dangerous and The best way to minimize nausea and vomiting is to will resolve without treatment. However, it is important use the levonorgestrel-only regimen instead of the com- not to discount the possibility that irregular bleeding after bined regimen whenever possible. Nausea and vomiting ECP use may be due to another more serious cause, such are uncommon enough with the levonorgestrel-only regi- as ectopic pregnancy. Consideration should be given to men that prophylactic administration of an antiemetic drug evaluating this symptom with a pregnancy test and other is not routinely warranted. However, if the combined reg- appropriate tests if the woman has other symptoms of imen is used, antiemetic pretreatment may be considered, ectopic pregnancy, such as lower abdominal pain. depending on program and client resources. A single dose Other side effects of ECPs of meclizine (50 mg), taken one hour before the first dose of the regimen, reduces the risk of nausea by about 30 per- Other side effects may include abdominal pain, breast cent and the incidence of vomiting by about 60 percent. tenderness, headache, dizziness, and fatigue. These side effects usually do not occur more than a few days after Clients who use meclizine should be warned that it might 31 cause drowsiness.30 Metoclopramide, 10 mg taken one treatment, and they generally resolve within 24 hours. hour before each dose of the combined regimen, also Management reduces the incidence of nausea.32 Lower doses of these A nonprescription pain reliever can be used to reduce drugs and other antiemetics also may prevent nausea and discomfort due to headaches or breast tenderness. vomiting, but they have not been studied. It is not possible to predict which ECP users will have nausea or vomiting or Effects on pregnancy which women will benefit from antiemetic pretreatment. Results from studies of high-dose oral contraceptives Taking ECPs with food has not been shown to alter the suggest that neither the pregnant woman nor the fetus will risk of nausea.30,33 be harmed if ECPs are inadvertently used during early 36 Management pregnancy. Available evidence suggests that ECPs do not If vomiting occurs within two hours of taking an ECP increase the chance that a pregnancy following ECP use dose, many experts believe that the dose should be will be ectopic; in fact, like all contraceptive methods, ECPs reduce the absolute risk of ectopic pregnancy by pre- repeated. In cases of severe vomiting, ECPs can be admin- 37 istered vaginally. Studies of regular oral contraceptive pills venting pregnancy in general. administered by this route suggest that the hormones are well absorbed through the vaginal mucosa.34,35 2.5 Precautions No evidence exists to indicate that ECPs are danger- Delay in menses ous under any known circumstances or in women with any Clients should be informed that ECPs do not neces- particular medical condition. Although some product sarily bring on menses immediately (a potential mispercep-

9 X package inserts list precautions similar to those associated Use after coital act(s) more than 120 hours in with continuous use of combined oral contraceptives and lev- the past onorgestrel-only pills, experts believe that these precautions do not apply to ECPs because the treatment is so short. No data are available on efficacy if treatment is started Women with previous ectopic pregnancy may use ECPs. more than 120 hours after intercourse. However, since ECPs ECPs are not indicated for a woman who has a confirmed apparently pose no danger either to the woman or to the pregnancy because they will have no effect. However, if an embryo if the ECPs fail, it is reasonable to provide them if evaluation for pregnancy has not been performed or if preg- the client is fully counseled about the possibility of pregnancy. nancy status is unclear, ECPs may be provided, as there is no A more effective approach would be to insert a copper IUD evidence suggesting harm to the woman or to an existing (see Appendix), if the earliest unprotected act occurred pregnancy. In the absence of pregnancy evaluation, though, within the past seven days and the woman is otherwise a can- the client should understand that she could already be preg- didate for emergency IUD insertion. nant, in which case ECP treatment will not be effective. Use after more than one unprotected act 2.6 Screening ECPs should not be withheld if the client has had more than one unprotected or inadequately protected act Because ECPs are safe for all women, and clients can of intercourse, unless she is known to be already pregnant. determine for themselves whether they have had unprotected However, clients should be informed that the efficacy of or inadequately protected intercourse, the only purpose of the ECPs will decline as the interval between the earliest screening is to identify situations when ECPs are clearly not coital act and the use of the ECPs lengthens. Clients needed (e.g., the client is already pregnant) or when an emer- should be encouraged to use ECPs as promptly as possi- gency contraceptive treatment other than ECPs (i.e., an ble after an act of unprotected intercourse and not to wait IUD) should be considered. This screening can be done by a until they have had a series of unprotected acts. Only one clinician or other trained provider or by the client herself after ECP treatment should be given at a time, regardless of the written or oral instruction.38 Clinical assessments (e.g., preg- number of prior unprotected acts. nancy test, blood pressure measurement, laboratory tests, pelvic exam) are not required but can be offered if medically Repeated use indicated for other reasons and desired by the client. A preg- ECPs are not intended for repeated use (see Section nancy test may be helpful in detecting pregnancy if the client 2.3) and no direct data are available about the effects of fre- has missed a menstrual period. quent use of current regimens. However, experience with ECPs should not be withheld or delayed in order to similar regimens39 and with high-dose oral contraceptives carry out screening procedures. suggests that the likelihood of harm from limited repeat use is low. ECPs should not be denied just because the woman 2.7 Special Issues has used them before, even within the same menstrual cycle. All women who use ECPs, especially those who use Use in breastfeeding women them repeatedly, should be given information about other A woman who is less than six months postpartum, is forms of contraception and counseling about how to avoid exclusively breastfeeding, and has not had a menstrual future contraceptive failures. Certainly repeated use of period since delivery is unlikely to be ovulatory and there- ECPs is safer than pregnancy, in particular when the preg- fore is unlikely to need ECPs. However, a woman who is nancy is unintended and women do not have access to safe providing supplemental feeding to her infant or who has abortion services. had menses since delivery may be at risk for pregnancy. A single treatment with ECPs is unlikely to have an impor- Use of ECPs before intercourse tant effect on milk quantity or quality. An unknown No data are available about how long the contracep- amount of hormone may pass into the breast milk. Some tive effect of ECPs persists after the pills have been taken. authorities recommend that nursing women should feed Presumably ECPs taken immediately before intercourse the baby immediately before taking ECPs and then express are as effective as ECPs taken immediately afterwards. and discard the breast milk for the next six hours, but the However, if a woman has the opportunity to plan to use a need for this practice is not proven. contraceptive method before intercourse, a method other than ECPs, such as condoms or another barrier method, is recommended.

X 10 Use of ECPs during the “infertile period” • The client should take ECPs as soon as possible after Studies have shown that fertilization can result from intercourse to maximize efficacy. She should not intercourse only during a five- to seven-day interval around take extra doses unless she vomits within two hours the time of ovulation.40 Theoretically, ECPs should not be after a dose. needed if unprotected intercourse occurs at other times of • After taking ECPs, if the next menstrual period has the cycle, because the chance of pregnancy even without not come by a week after it was expected, the client ECPs would be zero. However, in practice, it is often should consider the possibility that she may be preg- impossible to determine for certain whether a specific act nant and seek evaluation and care. of intercourse occurred on a fertile or infertile cycle day. • If the client has irregular bleeding and lower abdomi- Therefore, ECPs generally should be provided any time nal pain, she should contact a health care provider for unprotected or inadequately protected intercourse occurs possible evaluation of ectopic pregnancy. and the client is concerned that she is at risk for pregnancy. In situations when the unprotected act is extremely • ECPs are not suitable for ongoing contraception. The unlikely to result in pregnancy, the client’s anxiety level and client should use a standard method of contraception the availability of program and client resources should be to prevent pregnancy from coital acts in the future. taken into account in making the decision. • ECPs do not protect against HIV or other sexually transmitted infections (STIs). The act of intercourse Drug interactions that prompted the request for ECPs may have put the No specific data are available about the interactions of client at risk for these infections, and she should con- ECPs with other drugs that the client may be taking. sider getting tested. However, it seems reasonable that drug interactions would Ideally, the client should also be given information be similar to those with regular oral contraceptive pills. A about efficacy, side effects, and mechanism of action of full discussion of this matter is beyond the scope of these ECPs, as well as information about other contraceptive guidelines, but several excellent references on the subject methods to use in the future and methods for preventing are available.41-45 Women taking drugs that may reduce the STIs. Whenever feasible, a regular method such as con- efficacy of oral contraceptives (including but not limited doms should be offered for her to use in the immediate to rifampicin, certain anticonvulsant drugs, and Saint future. Depending on the situation, the client should be John’s wort) should be advised that the efficacy of ECPs referred to facilities where she can obtain pregnancy care in may be reduced. Consideration may be given to increas- case of treatment failure, tests for STIs and HIV, and other ing the amount of hormone administered in the ECPs, needed services. either by increasing the amount of hormone in one or However, clients should not be overwhelmed with so both doses, or by giving an extra dose. much information that they cannot absorb it all. In addi- Use of other formulations tion, some clients may not want counseling on certain top- ics (such as information on other contraceptive methods One study has shown that a combined estrogen- or on the mechanism of action of ECPs) at the time they progestin pill formulation containing the progestin receive ECPs. Providers should not deny ECPs to women norethindrone offered an efficacy and side effect profile who refuse more than the minimum information needed similar to the standard combined pill regimen containing to ensure that they use ECPs correctly. levonorgestrel.33 These results suggest that oral contracep- tive pills containing progestins other than levonorgestrel 2.9 Counseling may be used for emergency contraception in situations when the two standard regimens are not available. Two studies have suggested that most women do not need any interaction with a health care provider in order to 2.8 Information for the Client use ECPs safely and effectively.38,46 However, counseling can serve to reinforce any messages given in writing and may Relevant information can be provided to ECP clients lead to better overall outcomes. Counselors should be mind- in person, over the telephone, in writing (e.g., in a pam- ful of possible unique sources of anxiety among women phlet or product package insert), or by a combination of requesting ECPs: embarrassment at failing to use contra- these methods. This information should include at least the ception effectively; rape-related trauma; concern about STIs, following key messages: including HIV, due to condom failure or non-use; and hes- itation due to a misperception that ECPs cause abortion.

11 X Counselors should be as supportive as possible of the client’s Respect and support her decision. Refer her to other choices and refrain from making judgmental comments or service providers as appropriate. indicating disapproval through body language or facial • If she decides to continue the pregnancy, reassure her expressions while discussing ECPs with clients. Supportive that there is no evidence of any teratogenic effect fol- attitudes will help set the stage for follow-up counseling lowing ECP use. Available data suggest that ECPs do about regular contraceptive use and prevention of STIs. not increase the likelihood that a subsequent preg- When possible, give clients written as well as oral instruc- nancy will be ectopic. tions for taking the ECPs. Pictorial instructions may help clients whose literacy may be limited. 2.12 Starting or Resuming Regular Actively involving the client in the counseling process is encouraged. For example, a provider might ask her what Contraception after ECP Use she has heard about ECPs, discuss her experience with Whenever possible, clients receiving ECPs should be other contraceptive methods (particularly the incident that given contraceptive counseling and provided with an led to the ECP request), and explore her current approach ongoing contraceptive method, such as condoms, for at to protecting herself from STIs. Validating or correcting least immediate future use. However, such counseling may her ideas as appropriate may be more effective in ensuring not be appropriate in all situations or may not be desired compliance than simply providing her with information. by clients at the time of ECP provision, and it should not Whenever possible, ensure that counseling is con- be a prerequisite for providing ECP services. Clients who ducted in private. In situations where privacy is inadequate need or desire counseling but who do not receive it at the (for instance, in many pharmacies), advise clients to contact ECP visit should be referred for a follow-up appointment a health care or family planning provider for additional at the earliest convenient time. information and counseling about regular contraceptive Clients may wish to restart their previous contracep- methods. Reassure all clients, regardless of age or marital tive method after taking ECPs, or they may prefer to initi- status, that all information that they give to the provider, as ate a new method. If the reason for requesting ECPs is well as the fact that they have received treatment, will be because the regular contraceptive method failed (for exam- kept confidential. ple, the condom broke or the client missed taking oral contraceptive pills), discuss with the client the reasons for 2.10 Follow-up failure and how it can be prevented in the future. In some No scheduled follow-up is required after ECP use cases, the need for ECPs may be an indication that a unless the client identifies a problem or question. However, change of methods should be considered. the client should be advised to seek follow-up care if she: ECP clients, particularly those with risk factors for STIs, such as young age, multiple partners, or residence in a • needs ongoing contraceptive counseling or a contra- location where STIs are especially prevalent, should ideally ceptive method; receive counseling on how to prevent STIs as well as preg- • has not had a menstrual period by a week after it was nancy by using condoms in addition to or as the primary expected; contraceptive method. • has irregular bleeding and lower abdominal pain; Guidelines for initiating or restarting • suspects she may be pregnant; contraceptive use after using ECPs • needs other services, such as evaluation for STIs; or Male or • has other reasons for concern. Can be used immediately. 2.11 If the Client Becomes Pregnant Diaphragm or A woman who has used ECPs may later find herself Can be used immediately. to be pregnant because the ECPs have failed, because she Spermicidal foam, tablets, jelly, cream, or film was already pregnant before taking the ECPs, or because coital acts after taking the ECPs led to pregnancy. In any Can be used immediately. of these cases: • Advise the client about all available options, and let her decide which is most appropriate for her situation.

X 12 Oral contraceptives, hormonal contraceptive intercourse occurs in the interim, an alternate con- patch, or traceptive method (such as condoms) or abstinence Two options are offered. Many experts recommend should be used. the first as preferable because the method is initiated Female or male sterilization sooner, which may reduce subsequent pregnancy risk. Perform the operation only after informed consent can a. The client may begin using the method the day be ensured. It is not recommended that clients make this after taking the ECPs. If she is newly starting the decision under the stressful conditions that often sur- method, she should begin with a new pill pack, patch, round ECP use. Defer female sterilization until after the or ring. If she was previously using the method (e.g., client’s first menstrual period, to ensure that she is not the ECPs were indicated because of missed pills or dis- pregnant. Use a backup method or abstain from inter- lodgement of the patch or ring), she may resume using course until the sterilization procedure is performed. the pill pack, patch, or ring that she was previously using. In this case, she should be reminded that the 3 ECP Service Delivery Systems patch or ring will not be effective past the original date on which it was scheduled to be removed. All clients Given that ECPs appear to be most effective when starting hormonal methods immediately after using taken soon after intercourse, every effort should be made ECPs should use a barrier method if they have inter- to ensure that women know about ECPs before they need course in the next seven days after starting or restart- them. This can be accomplished by: ing the method. Clients may have some irregular bleeding until the onset of menses. • routinely informing women about ECPs at the time of regular medical or family planning visits; b. The client may wait until the beginning of her next menstrual cycle and then start the method • including information about ECPs on Web sites or according to the standard instructions for that telephone answering machines; method. In this case, she should be advised to use a • distributing written information about ECPs with barrier contraceptive method or abstain from inter- other contraceptive supplies or medications; course for the remainder of the current cycle. • including information about ECPs within sexual edu- Injectables cation programs; or Initiate progestin-only injectables and combined • instituting mass-media informational campaigns and monthly injectables within seven days after the begin- advertising ECP services. ning of the next menstrual cycle. The client should use Information about ECPs is particularly relevant to a barrier contraceptive or abstain from intercourse adolescents who are not yet sexually active; to women who until she receives the injection. are using contraceptive methods that are often used incon- Implants sistently or incorrectly, such as barrier methods, oral con- Insert within seven days after the beginning of the traceptives, or ; and to other next menstrual cycle. Use a backup method or abstain high-risk women, such as youth, migrant workers and their from intercourse until the implants are inserted. spouses, and victims of sexual assault. It is also critical that women be able to obtain ECPs IUD quickly when the need arises. Because the instructions for Insert after the start of the next normal menstrual use of ECPs are simple and medical screening is not neces- period. The client should use a barrier contraceptive sary, the requirement for an immediate visit to a doctor is or abstain from intercourse until the IUD is inserted. not necessary for safe and effective use38 and may create barriers to access. Some approaches to facilitating access are: NOTE: If the client intends to use an IUD as a long- term method and meets IUD screening criteria, emer- • providing women with an advance prescription or gency insertion of a copper-bearing IUD may be a supply of ECPs;47 good alternative to ECP use (see Appendix). • prescribing ECPs by telephone without seeing the Natural family planning client; Natural family planning may be initiated after the • training nurses, midwives, pharmacists, or nonclinical first normal menstrual period following ECP use. If individuals such as community health workers and

13 X sexual assault counselors to provide ECPs, if allowed 3.2 Women Who Have Been Sexually by local regulations; Assaulted • ensuring that nonclinical staff in health facilities, whom Reaching women who have been forced to have inter- clients may contact before seeing a clinician, are aware course also poses special challenges. ECP providers should of the availability of ECPs; be attentive to the possibility that these women may be: • distributing ECPs through nonclinical settings, such • unaware that something can be done to prevent preg- as through community-based services, schools, social nancy after sexual assault; marketing programs, and the commercial sector (e.g., pharmacies); or • unwilling to report the assault and therefore unwilling to seek services; • distributing ECPs over the counter.48 • concerned they will be blamed for the assault by the All ECP providers should be given appropriate training medical provider; or and follow clear service delivery guidelines. Training should include information on indications for ECP use, • also in need of diagnosis and treatment for STIs. recommended ECP regimens, mode of action, efficacy, Program managers and providers should ensure that side effects and their management, precautions and screen- police stations, emergency health care centers, and other ing, client information and counseling needs, and follow- facilities where women may seek help after an assault can up procedures. In addition, because ECPs are a backup provide clients with ECPs, if appropriate, or at least with method, the training also should include information information about where to obtain ECPs and other needed about other contraceptive methods, if necessary for the treatments as promptly as possible. audience. The training often is most effective if it is partic- ipatory in nature and includes exercises to build participant skills in the areas of screening, counseling, and follow-up. To obtain provider-training curricula, please contact the International Consortium for Emergency Contraception or visit the Consortium’s Web site at www.cecinfo.org.

3.1 Youth Reaching adolescents with emergency contraceptive information and services poses special challenges to pro- grams. Young women may find it difficult to access relevant information about or services for emergency contraception because they: • are unaware of the availability of ECPs; • lack confidence or are embarrassed to visit a family planning clinic; • do not know of the existence of the clinic; • find the clinic hours inconvenient; • fear a pelvic examination; or • are anxious about judgmental attitudes of the providers. Programs should work to ensure that clinics serving adolescents are youth-friendly (for example, by ensuring privacy and confidentiality, accessible facilities, reasonably priced services, and flexible hours — particularly during evenings and weekends).

X 14 TABLE 1 ECP Formulations

Formulation (per pill) Common Brand Names Dose

Levonorgestrel-only LNG 1.50 mg (registrations pending) 1 tablet Regimen LNG 0.75 mg Imediat N, Levonelle-2, NorLevo, 2 tablets at once OR Plan B, Post-day, Postinor-2, Vika, 1 tablet, followed by Vikela 1 more 12 hours later

Combined Regimen EE 50 mcg + LNG 0.25 mg E-Gen-C, Eugynon, Fertilan, 2 tablets, followed by OR Imediat, Neogynon, Nordiol, 2 more 12 hours later EE 50 mcg + NG 0.50 mg Ogestrel, Ovral, Ovran, Preven, Tetragynon

EE 20 mcg + LNG 0.10 mg Alesse, Levlite, Aviane, Loette 5 tablets, followed by 5 more 12 hours later

EE 30 mcg + LNG 0.15 mg AnNa, Levlen, Levora, Lo/Femenal, 4 tablets, followed by OR Lo/Ovral, Low-Ogestrel, 4 more 12 hours later EE 30 mcg + NG 0.30 mg Microgynon 30, Nordette, Rigevidon

Abbreviations: EE = Ethinyl Estradiol LNG = Levonorgestrel NG = Norgestrel When using packs containing 28 pills, the last seven pills should not be used. For all regimens, pills should be taken as soon as possible after intercourse but optimally within 120 hours. This table was prepared in October 2003. An updated table may be found on the Consortium Web site at: www.cecinfo.org.

15 X APPENDIX: USE OF IUDS FOR EMERGENCY CONTRACEPTION

Copper-bearing IUDs can be used as a method of emer- infection, and those who are at high risk for STIs. In many gency contraception. They are most appropriate for instances, the act of intercourse that led to the request for women in stable relationships who wish to retain the IUD emergency contraception might put the woman at for long-term contraception and who meet the screening increased risk for STIs, in which case the IUD is not an requirements for regular IUD use. When inserted within optimal contraceptive choice. seven days after intercourse, copper-bearing IUDs are the For further information about use of IUDs for emer- most effective method of emergency contraception; they gency contraception, consult the IPPF Medical and Ser- reduce the risk of pregnancy by more than 99 percent.49,50 vice Delivery Guidelines. The most recent edition, which However, emergency IUD insertion requires a much contains information about emergency contraception, is higher degree of training and clinical oversight than available from IPPF, Regent’s College, Inner Circle, administration of ECPs. Clients must be screened to Regent’s Park, London NW1 4NS, UK; Web site: exclude those who are already pregnant, those who have www.ippf.org. pelvic inflammatory disease or another reproductive tract

X 16 REFERENCES

1. Trussell J, Koenig J, Stewart F, Darroch JE. Medical care 17. Taskin O, Brown RW, Young DC, Poindexter AN, Wiehle cost savings from adolescent contraceptive use. Fam Plann RD. High doses of oral contraceptives do not alter endome- Perspect 1997;29:248-55, 295. trial alpha 1 and alpha v beta 3 integrins in the late implan- 2. Trussell J, Koenig J, Ellertson C, Stewart F. Preventing unin- tation window. Fertil Steril 1994;61:850-5. tended pregnancy: the cost-effectiveness of three methods of 18. Kesseru E, Camacho-Ortega P, Laudahn G, Schopflin G. In emergency contraception. Am J Public Health 1997;87:932-7. vitro action of progestogens on sperm migration in human 3. Piaggio G, von Hertzen H, Grimes DA, Van Look PF. Tim- cervical mucus. Fertil Steril 1975;26:57-61. ing of emergency contraception with levonorgestrel or the 19. Kesseru E, Garmendia F, Westphal N, Parada J. The hor- Yuzpe regimen. Task Force on Postovulatory Methods of monal and peripheral effects of d-norgestrel in postcoital Fertility Regulation (letter). Lancet 1999;353:721. contraception. Contraception 1974;10:411-24. 4. von Hertzen H, Piaggio G, Ding J, et al. Low dose mifepri- 20. Ling WY, Wrixon W, Acorn T, Wilson E, Collins J. Mode of stone and two regimens of levonorgestrel for emergency action of dl-norgestrel and ethinylestradiol combination in contraception: a WHO multicentre randomised trial. Lancet postcoital contraception. III. Effect of preovulatory admin- 2002;360:1803-10. istration following the luteinizing hormone surge on ovar- 5. Task Force on Postovulatory Methods of Fertility Regula- ian steroidogenesis. Fertil Steril 1983;40:631-6. tion. Randomised controlled trial of levonorgestrel versus 21. Trussell J, Raymond EG. Statistical evidence about the the Yuzpe regimen of combined oral contraceptives for mechanism of action of the Yuzpe regimen of emergency emergency contraception. Lancet 1998;352:428-33. contraception. Obstet Gynecol 1999;93:872-6. 6. Yuzpe AA, Thurlow HJ, Ramzy I, Leyshon JI. Post coital 22. Bacic M, Wesselius de Casparis A, Diczfalusy E. Failure of contraception—a pilot study. J Reprod Med 1974;13:53-8. large doses of ethinyl estradiol to interfere with early embry- 7. Ellertson C, Evans M, Ferden S, et al. Extending the time onic development in the human species. Am J Obstet Gynecol limit for starting the Yuzpe regimen of emergency contra- 1970;107:531-4. ception to 120 hours. Obstet Gynecol 2003;101:1168-71. 23. Raymond E, Taylor D, Trussell J, Steiner M. Minimum 8. Grimes DA, Raymond EG. Emergency contraception. Ann effectiveness of the levonorgestrel regimen of emergency Intern Med 2002;137:180-9. contraception. Contraception 2004;in press. 9. Croxatto HB, Devoto L, Durand M, et al. Mechanism of action 24. Arowojolu AO, Okewole IA, Adekunle AO. Comparative of hormonal preparations used for emergency contraception: a evaluation of the effectiveness and safety of two regimens of review of the literature. Contraception 2001;63:111-21. levonorgestrel for emergency contraception in Nigerians. 10. Marions L, Hultenby K, Lindell I, Sun X, Stabi B, Gemzell Contraception 2002;66:269-73. Danielsson K. Emergency contraception with mifepristone 25. Ho PC, Kwan MS. A prospective randomized comparison and levonorgestrel: mechanism of action. Obstet Gynecol of levonorgestrel with the Yuzpe regimen in post-coital 2002;100:65-71. contraception. Hum Reprod 1993;8:389-92. 11. Durand M, del Carmen Cravioto M, Raymond EG, et al. 26. Trussell J, Rodriguez G, Ellertson C. Updated estimates of On the mechanisms of action of short-term levonorgestrel the effectiveness of the Yuzpe regimen of emergency contra- administration in emergency contraception. Contraception ception. Contraception 1999;59:147-51. 2001;64:227-34. 27. Kane LA, Sparrow MJ. Postcoital contraception: a family 12. Hapangama D, Glasier AF, Baird DT. The effects of peri- planning study. N Z Med J 1989;102:151-3. ovulatory administration of levonorgestrel on the menstrual 28. Trussell J, Ellertson C, Rodriguez G. The Yuzpe regimen of cycle. Contraception 2001;63:123-9. emergency contraception: how long after the morning after? 13. Swahn ML, Westlund P, Johannisson E, Bygdeman M. Effect of Obstet Gynecol 1996;88:150-4. post-coital contraceptive methods on the endometrium and the 29. Vasilakis C, Jick SS, Jick H. The risk of venous thromboem- menstrual cycle. Acta Obstet Gynecol Scand 1996;75:738-44. bolism in users of postcoital contraceptive pills. Contraception 14. Ling WY, Robichaud A, Zayid I, Wrixon W, MacLeod SC. 1999;59:79-83. Mode of action of DL-norgestrel and ethinylestradiol combina- 30. Raymond EG, Creinin MD, Barnhart KT, Lovvorn AE, tion in postcoital contraception. Fertil Steril 1979;32:297-302. Rountree RW, Trussell J. Meclizine for prevention of nausea 15. Young DC, Wiehle RD, Joshi SG, Poindexter AN 3rd. associated with use of emergency contraceptive pills: a ran- Emergency contraception alters progesterone-associated domized trial. Obstet Gynecol 2000;95:271-7. endometrial protein in serum and uterine luminal fluid. 31. Van Santen MR, Haspels AA. Interception II: postcoital low- Obstet Gynecol 1994;84:266-71. dose estrogens and norgestrel combination in 633 women. 16. Raymond EG, Lovely LP, Chen-Mok M, Seppala M, Kurman Contraception 1985;31:275-93. RJ, Lessey BA. Effect of the Yuzpe regimen of emergency 32. Ragan RE, Rock RW, Buck HW. Metoclopramide pretreat- contraception on markers of endometrial receptivity. Hum ment attenuates emergency contraceptive-associated nausea. Reprod 2000;15:2351-5. Am J Obstet Gynecol 2003;188:330-3.

17 X 33. Ellertson C, Webb A, Blanchard K, et al. Modifying the Yuzpe 41. Breckenridge AM, Back DJ, Orme M. Interactions between oral regimen of emergency contraception: a multicenter random- contraceptives and other drugs. Pharmacol Ther 1979;7:617-26. ized controlled trial. Obstet Gynecol 2003;101:1160-7. 42. Shenfield GM. Drug interactions with oral contraceptive 34. Back DJ, Grimmer SF, Rogers S, Stevenson PJ, Orme ML. preparations. Med J Aust 1986;144:205-11. Comparative pharmacokinetics of levonorgestrel and ethiny- 43. Szoka PR, Edgren RA. Drug interactions with oral contracep- loestradiol following intravenous, oral and vaginal adminis- tives: compilation and analysis of an adverse experience report tration. Contraception 1987;36:471-9. database. Fertil Steril 1988;49:31S-38S. 35. Alvarez F, Faundes A, Johansson E, Coutinho E. Blood lev- 44. Guerts TBP, Goorissen EM, Sitsen JMA. Summary of Drug els of levonorgestrel in women following vaginal placement Interactions with Oral Contraceptives. Carnforth, England: of contraceptive pills. Fertil Steril 1983;40:120-3. Parthenon Publishing Group, Ltd., 1993. 36. U.S. Department of Health and Human Services, Food and 45. Dickinson BD, Altman RD, Nielsen NH, Sterling ML. Drug Drug Administration. Prescription drug products; certain interactions between oral contraceptives and antibiotics. combined oral contraceptives for use as postcoital emergency Obstet Gynecol 2001;98:853-60. contraception. Fed Regist 1997;62:8610-2. 46. Raymond EG, Dalebout SM, Camp SI. Comprehension of a 37. Trussell J, Hedley A, Raymond E. Ectopic pregnancy follow- prototype over-the-counter label for an emergency contra- ing use of progestin-only ECPs (letter). J Fam Plann Reprod ceptive pill product. Obstet Gynecol 2002;100:342-9. Health Care 2003;29:249. 47. Glasier A, Baird D. The effects of self-administering emer- 38. Raymond EG, Chen PL, Dalebout SM. “Actual use” study gency contraception. N Engl J Med 1998;339:1-4. of emergency contraceptive pills provided in a simulated 48. Grimes DA, Raymond EG, Scott Jones B. Emergency con- over-the-counter manner. Obstet Gynecol 2003;102:17-23. traception over-the-counter: the medical and legal impera- 39. United Nations Development Programme/ United Nations tives. Obstet Gynecol 2001;98:151-5. Population Fund/World Health Organization/World Bank 49. Zhou L, Xiao B. Emergency contraception with Multiload Special Programme of Research, Development and Research Cu-375 SL IUD: a multicenter clinical trial. Contraception Training in Human Reproduction, Task Force on Post-Ovu- 2001;64:107-12. latory Methods of Fertility Regulation. Efficacy and side effects of immediate postcoital levonorgestrel used repeat- 50. Trussell J, Ellertson C. Efficacy of emergency contraception. edly for contraception. Contraception 2000;61:303-8. Fertil Control Rev 1995;4:8-11. 40. Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual inter- course in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N Engl J Med 1995;333:1517-21.

X 18 ABOUT THE INTERNATIONAL CONSORTIUM FOR EMERGENCY CONTRACEPTION

The mission of the International Consortium for Emergency update of emergency contraception activities worldwide. If Contraception is to expand access to and ensure safe and you would like to subscribe or contribute an article to this locally appropriate use of emergency contraception world- update, please contact the Consortium at the following wide within the broader context of family planning and address or the American Society for Emergency Contracep- reproductive health, with emphasis on developing countries. tion at [email protected]. The seven founding members of the Consortium ini- tially focused on introducing a dedicated emergency contra- Consortium Coordinator ceptive pill product in selected “demonstration” countries. International Consortium for Emergency Contraception As interest in emergency contraception and the Consortium E-mail: [email protected] grew, the Consortium expanded its membership to include a Web site: www.cecinfo.org wide range of organizations working to ensure that women The International Consortium encourages the forma- have access to all forms of emergency contraception. The tion of regional networks or consortia in order to better specific objectives of the Consortium are to: address specific issues and local barriers to EC access. For X serve as an authoritative source of information about information on these organizations, please contact the fol- emergency contraception; lowing addresses: X X be a voice for expanded access to and safe and appro- Africa: EC Afrique. Web site: www.ec-afrique.org; E-mail: priate use of emergency contraception; [email protected]; Mail: ECafrique Secretariat, Population Council, PO Box 17643, 00500 Nairobi, X serve as a strategic planning forum for emergency con- Kenya. traception service delivery and information, education, X and communication efforts; Latin America: Latin American Consortium for Emer- gency Contraception (LACEC)/Consorcio Latinoamer- X facilitate information sharing and networking among icano de Anticoncepcion de Emergencia (CLAE). Web Consortium members and other groups working to site: www.clae.info; E-mail: [email protected]; Mail: broaden knowledge of and access to emergency Instituto Chileno de Medicina Reproductiva (ICMER), contraception; Jose Victorino Lastarria 26, Depto. 21, Santiago, Chile. X encourage partnerships between public-sector organi- X Asia (Southeast): Asia Pacific Network on Emergency zations and private industry that are designed to make Contraception (APNEC). Web site: N/A; E-mail: equin- high-quality products for emergency contraception for [email protected]; Mail: Pacific Institute for Women’s large numbers of women worldwide at an affordable Health, 3450 Wilshire Boulevard, Suite 1000, Los Angeles, price; and CA 90010 USA. X seek and promote new emergency contraceptive X The Consortium maintains two listings of individuals and methods that are safe and effective. organizations working in the Arab and East European/ NIS/Balkan regions. To join either region’s listserve, The Consortium welcomes applications for member- please e-mail the following addresses: Arab region: arabre- ship from noncommercial agencies that share the Consor- [email protected]. East Europe, the Balkans, and the NIS tium’s overall goal of expanding access to emergency region: [email protected]. Additional information contraceptive products and services in developing countries. and updated contact information are available on the Con- Interested applicants should contact the Consortium Coor- sortium Web site: www.cecinfo.org. dinator. The Consortium and the American Society for Emergency Contraception also jointly produce an electronic

19 X X 20

INTERNATIONAL CONSORTIUM FOR EMERGENCY CONTRACEPTION

Association of Reproductive Health Professionals • British Pregnancy Advisory Service • Catholics for a Free Choice • Center for Reproductive Rights • Center for Research on Women and Gender, University of Illinois at Chicago • CEPAM • Concept Foundation • CONRAD Program • DKT International • EngenderHealth • Family Care International • Family Health International • Family Planning Association of Sri Lanka • The Futures Group International • Gynuity Health Projects • Ibis Reproductive Health • Institute for Reproductive Health • International Planned Parenthood Federation • Ipas • JSI Research and Training Center for Women’s Health • Management Sciences for Health • Marie Stopes International • Meridian Development Foundation • Pacific Institute for Women’s Health • Pathfinder International • Planned Parenthood Federation of America — International • Population Action International • Population Council • Population Services International • Program for Appropriate Technology in Health • ProSalud Inter-Americana • SHILO Pregnancy Advisory Service • Reproductive Health Initiative of the American Medical Women’s Association • Women’s Commission for Refugee Women and Children, Reproductive Health Program • World Health Organisation (WHO), Special Programme of Research, Development and Research Training in Human Reproduction !PPENDIX"

7EBSITE2ESOURCES

x !#/'S%MERGENCY#ONTRACEPTIVE0RACTICE"ULLETIN 4HE!MERICAN#OLLEGEOF/BSTETRICIANSAND'YNECOLOGYS!#/' 0RACTICE"ULLETINCONTAINS CLINICALMANAGEMENTGUIDELINESONEMERGENCYORALCONTRACEPTIONFORCLINICIANS)NFORMATION CONTAINEDINTHISDOCUMENTISBASEDONEVIDENCE BASEDRESEARCHANDlNDINGSONEMERGENCY CONTRACEPTION)TINCLUDESINFORMATIONONWHATEMERGENCYCONTRACEPTIONISANDTHEMECHANISM OFACTIONANDINFORMATIONONSAFETY EFlCACY RISKS ANDBENElTS)NADDITION CLINICAL RECOMMENDATIONSFORPRESCRIBINGANDDISPENSINGEMERGENCYCONTRACEPTIONTOPATIENTSISINCLUDED WITHINFORMATIONONSIDEEFFECTSANDBOTHDEDICATEDPRODUCTSANDUSEOFORALCONTRACEPTIVES ASEMERGENCYCONTRACEPTION2ECOMMENDATIONSAREMADEBASEDONSCIENTIlCEVIDENCEASWELL ASEXPERTOPINION4HE0RACTICE"ULLETINON%MERGENCY#ONTRACEPTION WHICHHASUSEFULAND ACCURATEINFORMATION ISAVAILABLEATKWWSZZZDFRJRUJ x !#/'.EWS2ELEASE3UPPORTING/VER THE #OUNTER0ROVISIONOF%#0S KWWSZZZDFRJRUJIURPBKRPHSXEOLFDWLRQVSUHVVBUHOHDVHVQUFIP x #ATALYST#ONSORTIUM7EBSITE )NFORMATIONABOUT#ATALYST#ONSORTIUMSPROJECTSANDTHEIRFOCUSPROGRAMAREASINCLUDING OPTIMALBIRTHSPACING POSTABORTIONCARE SOUTH TO SOUTHCOLLABORATION ADOLESCENCE EMPOWERMENT AND()6!)$3ANDSEXUALLYTRANSMITTEDINFECTIONPREVENTION KWWSZZZUKFDWDO\VWRUJ x #ENTERFOR2EPRODUCTIVE2IGHTS7EBSITE 4HE#ENTERFOR2EPRODUCTIVE2IGHTSWEBSITECONTAINSUPDATEDINFORMATIONONGLOBALISSUESAND EVENTSRELATEDTOREPRODUCTIVEHEALTHANDRIGHTS)TINCLUDESLINKSTOOTHERSITESPUBLICATIONS NEWSANDINFORMATIONONADVOCACY HUMANRIGHTS LEGALISSUES CONTRACEPTION ABORTION ADOLESCENTS EQUALITY ANDSAFEPREGNANCYKWWSZZZFUOSRUJ x #ONSORTIUMFOR%MERGENCY#ONTRACEPTIONIN)NDIAS7EBSITE 4HISSITECONTAINSINFORMATIONONTHECONSORTIUMMEETINGTHATWASHELDIN)NDIAIN*ANUARY AND)NDIASEFFORTSTOINTRODUCEEMERGENCYCONTRACEPTIONHTTPWWWECINDIAORG x %MERGENCY#ONTRACEPTIONANDTHE'LOBAL'AG2ULEˆ!N5NOFlCIAL'UIDE !PUBLICATIONBY0OPULATION!CTION)NTERNATIONAL0!) WHICHPROVIDESINFORMATIONABOUTTHE GLOBALGAGRULECANBEACCESSEDATTHE0!)WEBSITE KWWSZZZSRSXODWLRQDFWLRQRUJUHVRXUFHVSXEOLFDWLRQVJOREDOJDJUXOH*DJ5XOH?DOWNLOADHTM x &AMILY(EALTH)NTERNATIONAL&() 4HISSITEINCLUDESINFORMATIONABOUTEMERGENCYCONTRACEPTIONINlVELANGUAGES %NGLISH &RENCH 3PANISH 2USSIANAND!RABIC)TALSOINCLUDESTRAININGMATERIALSFORBOTHINDIVIDUALANDGROUP EMEGENCYCONTRACEPTIONTRAININGSKWWSZZZIKLRUJHQ7RSLFV(&3KWP !PPENDIX 4HE)00&SSTATEMENTONEMERGENCYCONTRACEPTIONCANBEFOUNDA 5PDATEDANDACCURATEINFORMATIONPUBLISHEDBYTHE)#%#INCLUDI 5SEFULDATAFOR%#0ADVOCACYFROMTHE'LOBAL(EALTH#OUNCILCA 4HE'LOBAL(EALTH#OUNCILS2EPORT h0ROMISESTO+EEP4HE4OL 4HE'LOBAL(EALTH#OUNCILSWEBSITECONTAINSINFORMATIONONIN x )NDIVIDUALCOUNTRYDATACANBEACCESSEDAT x 4HE)00&HASMADEITS$IRECTORYOF(ORMONAL#ONTRACEPTIVESAVA x x 4HISRESOURCECANBEACCESSEDTHROUGHTHE0ACIlC)NSTITUTEFOR x 4HISRESOURCEPROVIDESMEDICALGUIDELINESTHATCANSERVEASA x !MONGTHEINFORMATIONAVAILABLEATTHISSITEISALISTOFCOUN 0ROVIDESUSEFULINFORMATIONABOUTEMERGENCYCONTRACEPTION x KWWSPLUURULSSIRUJPHGLFDOLPDSVWDWHPHQWVHQJBEKWP KWWSZZZFHFLQIRRUJKWPOUHVGRZQORDGDEOHPWUOVKWP MEDICALABORTION MECHANISMOFACTION TIMINGANDDOSAGE REPEA KWWSZZZJOREDOKHDOWKRUJQHZVDUWLFOH KWWSZZZJOREDOKHDOWKRUJDVVHWVSXEOLFDWLRQV3URPLVHV7R.HHS LINKSTOOTHERDATASOURCES STATISTICSONUNINTENDEDPREGNANCYANDABORTIONANDRELATEDMAT 0REGNANCIESON7OMENS,IVESINTHE$EVELOPING7ORLD vCONTAINS KWWSJOREDOKHDOWKRUJ ISSUESANDNEWSFROMAROUNDTHEWORLD ASWELLASPUBLICATIONS 'LOBAL(EALTH#OUNCIL7EBSITE KWWSZZZPHDVXUHGKVFRPFRXQWULHVVWDUWFIP -EASURE$EMOGRAPHICAND(EALTH3URVEYS7EBSITE MANUFACTURER %NGLISH &RENCH AND3PANISH5SERSCANSEARCHBYCOMPOSITION FRIENDLY SEARCHABLEDATABASEOFHORMONALCONTRACEPTIVESUSEDW )NTERNATIONAL0LANNED0ARENTHOOD&EDERATION)00& 7EBSITE )#%# AT ,ATIN!MERICAN#ONSORTIUMFOR%MERGENCY#ONTRACEPTION7EBSITE KWWSZZZFHFLQIRRUJKWPOUHVGRZQORDGDEOHPWUOVKWP IMPLEMENTINGASERVICEPROTOCOLAROUND%#0S )#%#h%MERGENCY#ONTRACEPTION0ILLS-EDICALAND3ERVICE$ELIVE KWWSZZZFHFLQIRRUJ¿OHVHFVWDWXVDYDLODELOLW\SGI DEDICATED%#0PRODUCTS4HELIST WHICHISUPDATEDANNUALLY CA !MERICAWHEREEMERGENCYCONTRACEPTIONISAVAILABLEWITHINFORMA )NTERNATIONAL#ONSORTIUMFOR%MERGENCY#ONTRACEPTION KWWSZZZSLZKRUJODWLQDPHULFDKWPOFRQVRUWLXP 0OLICY3TATEMENTSON%#0S KWWSZZZFRQWUDFHSWLYHLSSIRUJ        TRIESIN!FRICA !SIA AND,ATIN )#%# 7EBSITE KWWSZZZFHFLQIRRUJ STANDARDOFCAREFOR 7OMENS(EALTHWEBSITE USEFULFORADVOCATES NBEACCESSEDAT ERNALMORTALITY ASWELLAS TERNATIONALPUBLICHEALTH ORLDWIDEISAVAILABLEIN BRANDNAME TYPE OR NGlVESTATEMENTSON LOF5NINTENDED TUSE ANDACCESS NBEACCESSEDAT T ILABLEONLINE4HISUSER  SGI TIONABOUTTHESTATUSOF GLOBALANDREGIONAL RY'UIDELINESv  !PPENDIX  0ROJECT ITIS ELINESAND  RMACY0ROGRAM  ICA IVES ISACCESSIBLEON RWHERRN %VALUATION DEDBYTHE.ATIONAL OREEXTENSIVELYv !FRICAS$EPARTMENT DUCTIVERIGHTSIN,ATIN ANDANSWERS EMERGENCY TESSTRATEGIESTHAT CONTRACEPTIONPDF VELOPEDBYTHE5NITED CONTRACEPTIONPDF NTRACEPTIVESAND%#0 CESTOASSISTINTHE EWORLDWIDE PROMOTIONAL ABOUTEMERGENCY INGSESSIONS E h)NTHEEVENTOFCONDOM OTEEMERGENCY          KWWSHFSULQFHWRQHGX KWWSZZZSLZKRUJODWLQDPHULFDKWPO  KWWSZZZFSFXQFHGXPHDVXUHPHUOLQPHUOLQKWPO AND KWWSZZZSRSFRXQFLORUJUKISHFKWPO KWWSHFSULQFHWRQHGXZRUOGZLGHGHIDXOWDVS KWWSZZZSLZKRUJ 0ACIlC)NSTITUTEFOR7OMENS(EALTH0)7( 7EBSITE 0!4(S%MERGENCY#ONTRACEPTIONFOR$IVERSE#OMMUNITIES0ROJECT KWWSZZZSDWKRUJUHVRXUFHVHFBGLYHUVHFRPPXQLWLHVSURMKWPQ 0OPULATION#OUNCIL7EBSITE CONTRACEPTION AVAILABLEONTHE)NTERNETAT PRODUCTS DRAWNFROM)00&$IRECTORYOF(ORMONAL#ONTRACEPT THEWEBSITE !MERICA 0!4(S9OUTH &RIENDLY0HARMACY0ROGRAM)MPLEMENTATION+IT'UID 4OOLSFOR)MPLEMENTINGA9OUTH &RIENDLY2EPRODUCTIVE(EALTH0HA .OT  ,ATE7EBSITE MONITORINGANDEVALUATIONOFHEALTHANDPOPULATIONSERVICES$E 3TATES!GENCYFOR)NTERNATIONAL$EVELOPMENT FUNDED-%!352% CONTRACEPTION)NFORMATIONONTHISSITEINCLUDES%#0SAVAILABL MATERIALSDEVELOPEDBYOTHERORGANIZATIONSWORLDWIDE QUESTIONS CONTRACEPTIONNEWS ANDREFERENCES -%2,).6IRTUAL,IBRARYˆ-ONITORINGAND%VALUATION2ESOURCES KWWSZZZQRWODWHFRP .ATIONAL#ONTRACEPTION0OLICY'UIDELINES 2EPUBLICOF3OUTH!FR PREVENTBOTHUNWANTEDPREGNANCYAND34)()6INFECTION ISPROVI #ONTRACEPTION0OLICY'UIDELINESISSUEDBYTHE2EPUBLICOF3OUTH OF(EALTH)NDISCUSSINGBARRIERMETHODS THESEGUIDELINESSTAT FAILURE ACCESSTOEMERGENCYCONTRACEPTIONSHOULDBEPROMOTEDM HTTPWWWDOHGOVZADOCSFACTSHEETSGUIDELINESCONTRACEPTION x HTTPWWWPATHORGlLES2(?00)+?PDF HTTPWWWPATHORGlLES2(?00)+?PDF HTTPWWWPATHORGlLES2(?00)+?PDF HTTPWWWPATHORGlLES2(?00)+?PDF x 4HISINCLUDESRESOURCESFORDEVELOPINGCLINICIAN FOCUSEDTRAIN x 4HISSITEPROVIDESUSEFULINFORMATIONONTHEIREFFORTSTOPROM 3PECIlCINFORMATIONABOUTTHEAVAILABILITYOFCOMBINEDORALCO 4HISWEBSITEHASEXTENSIVEINFORMATIONABOUTWOMENSANDREPRO x !RESOURCEFORDEVELOPINGTRAININGSESSIONSFORPHARMACISTS HTTPWWWPATHORGlLES2(?00)+?PDF HTTPWWWDOHGOVZADOCSFACTSHEETSGUIDELINESCONTRACEPTION x 4HISSITEPROVIDESINFORMATIONIN%NGLISH 3PANISH AND!RABIC !COMPREHENSIVECOLLECTIONOFBOTHPRINTANDELECTRONICRESOUR x x !MODELFORADUALPROTECTIONAPPROACHANAPPROACHTHATPROMO !PPENDIX 4HISWEBSITEPROVIDESINDIVIDUALCOUNTRYDATA 0ROFAMILIAISTHE)00&AFlLIATEIN#OLOMBIA)NFORMATIONONTH x 4HISISAUSEFULTOOLTHATCANHELPPROGRAMPLANNERSPREPAREF x KWWSZZZZJQUURUJ  4HE7'.22ISANAUTONOMOUSNETWORKOFGROUPSANDINDIVIDUALSW x x -ILLIONSOFUNWANTEDPREGNANCIESANDABORTIONSCOULDBEAVOIDE )NDIVIDUALCOUNTRYDATAISAVAILABLEAT 4HISWEBSITELINKSTOADDITIONALDATARESOURCES x x x x KWWSZZZXQRUJHVDSRSXODWLRQSXEVDUFKLYHZFXZFXKWP EFFORTS BEFOUNDONTHISWEBSITE INCLUDINGLINKSTOINFORMATIONONTHE 0ROFAMILIA#OLOMBIA7EBSITE SERVICESCURRENTLYBEINGDELIVERED CONTRACEPTIVEMETHODBYASSESSINGUSERPERSPECTIVES ASWELLAS !SSESSMENTSTO"ROADEN#ONTRACEPTIVE#HOICEAND)MPROVE1UALITY 7(/-AKING$ECISIONSABOUT#ONTRACEPTIVE)NTRODUCTION!'UIDE MANYSUBJECTSTHATWILLBEUSEFULTOTHOSEADVOCATINGFORINCRE ANDSUPPORTREPRODUCTIVERIGHTSFORWOMEN4HEIRWEBSITECONTAI 7OMENS'LOBAL.ETWORKFOR2EPRODUCTIVE2IGHTS7'.22 7EBSITE FLJXLGHSGI KWWSZZZZKRLQWUHSURGXFWLYHKHDOWKSXEOLFDWLRQVUKUBBBF KWWSZZZZKRLQWPHGLFLQHVRUJDQL]DWLRQSDUHGOH[SFRPOLVW 7(/%SSENTIAL-EDICINES,IST SXEOLFDWLRQV)33BB)33BBBDEVWUDFWHQKWPO THEMAJORITYOFWOMENWHOMAYNEEDTHEM 4HISBOOKLETEXPLAINSHOWAVAILABLEMETHODSAREEFFECTIVE EASY ADVICEONHOWTOINTRODUCEEMERGENCYCONTRACEPTIONINTOFAMILY CONTRACEPTIVESWEREEASILYACCESSIBLE4HISBOOKLETPROVIDESTE 0OPULATION2EFERENCE"UREAU7EBSITE 7(/%MERGENCY#ONTRACEPTIONˆ!'UIDEFOR3ERVICE$ELIVERY KWWSZZZPHDVXUHGKVFRPFRXQWULHVVWDUWFIP -EASURE$EMOGRAPHICAND(EALTH3URVEYSWEBSITECANBEACCESSED 5NITED.ATIONS7ORLD#ONTRACEPTIVE5SE7EBSITE KWWSZZZFHFLQIRRUJKWPOUHVGRZQORDGDEOHPWUOVKWP SOMEABSTRACTSAREPROVIDED LITERATUREREGARDINGEMERGENCYCONTRACEPTIONCOMPILEDBY7(/(2 4HE)#%#SWEBSITELINKSTOTHE7(/$ATABASE2EPORTS WHICHLIS 7ORLD(EALTH/RGANIZATION7(/ $ATABASE2EPORTS KWWSZZZSURIDPLOLDRUJFR   KWWSZZZZRUOGSRSRUJGDWD¿QGHUKWP KWWSZZZZKRLQWUHSURGXFWLYHKHDOWK -EASURE    AND0OP.ET  RQWUDFHSWLYHBLQWURGXFWLRQ  ORINTRODUCTIONOFANEW ASEDACCESSTO%#0S EIRPROGRAMSANDWORKCAN IREMERGENCYCONTRACEPTION CHNICALANDMANAGERIAL QUALITYOFFAMILYPLANNING TOUSE ANDSAFEFOR NSUSEFULINFORMATIONON DIFEMERGENCY PLANNINGPROGRAMS BDSUGRF TCURRENTSCIENTIlC AT 0&ULLCITATIONSAND HOAIMTOACHIEVE KWWSZZZSUERUJ OF#ARE FOR#ONDUCTING ANDTHE